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 This thesis describes the development of methods for the stereoselective synthesis 
of protected pyrrolidines and α-alkyl-α,β-dihydroxy esters. The method for the synthesis 
of protected pyrrolidines is a palladium-catalyzed carboamination of protected γ-amino 
alkenes with aryl halides, and accomplishes the formation of both a carbon-nitrogen and 
carbon-carbon bond and up to two stereocenters in a single step with up to >20:1 
diastereoselectivity. The scope of this transformation is described in detail, along with a 
refinement of reaction conditions which improve the functional group tolerance, and 
broaden the range of substrates that can be effectively transformed. A discussion of the 
diastereoselectivity obtained in the formation of disubstituted protected pyrrolidines is 
also presented. This methodology has been applied to the stereoselective synthesis of 
antifungal and antitumor agents preussin and 3-epi-preussin, along with new preussin 
analogs that differ in their aromatic ring substitution. Studies towards the synthesis of 
pyrrolidine alkaloid anisomycin are also described. 
During the course of studies on Pd-catalyzed carboamination reactions that employ 
mild bases, we discovered a tandem directed carbopalladation/C–H bond 
functionalization that afforded cyclopentane-fused benzocyclobutene molecules. The 
scope of this new reaction is discussed along with a mechanistic hypothesis on the origin 
of these products. 




α,β-dihydroxy esters. This transformation involves a tandem Wittig rearrangement-
aldolreaction of methyl O-benzyl and methyl O-allyl glycolate esters, and was discovered 
during our work towards the synthesis of anisomycin. The reaction affords α-alkyl-α,β-
dihydroxy esters in one step with >20:1 diastereoselectivity. The scope, limitations and 




















The pyrrolidine moiety is displayed in many biologically active natural products 
and pharmaceutical agents (Figure 1).1 For example, early studies on the natural product 
preussin (I-1) revealed its antifungal properties,2 and more recent screens indicated that 
preussin (I-1) also has antitumor3 and antiviral4 activity (vide infra, Chapter V). The 
pyrrolidine alkaloid anisomycin (I-2) has also been shown to exhibit antifungal5 and 
cytotoxic6 activity (vide infra, Chapter VI), and broussonetine C (I-3), a member of the 
broussonetine family of alkaloids, 7  inhibits a variety of glycosidases.7a The drug 
Captopril (I-4a), marketed by Bristol-Myers Squibb under the trade name Capoten®, 
inhibits angiotensin converting enzyme (ACE) and is used in the treatment of 
hypertension.8 Additionally, synthetic derivatives of Captopril with substituents at C2 and 
C3 such as I-4b, have shown even greater activity in ACE inhibition assays.9 Finally, 
scientists at Schering-Plough identified pyrrolidine I-5 as one of the most potent BACE-1 
















I-4a, R = R' = H

























Figure 1. Biologically Active Pyrrolidines 
 
Due to the interesting biological activity pyrrolidines exhibit, the synthesis of this 
nitrogen heterocycle has been the subject of extensive methodology development.1,11 The 
methods developed can be divided in two general classes. The first class involves starting 
with the pyrrolidine ring from a common and inexpensive material (eg. proline) and 
functionalization of the heterocycle ring.12  A more relevant class of reactions for the 
current report involves the formation of the pyrrolidine ring (I-6) from an acyclic 
precursor (Scheme 1). The [3+2] cycloaddition of azomethine ylides 13  (I-7) with 
substituted olefins (I-8) is a powerful method to rapidly obtain highly substituted 
pyrrolidine rings. Additionally, the pyrrolidine ring can be formed via intramolecular ring 
closure of I-9 in a SN2 reaction, 14  via reductive amination 15  of I-10 or via radical 
cyclization of I-11.16 Another traditional method to effect the pyrrolidine ring formation 




using activating reagents such as I2 or Hg(OAc)2 (eq 1).1, 17 , 18  This method allows 
formation of the pyrrolidine ring with concomitant formation of a C1’ halogen bond or 
C1’ mercury bond (eq 1, R’ = X or HgX, I-13). In contrast, the carboamination chemistry 
discussed in this thesis allows for the formation of the pyrrolidine ring and a new C1’–C 
bond (eq 1, R’ = alkenyl or aryl).19 














































R' = X or HgX  
 
Palladium-Catalyzed Carboamination Reactions for the Synthesis of Pyrrolidines 
The first examples of Pd-catalyzed alkene carboamination reactions were 
discovered by Tamaru and co-workers, and involved Pd(II)-catalyzed carbonylation of γ-
aminoalkenes to afford pyrrolidines bearing C1’ ester groups (Scheme 2).20 For example, 
γ-aminoalkene I-14 underwent anti-aminocarbonylation upon treatment with catalytic 
PdCl2 and excess CuCl2 in MeOH under an atmosphere of CO to afford I-15 in moderate 




coordination to Pd(II), followed by anti-aminopalladation to provide I-17, and CO 
insertion into the C1’–Pd bond to afford acylpalladium intermediate I-18. Methanolysis 
of intermediate I-18 then affords pyrrolidine I-15. Other substrates bearing nitrogen 
nucleophiles such as sulfonamides20 and ureas20b–e were also transformed into 
pyrrolidines in a similar fashion, and this methodology has been employed in the racemic 
synthesis of natural products ferruginine and anatoxin A.22 



































Although Pd(II)-catalyzed aminocarbonylation of γ-aminoalkenes has proven 
useful for the synthesis of pyrrolidine derivatives bearing C1’ ester substituents, it is not 
without limitations. For example, synthetic manipulations would be required to convert I-
15 to alkyl, aryl, or vinyl substituted pyrrolidine derivatives. Additionally, the synthesis 
of pyrrolidines bearing multiple stereocenters around the ring has not been fully explored. 
In later work, Larock and Weinreb reported the palladium-catalyzed 1,1-
carboamination reaction of β-amino alkenes with vinyl bromides for the synthesis of 2-




tol)3 effects the coupling of I-19 with 2-bromopropene to afford product I-21 in moderate 
yield and high diastereoselectivity (eq 2). This reaction is believed to proceed via a Heck-
type reaction between I-19 and 2-bromopropene, which leads to π-allyl palladium 
intermediate I-20. Intramolecular trapping of π-allyl intermediate I-20 by the amine 
moiety affords I-21. Τhis method is effective for the preparation of various 2-vinyl 
pyrrolidines in moderate to good yield, however the stereochemical outcome of the 
reactions involving substituted amine substrates other than the example shown in eq 2 





5 mol % Pd(OAc)2














More recently, Stahl reported a palladium-catalyzed carboamination reaction 
between electron-rich alkenes or styrene derivatives with allylic sulfonamides that 
generates 2,4-disubstituted pyrrolidines.24 For example, treatment of I-22 with butyl vinyl 
ether in the presence of catalytic amounts of Pd(OAc)2, Cu(OAc)2 and catechol under an 
O2 atmosphere affords product I-23 (Scheme 3). The proposed mechanism for this 
reaction involves activation of the butyl vinyl ether by Pd(II) followed by 
aminopalladation to generate I-24. Migratory insertion followed by β-hydride elimination 
of I-25 affords I-23. Although this reaction generates pyrrolidine products in good yields, 




partner is required when styrene derivatives are used instead of butyl vinyl ether. 




5 mol % Pd(OAc)2
5 mol % Cu(OAc)2

















I-24 I-25  
 
In a seminal publication in 2004, Wolfe and Ney demonstrated the palladium(0)-
catalyzed cyclization of γ-aryl amino alkene substrates I-26 with aryl bromides to afford 
N-aryl pyrrolidines I-27 (eq 3).25,26 Regioisomeric products I-28 were also formed in 
various ratios (8:1– >100:1), and competing N-arylation of the substrate was observed 
when electron-deficient aryl bromides were employed. Interestingly, as shown in 
equation 4, yields and regioselectivity increased dramatically when the phenyl N-
substituent was replaced with an electron-withdrawing p-cyanophenyl group (I-30 




ArHN NaOtBu, Toluene, 60 oCR












I-31, Ar = Ph, 45%, 25:1 regio
I-32, Ar = p-(NC)C6H4, 86%, >100:1 regio
(3)
ArBr
ArHN NaOtBu, Toluene, 60 oC




I-29, Ar = Ph
I-30, Ar = p-(NC)C6H4  
 
The Pd-catalyzed carboamination reactions shown in eqs 3-4 are believed to 
proceed via the catalytic cycle illustrated below (Scheme 4). Oxidative addition of the 
ArBr to palladium(0) forms the palladium(II) complex I-33. Intermediate I-33 is then 
converted to the Pd-amido complex I-35 through reaction with the amine I-34 and base.27 
Intermediate I-35 then undergoes intramolecular syn-aminopalladation28 via transition 
state I-36 to produce intermediate I-37, and C–C bond forming reductive elimination 




































Regioisomer formation is believed to occur from competing β-hydride 
elimination of intermediate I-37 to afford intermediate I-39 (eq 5). Reinsertion of the Pd-
H species with inverse regiochemistry followed by β-hydride elimination/reinsertion 
































This new methodology allowed access to 2,5-cis (eq 6) and 2,3-trans (eq 7) 
disubstituted pyrrolidines in good yield and high diastereoselectivity (>20:1 dr). 
Formation of 2,4-cis disubstituted pyrrolidines was also achieved in high yield, albeit in 






































2 mol % dppe
88%,  2:1 dr
10:1 regioselectivity
N + NaOt-Bu, Toluene 
100 oC
1mol % Pd2(dba)3




















An hypothesis was developed to rationalize the observed product stereochemistry 
(Scheme 5). The formation of 2,5-cis pyrrolidines is believed to occur via transition state 
I-47, in which the α-phenyl group lies in a pseudoaxial position to avoid A(1,3)-strain with 
the N-aryl substituent.30  In the case of 2,3-trans pyrrolidines (I-52), cyclization occurs 
with the phenyl side-chain oriented in a pseudo-equatorial position. The low 
diastereoselectivity observed in the formation of 2,4-cis disubstituted pyrrolidines has 




as seen in transition states I-55 or I-57. 


































































































Evidence for the syn-aminopalladation mechanism was obtained in the reaction 




I-61. However, both the new C–N and C–C bonds were formed on the same side of the 
cyclopentane ring, indicating a syn insertion process. In addition, the side-products I-60, 
I-62 and I-63 were also isolated. 
N
1.1 equiv  ArBr
1 mol% Pd2(dba)3
























The authors considered two different mechanisms for the formation of product I-
61 from amido complex I-64: carbopalladation 31  (Scheme 6) and aminopalladation 
(Scheme 7). As shown in Scheme 6, intermediate I-65 is accessed via olefin insertion in 
the Pd–Ar bond. From intermediate I-65, an unprecedented32 palladium mediated sp3 C–
N bond forming reductive elimination could afford product I-61. However, this pathway 
cannot account for the formation of side products I-62 and I-63 (eq 9). In addition, imine 
I-66, a likely side-product resulting from β-hydride elimination of I-65 was not observed 
















































In the proposed aminopalladation mechanism shown in Scheme 7, intermediate I-
67 is produced by insertion into the Pd–N bond, and C–C bond forming reductive 
elimination29 from I-67 would afford product I-61. The observed side products I-62 and 
I-63 arise from intermediate I-68. Alkene displacement from I-68 would afford I-62. 
Alternatively, alkene reinsertion into the Pd–H bond of I-68 with inverse regioselectivity 
affords I-69, and C–C bond reductive elimination would afford product I-63. 
 










































In 2005, Wolfe and Ney further investigated the reaction mechanism for the 
formation of products I-61, I-62 and I-63.33 Since the formation of each product is linked 
to the relative rate of a particular step in the aminopalladation pathway, they 
hypothesized that modifying the catalyst should have an effect on product distribution. 
Indeed, it was found that the phosphine ligand properties had a dramatic influence on the 
product outcome. They demonstrated that each product could be favored with choice of 
an appropriate ligand (eq 10). For example, N-arylation product I-70 was selectively 
formed when bulky, electron rich phosphine ligand t-Bu2P(o-biphenyl) was used.27a,34 
Use of a small and electron rich ligand PMe3•HBF4 permitted selective access to product 
I-72.35 Product I-73 was produced in good yield with the use of a medium-sized electron 
rich ligand that favored β-hydride elimination to I-67 followed by C–C reductive 
elimination. Product I-71 was more difficult to obtain because the necessary chelating 
ligand favoring C–C bond reductive elimination of I-67 was also effecting C–N bond-
forming reductive elimination of I-64 (Scheme 7).  Better results were obtained when an 
electron-deficient nitrogen substituent was used to reduce the amount of N-arylation side-
product (Ar = C6H4p-CO2t-Bu). Overall, the ligand effects observed are consistent with 
the proposed mechanism. This transformation is synthetically useful as four different 







































Concurrent with the Wolfe group’s studies on pyrrolidine synthesis, a copper 
mediated intramolecular carboamination of N-tosylsulfonyl γ-aminoalkene substrates I-
74 was developed by Chemler and co-workers (eq 11).36 The proposed mechanism for 
this transformation involves syn-aminocupration (I-75) followed by C–C bond formation 
via an intramolecular cyclization of a primary alkyl radical onto the proximal aromatic 
ring. 37  The mechanistic proposal is based on the diastereoselectivity obtained in 
comparison with the Pd-catalyzed carboamination chemistry, and was confirmed through 
deuterium-labeling experiments. Although this method is useful for the preparation of 
compounds such as I-76, release of the pyrrolidine product requires an additional 
chemical step to cleave the N–S bond. Also, modification of the aromatic ring electronic 
or steric properties leads to reduced yields of the desired pyrrolidine products due to 





















Proposed Palladium-Catalyzed Carboamination Reactions of Protected γ-Amino 
Alkenes 
 
The palladium-catalyzed carboamination reactions of γ-(N-arylamino)alkenes are 
useful for the stereoselective preparation of various N-aryl pyrrolidines. However there 
are three main limitations that restricted the synthetic utility of this chemistry. First, 
deprotection of the N-aryl pyrrolidine would be necessary for further chemical 
modification of the nitrogen atom,38 but N-aryl groups are difficult to cleave. Second, the 
scope of the aryl bromide coupling partner was limited to electron-rich and electron-
neutral aryl bromides unless substrates bearing electron-poor N-aryl groups were 
employed. Finally, various amounts of pyrrolidine regioisomers were formed which were 
generally not separable by flash chromatography. 
We hypothesized that one solution could potentially solve these three main 
limitations: use of carbamate or amide nitrogen protecting groups (eq 12). These 
protecting groups could be readily removed from the pyrrolidine products,39 and the 
electron-withdrawing nature should help to minimize competing N-arylation 
and regioisomer formation. 
N
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I-77, R = Me










much less nucleophilic which should slow down C–N bond forming reductive 
elimination.35b,40 This effect is well documented in Pd-catalyzed N-arylation chemistry,34 
and has been previously observed in the N-aryl pyrrolidine synthesis; a higher yield of I-
32 was obtained when a benzonitrile substituent was present on nitrogen (eq 4).  
The electron-withdrawing group on nitrogen should also suppress the β-hydride 
elimination process that would take place from I-80, thus reducing the amount of 
regioisomer. This hypothesis was also demonstrated in the N-aryl pyrrolidine synthesis 
when a benzonitrile substituent on nitrogen significantly decreased the amount of 
regioisomer observed (eq 4). Moreover, since a partial positive charge develops at the 
reactive carbon during the β-hydride elimination process,41 it is likely that this process 
would be disfavored by an electron-deficient nitrogen. Finally, it was believed that 
carbonyl chelation with the palladium catalyst (I-80) could also disfavor competing β-
hydride elimination,42 which requires an open coordination site on the metal and a co-
planar relationship between the β-hydrogen atom and the metal. 43  In the event that 
carbonyl chelation occurred, a coordination site would be occupied and the chelation 
could prevent the required spacial arrangement for β-hydride elimination to occur. 
When we set out to investigate the use of other nitrogen substituents, we were 
aware of the potential challenges of this proposal (Scheme 8). As a first step in the 
catalytic cycle, formation of Pd-amido complex I-79 is required. In the event that this 
step is slow, a competing Heck arylation of the starting material (I-77 or I-78) would 
afford I-82.31 However, Pd-amido complex formation (I-79) should occur as the 




complex. Furthermore, N-arylation of amides and carbamates, presumably occurring via 
Pd-amido complexes similar to I-79, is precedented in similar systems.34 A fast olefin 
insertion process would then be necessary to avoid N-arylation (I-83) and/or Heck-type 
(I-82) side-reactions from I-79. At the time of our study, the effects of nitrogen 
electronics on the olefin insertion in the Pd-N bond were unknown. Finally, carbonyl 
group chelation (I-80) would disfavor C-C reductive elimination; dissociation of a ligand 
would be required for the event to occur.44 Despite these challenges, we were optimistic 
that the reaction proposed in equation 12 was feasible, and that suitable catalysts and 
conditions could be discovered that would facilitate the formation of I-81. 
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The chapters that follow describe our efforts to develop conditions appropriate for 
the carboamination reactions of protected γ-amino alkenes, the scope and limitations of 
the method, its application towards the synthesis of the natural product preussin and 
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Carboamination of Protected γ-Amino Alkenes with Aryl Bromides1 
In our studies of alkene carboamination, we explored the reactions of various N-
substituted γ-amino alkenes with aryl and vinyl bromides.2 We chose to employ amides 
and carbamates as nitrogen protecting groups due to their ease of preparation, handling, 
and cleavage from the pyrrolidine products. Aryl and vinyl bromides were chosen as 
coupling partners due to their widespread availability from commercial sources. This 
chapter describes the synthesis of starting materials and development of reaction 
conditions for the carboamination. This chapter also outlines the scope, limitations, and 
diastereoselectivity of the method. 
Substrate Synthesis 
 The protected γ-amino alkene substrates employed in the carboamination 
reactions described in this and the following chapters were prepared in 1–5 steps from 
commercial materials by one of several methods (Scheme 9). Substrates II-5–II-8 were 
prepared starting from carboxylic acids II-1 or II-2.3 Treatment of the acids with (COCl)2 
followed by NH4OH provided primary pent-4-enoyl amides II-34 and II-4. Reduction of 
the amides with lithium aluminum hydride followed by treatment of the primary amine 
with Boc2O, Ac2O, BzCl or CDI/ArCO2H afforded the protected substrates II-5–II-8 and 




convert cyclopent-2-enyl-acetic acid (II-12) to protected substrates II-14 and II-15 (eq 
15). As shown in equation 16, the N-protected allylaniline substrates II-175 and II-186 
were prepared via benzyl7 or Boc protection of 2-allylaniline (II-16).8 Substrates II-21 
and II-22 bearing a phenyl substituent at the 1-position were obtained via a two-step 
reductive amination of known ketone II-19,9  followed by protection of the resulting 
primary amine II-20 (eq 17). Finally, substrate II-23 bearing an allyl substituent at the 2-
position was obtained via alkylation of acetonitrile with allyl bromide, reduction of the 
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II-3, R = H 
II-4, R = Me
II-5, R = H, Pg = Boc
II-6, R = H, Pg = Ac
II-7, R = Me, Pg = Boc
II-8, R = Me, Pg = Ac
II-9 II-10, R = CF3
II-11, R = OMe
R
II-17, Pg = Boc




II-21, Pg = Boc







2) Boc2O or 
Ac2O
NHPg (15)
II-14, Pg = Boc






In order to investigate the formation of N-protected pyrrolidines via the Pd-




palladium-catalyzed reaction of N-(4-pentenyl)acetamide II-6 (Table 1). Since the nature 
of the ligand had an important effect in the reaction of γ-(N-arylamino)alkenes with aryl 
bromides, 10  we first performed a ligand screen. Substrate II-6 was treated with 2-
bromonaphthalene (1.2 equiv) and NaOt-Bu (2 equiv) in the presence of catalytic amount 
of Pd2(dba)3 (1 mol %) and various ligands (2–4 mol %). The reactions were heated to 
110 oC for 9h, then quenched, and assayed by GC. Use of dppb as ligand, which had been 
employed in related carboamination reactions of γ-(N-arylamino)alkenes, resulted in only 
61% conversion to 1-(2-naphthalen-2-ylmethylpyrrolidin-1-yl)ethanone (II-24) (Table 1, 
entry 1). A side-product11 (II-25) resulting from a Heck arylation was observed in this 
reaction, and was the major side product generated in all reactions of II-6 that were 
conducted. The best results were obtained with Dpe-phos as the ligand; a 96% conversion 
was observed with a 85:15 GC ratio of II-24 to II-25. In general, the use of a rigid 
bidentate ligand provided higher yields than monodentate ligands. Additional studies 
described below have indicated that the optimal ligand for these transformations varies 












2 mol % Ligand
NaOt-Bu, toluene
110 oC, 9 h
Ar = 2-naphthyl
+
Ligand % Conversion II-24 II-25 Othera
59 34 6 19
P(o-tol)3b,c 35 9 23 3
dppb 61 53 8 -
dppf 91 76 10 5
Xantphos 95 84 7 4












aSmall amounts of other side-products including regioisomers of II-25 and N-arylated compounds were 
also formed. bThe reaction was conducted for 20 h. cThe amount of monodentate ligand used was 4 mol %. 
 
Next, we investigated the effect of N-protecting groups with the newly found 
optimized reaction conditions. Various N-protected γ-amino alkene derivatives were 
treated with 2-bromonaphthalene (1.2 equiv) in the presence of NaOt-Bu (2 equiv) and a 
catalytic amount of Pd2(dba)3/Dpe-phos (2 mol % Pd, 4 mol % ligand) (Table 2). These 
reactions afforded the desired pyrrolidine II-26 along with Heck-type product II-28 and 
N-arylation side-product II-27. It was found that the nitrogen electronics had a large 
impact on the product distribution. In most cases, as the electron-withdrawing ability of 
the protecting group increased, the amount of N-arylation decreased but the amount of 
Heck olefination increased. For example, the reaction of N-phenyl bearing substrate (II-




31 provided a 58:42 ratio of II-26:II-27; the formation of II-28 was not observed. The 
best results were obtained with N-acyl and N-Boc substituted substrates II-6 and II-5, 
which were converted to the desired pyrrolidines in good yield.  In the reactions of benzyl 
(II-29) and N-(p-trifluoromethylbenzoyl) (II-10) substituted substrates, none of the 
desired pyrrolidines were observed. 
The effect of other reaction parameters such as solvent and base was also 
investigated. In most cases, use of weak bases lead to formation of large amounts of Heck 
arylation side-products. However, this problem was eventually solved, and studies on the 
use of weak bases in these reactions are described in Chapter III. The solvent toluene was 
found to be optimal although ethereal solvents such as DME and dioxane proved 
satifactory in many instances. Use of THF as solvent in reactions of Boc-protected 




















Ar1 mol %. Pd2(dba)3
2 mol % Dpe-phos
NaOt-Bu, toluene
110 oC, 9 h
Ar = 2-naphthyl
+
N-Substituent II-26 II-27 II-28
- 40b 34
R = Ph (II-30) 75 (63%)c-e - 25
R = Aca (II-6) 88 (72%) 12 -
R = Boca (II-5) 82 (77%) 4b -
R = 4-MeO-Bz (II-11) 77 (63%) 23 -
R = Bz (II-31) 58 (48%) 42 -
II-27
II-28
R = 4-F3C-Bza (II-10) - 89b -











aOther minor, unidentified side-products were also observed. bMixtures of alkene regioisomers were 
obtained. cGC yield. dThis product was obtained as a 15:1 mixture of regioisomers. eUse of dppb as ligand 
provided a 94% isolated yield of II-26 as a 25:1 mixture of regioisomers. See ref. 10. 
 
Scope and Diastereoselectivity 
As shown in Table 3, reactions of N-Boc and N-acyl protected substrates II-5 and 
II-6 with electron poor and electron-neutral aryl bromide coupling partners afforded good 
yields of the pyrrolidine products. Use of an electron-rich aryl bromide afforded a 
moderate yield of II-38, and partial oxidation of the N-acyl pyrrolidine product to the 
corresponding 2,3-dihydropyrrole occurred under the reaction conditions. 14  A single 
product regioisomer was observed in all cases examined. The major side-products 
observed in the reactions of II-5 and II-6 resulted from Heck arylation and/or N-arylation 
of the substrate. The competing Heck arylation was more problematic in the reactions of 




   Most transformations are efficiently catalyzed by mixtures of Pd2(dba)3 and Dpe-
phos. However, use of dppe as ligand provided higher yields for some substrate 
combinations by minimizing competing N-arylation or N-vinylation processes (Table 3, 
entries 4 and 6).15 The reaction of the electron-rich N,N-dimethyl-4-bromoaniline was 
most efficiently catalyzed by a mixture of Pd2(dba)3 and Xantphos (entry 7).  
   The results obtained in the reactions of II-5 and II-6 described above contrast 
with related transformations of N-phenyl substituted substrate II-30. For example, the Pd-
catalyzed reaction of II-6 with 4-bromobenzophenone proceeded in 78% isolated yield 
(entry 6), whereas the analogous reaction of II-30 provided only a modest 45% yield.10 
Additionally, the Pd2(dba)3/Dpe-phos catalyzed reaction of II-5 with β−bromostyrene 
proceeded in low yield due to competing N-vinylation, 16 , 17  but the Pd(OAc)2/dppe 
catalyzed reaction of II-5 with this vinyl bromide afforded the desired product in 75% 
isolated yield (entry 4).  
   The synthesis of N-protected indolines from N-allylaniline derivatives was also 
briefly examined (Table 3, entries 8–9). Treatment of N-Boc-2-allylaniline (II-17) with 
2-bromonaphthalene under the optimized reaction conditions afforded a 50% yield of the 
desired indoline product II-39. The moderate yield in this transformation was mainly due 
to competing base-induced cleavage of the Boc-group from the substrate12 and/or base-
induced olefin isomerization of the substrate.18 In contrast to the reactions of N-benzyl 
protected aliphatic amine substrates, which did not generate significant amounts of the 
desired pyrrolidine products, N-benzyl-2-allylaniline (II-18) was converted to the N-
benzyl-2-benzylindoline II-40 in 48% yield. The major side product obtained in this 




oxidative amination of the substrate (see Mechanistic Considerations Chapter III). 19 
Attempts to transform N-acyl-2-allylaniline to the corresponding indoline were 




Table 3. Synthesis of N-Protected Pyrrolidines and Indolinesa 





























































































aConditions: 1.0 equiv substrate, 1.1–1.2 equiv ArBr, 1.2–2.0 equiv NaOt-Bu, 2 mol % Pd (1 mol % 
Pd2(dba)3 or 2 mol % Pd(OAc)2), 2–4 mol % ligand, toluene (0.25 M), 105 oC. bThe reaction was conducted 





The stereoselective synthesis of disubstituted pyrrolidines bearing N-Boc or N-
acyl groups was achieved via Pd-catalyzed carboamination of substrates II-7, II-8, II-14, 
II-15, II-21, II-22 and II-23 bearing substituents on the tether between the alkene and the 
nitrogen (Table 4). Comparable diastereoselectivities were obtained with both N-acyl and 
N-Boc protected substrates, and the nature of the aryl bromide did not have a large effect 
on diastereoselectivity in the transformations examined. The synthesis of trans-2,3-
disubstituted pyrrolidines (entries 4–6) and cis-2,5-disubstituted pyrrolidines (entries 1–
2) was effected in good yield with good levels of diastereoselectivity. Proton NMR 
analysis of the crude reaction mixtures revealed diastereomer ratios of 10–20:1; the minor 
diastereomer was usually readily separated by chromatography to provide isolated 
products with >20:1 dr. 20  In contrast, the reaction of II-23 with tert-butyl-(4-
bromo)benzoate afforded a 2,4-disubstituted pyrrolidine product in 72% yield, but with 
only modest (c.a. 3:1) diastereoselectivity (entry 3). The reactions of II-7, II-8, II-14, II-
15, II-21, II-22 and II-23 proceed with similar diastereoselectivities and significantly 
higher regioselectivities than transformations of the analogous N-aryl substituted 
substrates discussed in Chapter I.10  
   The yields obtained in reactions of substrates bearing substituents at the 1- or 3-
position were slightly lower than yields obtained in reactions of unsubstituted substrates. 
The diminished yields are due in part to competing base-induced cleavage of the Boc 
group from the more hindered substrates.12 The rate of Boc cleavage is relatively rapid in 
THF at 65 °C and toluene at 110 °C, whereas little or no cleavage occurs in toluene at 65 




or C3 increases. The Heck-arylation side-products formed in reactions of N-acylated 
substrates were more difficult to separate from the desired product than the side-products 
obtained in analogous reactions of Boc-protected substrates, which also led to slightly 
diminished yields. 
   The transformations of substrates II-14 and II-15 bearing internal cyclic alkenes 
proceeded in moderate yield with excellent regioselectivity and diastereoselectivity 
(>20:1) to afford products II-47 and II-48 (entries 7–8). In both reactions the observed 
diastereomer derives from syn addition of the nitrogen and the aryl group across the 
double bond.20 The yields and regioselectivities in these transformations sharply contrast 
with those obtained in the reaction of the analogous N-(4-methoxyphenyl)-substituted 
substrate discussed in Chapter I, which afforded a mixture of two regioisomeric products 
along with an N-arylated side product and a side product derived from oxidative 




Table 4. Stereoselective Synthesis of N-Protected Pyrrolidinesa 



































































































aConditions: 1.0 equiv substrate, 1.1–1.2 equiv ArBr, 1.2–2.0 equiv NaOt-Bu, 2 mol % Pd(1 mol % 
Pd2(dba)3 or 2 mol % Pd(OAc)2), 2–4 mol % ligand, toluene (0.25 M), 105 oC. bDiastereomeric ratios for 
the isolated product upon which the yield is based. Diastereomeric ratios observed in crude reaction 
mixture are shown in parentheses. cThe Pd2(dba)3/dppb catalyst system was used for this example. dThe 
Pd2(dba)3/Dpe-phos catalyst was used for this example. eThe Pd(OAc)2/Dpe-phos catalyst system was used 
for this example. fThe reaction was conducted at 65 oC. gThe Pd(OAc)2/Nixant-phos catalyst system was 
used for this example. hThe reaction was conducted using 2.5 mol % Pd2(dba)3 and 5 mol % Nixantphos. 




Cyclization of N-protected internal alkene substrates would fully maximize the 
potential of the carboamination reaction since two new stereocenters would be formed in 
a single operation (eq 19). Preliminary studies indicated that higher catalyst loading was 
required to promote the conversion of substrate II-49 to product II-50.22,23 The desired 
pyrrolidine (II-50) was isolated in 27% yield as a single diastereoisomer; the main side-
product observed resulted from N-arylation of the starting material. A ligand screen 
revealed (S)-Phane-phos to be a superior ligand for this reaction, and pyrrolidine II-50 
was isolated in 57% yield and 33% ee. Although the yield of the carboamination reaction 
was increased, the large amounts of palladium catalyst and expensive chiral ligand 
required limited the utility of this transformation.24 A more practical solution to this 
















   
Mechanistic Considerations 
The proposed catalytic cycle for this transformation is analogous to that 
previously proposed for reactions of γ–(N-arylamino)alkene substrates (Scheme 4, 
Chapter I).25 As shown below (Scheme 10), the catalytic cycle presumably commences 
with oxidative addition of the aryl bromide to the Pd(0) catalyst to afford Pd(Ar)(Br) 
complex II-51. Reaction of this complex with the γ−aminoalkene substrate (II-52) in the 




53,15 which undergoes insertion of the alkene into the Pd–N bond25,26 followed by C–C 
bond-forming reductive elimination27 of the resulting intermediate II-54 to afford the 
observed pyrrolidine II-55. The formation of products that result from syn addition of the 
aryl group and the nitrogen across the C–C double bond (Table 4, entries 7–8) is 
consistent with this mechanistic proposal. The increased yields obtained in reactions of 
N-Boc and N-acyl protected amines with electron-deficient aryl bromides and vinyl 
bromides compared to N-aryl amines is likely due to the fact that C–N bond-forming 
reductive elimination of intermediate II-53 slows as the nucleophilicity of the amine, 
amide, or carbamate decreases.28 This mechanism also accounts for the formation of N-
benzyl-2-methylindole as a side product in the reaction of N-benzyl-2-allylaniline (Table 
3, entry 9). As shown in Scheme 11, the N-benzyl-2-methylindole II-58 likely derives 
from competing β−hydride elimination of intermediate II-56 followed by double bond 
isomerization.19a Further discussions on the mechanism and diastereoselectivity of the 











































BocII-56 II-57 II-58  
  
Conclusion  
   In conclusion, the synthesis of N-Boc and N-acyl pyrrolidine derivatives via 
reactions of N-protected γ−aminoalkenes is achieved in good yield with excellent 
regioselectivity and diastereoselectivities of up to >20:1 dr. In contrast to related 
transformations of γ−(N-arylamino)alkenes, reactions of N-boc or N-acyl protected 
substrates with vinyl bromides or electron-deficient aryl bromides proceed in good yield 




be readily cleaved from the products, which allows for potential access to a broad variety 
of pyrrolidine derivatives. Further efforts to expand the scope of these transformations 




   General Considerations. All reactions were carried out under an argon or 
nitrogen atmosphere in oven or flame dried glassware. Palladium acetate, 
tris(dibenzylideneacetone)dipalladium (0), and all phosphine ligands were purchased 
from Strem Chemical Co. and used without further purification. Acetic anhydride, di-tert-
butyldicarbonate, cyclopent-2-enyl-acetic acid, and all aryl bromides were obtained from 
commercial sources (Aldrich Chemical CO or Acros Chemical CO) and were used as 
without purification. Pent-4-enylphenylamine (II-30),10 N-benzyl-4-pentenylamine (II-
29),29 N-(pent-4-enyl-benzamide) (II-31),30 and 2-allylaniline8 were prepared according 
to published procedures. Toluene and THF were purified using a GlassContour solvent 
purification system. Product regiochemistry was assigned on the basis of 1H NMR 2-D 
COSY experiments; stereochemistry was assigned on the basis of 1H NMR nOe 
experiments. Ratios of regioisomers and/or diastereomers were determined by either 1H 
NMR or capillary GC analysis of crude reaction mixtures. Yields refer to isolated yields 
of compounds estimated to be ≥95% pure as determined by 1H NMR, and either capillary 
GC (known compounds) or combustion analysis (new compounds). The yields reported 




reported in Tables 3–4 are average yields of two or more experiments. Thus, the yields 
reported in the experimental section may differ from those shown in Tables 3–4. 
 
Synthesis of N-Protected γ-Aminoalkenes 
 N-Pent-4-enyl-acetamide (II-6).31 A flame-dried flask was cooled under a stream of 
nitrogen and charged with 4-pentenoic acid (5.7 mL, 49.8 mmol). The flask was purged 
with nitrogen, benzene (100 mL) was added and the resulting solution was cooled to c.a. 
10 °C using an ice water bath. Oxalyl chloride (8.7 mL, 100 mmol) was added dropwise 
via syringe to the solution and the resulting mixture was warmed to rt, stirred for 1h, and 
then concentrated in vacuo. The crude 4-pentenoyl chloride was dissolved in THF (100 
mL), and slowly added to a separate flask containing aqueous ammonium hydroxide (100 
mL) at 0 °C. The resulting mixture was stirred for 6 h and then concentrated in vacuo. 
The mixture was diluted with H2O (50 mL) and ethyl acetate (100 mL), the layers were 
separated and the aqueous layer was extracted with ethyl acetate (2 x 100 mL). The 
combined organic extracts were dried over anhydrous sodium sulfate, filtered, and 
concentrated in vacuo to afford 3.86 g (77%) of 4-pentenamide4 as a white solid, m.p. 
104–106 °C (lit. m.p. 106 °C)4 that was used without further purification. 
   A flame-dried round-bottom flask was cooled under a stream of nitrogen and 
charged with 4-pentenamide (3.30 g, 33.3 mmol). The flask was purged with nitrogen, 
THF (100 mL) was added via syringe and the resulting solution was cooled to 0 °C. A 
solution of LiAlH4 in THF (100 mL, 100 mmol, 1.0 M) was added dropwise via syringe. 
The reaction mixture was warmed to rt and stirred for 36 h, then was cooled to 0 °C, 




NaOH (30 mL, 10 M) was added and an insoluble white material precipitated. The 
organic supernatant was decanted to a clean Erlenmeyer flask and the precipitate was 
washed with ether (100 mL). The combined organic extracts were dried over anhydrous 
sodium sulfate and filtered to afford a solution of 4-pentenylamine32 in diethyl ether (c.a. 
0.1 M), which was used without further purification. 
   A flame-dried round-bottom flask was cooled under a stream of nitrogen and 
charged with a solution of 4-pentenylamine in diethyl ether (165 mL, 16.5 mmol, 0.1 M). 
The solution was cooled to 0 °C and acetic anhydride (4.7 mL, 5.10 g, 50 mmol) was 
added via syringe.  The resulting mixture was stirred for 5 h and then aqueous NaOH 
(100 mL, 1.0 M) was added. The biphasic mixture was vigorously stirred for 12 h and 
then the layers were separated. The aqueous layer was extracted with ethyl acetate (3 x 75 
mL). The combined organic extracts were dried over anhydrous sodium sulfate, filtered, 
and concentrated in vacuo. The crude product was then purified by flash chromatography 
on silica gel to afford 1.36 g (65%) of the title compound as a colorless oil. 1H NMR (400 
MHz, CDCl3) δ 5.86–5.57 (m, 2 H), 5.07–4.93 (m, 2 H), 3.25 (q, J = 6.0 Hz, 2 H), 2.12–
2.02 (m, J = 5.8 Hz, 2 H), 1.95 (s, 3 H), 1.59 (p, J = 7.7 Hz, 2 H).  
    
 Pent-4-enyl-carbamic acid tert-butyl ester (II-5).33 A flame-dried round bottom flask 
was cooled under a stream of nitrogen and charged with a solution of 4-pentenylamine 
(165 mL, 16.5 mmol, 0.1 M). Di-tert-butyl dicarbonate (5.4 g, 25 mmol) was added to the 




1.0 M) was added. The biphasic mixture was vigorously stirred for 12 h and then the 
layers were separated. The aqueous layer was extracted with ethyl acetate (3 x 75 mL). 
The combined organic extracts were dried over anhydrous sodium sulfate, filtered, and 
concentrated in vacuo.  The crude product was then purified by flash chromatography on 
silica gel to afford 2.05 g (67%) of the title compound as a colorless oil. 1H NMR (500 
MHz, CDCl3) δ 5.80–5.70 (m, 1 H), 5.01–4.90 (m, 2 H), 4.54 (s, br, 1 H), 3.13–2.98 (m, 
2 H), 2.03 (q, J = 6.6 Hz, 2 H), 1.52 (p, J = 6.6 Hz, 2 H), 1.39 (s, 9 H). 
    
   N-(pent-4-enyl)-4-methoxybenzamide (II-11).30 An oven-dried round-bottom 
flask was charged with 1,1'-carbonyldiimidazole (486 mg, 3.0 mmol) and then purged 
with argon.  THF (15 mL) and 4-methoxybenzoic acid (456 mg, 3.0 mmol) were added to 
the flask, and the resulting mixture was stirred at room temperature for 1 h. A solution of 
4-pentenylamine in ether (30 mL, 3.0 mmol, 0.1 M) was then added via syringe and the 
mixture was stirred at room temperature for 4 h. The reaction mixture was then diluted 
with ethyl acetate (15 mL) and H2O (15 mL), the layers were separated, and the aqueous 
layer was extracted with ethyl acetate (3 x 40 mL). The combined organic extracts were 
washed with saturated aqueous NaHCO3 (50 mL), dried over anhydrous sodium sulfate, 
filtered, and concentrated in vacuo to afford 438 mg (67%) of the title compound as a 
white solid, m.p. 42–44 °C (lit m.p not reported). 1H NMR (400 MHz, CDCl3) δ 7.68 (d, 
J = 8.8 Hz, 2 H), 6.87 (d, J = 8.8 Hz, 2 H), 6.10 (br s, 1 H), 5.85–5.75 (m, 1 H), 5.05–




= 7.7 Hz, 2 H). 
 
   N-Pent-4-enyl-4-trifluoromethyl benzamide (II-10). Treatment of 570 mg (3.0 
mmol) of 4-(trifluoromethyl)benzoic acid with a solution of 4-pentenylamine in ether (30 
mL, 3.0 mmol) using a procedure analogous to that described above in the synthesis of 
II-11 afforded 475 mg (63%) of the title compound as a white solid m.p. 69–71 °C. 1H 
NMR (500 MHz, CDCl3) δ 7.80 (d, J = 8.1 Hz, 2 H), 7.60 (d, J = 8.1 Hz, 2 H), 6.60 (s, 
br, 1 H), 5.83–5.70 (m, 1 H), 5.05–4.90 (m, 2 H), 3.45–3.36 (m, 2 H), 2.15–2.05 (m, 2 
H), 1.73–1.62 (m, 2 H); 13C NMR (125 MHz, CDCl3) δ 166.5, 138.2, 137.8, 133.2 (q, J = 
41 Hz), 127.5, 125.7, 123.8 (q, J = 340 Hz), 115.6, 40.0, 31.4, 28.8;  IR (film) 3309, 
2930, 1638, 1550 cm-1. Anal calcd for C13H14F3NO2: C, 60.70; H, 5.49; N, 5.44. Found: 
C, 60.97; H, 5.46; N, 5.40. 
 
   (2-Allylphenyl)carbamic acid tert-butyl ester (II-17).5 Treatment of 904 mg 
(6.8 mmol) of 2-allylaniline8 with 2.2 g (10.2 mmol) of di-tert-butyldicarbonate using a 
procedure analogous to that described above in the synthesis of II-5 (with THF used in 
place of diethyl ether as solvent) afforded 1.11 g (70 %) of the title compound as a 
colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.75 (d, J = 7.7 Hz, 1 H), 7.20 (t, J = 8.4 Hz, 
1 H), 7.11 (d, J = 7.7 Hz, 1 H), 7.02 (t, J = 7.3 Hz, 1 H), 6.41 (s, br, 1 H), 5.97–5.88 (m, 1 





   (1-Phenylpent-4-enyl)carbamic acid tert-butyl ester (II-21). A flame-dried 
round bottom flask was cooled under a stream of argon and charged with 1-phenylpent-4-
en-1-one9 (11.0g, 69.0 mmol), activated 3 Å molecular sieves (10.0 g), and methanol 
(200 mL). The mixture was stirred at rt for 5 min and then ammonium acetate (53 g, 690 
mmol) and sodium cyanoborohydride (4.3 g, 69 mmol)  were added. The flask was 
purged with argon and then stirred at rt for 19 h. Ether (500 mL) was added, the mixture 
was decanted, and the organic phase was washed with 200 mL of aqueous NaHCO3. The 
layers were separated, the aqueous phase was extracted with ether (1 x 100 mL), and the 
combined organic layers were extracted with 1 M HCl (3 x 100 mL). The organic phase 
was discarded and the combined acidic aqueous extracts were basicified to pH 10 with 
10M NaOH and extracted with ether (3 x 100 mL). The combined organic extracts were 
diluted with hexanes (100 mL), dried over anhydrous sodium sulfate, filtered, and 
concentrated in vacuo. The crude product was purified by flash chromatography on silica 
gel to afford 2.1 g (19%) of 1-phenyl-pent-4-enylamine34 as a yellow oil. 1H NMR (400 
MHz, CDCl3) 7.36–7.29 (m, 4 H), 7.27–7.21 (m, 1 H), 5.87–5.76 (m, 1 H), 5.05–4.94 (m, 
2 H), 3.92–3.87 (m, 1 H), 2.14–1.96 (m, 2 H), 1.84–1.70 (m, 2 H), 1.52 (s, 2 H).  
   Treatment of 1.51 g (9.4 mmol) of 1-phenylpent-4-enylamine with 2.62 g (12.0 
mmol) of di-tert-butyl dicarbonate using a procedure analogous to that described above in 
the synthesis of II-5 provided 2.26 g (92%) of the title compound as a white solid m.p. 
76-78 °C. 1H NMR (500 MHz, CDCl3) δ 7.33–7.16 (m, 5 H), 5.83–5.70 (m, 1 H), 5.02–




1.71 (m, 2 H), 1.38 (s, 9 H); 13C NMR (125 MHz, CDCl3) δ 155.4, 143.0, 137.8, 128.8, 
127.4, 126.6, 115.4, 79.6, 54.7, 36.2, 30.6, 28.6;  IR (film) 3370, 2978, 1687, 1519 cm-1. 
Anal calcd for C16H23NO2: C, 73.53; H, 8.87; N, 5.36. Found: C, 73.41; H, 8.78; N, 5.32. 
 
   N-(1-Phenylpent-4-enyl)-acetamide (II-22). Treatment of 517 mg (3.21 mmol) 
of 4-pentenylamine with 0.8 mL (8.03 mmol) of acetic anhydride using a procedure 
analogous to that described above in the synthesis of II-6 provided 530 mg (81%) of the 
title compound as a white solid, m.p. 44–46 °C. 1H NMR (500 MHz, CDCl3) δ 7.31–7.16 
(m, 5 H), 6.25 (d, J = 8.1 Hz, 1 H), 5.80–5.70 (m, 1 H), 4.97–4.90 (m, 3 H), 2.09–1.92 
(m, 2 H), 1.90 (s, 3 H), 1.88–1.73 (m, 2 H); 13C NMR (125 MHz, CDCl3) δ 169.6, 142.4, 
137.8, 128.8, 127.5, 126.8, 115.4, 53.3, 35.5, 30.6, 23.5 IR (film) 3279, 2934, 1646, 1549 
cm-1. MS (ESI) 226.1206 (226.1208 calcd for C13H17NO, M + Na+). 
 
   1-Allylbut-3-enyl-carbamic acid tert-butyl ester (II-23).  A flame-dried round 
bottom flask was cooled under a stream of nitrogen and charged with diisopropylamine 
(8.4 mL, 60 mmol) and THF (100 mL). The flask was cooled to –78 °C and a solution of 
n-butyllithium in hexanes (22 mL, 55 mmol, 2.5 M) was added dropwise. The mixture 
was stirred at –78 °C for 1 h and then acetonitrile (2.6 mL, 50 mmol) was added 
dropwise. The mixture was warmed to rt and stirred for 3 h, then allyl bromide (4.8 mL, 
55 mmol) was added dropwise. The mixture was stirred for 1 h, then a solution of 




with ether (3 x 150 mL), dried over anhydrous sodium sulfate, filtered, and concentrated 
in vacuo to afford a mixture of 4-cyano-1-butene, 4-cyano-4-allyl-1-butene, and 4-cyano-
4,4-diallyl-1-butene (c.a. 50 mmol) that was used without further purification. 
   A flame-dried round-bottom flask was cooled under a stream of nitrogen and 
charged with a mixture of 4-cyano-1-butene, 4-cyano-4-allyl-1-butene, and 4-cyano-4,4-
diallyl-1-butene (c.a. 50 mmol) The flask was purged with nitrogen, ether (200 mL) was 
added via syringe and the resulting solution was cooled to 0 °C. A solution of LiAlH4 in 
ether (150 mL, 150 mmol, 1.0 M) was added dropwise via syringe. The reaction mixture 
was warmed to rt and stirred for 12 h, then was cooled to 0 °C, quenched with H2O (30 
mL), and diluted with ether (150 mL). An aqueous solution of NaOH (80 mL, 10 M) was 
added and an insoluble white material precipitated. The organic supernatant was decanted 
to a clean Erlenmeyer flask and the solution was dried over anhydrous sodium sulfate and 
filtered to afford a mixture of 4-pentenylamine, 3-allyl-4-pentenylamine, and 3,3-diallyl-
4-pentenylamine as a solution in diethyl ether (550 mL, c.a. 0.1 M). This mixture was 
used without further purification. 
   A solution containing a mixture of 4-pentenylamine, 3-allyl-4-pentenylamine, and 
3,3-diallyl-4-pentenylamine in ether (100 mL, 10 mmol, 0.1 M) was treated with 2.62 g 
(12 mmol) of di-tert-butyl dicarbonate using a procedure analogous to that described 
above in the synthesis of II-5. The three products were separated by flash 
chromatography on silica gel to afford 675 mg (30%) of II-23 as a pale yellow oil. 1H 
NMR (500 MHz, CDCl3) δ 5.80–5.67 (m, 2H), 5.04–4.96 (m, 4 H), 4.52 (s, br, 1 H), 3.03 




MHz, CDCl3) δ 156.2, 136.5, 116.8, 79.9, 43.7, 38.3, 36.2, 28.6;  IR (film) 3351; 2978, 
1694, 1515 cm-1. Anal calcd for C13H23NO2: C, 69.29; H, 10.29; N, 6.22. Found: C, 
69.27; H, 10.26; N, 6.22. 
 
   (3-Methylpent-4-enyl)-carbamic acid tert-butyl ester (II-7). 3-Methyl-pent-4-
enoic acid3 (3.33 g, 29.2 mmol) was converted to 3.0 g (52 %) of the title compound 
using a four-step procedure analogous to that described above for the conversion of 4-
pentenoic acid to II-5. The product was obtained as a colorless oil. 1H NMR (400 MHz, 
CDCl3) δ 5.62–5.53 (m, 1 H), 4.90–4.82 (m, 2 H), 4.59 (s, br, 1 H), 3.09–2.91 (m, 2 H), 
2.15–2.02 (m, 1 H), 1.44–1.27 (m, 11 H), 0.91 (d, J = 6.6 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 156.1, 143.9, 113.4, 79.0, 38.9, 36.7, 35.8, 28.5, 20.3 IR (film) 3351, 2977, 
1694, 1526 cm-1. Anal calcd for C11H21NO2: C, 66.29; H, 10.62; N, 7.03. Found: C, 
66.04; H, 10.60; N, 6.97. 
 
   N-(3-Methylpent-4-enyl)acetamide (II-8). Treatment of a solution of 3-methyl-
4-pentenylamine in ether (100 mL, 10 mmol, 0.1 M) with 3 mL (30 mmol) of acetic 
anhydride using a procedure analogous to that described above in the synthesis of II-6 
provided 720 mg (51%) of the title compound as a colorless oil. 1H NMR (500 MHz, 
CDCl3) δ 6.27 (s, br, 1 H), 5.61–5.52 (m, 1 H), 4.90–4.82 (m, 2 H), 3.15–3.07 (m, 2 H), 
2.13–2.03 (m, 1 H), 1.85 (s, 3 H), 1.46–1.32 (m, 2 H); 0.90 (d, J = 7.0 Hz, 3 H); 13C 




3290, 2964, 1649, 1558 cm-1. MS (ESI) 142.1228 (142.1232 calcd for C8H16NO, M + 
H+). 
 
   (2-Cyclopent-2-enylethyl)carbamic acid tert-butyl ester (II-14). Cyclopent-2-
enyl-acetic acid (3.0 g, 23.8 mmol) was converted to 2.41 g (48 %) of the title compound 
using a four-step procedure analogous to that described above the conversion of 4-
pentenoic acid to II-5. 1H NMR (400 MHz, CDCl3) δ 5.69–5.65 (m, 1 H), 5.62–5.57 (m, 
1 H), 4.52 (s, br, 1 H), 3.16–2.99 (m, 2 H), 2.67–2.56 (m, 1 H), 2.34–2.15 (m, 2 H), 2.06–
1.94 (m, 1 H), 1.59–1.48 (m, 1 H), 1.45–1.31 (m, 11 H); 13C NMR (100 MHz, CDCl3) δ 
156.1, 134.5, 131.0, 79.2, 43.2, 39.5, 36.4, 32.1, 29.9, 28.6;   IR (film) 3351, 2977, 1692, 
1524 cm-1. Anal calcd for C12H21NO2: C, 68.21; H, 10.02; N, 6.63. Found: C, 67.99 ; H, 
10.06; N, 6.63. 
 
   N-(2-Cyclopent-2-enylethyl)acetamide (II-15). Cyclopent-2-enyl-acetic acid 
(2.0 g, 15.9 mmol) was converted to 1.27 g (52 %) of the title compound using a four-
step procedure analogous to that described above the conversion of 4-pentenoic acid to 
II-6. The product was obtained as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 5.99 (s, 
br, 1 H), 5.68–5.63 (m, 1 H), 5.59–5.55 (m, 1 H), 3.18 (q, J = 7.3 Hz, 2 H), 2.65–2.55 (m, 
1 H), 2.33–2.14 (m, 2 H), 2.03–1.93 (m, 1 H), 1.89 (s, 3 H), 1.59–1.49 (m, 1 H), 1.45–
1.28 (m, 2 H); 13C NMR (125 MHz, CDCl3) δ 170.4, 134.3, 131.1, 43.3, 38.5, 35.8, 32.1, 






General procedures for the Pd-catalyzed synthesis of pyrrolidines 
   General procedure A: Palladium-catalyzed synthesis of pyrrolidines and 
indolines using Pd(OAc)2.  A flame-dried Schlenk tube was cooled under a stream of 
nitrogen and charged with Pd(OAc)2 (2 mol %) and a bidentate phosphine ligand (4 mol 
%).  The tube was purged with nitrogen and toluene was added (2 mL/mmol amine).  The 
mixture was stirred at rt for ~2 min then the aryl bromide (1.2 equiv) was added followed 
by a solution of the amine (1 equiv) in toluene (2 mL/mmol amine). The mixture was 
allowed to stir ~ 1 min before the addition of NaOt-Bu (2.0 equiv). The tube was purged 
with nitrogen and the sides of the flask were rinsed with toluene (2 mL/mmol amine; 
final concentration = 0.17 M). The mixture was heated to 65 °C with stirring until the 
starting material had been consumed as judged by GC or 1H NMR analysis. The reaction 
mixture was cooled to rt, quenched with saturated aqueous NH4Cl and diluted with ethyl 
acetate. The layers were separated, the aqueous layer was extracted with ethyl acetate, 
and the combined organic extracts were dried over anhydrous sodium sulfate, filtered and 
concentrated in vacuo. The crude product was then purified by flash chromatography on 
silica gel. 
   General procedure B: Palladium-catalyzed synthesis of pyrrolidines and 
indolines using Pd2(dba)3. A flame-dried Schlenk tube was cooled under a stream of 




phosphine ligand (2 mol %), NaOt-Bu (1.2 equiv), and the aryl bromide (1.1 equiv). The 
tube was purged with nitrogen and a solution of the amine substrate (1.0 equiv) in toluene 
(4 mL/mmol amine) was added. The mixture was heated to 105 °C with stirring until the 
starting material had been consumed as judged by GC or 1H NMR analysis. The reaction 
mixture was cooled to rt, quenched with saturated aqueous NH4Cl and diluted with ethyl 
acetate. The layers were separated, the aqueous layer was extracted with ethyl acetate, 
and the combined organic extracts were dried over anhydrous sodium sulfate, filtered and 
concentrated in vacuo. The crude product was then purified by flash chromatography on 
silica gel. 
   (4-Methoxyphenyl)-(2-naphthalen-2-ylmethylpyrrolidin-1-yl)methanone 
(Table 2, Entry 5) Reaction of 52 mg (0.25 mmol) of II-11 with 2-bromonaphthalene 
(57 mg, 0.28 mmol), Dpe-phos (2.7 mg, 0.005 mmol, 2 mol %) and NaOt-Bu (29 mg, 
0.30 mmol) following general procedure B afforded 54.3 mg (63%) of the title compound 
as a pale yellow oil that was contaminated with c.a. 5% of Heck-type side product II-27. 
The title compound was found to exist as a c.a. 9:1 mixture of rotamers as judged by 1H 
NMR analysis. Data are for the major rotamer. 1H NMR (400 MHz, CDCl3) δ 7.84–7.58 
(m, 4 H), 7.57–7.30 (m, 5 H), 6.88 (d, J = 8.8 Hz, 2 H), 4.62–4.49 (m, 1 H), 3.80 (s, 3 H), 
3.45–3.30 (m, 2 H), 3.26–3.14 (m, 1 H), 3.13–3.00 (m, 1 H), 2.01–1.83 (m, 1 H), 1.82–
1.51 (m, 3 H) 13C NMR (125 MHz, CDCl3) δ 169.9, 161.2, 136.4, 133.7, 132.4, 129.6, 
128.7, 128.4, 127.9, 127.8, 127.7, 126.1, 125.5, 113.7, 58.7, 55.5, 51.1, 39.0, 29.6, 25.3 
(two aromatic signals are incidentally equivalent); IR (film) 2967, 1608, 1420 cm-1. MS 





   (2-Naphthalen-2-ylmethylpyrrolidin-1-yl)phenylmethanone (Table 2, Entry 
6) Reaction of 48 mg (0.25 mmol) of II-31 with 2-bromonaphthalene (57 mg, 0.28 
mmol), Dpe-phos (2.7 mg, 0.005 mmol, 2 mol %) and NaOt-Bu (29 mg, 0.30 mmol) 
following general procedure B afforded 38 mg (48%) of the title compound as a pale 
yellow oil. This compound was found to exist as a 4:1 mixture of rotamers as judged by 
1H NMR analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.86–7.78 (m, 
3 H), 7.78–7.74 (m, 0.2 H), 7.72 (s, 0.8 H), 7.70–7.60 (m, 0.8 H), 7.56–7.42 (m, 1.4 H), 
7.50–7.38 (m, 5.8 H), 7.19 (s, 0.2 H), 6.74–6.68 (m, 0.2 H), 4.62–4.52 (m, 1 H), 4.20–
4.11 (m, 0.2 H), 3.78–3.67 (m, 0.4 H), 3.43–3.29 (m, 1.6 H), 3.22–3.13 (m, 0.8 H), 3.12–
3.03 (m, 0.8 H), 2.77–2.18 (m, 0.2 H), 2.61–2.50 (m, 0.2 H), 2.04–1.88 (m, 1 H), 1.87–
1.73 (m, 1 H), 1.72–1.54 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 170.2, 137.6, 136.4, 
135.8, 133.7, 132.4, 130.2, 129.6, 128.7, 128.5, 128.3,  128.0, 127.8, 127.7, 127.5, 127.3, 
126.7, 126.2, 126.1, 125.7, 125.5, 60.9, 58.7, 50.9, 46.0, 41.2, 39.0, 29.9, 29.5, 25.1, 22.1 
(three sets of carbons are incidentally equivalent); IR (film) 2968, 1625, 1412 cm-1. MS 
(ESI) 338.1519 (338.1521 calcd for C22H21NO, M + Na+). 
 
   2-Napthalen-2-ylmethylpyrrolidine-1-carboxylic acid tert-butyl ester (Table 
2, Entry 4, II-32).  Reaction of 93 mg (0.50 mmol) of II-5 with 2-bromonaphthalene 
(124 mg, 0.60 mmol), Dpe-phos (11 mg, 0.02 mmol 4 mol %) and NaOt-Bu (96 mg, 1.0 




pale yellow oil. This compound was found to exist as a 1:1 mixture of rotamers as judged 
by 1H NMR analysis; data are for the mixture.  1H NMR (400 MHz, CDCl3) δ 7.84–7.74 
(m, 3 H), 7.78–7.58 (m, 1 H), 7.51–7.30 (m, 3 H), 4.21–4.02 (m, 1 H), 3.46–3.18 (m, 3 
H), 2.78–2.63 (m, 1 H), 1.73 (m, 4 H), 1.49 (s, 9 H); 13C NMR (100 MHz, CDCl3) δ 
154.8, 137.0, 133.8, 132.3, 128.5, 128.2, 128.0, 127.8, 127.7, 126.2, 126.1, 125.6 125.5, 
79.5, 79.3, 59.0, 47.1, 46.5, 41.0, 39.9, 29.9, 29.1, 28.8, 23.7, 22.9 (nine sets of carbons 
are incidentally equivalent); IR (film) 3052, 2973, 1692, 1395 cm-1. Anal calcd for 
C20H25NO2: C, 77.14; H, 8.09; N, 4.50. Found: C, 76.78; H, 8.24; N, 4.57. 
 
   2-(2-Methylbenzyl)pyrrolidine-1-carboxylic acid tert-butyl ester (II-33).  
Reaction of 93 mg (0.5 mmol) of II-5 with 2-bromotoluene (66 μL, 94 mg, 0.55 mmol), 
Dpe-phos (5.4 mg, 0.01 mmol,  2 mol %) and NaOt-Bu (58 mg, 0.6 mmol) following 
general procedure B afforded 112 mg (81%) of the title compound as a pale yellow oil. 
This compound was found to exist as a 2:1 mixture of rotamers as judged by 1H NMR 
analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.10–7.08 (m, 4 H), 
4.02 (s, br, 1 H), 3.42–3.02 (m, 3 H), 2.50–2.29 (m, 4 H), 1.92–1.59 (m, 4 H), 1.44 (s, 9 
H); 13C NMR (100 MHz, CDCl3) δ 154.8; 154.2, 137.9, 137.2, 130.7, 130.5, 126.9, 
126.6, 126.1, 79.7, 79.6, 57.5, 46.9. 46.4, 38.5, 37.7, 37.0, 29.7, 29.2, 28.8, 28.7, 23.7, 
22.8, 20.0, 19.9 (three sets of signals are incidentally equivalent); IR (film) 2973, 1693, 
1394 cm-1. Anal calcd for C17H25NO2: C, 74.14; H, 9.15; N, 5.09. Found: C, 73.84; H, 





   2-(4-Cyanobenzyl)pyrrolidine-1-carboxylic acid tert-butyl ester (I-34).  
Reaction of 185 mg (1.00 mmol) of II-5 with 4-bromobenzonitrile (200 mg, 1.10 mmol), 
dppb (8.8 mg, 0.02 mmol, 2 mol %) and NaOt-Bu (116 mg, 1.20 mmol) following 
general procedure B afforded 203 mg (71%) of the title compound as a pale yellow oil. 
This compound was found to exist as a 1:1 mixture of rotamers as judged by 1H NMR 
analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.50–7.46 (m, 2 H), 
7.26–7.22 (m, 2 H), 3.80–3.97 (m, 1 H), 3.35–2.95 (m, 4 H), 2.62–2.55 (m, 1 H), 1.81–
1.52 (m, 3 H), 1.40 (s, 9 H); 13C NMR (100 MHz, CDCl3) δ 154.6, 145.1, 132.6, 132.2, 
130.4, 128.2, 119.0, 110.3, 79.5, 58.4, 46.81, 46.79, 41.0, 40.1, 30.1, 28.9, 28.7, 23.6, 
22.9 (five sets of signals are incidentally equivalent); IR (film) 2974, 2228, 1690, 1395 
cm-1. Anal calcd for C17H22N2O2: C, 71.30; H, 7.74; N, 9.78. Found: C, 71.15; H, 7.82; 
N, 9.69. 
 
   2-(3-Phenylallyl)pyrrolidine-1-carboxylic acid tert-butyl ester (II-35). 
Reaction of 93 mg (0.50 mmol) of II-5 with β-bromostyrene (80 μL, 110 mg, 0.60 
mmol), dppe (8 mg, 0.02 mmol, 4 mol %) and NaOt-Bu (96 mg, 1.00 mmol) following 
general procedure A afforded 108 mg (79%) of the title compound as a pale yellow oil. 
This compound was found to exist as a 1:1 mixture of rotamers as judged by 1H NMR 
analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.35–7.10 (m, 5 H), 




2.71–2.52 (m, 1 H), 2.32–2.23 (m, 1 H), 1.95–1.73 (m, 4 H); 1.44  (s, 9 H) 13C NMR (100 
MHz, CDCl3) δ 154.8, 138.0, 137.7, 132.4, 128.7, 127.2, 126.2, 79.39, 79.36, 57.4, 46.9, 
46.6, 38.4, 37.6, 30.5, 29.6, 28.8, 23.9, 23.2 (nine sets of signals are incidentally 
equivalent); IR (film) 2972, 1693, 1394 cm-1. Anal calcd for C18H25NO2: C, 75.22; H, 
8.77; N, 4.87. Found: C, 75.24; H, 8.59; N, 4.81. 
 
   1-(2-Naphthalen-2-ylmethylpyrrolidin-1-yl)ethanone (II-36). Reaction of 32 
mg (0.25 mmol) of II-6 with 2-bromonaphthalene (57 mg, 0.28 mmol), Dpe-phos (2.7 
mg, 0.005 mmol, 2 mol %) and NaOt-Bu (29 mg, 0.30 mmol) following general 
procedure B afforded 44 mg (70%) of the title compound as a pale yellow oil. This 
compound was found to exist as a 7:3 mixture of rotamers as judged by 1H NMR 
analysis; data are for the mixture. 1H NMR (500 MHz, CDCl3) δ 7.83–7.78 (m, 3 H), 
7.66 (s, 0.3 H), 7.60 (s, 0.3 H), 7.51–7.40 (m, 3 H), 4.45–4.38 (m, 0.7 H), 4.15–4.08 (m, 
0.3 H), 3.63–3.48 (m, 0.7 H), 3.43–3.31 (m, 2 H), 3.07–3.00 (m, 0.3 H), 2.84–2.70 (m, 1 
H), 2.14–2.03 (m, 3 H), 1.96–1.69 (m, 4 H); 13C NMR (125 MHz, CDCl3) δ 169.5, 169.4, 
137.0, 135.7, 135.7, 133.8, 132.5, 132.4, 128.7, 128.4, 128.15, 128.05, 128.03, 127.94, 
127.87, 127.76, 127.72, 126.5, 126.2, 126.0, 125.6, 60.3, 58.6, 48.2, 45.8, 41.2, 39.1, 
30.3, 28.7, 24.0, 23.4, 22.4, 22.1 (one set of carbons are incidentally equivalent); IR 






   1-[2-(4-Benzoylbenzyl)pyrrolidin-1-yl]ethanone (II-37). Reaction of 32 mg 
(0.25 mmol) of II-6 with 4-bromobenzophenone (72 mg, 0.28 mmol), dppe (2.0 mg, 
0.005 mmol, 2 mol %) and NaOt-Bu (29 mg, 0.30 mmol) following the general procedure 
B afforded 61 mg (80%) of the title compound as a pale yellow oil. This compound was 
found to exist as a 3:1 mixture of rotamers as judged by 1H NMR analysis. 1H NMR (500 
MHz, CDCl3) δ 7.80–7.64 (m, 4 H), 7.58–7.51 (m, 1 H), 7.47–7.40 (m, 2 H), 7.32–7.22 
(m, 2 H), 4.34–4.26 (m, 0.75 H), 4.08–4.00 (m, 0.25 H), 3.60–3.32 (m, 2 H), 3.24 (dd, J 
= 3.3, 12.8 Hz, 0.75 H), 2.92 (dd, J = 5.1, 13.6 Hz, 0.25 H), 2.72 (m, 0.25 H), 2.67–2.60 
(m, 0.75 H), 2.20–2.05 (m, 0.75 H), 2.06–1.98 (m, 3 H), 1.90–1.74 (m, 3.25 H); 13C 
NMR (125 MHz, CDCl3) δ 196.7, 196.6, 169.6, 169.5, 144.5, 143.0, 138.3, 138.0, 136.2, 
135.8, 132.7, 132.5, 130.8, 130.5, 130.2, 129.6, 129.4, 128.5, 128.4, 60.0, 58.4, 48.2, 
45.7, 41.1, 39.0, 30.3, 28.7, 24.0, 23.2, 22.3, 22.0 (one set of carbons are incidentally 
equivalent); IR (film) 2960, 1638, 1414 cm-1. MS (ESI) 330.1466 (330.1470 calcd for 
C20H21NO2, M + Na+). 
 
   1-[2-(4-Dimethylaminobenzyl)pyrrolidin-1-yl]ethanone (II-38).  Reaction of 
32 mg (0.25 mmol) of II-6 with N,N−dimethyl-4-bromoaniline (55 mg, 0.28 mmol), 
Xantphos (2.9 mg, 0.005 mmol, 2 mol %) and NaOt-Bu (29 mg, 0.30 mmol) following 
general procedure B afforded 42 mg (67%) of the title compound as a pale yellow oil. 
This compound was found to exist as a 3:2 mixture of rotamers as judged by 1H NMR 
analysis. This material contained c.a. 15% of the corresponding 2,3-dihydropyrrole (1-[5-




separated by chromatography. 1H NMR (500 MHz, CDCl3) δ 7.29–6.95 (m, 2 H), 6.72–
6.57 (m, 2 H), 4.32–4.20 (m, 0.6 H), 4.01–3.88 (m, 0.4 H), 3.57–3.39 (m, 0.8 H), 3.38–
3.29 (m, 1.2 H), 3.06–2.98 (m, 0.6 H), 2.93–2.85 (m, 6 H), 2.77–2.70 (m, 0.4 H), 2.57–
2.43 (m, 1 H), 2.07–1.95 (m, 3 H), 1.89–1.67 (m, 4 H); 13C NMR (125 MHz, CD3OH) δ 
170.9, 170.6, 150.1, 149.8, 129.9, 129.8, 113.4 113.3, 112.6, 112.4, 60.9, 59.0, 45.3, 40.1, 
40.0, 39.9, 39.8, 39.1, 38.9, 36.9, 23.1, 21.5, 21.33, 21.28, 20.6; IR (film) 2930, 1638, 
1417 cm-1. MS (ESI) 269.1361 (269.1630 calcd for C15H22N2O, M + Na+). 
 
   2-Naphthalen-2-ylmethyl-2,3-dihydroindole-1-carboxylic acid tert-butyl ester 
(II-39). Reaction of 59 mg (0.25 mmol) of II-17 with 2-bromonaphthalene (57 mg, 0.28 
mmol), Dpe-phos (2.7 mg, 0.005 mmol, 2 mol %) and NaOt-Bu (29 mg, 0.30 mmol) 
following general procedure B afforded 44 mg (50%) of the title compound as a pale 
yellow oil.  1H NMR (500 MHz, CDCl3) δ 7.84–7.76 (m, 3 H), 7.63 (s, 1 H), 7.48–7.34 
(m, 4 H), 7.22–7.30 (m, 2 H), 6.94 (t, J = 7.3 Hz, 1 H), 4.71 (s, br, 1 H), 3.41 (s, br, 1 H) 
3.21–3.00 (m, 1 H), 2.81–2.67 (m, 2 H), 1.59 (s, 9 H); 13C NMR (125 MHz, CDCl3) δ 
152.5, 142.2, 135.7, 133.8, 132.5, 130.2, 128.3, 128.2, 128.0, 127.9, 127.7, 127.6, 126.2, 
125.7, 125.3, 122.7, 115.6, 81.1, 60.8, 40.6, 31.7, 28.7; IR (film) 2974, 1702, 1483, 1392 
cm-1. MS (ESI) 382.1787 (382.1783 calcd for C24H25NO2, M + Na+). 
 
   1-Benzyl-2-(4-methylbenzyl)-2,3-dihydro-1H-indole (II-40).  Reaction of 65 




(3.2 mg, 0.0058 mmol, 2 mol %) and NaOt-Bu (34 mg, 0.30 mmol) following general 
procedure B afforded 44 mg (48%) of the title compound as a pale yellow oil. 1H NMR 
(500 MHz, CDCl3) δ 7.36–7.22 (m, 5 H), 7.07–6.94 (m, 6 H), 6.59 (t, J = 7.0 Hz, 1 H), 
6.33 (d, J = 7.7 Hz, 1 H), 4.46 (d, J = 16.1 Hz, 1 H), 4.24 (d, J = 16.1 Hz, 1 H), 3.86–3.78 
(m, 1 H), 3.12 (dd, J = 4.0, 13.2 Hz, 1 H), 2.96–2.89 (m, 1 H), 2.78–2.62 (m, 2 H), 2.29 
(s, 3 H) 13C NMR (125 MHz, CDCl3) δ 152.7, 139.2, 136.0, 135.6, 129.33 129.29, 
128.69, 128.67 127.56, 127.54, 127.2, 124.4, 117.7, 107.1, 66.7, 51.8, 40.1, 35.1, 21.2; 
IR (film) 2921, 2360, 1484 cm-1; MS (ESI) 314.1901 (314.1909 calcd for C23H23N, M + 
H+). 
 
   (±)–(2S,5R)-2-(4-Methoxybenzyl)-5-phenylpyrrolidine-1-carboxylic acid tert-
butyl ester (II-41).  Reaction of 261 mg (1.00 mmol) of II-21 with 4-bromoanisole (140 
μL, 206 mg, 1.1 mmol), dppb (8.0 mg, 0.02 mmol, 2 mol %) and NaOt-Bu (116 mg, 1.20 
mmol) following general procedure B afforded 219 mg (60%) of the title compound as a 
pale yellow oil. This compound was found to exist as a 7:3 mixture of rotamers as judged 
by 1H NMR analysis. 1H NMR (500 MHz, CDCl3) δ 7.33–7.05 (m, 7 H), 6.82 (d, J = 8.4 
Hz, 2 H), 4.97–4.61 (m, 1 H), 4.22–3.98 (m, 1 H), 3.76 (s, 3 H), 3.56–3.29 (m, 1 H), 2.59 
(t, J = 11.4 Hz, 1 H), 2.22 (sx, J = 6.6 Hz, 1 H), 1.97–1.81 (m, 1 H), 1.82–1.66 (m, 2 H), 
1.62–1.04 (m, 9 H); 13C NMR (125 MHz, CDCl3) δ 158.4, 155.1, 131.6, 130.5, 128.5, 
128.3, 126.6, 125.8, 114.1, 79.5, 63.3, 61.3, 55.4, 40.6, 34.4, 28.5 (nine sets of carbons 




(390.2045 calcd for C23H29NO3, M + Na+). 
 
   (±)–(2S,5R)-1-(2-Phenyl-5-pyridin-3-ylmethylpyrrolidin-1-yl)ethanone (II-
42).  Reaction of 51 mg (0.25 mmol) of II-22 with 3-bromopyridine (27 μL, 43.5 mg, 
0.28 mmol), dppb (2.2 mg, 0.005 mmol,  2 mol %) and NaOt-Bu (29 mg, 0.3 mmol) 
following general procedure B afforded 57.2 mg (82%) of the title compound as a pale 
yellow oil. 1H NMR (500 MHz, CDCl3) δ 8.49–8.41 (m, 2 H), 7.67–7.62 (m, 1 H), 7.38–
7.18  (m, 6 H), 4.85 (t, J = 7.3 Hz, 1 H), 4.41–4.34 (m, 1 H), 3.62 (dd, J = 7.3, 12.8 Hz, 1 
H), 2.59 (dd, J = 10.6, 12.8 Hz, 1 H), 2.34 (sx, J = 7.6 Hz, 1 H),  2.03–1.94 (m, 1 H), 
1.80–1.72 (m, 4 H), 1.66–1.58 (m, 1 H); 13C NMR (125 MHz, CDCl3) δ 171.4, 150.6, 
148.1, 143.2, 137.0, 134.8, 129.2, 127.6, 125.7, 123.7, 64.1, 60.6, 37.6, 35.5, 28.2, 23.4; 
IR (film) 2968, 1643, 1404 cm-1. MS (ESI) 281.1653 (281.1654 calcd for C18H20N2O, M 
+ H+). 
    
   4-Allyl-2-(4-tert-butoxycarbonyl-benzyl)pyrrolidine-1-carboxylic acid tert-
butyl ester (II-43).  Reaction of 57 mg (0.25 mmol) of II-23 with 4-bromo-tert-butyl 
benzoate (71 mg, 0.28 mmol), Dpe-phos (2.7 mg, 0.005 mmol, 2 mol %) and NaOt-Bu 
(29 mg, 0.3 mmol) following general procedure B afforded 80 mg (70%) of the title 
compound as a pale yellow oil. This product was isolated as a c.a. 3:1 mixture of 
diastereomers. Data are for the mixture. 1H NMR (500 MHz, CDCl3) δ 7.90–7.79 (m, 2 




2.76–2.48 (m, 2 H), 2.07–1.88 (m, 4 H), 1.57–1.40 (m, 18 H), 1.27–1.11 (m, 1 H); 13C 
NMR (125 MHz, CDCl3) δ 166.0, 157.5, 154.7, 149.5, 146.2, 143.8, 136.4, 130.2, 129.7, 
116.3, 116.2, 81.0, 79.4, 77.6, 77.2, 76.9, 58.7, 52.7, 52.1, 51.7, 41.8, 41.0, 40.1, 37.9, 
37.7, 37.3, 37.0, 36.3, 35.6, 34.9, 28.8, 28.4; IR (film) 2976, 1712, 1694, 1395 cm-1. Anal 
calcd for C24H35NO4: C, 71.79; H, 8.79; N, 3.49. Found: C, 71.60; H, 8.75; N, 3.45. 
 
   (±)–(2R,3S)-3-Methyl-2-naphthalen-2-ylmethyl-pyrrolidine-1-carboxylic acid 
tert-butyl ester (II-44). The reaction of 100 mg (0.5 mmol) of II-7 with 2-
bromonaphthalene (124 mg, 0.60 mmol), Dpe-phos (10.8 mg, 0.02 mmol, 4 mol %) and 
NaOt-Bu (96 mg, 1.00 mmol) was conducted following general procedure A. 1H NMR 
analysis of the crude product showed the formation of the desired product as a 10:1 
mixture of diastereomers. The minor diastereomer was separated upon chromatographic 
purification to afford 106 mg (65%) of the title compound as a white solid with >20:1 dr, 
m.p. 107 °C. Data are for the major diastereomer, which was found to exist as a 1:1 
mixture of rotamers as judged by 1H NMR analysis. 1H NMR (500 MHz, CDCl3) δ 7.85–
7.73 (m, 3 H), 7.62 (d, J = 16.3 Hz, 1 H), 7.50–7.28  (m, 3 H), 3.78–3.60 (m, 1 H), 3.61–
3.38 (m, 1 H), 3.33–3.08 (m, 2 H), 2.96–2.73 (m, 1 H), 2.15–2.09 (m, 1 H), 1.98–1.80 
(m, 1 H), 1.53 (s, 9 H), 1.49–1.34 (m, 1 H), 0.84 (s, br, 3 H); 13C NMR (125 MHz, 
CDCl3) δ 155.0, 136.8, 133.7, 132.3, 128.6, 128.2, 128.0, 127.8, 127.7, 126.2, 126.0, 
125.5, 125.4, 79.6, 79.5, 66.0, 65.7, 45.7, 45.0, 40.6, 39.1, 37.0, 36.1, 31.3, 30.4, 28.8, 




cm-1. MS (ESI) 348.1943 (348.1939 calcd for C21H27NO2, M + Na+). 
 
   (±)–(2R,3S)-2-(4-tert-Butylbenzyl)-3-methyl-pyrrolidine-1-carboxylic acid 
tert-butyl ester (II-45). The reaction of 100 mg (0.5 mmol) of II-7 with 4-bromo-tert-
butylbenzene (105 μL, 128 mg, 0.60 mmol), Dpe-phos (10.8 mg, 0.02 mmol, 4 mol %) 
and NaOt-Bu (96 mg, 1.00 mmol) was conducted following general procedure A. 1H 
NMR analysis of the crude product showed the formation of the desired product as a 10:1 
mixture of diastereomers. The minor diastereomer was separated upon chromatographic 
purification to afford 97.4 mg (59%) of the title compound as a pale yellow oil with 
>20:1 dr. Data are for the major diastereomer, which was found to exist as a 3:2 mixture 
of rotamers as judged by 1H NMR analysis. 1H NMR (500 MHz, CDCl3) δ 7.35–7.25 (m, 
2 H), 7.16–7.06 (m, 2 H), 3.69–3.37 (m, 2 H), 3.31–2.92 (m, 2 H), 2.76–2.56 (m, 1 H), 
2.05 (s, br, 1 H), 1.97–1.79 (m, 1 H), 1.51 (s, 9 H), 1.45–1.35 (m, 1 H), 1.32 (s, 9 H), 0.88 
(d, J = 6.8 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 155.0, 149.2, 149.0, 136.1, 129.5, 
129.3, 125.5, 125.3, 79.4, 79.1, 66.1, 65.6, 45.6, 45.0, 39.9, 38.5, 37.1, 36.0, 34.6, 31.6, 
31.2, 30.4, 28.8, 19.7, 19.5 (five sets of carbons are incidentally equivalent); IR (film) 
2963, 1696, 1395 cm-1. MS (ESI) 354.2402 (354.2409 calcd for C21H33NO2, M + Na+). 
 
   (±)–(2R,3S)-1-[2-(4-Chlorobenzyl)-3-methyl pyrrolidin-1-yl]ethanone (II-46). 
The reaction of 72 mg (0.5 mmol) of II-8 with 4-bromochlorobenzene (106 mg, 0.55 




conducted following general procedure B. 1H NMR analysis of the crude product showed 
the formation of the desired product as a 10:1 mixture of diastereomers. The minor 
diastereomer was separated upon chromatographic purification to afford 69.4 mg (61%) 
of the title compound as a pale yellow oil with >20:1 dr. Data are for the major 
diastereomer, which was found to exist as a 7:3 mixture of rotamers as judged by 1H 
NMR analysis. 1H NMR (500 MHz, CDCl3) δ 7.27–7.16 (m, 2 H), 7.12–7.00 (m, 2 H), 
3.86–3.78 (m, 0.7 H), 3.71–3.60 (m, 0.3 H), 3.55–3.48 (m, 0.3 H), 3.47–3.29 (m, 1 H), 
3.26–3.16 (m, 0.7 H), 3.08–2.98 (m, 0.7 H), 2.81–2.73 (m, 0.3 H), 2.72–2.57 (m, 1 H), 
2.14–2.08 (m, 0.3 H), 2.07–1.95 (m, 3.1 H), 1.92–1.84 (m, 1.6 H), 1.52–1.38 (m, 1 H), 
0.89–0.80 (m, 3 H) 13C NMR (125 MHz, CDCl3) δ 169.8, 169.7, 137.5, 136.5, 132.8, 
132.1, 131.1, 130.7, 129.1, 128.6, 67.4, 65.3, 46.9, 44.1, 40.6, 37.7, 37.2, 35.6, 31.4, 29.1, 
23.2, 22.2, 19.8, 19.3; IR (film) 2961, 1641, 1417 cm-1. MS (ESI) 274.0969 (274.0975 
calcd for C14H18ClNO, M + Na+). 
 
   (±)–(3aR,6S,6aS)-6-Biphenyl-4-yl-hexahydrocyclopenta[b]pyrrole-1-
carboxylic acid tert-butyl ester (II-47) Reaction of 53 mg (0.25 mmol) of II-14 with 4-
bromobiphenyl (64 mg, 0.28 mmol), Xantphos (5.8 mg, 0.01 mmol, 4 mol %) and NaOt-
Bu (36 mg, 0.38 mmol) following general procedure A afforded 42.8 mg (47%) of the 
title compound as a white solid, m.p. 128 °C. This compound was found to exist as a 3:2 
mixture of rotamers as judged by 1H NMR analysis. 1H NMR (500 MHz, CDCl3) δ 7.55–
7.34 (m, 6 H), 7.32–7.16 (m, 3 H), 4.54–4.30 (m, 1 H), 3.83–3.71 (m, 0.6 H), 3.55–3.17 




H) 13C NMR (125 MHz, CDCl3) δ 154.5, 141.6, 141.2, 139.4, 129.6, 128.9, 127.2, 127.1, 
127.0, 126.6, 94.6, 79.0, 65.4, 52.3, 51.2, 47.8, 43.5, 42.5, 34.2, 33.7, 32.4, 32.2, 31.8, 
28.4, 27.9 (thirteen sets of carbons are incidentally equivalent); IR (film) 2952, 1689, 
1392 cm-1. MS (ESI) 386.2105 (386.2096 calcd for C24H29NO2, M + Na+). 
 
   (±)–(3aR,6S,6aS)-1-(6-Naphthalen-2-yl-hexahydrocyclopenta[b]pyrrol-1-
yl)ethanone (II-48) Reaction of 78 mg (0.25 mmol) of II-15 with 2-bromonaphthalene 
(114 mg, 0.55 mmol), Nixantphos (13.8 mg, 0.025 mmol, 5 mol %), Pd2(dba)3 (11.4 mg, 
0.0125 mmol, 2.5 mol %) and NaOt-Bu (58 mg, 0.60 mmol) following general procedure 
B afforded 85 mg (61%) of the title compound as a pale yellow oil. This compound was 
found to exist as a 7:3 mixture of rotamers as judged by 1H NMR analysis. 1H NMR (400 
MHz, CDCl3) δ 7.82–7.69 (m, 3 H), 7.57 (s, 1 H), 7.48–7.34 (m, 2 H), 7.28–7.24 (m, 1 
H), 4.90 (t, J = 8.6 Hz, 0.3 H), 4.43 (t, J = 7.0 Hz, 0.7 H), 4.14–4.06 (m, 0.70 H), 3.54 (q, 
J = 8.1 Hz, 0.3 H), 3.48–3.20 (m, 2 H), 3.13–3.04 (m, 0.7 H), 2.92–2.82 (m, 0.3 H), 2.17–
1.92 (m, 4 H), 1.85–1.72 (m, 2 H), 1.64 (s, 0.6 H), 1.11 (s, 2.4 H); 13C NMR (100 MHz, 
CDCl3) δ 170.6, 168.8, 139.2, 138.2, 133.6, 133.5, 132.7, 132.4, 128.31, 128.29, 128.1, 
127.91, 127.90, 129.86, 127.81, 127.2, 127.0, 126.6, 126.4, 125.9, 125.8, 125.3, 67.0, 
65.2, 53.4, 49.9, 49.1, 47.4, 44.0, 42.3, 33.7, 32.6, 32.4, 32.3, 32.2, 31.4, 22.5, 21.8; IR 






Assignment of Stereochemistry 
 
2,5-Disubstituted Pyrrolidines (II-41 and II-42). The cis stereochemistry of the 
2,5-disubstituted pyrrolidine products (±)–(2S,5R)-2-(4-Methoxybenzyl)-5-
phenylpyrrolidine-1-carboxylic acid tert-butyl ester (II-41) and (±)–(2S,5R)-1-(2-Phenyl-
5-pyridin-3-ylmethylpyrrolidin-1-yl)ethanone (II-42) was assigned on the basis of nOe 
signals between the ortho protons of the C5 phenyl group and one of the benzylic 








2,3-Disubstituted Pyrrolidine (II-44, II-45, II-46). The trans stereochemistry of 
the 2,3-disubstituted pyrrolidine products (±)–(2R,3S)-3-Methyl-2-naphthalen-2-
ylmethyl-pyrrolidine-1-carboxylic acid tert-butyl ester (II-44),  (±)–(2R,3S)-2-(4-tert-
Butylbenzyl)-3-methyl-pyrrolidine-1-carboxylic acid tert-butyl ester (II-45) and (±)–
(2R,3S)-1-[2-(4-Chlorobenzyl)-3-methyl pyrrolidin-1-yl]ethanone (II-46) was assigned 

















carboxylic acid tert-butyl ester (II-47) and (±)–(3aR,6S,6aS)-1-(6-Naphthalen-2-yl-
hexahydrocyclopenta[b]pyrrol-1-yl)ethanone (II-48) was assigned on the basis of nOe 
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Development of Milder Reaction Conditions for the Carboamination Reaction1 
 A significant improvement of the carboamination methodology described in 
Chapter II would involve the development of milder reaction conditions. Indeed, the 
reactions are typically conducted in the presence of the strong base NaOt-Bu, which 
limits the scope of the methodology in terms of substrates and coupling partners. For 
example, Cbz nitrogen protecting groups, which are frequently employed in the synthesis 
of complex alkaloids, are incompatible with the strongly basic conditions. Additionally, 
aryl triflates, desirable coupling partners since they are readily available synthetic 
intermediates from the corresponding phenol,2 decompose in the presence of strong base. 
Their use has not been reported in the carboamination chemistry. Finally, many common 
functional groups, such as enolizable ketones and unhindered esters, are not tolerated 
under the strongly basic conditions. This chapter describes the development of new 
conditions that replace NaOt-Bu with weaker bases (Cs2CO3 or K3PO4), which 
significantly expands the scope of the carboamination method. This chapter also presents 






In our preliminary studies on palladium-catalyzed carboamination reactions of γ-
(N-Boc-amino) or γ-(N-acylamino)alkenes, our attempts to conduct the transformations 
using bases other than NaOt-Bu were met with limited success. For example, the 
Pd2(dba)3/Dpe-phos catalyzed carboamination of II-5 with 4-bromo-tert-butylbenzene 
afforded III-1 in 81% yield when the reaction was conducted in toluene solvent with 
NaOt-Bu as base (Table 5, entry 1). However, use of Cs2CO3 in place of NaOt-Bu 
provided only a 38% isolated yield of III-1, and led to the formation of large amounts of 
side-products resulting from Heck arylation (entry 2).3 Other weak bases such as K2CO3 
and Et3N also provided unsatisfactory yields of pyrrolidine products. To improve the 
yields obtained in Pd-catalyzed carboamination reactions that employ mild bases, the 
effect of palladium source and solvent were systematically examined; the key results of 
these studies are summarized in Table 5. After some experimentation, it was discovered 
that use of Pd(OAc)2 in place of Pd2(dba)3 leads to significantly improved yields of III-1 
(63%, entry 3), and replacement of toluene with dioxane as solvent provides optimal 






































aConditions: 1.0 equiv substrate, 1.2 equiv ArBr, 2.3 equiv base, 1 mol % Pd2(dba)3 (2 mol % Pd) or 2 mol 
% Pd(OAc)2, 2 mol % Dpe-phos (with Pd2(dba)3) or 4 mol % Dpe-phos (with Pd(OAc)2), solvent (0.25 M), 
105 °C. bThe reaction was conducted at 100 °C. 
 
Scope and Diastereoselectivity 
As shown in Tables 6 and 7, the new reaction conditions described above are 
effective for the transformation of a number of different substrate combinations. A 
variety of functional groups are tolerated under these mild conditions, including 
aldehydes (entry 3, Table 6), enolizable ketones (entry 4, Table 6), nitro groups (entry 6, 
Table 6 and entry 3, Table 7), methyl esters (entry 8, Table 6), and alkyl acetates (entry 1, 
Table 7). In addition, the carboamination reactions of electron-rich (entry 2, Table 7), 
electron-neutral (entries 1, 2, 5, and 7, Table 6), and heterocyclic (entry 4, Table 7) aryl 
bromides proceed with good chemical yields. In addition to providing increased tolerance 
of base-sensitive functional groups, the new reaction conditions also allow the efficient 
carboamination of substrates bearing Cbz-protecting groups. For example, the Pd-
catalyzed coupling of III-2 with 2-bromonaphthalene using Cs2CO3 as base provided the 




Cbz-group from the substrate was problematic when reactions were conducted with 
NaOt-Bu as base; these conditions provided only a 17% yield of III-9. 
Table 6. Palladium-Catalyzed Carboamination of N-Protected γ−Aminoalkenes with 
Functionalized Aryl Bromidesa 



































































aConditions: 1.0 equiv amine, 1.2 equiv ArBr, 2.3 equiv Cs2CO3, 2 mol % Pd(OAc)2, 4 mol % Dpe-phos, 
dioxane (0.2–0.25 M), 100 °C. bYield refers to average isolated yield obtained in two or more experiments. 
cDppe used in place of Dpe-phos. dNaOt-Bu used in place of Cs2CO3. eThe reaction was conducted at 85 °C 




The mild conditions are also effective for stereoselective reactions, and provide 
selectivities that are comparable to those observed in reactions that use NaOt-Bu as base 
(Chapter II). For example, transformation of starting material substrates III-11 and II-7, 
which are substituted at the allylic position, are transformed to trans-2,3-disubstituted 
products III-12 and III-13 with good stereocontrol (Table 7, entries 1–2). Similarly, 
substrates II-21 and III-15 bearing a substituent adjacent to the nitrogen atom, provide 
cis-2,5-disubstituted products III-14 and III-16 with excellent (>20:1) 
diastereoselectivity (entries 3–4). 
 
Table 7. Palladium-Catalyzed Carboamination of Substituted N-Protected 
γ−Aminoalkenes with Functionalized Aryl Bromidesa 
 


















































aConditions: 1.0 equiv amine, 1.2 equiv ArBr, 2.3 equiv Cs2CO3, 2 mol % Pd(OAc)2, 4 mol % Dpe-phos, 
dioxane (0.2–0.25 M), 100 °C. bYield refers to average isolated yield obtained in two or more experiments. 
 




straightforward access to 1-substituted tetrahydropyrroloisoquinolin-5-ones. As shown in 
Scheme 12, the Pd-catalyzed reaction of II-7 with methyl-2-bromobenzoate afforded 
pyrrolidine III-17 in 73% yield with 14:1 dr. Treatment of this product with 
trifluoroacetic acid followed by an alkaline workup gave III-18 in 95% yield. 
 




2 mol % Pd(OAc)2
4 mol % Dpe-phos














Finally, we investigated the stereochemistry of olefin insertion in the reactions of 
terminal alkenes using these new, mild reaction conditions. We conducted a deuterium 
labeling experiment to accomplish this task (Scheme 13). The strategy involved the 
coupling of a substrate (III-19) containing a deuterium atom at the terminal carbon with 
methyl 2-bromobenzoate under the optimized carboamination reaction conditions. 
Product III-20 was obtained in moderate yield and was subjected to our newly developed 
protocol for tetrahydropyrroloisoquinolin-5-one synthesis to afford derivative III-21. The 
same two-step sequence was performed with the all-proteo substrate II-5. 1H NMR 
analysis of both cyclic derivatives permitted assignment of the stereochemistry at the 




process occurred in a syn fashion under the mild reaction conditions. 
 
Scheme 13. Deuterium-Labeling Experiment 
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Important substrates in the carboamination chemistry are N-protected internal 
alkenes, since their cyclization would create two new stereocenters in one step. Previous 
studies5 with the strong base NaOt-Bu indicated that high catalyst loading (10 mol %) 





















 We investigated the cyclization of substrate II-49 under the mild reaction 
conditions and, following an extensive ligand screen, we found that the ligands 
Nixantphos and (±)-BINAP were optimal (Table 8). Catalyst loadings of 5 mol % were 
needed to effect complete conversion of the starting materials, along with reaction times 
of 24–72 h. The substrate scope was limited to electron-neutral and electron-poor aryl 
bromides; use of electron-rich aryl bromides led to low conversions (<50%) and 
formation of large amounts of side-products resulting from competing Heck arylation of 
the alkene. Moderate yields of the desired pyrrolidine products were obtained in high 
diastereoselectivity (>20:1 dr). Regioisomeric product III-29 (Figure 2) was also 
observed in the reactions of N-Boc substrate II-49 used in combination with electron-





Table 8. Palladium-Catalyzed Carboamination of N-Protected γ−Aminoalkenes II-49 and 
III-26 with Functionalized Aryl Bromidesa 
 














































aConditions: 1.0 equiv amine, 1.2 equiv ArBr, 2.3 equiv Cs2CO3, 5 mol % Pd(OAc)2, 7.5 mol % 
Nixantphos, dioxane (0.25 M), 100 °C, 24 h. bYield refers to average isolated yield obtained in two or more 
experiments. cThis reaction was conducted at 100 °C for 48 h. d(±)-BINAP used in place of Nixantphos. 
eThis reaction was conducted at 100 °C for 72 h. fThis reaction was conducted with 2.0 equiv ArBr, 10 mol 










A change in phosphine ligand from Nixantphos to (±)-BINAP was required for 
the optimal cyclization of N-protected (Z)-aminoalkene substrates III-30 and III-35 
(Table 9). Moderate yields of the pyrrolidine products were obtained with electron-
neutral and electron-poor aryl bromides. However, use of electron-rich aryl bromides 
lead to low conversions (<50%) and formation of large amounts of side-products 
resulting from Heck arylation. In most cases, high diastereoselectivity (dr >20:1) and 
regioselectivity was observed. In general, the reaction of N-protected (Z)-aminoalkene 
substrates III-30 and III-35 were faster than N-protected (E)-aminoalkene substrates II-
49 and III-26. For example, reaction of II-49 with methyl 4-bromobenzoate required 48 





Table 9. Palladium-Catalyzed Carboamination of N-Protected γ−Aminoalkenes III-30 
and III-35 with Functionalized Aryl Bromidesa 


















































aConditions: 1.0 equiv amine, 1.2 equiv ArBr, 2.3 equiv Cs2CO3, 5 mol % Pd(OAc)2, 7.5 mol % (±)-
BINAP, dioxane (0.25 M), 100 °C, 24 h bYield refers to average isolated yield obtained in two or more 
experiments. cThis reaction proceeded to 94% conversion. dThis reaction was conducted at 100 °C for 48 h. 
eThis reaction was conducted with 2.0 equiv ArBr, 10 mol % Pd(OAc)2 and 15 mol % (±)-BINAP for 72 h. 
 
Interestingly, regioisomeric product III-38 was isolated in 70% yield when 2-
bromochlorobenzene was used as an aryl bromide (eq 21). However, the analogous 




under the same reaction conditions resulted in a complex mixture of products containing 









5 mol % Pd(OAc)2
7.5 mol % (±)−Binap








5 mol % Pd(OAc)2
7.5 mol % (±)−Binap







The C2/C1’relative stereochemistry in products II-50 and III-31 was determined 
by nOe experiments on cyclic lactam derivatives III-39 and III-40, respectively, 
prepared via intramolecular Bischler-Napieralski cyclization (eqs 23 and 24).6 A crystal 
structure of derivative III-39 was obtained to confirm the stereochemical assignment. 
This experiment also provided the information that the olefin insertion process occurred 









































The cyclization of substituted olefin substrates III-41 and III-42 was achieved 
using the ligand Nixantphos (Table 10). The 1,1-disubstituted alkenes were more reactive 
than the 1,2-disubstituted alkenes, and cyclization of III-41 and III-42 could be 
effectively achieved using only 2 mol % Pd. As shown in Table 10, various aryl bromides 
were effectively coupled, including electron-poor, electron-rich and heteroatom 
substituted aryl bromides. These reactions afforded moderate to good yields of the 
corresponding pyrrolidine products containing a quaternary carbon at C2. 
 
Table 10. Palladium-Catalyzed Carboamination of Substrates III-41 and III-42.a 












































aConditions: 1.0 equiv amine, 1.2 equiv ArBr, 2.3 equiv Cs2CO3, 2 mol % Pd(OAc)2, 4 mol % Nixantphos, 
dioxane (0.25 M), 100 °C. bYield refers to average isolated yield obtained in two or more experiments. 




Interestingly, attempts to couple cyclic 1,2-disubstituted olefin substrate II-14 
with 4-bromobiphenyl under the optimized mild reaction conditions afforded less than 
5% of II-47 (eq 25). Instead, the majority of the material was converted to 
benzocyclobutene III-48, which was isolated in 72% yield and >20:1 dr. Details on the 






2 mol % Pd(OAc)2



















In addition to greatly expanding the scope of Pd-catalyzed carboamination 
reactions involving aryl bromide substrates, the use of mildly basic reaction conditions 
also allowed the first Pd-catalyzed carboamination reaction with aryl triflates. Our 
preliminary efforts to conduct these transformations with the strong base NaOt-Bu were 
unsuccessful due to competing cleavage of the trifluoromethanesulfonate ester, which 
resulted in conversion of the aryl triflate to the corresponding phenol. For example, 
treatment of II-5 with 4-formylphenyl triflate in the presence of catalytic Pd(OAc)2/Dpe-
phos and stoichiometric NaOt-Bu failed to generate the desired pyrrolidine product III-
49 (Table 11). However, subsequent experiments demonstrated that use of K3PO4 as base 
provided the desired pyrrolidine III-49 in 67% yield (Table 11, entry 1). These 




diastereoselectivities are similar to those obtained in related reactions with aryl bromide 
electrophiles (entries 3-4).   
 
Table 11. Palladium-Catalyzed Carboamination of Aryl Triflatesa 














































aConditions: 1.0 equiv amine, 1.2 equiv ArOTf, 2.3 equiv K3PO4, 4 mol % Pd(OAc)2, 8 mol % Dpe-phos, 
dioxane (0.25 M), 100 °C. bYield refers to average isolated yield obtained in two or more experiments. c. 




   The proposed catalytic cycle for the Pd-catalyzed carboamination reaction 
described in Chapters II and III is likely analogous to that previously proposed for 
reactions of γ–(N-arylamino)alkene substrates. 7  As shown below (Scheme 14), the 




Pd(0) catalyst to afford Pd(Ar)(Br) complex III-53. Reaction of this complex with the 
γ−aminoalkene substrate in the presence of base likely results in the formation of 
palladium aryl(amido) complex III-55,3 which undergoes insertion of the alkene into the 
Pd–N bond25,8 followed by C–C bond-forming reductive elimination9 of the resulting 
intermediate III-56 to afford the observed pyrrolidine with concomitant regeneration of 
the Pd(0) catalyst. The formation of products that result from syn addition of the aryl 
group and the nitrogen across the C–C double bond is consistent with this mechanistic 
proposal. 
  The observed stereochemical outcomes of reactions of chiral γ-(N-Boc-amino) and 
γ-(N-acyl-amino) alkenes are similar to the stereoselectivity observed in related reactions 
of γ-(N-arylamino) substrates. For example, cyclization of substrates II-21 and I-41 both 
afforded 2,5-cis-pyrrolidine products (III-14 and I-42) with high diastereoselectivity 
(Scheme 15). The results can be rationalized on the basis of the same cyclic, chair-like 
transition state models III-58 and III-59 describing the amidopalladation step of the 
catalytic cycle. Pseudoaxial orientation of the phenyl group is favored to minimize A(1,3)-
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The mechanism shown in Scheme 14 also accounts for the formation of several 
observed side-products. The formation of regioisomer III-29 from N-protected (E)-




intermediate III-61 to afford π-olefin complex III-62 (Scheme 16).10 Reinsertion of the 
olefin into the Pd–H bond with reversal of regiochemistry would provide III-63,11 which 
could undergo a second β-hydride elimination/reinsertion process to afford III-65. 
Carbon–carbon bond-forming reductive elimination would generate regioisomer III-29 
with concomitant regeneration of the palladium(0) catalyst.9,12 
 





























III-63 III-64 III-65 III-29  
 
Formation of 3-aryl pyrrolidines side-products is observed in most 
carboamination reactions of γ-(N-arylamino) alkenes. However, this has only been 
observed in analogous reactions of γ-N-Boc-aminoalkenes when substrates bearing (Z)-
1,2-disubstituted alkenes are employed. The absence of these side-products in reactions 
of N-Boc and N-acyl protected substrates may result from a decrease in the rate of 
β−hydride elimination of intermediate III-56 relative to the analogous N-arylamino 
derivative (Scheme 14). This may be due to stabilization of III-56 through chelation of 
the metal to the carbonyl of the amide or carbamate,13 or due to electronic effects induced 




are known to facilitate β−hydride elimination by stabilizing the developing positive 
charge on the β−carbon in the transition state (Figure 3).14 The small size of the N-acyl 
and N-Boc substituents relative to N-aryl groups may also alter the rate of β−hydride 









Figure 3. Beta-Hydride Elimination Transition State III-66. 
 
 
The formation of regioisomeric product III-38 (eq 21) likely involves β-hydride 
elimination from the C2’ terminal carbon of intermediate III-67 (Scheme 17). The 
formation of a 2(1-phenylethyl)pyrolidine side-product has only been observed with 2-
bromochlorobenzene as coupling partner. The steric bulk at the metal center in III-67 
may slow reductive elimination and/or facilitate β-hydride elimination and migration 
towards C2’ to release steric strain. It appears that a considerable energy difference exists 
between diastereomeric intermediates III-67 and III-60 and/or the respective transition 
states for reductive elimination or β-hydride elimination from these intermediate (Scheme 
16) since the use of 2-bromochlorobenzene with N-protected (E)-aminoalkene substrate 
II-49 under the same conditions lead to a complex mixture of products with less than 


























The large energy difference between diastereomeric intermediates III-67 and III-
60 could also be responsible for the different regioselectivities observed in the reaction of 
electron-poor aryl bromide with N-protected (E)-aminoalkene substrate II-49 and N-
protected (Z)-aminoalkene substrate III-30. In the former case, a regioisomer was 
observed indicating that III-60 and/or the transition state leading to III-60 is higher in 
energy. In addition, formation of regioisomer III-29 was only observed in the cases of N-
Boc protected substrates. This is possibly due to steric reasons, the Boc t-butyl group 
being more bulky and less flexible that the Cbz benzyl group, thus disfavoring reductive 
elimination from III-60. Finally, a regioisomer was observed only in cases where an 
electron-poor aryl bromide was used (Table 8, entries 2-3). It is possible that an electron 
deficient aryl substituent on the palladium(II) species shown in III-60 would facilitate β-
hydride elimination due to the increased electrophilicity of the metal. The difference in 
reactivity between N-protected (E)-aminoalkene substrate II-49 and N-protected (Z)-
aminoalkene substrate III-30 presumably originates from a different rate of olefin 
insertion (Figure 4). This hypothesis implies an important energy difference between the 





















Figure 4. Transition State Analysis for (Z)- and (E)-Olefin Insertions 
 
Conclusion  
In conclusion, we have developed new conditions for palladium-catalyzed 
carboamination reactions of N-protected γ−aminoalkenes with aryl bromides and triflates. 
These conditions, which use Cs2CO3 or K3PO4 in place of the strong base NaOt-Bu, 
tolerate the presence of a broad array of functional groups, and significantly expand the 
scope of the carboamination methodology. In addition, the mild conditions also allow the 
cyclization of substrates containing 1,1- and 1,2-disubstituted alkenes, forming two 
stereocenters in one step in high diastereoselectivity. The mechanism of these reactions is 
likely analogous to that previously demonstrated for related reaction of γ-N-arylamino 
alkenes. Results from deuterium labeling studies indicate that the olefin insertion occurs 
in a syn fashion for both terminal and internal alkene substrates. Application of these new 
mild reaction conditions towards the synthesis of interesting benzocyclobutene 






General Considerations. All reactions were carried out under an argon or 
nitrogen atmosphere in oven- or flame-dried glassware. All catalysts, reagents, anhydrous 
dioxane, and anhydrous DME were obtained from commercial sources and were used 
without further purification. Pent-4-enyl-carbamic acid tert-butyl ester (II-5),15 N-pent-4-
enylacetamide (II-6),15 (3-methylpent-4-enyl)carbamic acid tert-butyl ester (II-7),15 (1-
phenylpent-4-enyl)carbamic acid tert-butyl ester (II-21),15 4-pentenylamine,15 4-
formylphenyl trifluromethanesulfonate,16 and 2-methylphenyltrifluoromethanesulfonate16 
were prepared according to published procedures. Ratios of regioisomers and/or 
diastereomers were determined by 1H NMR and/or capillary GC analysis of crude 
reaction mixtures. Yields refer to isolated yields of compounds estimated to be ≥95% 
pure as determined by 1H NMR, GC, and/or combustion analysis unless otherwise noted. 
The yields reported in the experimental section describe the result of a single experiment, 
whereas the yields reported in Tables 6–11, Scheme 2 and equation 21 are average yields 
of two or more experiments. Thus, the yields reported in the experimental section may 
differ from those shown in Tables 6–11, Scheme 2 and equation 21. 
 
Synthesis of Substrates 
4-Bromobenzyl acetate.2b A flame-dried flask equipped with a magnetic stirbar 
was cooled under a stream of nitrogen and charged with 4-bromobenzyl alcohol (4.0 g, 




mmol, 10 mol %). The tube was purged with nitrogen, and the mixture was stirred at rt 
for 22 h until the starting material had been consumed as determined by TLC analysis. 
Water (10 mL) and ethyl acetate (10 mL) were added, and the layers were separated. The 
organic layer was washed with 1 M aqueous HCl (10 mL) and brine (10 mL). The 
organic layer was then dried over Na2SO4, filtered, and concentrated in vacuo. The crude 
product was purified by flash chromatography using 5% ethyl acetate/hexanes as the 
eluent to afford 4.4 g (90%) of the title compound as a colorless oil. 1H NMR (400 MHz, 
CDCl3)  7.45 (d, J = 8.4 Hz, 2 H), 7.21 (d, J = 8.2 Hz, 2 H), 5.03 (s, 2 H), 2.08 (s, 3 H). 
 
Pent-4-enylcarbamic acid benzyl ester (III-2).17 A flame-dried flask was cooled 
under a stream of nitrogen and charged with a solution of 4-pentenylamine (175 mL, 17.5 
mmol, 0.1 M in diethyl ether). Triethylamine (7.4 mL, 52.5 mmol) and benzyl 
chloroformate (3.8 mL, 26.3 mmol) were added, and the resulting mixture was stirred at 
rt until the starting material was consumed as judged by TLC analysis (ca. 2 h). A 
solution of aqueous HCl (100 mL, 1.0 M) was added, the mixture was transferred to a 
separatory funnel, and was extracted with diethyl ether (100 mL). The layers were 
separated and the organic layer was washed with a solution of saturated aqueous Na2CO3 
(100 mL) and brine (100 mL). The organic layer was then dried over anhydrous Na2SO4, 
filtered and concentrated in vacuo. The crude material was purified by flash 
chromatography using 10%  15% ethyl acetate/hexanes as the eluent to afford 1.9 g 
(50%) of the title compound as a colorless oil. 1H NMR (400 MHz, CDCl3) 7.42–7.27 




H), 2.16–2.00 (m, 2 H), 1.67–1.52 (m, 2 H). 
 
3-Methylpent-4-enylcarbamic acid benzyl ester (III-11). A flame-dried flask 
was cooled under a stream of nitrogen and charged with 3-methylpent-4-enoic acid18 
(6.85 g, 60 mmol). The flask was purged with nitrogen, benzene (100 mL) was added and 
the resulting solution was cooled to ca. 10 °C using an ice water bath. Oxalyl chloride (14 
mL, 160 mmol) was added dropwise via syringe to the solution and the resulting mixture 
was warmed to rt, stirred for 1 h, and then concentrated in vacuo. The crude 3-
methylpentenoyl chloride product of this reaction was dissolved in THF (100 mL), and 
slowly added to a separate flask containing aqueous ammonium hydroxide (100 mL) at 0 
°C. The resulting mixture was stirred for 6 h and then concentrated in vacuo. The mixture 
was diluted with H2O (50 mL) and ethyl acetate (100 mL), the layers were separated and 
the aqueous layer was extracted with ethyl acetate (2 x 100 mL). The combined organic 
extracts were dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. 
The resulting crude 3-methylpent-4-enylcarboxamide was dissolved in THF (100 mL) 
and cooled to 0 °C. A solution of LiAlH4 in THF (200 mL, 200 mmol, 1.0 M) was added 
dropwise. The reaction mixture was warmed to rt and stirred for 36 h, then was cooled to 
0 °C, quenched with H2O (16 mL), and diluted with ether (200 mL). An aqueous solution 
of NaOH (30 mL, 10 M) was added and an insoluble white material precipitated. The 
organic supernatant was decanted to a clean Erlenmeyer flask and the precipitate was 
washed with ether (100 mL). The combined organic extracts were dried over anhydrous 
sodium sulfate and filtered to afford a solution of 3-methylpentenylamine in diethyl ether 




cooled to 0 °C, triethylamine (11.5 mL, 90 mmol) and benzyl chloroformate (6.6 mL, 45 
mmol) were added, and the resulting mixture was stirred at rt until the starting material 
was consumed as judged by TLC analysis (ca. 16 h). A solution of 1.0 M aqueous HCl 
(200 mL) was added, the mixture was transferred to a separatory funnel, and was 
extracted with diethyl ether (100 mL). The combined organic extracts were washed with 
saturated aqueous NaHCO3 (200 mL) and brine (100 mL). The organic layer was then 
dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The crude material was 
purified by flash chromatography using 5%  10% ethyl acetate/hexanes as the eluent to 
afford 1.2 g (17% over the five steps) of the title compound as a colorless oil. 1H NMR 
(400 MHz, CDCl3) δ 7.39–7.26 (m, 5 H), 5.73–5.60 (m, 1 H), 5.16–5.05 (m, 2 H), 5.02–
4.90 (m, 2 H), 4.87–4.58 (m, 1 H), 3.27–3.08 (m, 2 H), 2.25–2.11 (m, 1 H), 1.58–1.40 
(m, 2 H), 1.00 (d, J = 6.8 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 156.3, 143.6, 136.6, 
128.4, 128.1, 128.0, 113.4, 66.5, 39.2, 36.4, 35.6, 20.2; IR (film) 1706 cm–1. Anal calcd 
for C14H19NO2: C, 72.07; H, 8.21; N, 6.00. Found: C, 72.28; H, 8.29; N, 6.08. 
 
1-Phenylpent-4-enylcarbamic acid benzyl ester (III-15). Treatment of a 
solution of 1-phenylpent-4-enyl-amine1 in diethyl ether (250 mL, 25 mmol, 0.1 M) with 
triethylamine (9.6 mL, 75 mmol) and benzyl chloroformate (5.5 mL, 37.5 mmol) using a 
procedure analogous to that described above for the synthesis of 6 afford 3.86 g (52%) of 
the title compound as a waxy white solid, m.p. 51–53 °C. 1H NMR (400 MHz, CDCl3) 
δ 7.54–6.97 (m, 10 H), 5.86–5.65 (m, 1 H), 5.43–5.21 (m, 1 H), 5.14–4.90 (m, 4 H), 




CDCl3) δ 155.6, 142.3, 137.4, 136.4, 128.5, 128.4, 128.0, 127.2, 126.3, 115.2, 66.6, 54.9, 
35.6, 30.2 (two aromatic carbons are incidentally equivalent); IR (film) 1710 cm–1. Anal 
calcd for C19H21NO2: C, 77.26; H, 7.17; N, 4.74. Found: C, 77.06; H, 7.19; N, 4.69. 
 
(E)-tert-Butyl hex-4-enylcarbamate (II-49). A flame-dried flask equipped with a 
distillation apparatus and magnetic stirbar was cooled under a stream of nitrogen and 
charged with 3-buten-2-ol (6.4 g, 100 mmol), triethyl orthoacetate (37 mL) and acetic 
acid (0.4 mL, 0.006 mmol). The mixture was heated until all the ethanol generated in the 
reaction had distilled over (80  120 oC).  The mixture was then heated to 140 oC with 
stirring for 12 h. The solution was cooled to rt, tetrahydrofuran (50 mL) and 1 M HCl 
(100 mL) were added and the mixture was stirred at rt for 1 h. Ethyl acetate (50 mL) was 
added and the layers were separated. The organic layer was washed with water (50 mL) 
and brine (30 mL). The organic layer was then dried over Na2SO4, filtered, and 
concentrated in vacuo. The crude product was purified by flash chromatography using 
5% ethyl acetate/hexanes as the eluent to afford 7.5 g (53%) of (E)-ethyl hex-4-enoate19 
as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 5.54–5.38 (m, 2 H), 4.13 (p, J = 7.1 Hz, 
2 H), 2.37–2.33 (m, 2 H), 2.32–2.27 (m, 2 H), 1.66–1.63 (m, 3 H), 1.25 (t, J = 7.1 Hz, 3 
H). 
A flame-dried flask was cooled under a stream of nitrogen and charged with 
ammonium chloride (4.3 g, 80.1 mmol), and toluene (100 mL), and was cooled to 0 oC. A 
solution of trimethylaluminum in toluene (40 mL, 80 mmol, 2.0 M) was then added 




observed). To another flame-dried flask cooled under a stream of nitrogen was added (E)-
ethyl hex-4-enoate (4.6 g, 32.0 mmol), and toluene (30 mL) and the solution was cooled 
to 0 oC. The first solution was then added dropwise to this mixture slowly.  The resulting 
mixture was heated to 50 oC with stirring until the starting material was consumed as 
judged by TLC analysis (ca. 18h). The mixture was cooled to 0 oC and a 1 M solution of 
HCl was added slowly dropwise (60 mL). Ethyl acetate was added and the layers were 
separated. The organic layer was washed with a solution of saturated aqueous NaHCO3 
(100 mL) and brine (100 mL). The organic layer was then dried over anhydrous Na2SO4, 
filtered and concentrated in vacuo to afford 2.39 g (66%) of (E)-hex-4-enamide20 as a 
white solid; m.p. 97-98 oC (lit. m.p. 98-100 oC)20 that was used without further 
purification. 1H NMR (500 MHz, CDCl3) δ 5.92 (s, br, 1 H), 5.61 (s, br, 1 H), 5.56–5.48 
(m, 1 H), 5.47–5.40 (m, 1 H), 2.35–2.25 (m, 4 H), 1.67–1.64 (m, 3 H). 
A flame-dried round-bottom flask was cooled under a stream of nitrogen and 
charged with (E)-hex-4-enamide (2.83 g, 25 mmol). The flask was purged with nitrogen, 
THF (100 mL) was added, and the resulting solution was cooled to 0 oC. A solution of 
LiAlH4 in THF (75 mL, 75 mmol, 1.0 M) was added dropwise. The reaction mixture was 
warmed to rt and stirred for 21 h, then was cooled to 0 oC, quenched with H2O (10 mL), 
and diluted with ether (50 mL).  An aqueous solution of NaOH (20 mL, 10 M) was added 
followed by H2O (4 mL), and an insoluble white material precipitated. The organic 
supernatant was decanted to a clean Erlenmeyer flask and the precipitate was washed 
with ether (150 mL).  The combined extracts were dried over anhydrous sodium sulfate 




which was used without purification. 
A flame-dried round-bottom flask was cooled under a stream of nitrogen and 
charged with a solution of (E)-hex-4-en-1-yl-amine (250 mL, 25 mmol, 0.1M). Di-tert-
butyl dicarbonate (8.2 g, 37.5 mmol) was added to the solution and the resulting mixture 
was stirred for 3 h and then aqueous NaOH (200 mL, 1.0 M) was added. The biphasic 
mixture was vigorously stirred for 12 h and then the layers were separated. The aqueous 
layer was extracted with diethyl ether (3 x 100 mL).  The combined organic layers were 
dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo.  The crude 
product was then purified by flash chromatography using 5%  10% ethyl 
acetate/hexanes as the eluent to afford 3.56 g (71%) of the title compound as a colorless 
oil. 1H NMR (500 MHz, CDCl3) δ 5.49–5.36 (m, 2 H), 4.65 (s br, 1 H), 3.16–3.04 (m, 2 
H), 2.03–1.97 (m, 2 H), 1.64 (d, J = 5.4 Hz, 3 H), 1.53 (p, J = 7.1 Hz, 2 H), 1.44 (s, 9 H); 
13C NMR (125 MHz, CDCl3) δ 155.9, 130.2, 125.4, 78.8, 40.0, 29.7, 28.3, 17.8 (two 
aliphatic carbons are incidentally equivalent). IR (film) 1694 cm–1. MS (ESI): 222.1463 
(222.1470 calculated for C11H21NO2, M + Na+). 
 
(E)-Benzyl hex-4-enylcarbamate (III-26). Treatment of a solution of (E)-hex-4-
en-1-yl-amine (prepared as described above) in diethyl ether (210 mL, 21 mmol, 0.1 M) 
with triethylamine (8.5 mL, 63 mmol) and benzyl chloroformate (6.0 mL, 42 mmol) 
using a procedure analogous to that described above for the synthesis of (II-49) afforded 
3.4 g (69%) of the title compound as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.42–




Hz, 2 H), 2.08–1.95 (m, 2 H), 1.63 (d, J = 4.9 Hz, 3 H), 1.54 (p, J = 7.2 Hz, 2 H); 13C 
NMR (125 MHz, CDCl3) δ 156.3, 136.6, 130.1, 128.4, 128.1, 128.0, 125.7, 66.5, 40.5, 
29.7, 29.6, 17.8; IR (film) 1706 cm–1. MS (ESI): 256.1319 (256.1313 calculated for 
C14H19NO2, M + Na+). 
 
(Z)-tert-Butyl hex-4-enylcarbamate (III-30). A flame-dried flask was cooled 
under a stream of nitrogen and charged with phthalimide (6 g, 40.8 mmol), 
triphenylphosphine (7.85 g, 30 mmol), THF (120 mL), and cis-4-hexenol (2.5 g, 25 
mmol). The resulting mixture was cooled to 0 oC, and diethylazodicarboxylate (4.72 mL, 
30 mmol) was added slowly over 15 min.  The mixture was allowed to warm to rt and 
was stirred until the starting material was consumed as judged by TLC analysis (ca. 3h). 
Hexanes (500 mL) was added to the mixture and an insoluble white material precipitated.  
The solution was filtered through a fritted funnel and the residue was rinsed with a 
solution of 5% EtOAc/Hexanes (3 x 100 mL). The filtrate was concentrated in vacuo and 
the crude material was purified by flash chromatography using 10%  20% ethyl 
acetate/hexanes as the eluent to afford 4.75 g (83%) of (Z)-2-(hex-4-enyl)isoindoline-1,3-
dione21 as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.84–7.79 (m, 2 H), 7.73–7.69 
(m, 2 H), 5.51–5.43 (m, 1 H), 5.42–5.35 (m, 1 H), 3.69 (t, J = 6.3 Hz, 2 H), 2.11 (q, J = 
7.3 Hz, 2 H), 1.75 (p, J = 7.6 Hz, 2 H), 1.61–1.57 (m, 3 H). 
A flame-dried flask was cooled under a stream of nitrogen and charged with (Z)-
2-(hex-4-enyl)isoindoline-1,3-dione (4.75 g, 20.7 mmol), ethanol (80 mL), and hydrazine 




starting material was consumed as judged by TLC analysis (ca. 16h). The reaction 
mixture was cooled to rt and di-tert-butyl dicarbonate (10.4 g, 37.5 mmol) was added. 
The resulting mixture was stirred at rt for 4 h and then aqueous 1 M NaOH (200 mL) was 
added. The biphasic mixture was vigorously stirred for 12 h and the mixture was 
concentrated in vacuo. The aqueous layer was extracted with diethyl ether (3 x 100 mL), 
and the combined organic layers were then dried over anhydrous sodium sulfate, filtered, 
and concentrated in vacuo.  The crude product was purified by flash chromatography 
using 10% ethyl acetate/hexanes as the eluent to afford 4.03 g (98%) of the title 
compound as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 5.53–5.42 (m, 1 H), 5.41–
5.32 (m, 1 H), 4.56 (s, br, 1 H), 3.18–3.06 (m, 2 H), 2.07 (q, J = 7.2 Hz, 2 H), 1.62–1.58 
(m, 3 H), 1.57–1.50 (m, 2 H), 1.44 (s, 9 H); 13C NMR (100 MHz, CDCl3) δ 155.9, 129.5, 
124.6, 77.3, 40.2, 29.8, 28.4, 24.1, 12.7; IR (film) 1694 cm–1. MS (ESI): 222.1471 
(222.1470 calculated for C11H21NO2, M + Na+). 
 
(Z)-Benzyl hex-4-enylcarbamate (III-35). A solution of (Z)-hex-4-en-1-yl-
amine in ethanol (200 mL, 13.7 mmol, 0.07 M) obtained via the procedure described 
above for the synthesis of 30 was treated with triethylamine (8.5 mL, 63 mmol) and 
benzyl chloroformate (6.0 mL, 42 mmol) at rt.  The mixture was stirred for 12 h and was 
then concentrated in vacuo. The aqueous layer was extracted with diethyl ether (3 x100 
mL), and the combined organic layers were dried over anhydrous sodium sulfate, filtered, 
and concentrated in vacuo.  The crude product was then purified by flash chromatography 




compound as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.41–7.28 (m, 5 H), 5.54–
5.42 (m, 1 H), 5.41–5.30 (m, 1 H), 5.19–5.05 (m, 2 H), 4.83 (s, br, 1 H), 3.26–3.11 (m, 2 
H), 2.14–2.01 (m, 2 H), 1.66–1.48 (m, 4 H); 13C NMR (100 MHz, CDCl3) δ 156.3, 136.6, 
129.3, 128.4, 128.1, 128.0, 124.7, 66.5, 40.7, 29.6, 24.0, 12.7; IR (film) 1704 cm–1. MS 
(ESI): 256.1314 (256.1313 calculated for C14H19NO2, M + Na+). 
 
tert-Butyl 5-methylhex-5-enoate (III-41). A flame-dried flask equipped with a 
distillation apparatus and magnetic stirbar was cooled under a stream of nitrogen and 
charged with 2-methyl-propen-1-ol (3.6 g, 50.0 mmol), triethyl orthoacetate (22 mL) and 
acetic acid (0.2 mL, 0.003 mmol). The mixture was heated until all the ethanol generated 
in the reaction had distilled over (80  120 oC).  The mixture was then heated to 140 oC 
with stirring for 15 h. The solution was cooled to rt, tetrahydrofuran (25 mL) and 1 M 
HCl were added and the mixture was stirred at rt for 1 h. Ethyl acetate (50 mL) was 
added and the layers were separated. The organic layer was washed with water (50 mL) 
and brine (30 mL). The organic layer was then dried over Na2SO4, filtered, and 
concentrated in vacuo. The crude product was purified by flash chromatography using 
5% ethyl acetate/hexanes as the eluent to afford 4.5 g (64%) of ethyl 4-methylpent-4-
enoate22 as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 4.74 (s, 1 H), 4.69 (s, 1 H), 4.13 
(q, J = 7.1 Hz, 2 H), 2.47–2.42 (m, 2 H), 2.37–2.31 (m, 2 H), 1.74 (s, 3 H), 1.25 (t, J = 
7.1 Hz, 3 H). 
A flame-dried flask was cooled under a stream of nitrogen and charged with 




solution of trimethylaluminum in toluene (35 mL, 70 mmol, 2.0 M) was then added 
slowly.  The mixture was allowed to warm up to rt and was stirred for 30 min (bubbling 
was observed). To another flame-dried flask cooled under a stream of nitrogen was added 
ethyl 4-methylpent-4-enoate (3.0 g, 21.1 mmol), and toluene (20 mL), and the solution 
was cooled to 0 oC. The first solution was then added dropwise to this mixture slowly.  
The resulting mixture was heated to 50 oC with stirring until the starting material was 
consumed as judged by TLC analysis (ca. 22h). The mixture was cooled to 0 oC and a 1 
M solution of HCl was added slowly dropwise (60 mL). Ethyl acetate was added and the 
layers were separated. The organic layer was washed with a solution of saturated aqueous 
NaHCO3 (100 mL) and brine (100 mL). The organic layer was then dried over anhydrous 
Na2SO4, filtered and concentrated in vacuo to afford 965 mg (40%) of 4-methylpent-4-
enamide23 as a white solid; m.p. 80-81 oC (lit. m.p. 79-80 oC)23 that was used without 
further purification. 1H NMR (500 MHz, CDCl3) δ 5.87 (s, br, 1 H), 5.62 (s, br, 1 H), 
4.81–4.71 (m, 2 H), 2.43–2.32 (m, 4 H), 1.76 (s, 3 H). 
A flame-dried round-bottom flask was cooled under a stream of nitrogen and 
charged with of 4-methylpent-4-enylamide (965 mg, 8.5 mmol). The flask was purged 
with nitrogen, THF (20 mL) was added via syringe and the resulting solution was cooled 
to 0 oC. A solution of LiAlH4 in THF (35 mL, 35 mmol, 1.0 M) was added dropwise via 
syringe. The reaction mixture was warmed to rt, and stirred for 20 h, then was cooled to 0 
oC, quenched with H2O (5 mL), and diluted with ether (20 mL).  An aqueous solution of 
NaOH (10 mL, 10 M) was added followed by H2O (2 mL), and an insoluble white 




and the precipitate was washed with ether (60 mL).  The combined organic layers were 
dried over anhydrous sodium sulfate and filtered to afford a solution of 4-methylpent-4-
en-1-yl-amine24 in diethyl ether (ca 0.1 M), which was used without purification. 
 
A flame-dried round-bottom flask was cooled under a stream of nitrogen and 
charged with a solution of 4-methylpent-4-en-1-yl-amine (85 mL, 8.5 mmol, 0.1M). Di-
tert-butyl dicarbonate (2.8 g, 12.8 mmol) was added to the solution, the resulting mixture 
was stirred for 4 h, and then aqueous 1M NaOH (100 mL) was added.  The biphasic 
mixture was vigorously stirred for 12 h and then the layers were separated. The aqueous 
layer was extracted with diethyl ether (3 x 75 mL).  The combined organic layers were 
dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo. The crude 
product was then purified by flash chromatography using 5%  10% ethyl 
acetate/hexanes as the eluent to afford 1.1 g (62%) of the title compound as a colorless 
oil. 1H NMR (500 MHz, CDCl3) δ 4.84 (s br, 1 H), 4.75–4.67 (m, 2 H), 3.16–3.04 (m, 2 
H), 2.03 (t, J = 7.6 Hz, 2 H), 1.72 (s, 3 H), 1.63 (p, J = 7.6 Hz, 2 H), 1.44 (s, 9 H); 13C 
NMR (125 MHz, CDCl3) δ 155.8, 144.7, 110.1, 78.6, 40.1, 34.8, 28.2, 27.8, 22.1; IR 
(film) 1692 cm–1. MS (ESI): 222.1465 (222.1470 calculated for C11H21NO2, M + Na+). 
 
Benzyl 4-methylpent-4-enylcarbamate (III-42). A flame-dried round-bottom 
flask was cooled under a stream of nitrogen and charged with a solution of 4-methylpent-
4-en-1-yl-amine (87 mL, 8.7 mmol, 0.1 M) obtained via the procedure above, and was 
cooled to 0 °C. Triethylamine (3.5 mL, 26.2 mmol) and benzyl chloroformate (2.5 mL, 




material was consumed as judged by TLC analysis (ca. 24 h). A solution of 1 M aqueous 
HCl (100 mL) was added, the mixture was transferred to a separatory funnel, and was 
extracted with diethyl ether (3 x 50 mL). The combined organic layers were washed with 
saturated aqueous NaHCO3 (100 mL) and brine (100 mL). The organic layer was then 
dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The crude material 
was purified by flash chromatography using 10% ethyl acetate/hexanes as the eluent to 
afford 1.3 g (64%) of the title compound as a colorless oil. 1H NMR (500 MHz, CDCl3) 
δ 7.39–7.27 (m, 5 H), 5.17–5.06 (m, 2 H), 4.85 (s, br, 1 H), 4.75–4.64 (m, 2 H), 3.24–
3.09 (m, 2 H), 2.03 (t, J = 7.6 Hz, 2 H), 1.71 (s, 3 H), 1.64 (p, J = 7.6 Hz, 2 H); 13C NMR 
(125 MHz, CDCl3) δ 155.8, 144.7, 110.1, 78.6, 40.1, 34.8, 28.2, 27.8, 22.1; IR (film) 
1699 cm–1. MS (ESI): 256.1307 (256.1313 calculated for C14H19NO2, M + Na+). 
 
Synthesis of Functionalized Pyrrolidines via Coupling with Aryl Bromides 
(Tables 6–7 and Scheme 12) 
General Procedure A for Pd-Catalyzed Carboamination Reactions of Aryl 
Bromides. A flame-dried Schlenk tube equipped with a magnetic stirbar was cooled 
under a stream of nitrogen and charged with the aryl bromide (1.2 equiv), Pd(OAc)2 (2 
mol %), Dpe-phos (4 mol %) and Cs2CO3 (2.3 equiv). The tube was purged with nitrogen 
and a solution of the N-protected amine substrate (1.0 equiv) in dioxane (5 mL/mmol 
substrate) was then added via syringe. The resulting mixture was heated to 100 °C with 
stirring until the starting material had been consumed as determined by GC analysis. The 




and ethyl acetate (1 mL) were added. The layers were separated, the aqueous layer was 
extracted with ethyl acetate (3 x 5 mL), and the combined organic layers were dried over 
Na2SO4, filtered, and concentrated in vacuo. The crude product was then purified by flash 
chromatography on silica gel. 
 
2-(4-tert-Butylbenzyl)pyrrolidine-1-carboxylic acid tert-butyl ester (III-1). 
General procedure A was employed for the reaction of 4-tert-butyl bromobenzene (52 
μL, 0.30 mmol) with pent-4-enyl-carbamic acid tert-butyl ester (47 mg, 0.25 mmol). This 
procedure afforded 66 mg (83%) of the title compound as a pale yellow oil. 1H NMR 
(300 MHz, CDCl3) δ 7.38–7.26 (m, 2 H), 7.22–7.07 (m, 2 H), 4.12–3.84 (m, 1 H), 3.49–
3.23 (m, 2 H), 3.23–2.96 (m, 1 H), 2.60–2.42 (m, 1 H), 1.92–1.67 (m, 4 H), 1.55–1.48 (s, 
9 H), 1.36–1.28 (s, 9 H); 13C NMR (100 MHz, CDCl3) δ 154.5, 148.9, 136.1, 129.1, 
125.2, 79.0, 58.8, 46.4, 40.0, 34.3, 31.4, 29.7, 28.6, 22.7; IR (film) 1695 cm–1. Anal calcd 
for C20H31NO2: C, 75.67; H, 9.84; N, 4.41. Found: C, 75.46; H, 9.88; N, 4.38. 
 
2-Napthalen-2-ylmethylpyrrolidine-1-carboxylic acid tert-butyl ester (III-
3).15 General procedure A was employed for the reaction of 2-bromonapthalene (62 mg, 
0.30 mmol) with pent-4-enyl-carbamic acid tert-butyl ester (47 mg, 0.25 mmol). This 
procedure afforded 58 mg (75%) of the title compound as a colorless oil. 1H NMR (300 
MHz, CDCl3) 7.85–7.74 (m, 3 H), 7.66–7.60 (m, 1 H), 7.51–7.40 (m, 2 H), 7.40–7.33 




H), 1.56–1.50 (s, 9 H). 
 
2-(4-Formylbenzyl)pyrrolidine-1-carboxylic acid tert-butyl ester (III-5). 
General procedure A was employed for the reaction of 4-bromobenzaldehyde (89 mg, 
0.48 mmol) with pent-4-enyl-carbamic acid tert-butyl ester (74 mg, 0.40 mmol) except 
DME was used in place of dioxane and the reaction was conducted at 85 °C. This 
procedure afforded 94 mg (81%) of the title compound as a colorless oil. This compound 
was found to exist as a 1:1 mixture of rotamers as judged by 13C NMR analysis; data are 
for the mixture. 1H NMR (400 MHz, CDCl3) δ 9.97 (s, 1 H), 7.80 (d, J = 8.0 Hz, 2 H), 
7.41–7.29 (m, 2 H), 4.13–3.92 (m, 1 H), 3.46–3.01 (m, 3 H), 2.74–2.58 (m, 1 H), 1.85-
1.60 (m, 4 H), 1.52–1.45 (s, 9 H); 13C NMR (100 MHz, CDCl3) δ 191.9, 154.4, 146.6, 
134.7, 130.1, 129.8, 79.3, 58.4, 46.3, 40.8, 39.9, 29.6, 28.5, 28.3, 23.4, 22.6; IR (film) 
1693, 1606 cm–1. Anal calcd for C17H23NO3: C, 70.56; H, 8.01; N, 4.84. Found: C, 70.45; 
H, 8.14; N, 4.72. 
 
2-(4-Acetylbenzyl)pyrrolidine-1-carboxylic acid tert-butyl ester (III-6). 
General procedure A was employed for the reaction of 4-bromoacetophenone (120 mg, 
0.60 mmol) with pent-4-enyl-carbamic acid tert-butyl ester (93 mg, 0.50 mmol) except 
DME was used in place of dioxane and the reaction was conducted at 85 °C. This 
procedure afforded 118 mg (78%) of the title compound as a white solid, m.p. 63–65 °C. 
This compound was found to exist as a 1:1 mixture of rotamers as judged by 1H NMR 




7.35–7.22 (m, 2 H), 4.11–3.94 (m, 1 H), 3.46–3.04 (m, 3 H), 2.74–2.55 (m, 4 H), 1.85–
1.60 (m, 4 H), 1.51 (s, 9 H); 13C NMR (125 MHz, CDCl3) δ 197.9, 197.7, 154.5, 154.4, 
145.0, 144.9, 135.3, 135.2, 129.7, 129.5, 128.5, 128.3, 79.4, 79.1, 58.5, 58.3, 46.7, 46.2, 
40.6, 39.6, 29.7, 28.9, 28.5, 26.5, 23.4, 22.6; IR (film) 1686, 1607 cm–1. Anal calcd for 
C18H25NO3: C, 71.26; H, 8.31; N, 4.62. Found: C, 71.18; H, 8.30; N, 4.60. 
 
1-[2-(Naphthalen-2-ylmethyl)pyrrolidin-1-yl]ethanone (III-7).1 General 
procedure A was employed for the reaction of 2-bromonapthalene (125 mg, 0.60 mmol) 
with N-pent-4-enyl-acetamide (64 mg, 0.50 mmol). This procedure afforded 101 mg 
(80%) of the title compound as a pale yellow oil. This compound was found to exist as a 
~ 3:1 mixture of rotamers as judged by 1H NMR analysis; data are for the mixture. 1H 
NMR (400 MHz, CDCl3) δ 7.84–7.74 (m, 3 H), 7.66–7.58 (m, 1 H), 7.51–7.37 (m, 2.3 
H), 7.32–7.27 (m, 0.7 H), 4.45–4.37 (m, 0.7 H), 4.17–4.09 (m, 0.3 H), 3.63–3.49 (m, 0.7 
H), 3.45–3.32 (m, 2 H), 3.09–3.02 (m, 0.3 H), 2.86–2.69 (m, 1 H), 2.11 (s, 2 H), 2.06 (s, 
1 H), 1.96–1.72 (m, 4 H). 
 
1-[2-(4-Nitrobenzyl)pyrrolidin-1-yl]ethanone (III-8). General procedure A was 
employed for the reaction of 1-bromo-4-nitrobenzene (97 mg, 0.48 mmol) with N-pent-4-
enyl-acetamide (51 mg, 0.4 mmol) except dppe was used in place of Dpe-phos as ligand, 
DME was used in place of dioxane and the reaction was conducted at 85 °C. This 
procedure afforded 77 mg (77%) of the title compound as a white solid, m.p. 139–140 
°C. This compound was found to exist as a ~ 7:1 mixture of rotamers as judged by 1H 




Hz, 0.3 H), 8.12 (d, J = 8.8 Hz, 1.7 H), 7.38 (d, J = 8.8 Hz, 1.7 H), 7.32 (d, J = 8.8 Hz, 
0.3 H), 4.34–4.24 (m, 0.85 H), 4.11–4.03 (m, 0.15 H), 3.64–3.51 (m, 0.3 H), 3.50–3.35 
(m, 1.7 H), 3.28 (dd, J = 3.4, 13.2 Hz, 0.85 H), 2.97 (dd, J = 5.2, 13.2 Hz, 0.15 H), 2.80 
(dd, J = 8.8, 13.6 Hz, 0.15 H), 2.68 (dd, J = 9.2, 13.2 Hz, 0.85 H), 2.07 (s, 2.55 H), 1.99 
(s, 0.45 H), 1.94–1.73 (m, 3.15 H), 1.71–1.60 (m, 0.85 H); 13C NMR (100 MHz, CDCl3) 
δ 169.4, 168.9, 147.0, 146.5, 145.5, 130.2, 130.0, 123.8, 123.5, 59.4, 57.9, 47.8, 45.4, 
40.6, 38.8, 30.1, 28.5, 23.7, 22.9 22.0, 21.7; IR (film) 1640, 1516 cm–1. Anal calcd for 
C13H16N2O3: C, 62.89; H, 6.50; N, 11.28. Found: C, 62.85; H, 6.44; N, 11.08. 
 
2-(Naphthalen-2-ylmethyl)pyrrolidine-1-carboxylic acid benzyl ester (III-9). 
General procedure A was employed for the reaction of 2-bromonaphthalene (125 mg, 0.6 
mmol) with pent-4-enylcarbamic acid benzyl ester (110 mg, 0.5 mmol). This procedure 
afforded 151 mg (88%) of the title compound as a colorless oil. This compound was 
found to exist as a 1:1 mixture of rotamers as judged by 1H NMR analysis; data are for 
the mixture. 1H NMR (500 MHz, CDCl3) δ 7.85–7.63 (m, 3.5 H), 7.56–7.32 (m, 7.5 H), 
7.25–7.19 (m, 1 H), 5.27–5.16 (m, 2 H), 4.28–4.12 (m, 1 H), 3.54–3.35 (m, 2.5 H), 3.25–
3.16 (m, 0.5 H), 2.82–2.69 (m, 1 H), 1.87–1.72 (m, 4 H); 13C NMR (125 MHz, CDCl3) 
δ 154.9, 154.8, 137.1, 136.8, 136.5, 136.4, 133.4, 132.1, 128.4, 128.1, 128.0, 127.9, 
127.85, 127.79, 127.74, 127.65, 127.6, 127.4, 125.93, 125.86, 125.34, 125.26, 67.0, 66.5, 
59.3, 58.8, 46.8, 46.6, 40.8, 39.6, 29.7, 28.9, 23.5, 22.7; IR (film) 1698 cm–1. Anal calcd 
for C23H23NO2: C, 79.97; H, 6.71; N, 4.05. Found: C, 80.01; H, 6.78; N, 4.11. 
 




(III-10). General procedure A was employed for the reaction of methyl 4-bromobenzoate 
(129 mg, 0.6 mmol) with pent-4-enylcarbamic acid benzyl ester (110 mg, 0.5 mmol) 
except DME was used in place of dioxane and the reaction was conducted at 85 °C. This 
procedure afforded 152 mg (86%) of the title compound as a pale yellow oil. This 
compound was found to exist as a 1:1 mixture of rotamers as judged by 1H NMR 
analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.98–7.86 (m, 2 H), 
7.44–7.23 (m, 6 H), 7.16–7.08 (m, 1 H), 5.22–5.11 (m, 2 H), 4.18–4.02 (m, 1 H), 3.90 (s, 
3 H), 3.51–3.31 (m, 2 H), 3.28–3.17 (m, 0.5 H), 3.11–3.00 (m, 0.5 H), 2.76–2.58 (m, 1 
H), 1.88–1.61 (m, 4 H); 13C NMR (100 MHz, CDCl3) δ 167.1, 167.0, 154.8, 144.4, 144.3, 
137.0, 136.7, 129.64, 129.56, 129.3, 128.5, 128.2, 128.1, 127.9, 127.8, 67.0, 66.5, 58.9, 
58.5, 52.0, 46.8, 46.6, 40.7, 39.5, 29.8, 28.9, 23.5, 22.7; IR (film) 1721, 1700 cm–1. Anal 
calcd for C21H23NO4: C, 71.37; H, 6.56; N, 3.96. Found: C, 71.15; H, 6.62; N, 4.03. 
 
(±)–(2R,3S)-2-[4-(Acetoxymethyl)benzyl]-3-methylpyrrolidine-1-carboxylic 
acid benzyl ester (III-12). General procedure A was employed for the reaction of 4-
bromobenzyl acetate (138 mg, 0.6 mmol) with 3-methylpent-4-enylcarbamic acid benzyl 
ester (117 mg, 0.5 mmol). The diastereoselectivity of the transformation was assessed by 
LAH reduction of the crude product obtained in a duplicate reaction, and was found to be 
12:1 dr as judged by 1H NMR analysis. The minor diastereomer was separated upon 
chromatographic purification to afford 143 mg (82%) of the title compound as a colorless 
oil with >20:1 dr. Data are for the major diastereomer, which was found to exist as a 1:1 




(500 MHz, CDCl3) δ 7.42–7.29 (m, 5 H), 7.28–7.13 (m, 3 H), 7.09–7.02 (m, 1 H), 5.23–
5.10 (m, 2 H), 5.09–5.02 (m, 2 H), 3.73–3.48 (m, 2 H), 3.34–3.18 (m, 1 H), 3.15–3.07 
(m, 0.5 H), 3.01–2.92 (m, 0.5 H), 2.82–2.73 (m, 0.5 H), 2.70–2.61 (m, 0.5 H), 2.12–1.99 
(m, 4 H), 1.94–1.80 (m, 1 H), 1.50–1.37 (m, 1 H), 0.87 (d, J = 6.6 Hz, 3 H); 13C NMR 
(125 MHz, CDCl3) δ 170.9, 155.1, 154.9, 138.8, 137.1, 136.8, 133.9, 133.7, 129.8, 129.6, 
128.5, 128.4, 128.3, 128.0, 127.9, 127.8, 67.0, 66.5, 66.15, 66.09, 65.9, 65.7, 45.4, 45.2, 
39.9, 38.3, 36.8, 35.8, 31.1, 30.2, 21.0, 19.3, 19.1. IR (film) 1740, 1698 cm–1. MS (ESI): 
404.1839 (404.1838 calculated for C20H27NO4, M + Na+). 
The stereochemistry of the above compound was assigned based on comparison 
of 1H and 13C NMR spectra to those obtained for the related product III-51, the 




butyl ester (III-13). General procedure A was employed for the reaction of 4-
bromoanisole (38 μL, 0.3 mmol) with 3-methylpent-4-enylcarbamic acid benzyl ester (50 
mg, 0.25 mmol). The diastereoselectivity of the transformation was assessed by TFA-
mediated deprotection of the crude product obtained in a duplicate reaction, and was 
found to be 15:1 dr as judged by 1H NMR analysis. The minor diastereomer was 
separated upon chromatographic purification to afford 58 mg (78%) of the title 
compound as a pale yellow oil with >20:1 dr. Data are for the major diastereomer, which 




for the mixture of rotamers. 1H NMR (400 MHz, CDCl3) δ 7.14–7.03 (m, 2 H), 6.86–6.78 
(m, 2 H), 3.79 (s, 3 H), 3.63–3.34 (m, 2 H), 3.26–3.06 (m, 1 H), 3.05–2.89 (m, 1 H), 
2.75–2.52 (m, 1 H), 2.09–1.95 (m, 1 H), 1.91–1.75 (m, 1 H), 1.51 (s, 9 H), 1.45–1.30 (m, 
1 H), 0.85 (d, J = 6.8 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 158.1, 154.7, 131.0, 
130.6, 130.3, 113.8, 113.6, 79.2, 78.9, 65.9, 65.5, 55.2, 45.5, 44.9, 39.1, 37.7, 36.7, 35.8, 
31.1, 30.3, 28.6, 19.4, 19.2; IR (film) 1692 cm–1. Anal calcd for C18H27NO3: C, 70.79; H, 
8.91; N, 4.59. Found: C, 70.56; H, 8.87; N, 4.60. 
The stereochemistry of the above compound was determined by 1H NMR nOe 
analysis of the product obtained through treatment of III-13 with TFA to afford III-13a 
















trifluoroacetate (III-13a). A flame-dried flask was cooled under a stream of nitrogen 
and charged with III-13 (42 mg, 0.14 mmol). Methylene chloride (1 mL) was added and 
the mixture was cooled to 0 °C. Trifluoroacetic acid (1 mL) was then added slowly and 
the resulting mixture was stirred at rt for 25 min. The crude mixture was concentrated in 
vacuo to afford 41 mg (96%) of the title compound as a yellow oil. 1H NMR (500 MHz, 
CDCl3) δ 9.41 (s, br, 1 H), 8.74 (s, br, 1 H), 7.10 (d, J = 8.5 Hz, 2 H), 6.80 (d, J = 8.5 Hz, 




(m, 2 H), 2.23–2.15 (m, 1 H), 2.14–2.05 (m, 1 H), 1.66–1.57 (m, 1 H), 0.99 (d, J = 6.6 
Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 161.5 (q, J = 36.8 Hz), 158.8, 129.9, 127.6, 
116.1 (q, J = 290.4 Hz), 114.2, 66.8, 55.1, 43.4, 38.3, 36.0, 32.2, 16.8; IR (film) 3502, 




butyl ester (III-14). General procedure A was employed for the reaction of 1-bromo-3-
nitrobenzene (122 mg, 0.6 mmol) with (1-phenylpent-4-enyl)carbamic acid tert-butyl 
ester (131 mg, 0.5 mmol). The diastereoselectivity of the transformation was assessed by 
TFA-mediated deprotection of the crude product obtained in a duplicate reaction, and 
was found to be >20:1 dr as judged by 1H NMR analysis. Chromatographic purification 
afforded 151 mg (79%) of the title compound as a colorless oil with >20:1 dr. 1H NMR 
(500 MHz, CDCl3) δ 8.16–8.05 (m, 2 H), 7.72–7.52 (m, 1 H), 7.50–7.44 (m, 1 H), 7.36–
7.16 (m, 5 H), 5.08–4.68 (m, 1 H), 4.28–4.09 (m, 1 H), 3.69–3.43 (m, 1 H), 2.88–2.76 
(m, 1 H), 2.36–2.24 (m, 1 H), 2.01–1.92 (m, 1 H), 1.91–1.81 (m, 1 H), 1.75–1.66 (m, 1 
H), 1.65–1.05 (m, 9 H); 13C NMR (100 MHz, CDCl3) δ 154.8, 148.2, 144.3, 141.1, 135.7, 
129.3, 128.2, 126.6, 125.5, 124.1, 121.4, 79.7, 63.0, 60.4, 40.6, 34.3, 28.1 (two aliphatic 
carbons are incidentally equivalent); IR (film) 1687, 1530 cm–1. Anal calcd for 
C22H26N2O4: C, 69.09; H, 6.85; N, 7.32. Found: C, 68.97; H, 6.98; N, 7.19. 
The stereochemistry of the above compound was determined by 1H NMR nOe 




aqueous NaOH, to afford III-14a as shown below. 
 
N
Boc 1) TFA: CH2Cl2 (1:1)
rt, 20 min










(±)–(2R,5S)-2-(3-Nitrobenzyl)-5-phenylpyrrolidine (III-14a). Treatment of III-
14 (100 mg, 0.26 mmol) with TFA/CH2Cl2 was effected using a procedure analogous to 
that described above for the preparation of compound III-13a, with the following 
modification. The crude residue obtained upon removal of TFA/CH2Cl2 was dissolved in 
CH2Cl2 (10 mL), and washed with 1.0 M NaOH (10 mL). The organic layer was dried 
over anhydrous Na2SO4, filtered, and concentrated in vacuo. This procedure afforded 65 
mg (88%) of the title compound as a yellow oil. 1H NMR (400 MHz, CDCl3) δ 8.17–8.12 
(m, 1 H), 8.09–8.02 (m, 1 H), 7.63–7.57 (m, 1 H), 7.44 (t, J = 8.0 Hz, 1 H), 7.40–7.35 (m, 
2 H), 7.31 (t, J = 7.2 Hz, 2 H), 7.25–7.18 (m, 1 H), 4.15 (t, J = 7.4 Hz, 1 H), 3.55–3.44 
(m, 1 H), 2.99–2.86 (m, 2 H), 2.20–2.09 (m, 1 H), 2.00–1.91 (m, 1 H), 1.85 (s, 1 H), 
1.75–1.55 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 148.2, 144.9, 142.3, 135.5, 129.1, 
128.2, 126.8, 126.5, 123.9, 121.2, 62.2, 59.6, 42.9, 33.9, 30.9; IR (film) 1526 cm-1; MS 
(ESI): 283.1435 (283.1447 calculated for C17H18N2O2, M + H+). 
 
(±)–(2S,5R)-2-Phenyl-5-(pyridin-3-ylmethyl)pyrrolidine-1-carboxylic acid 
benzyl ester (III-16). General procedure A was employed for the reaction of 3-




mg, 0.5 mmol). The diastereoselectivity of the transformation was assessed by HCl-
mediated deprotection of the crude product obtained in a duplicate reaction, and was 
found to be >20:1 dr as judged by 1H NMR analysis. Chromatographic purification 
afforded 144 mg (78%) of the title compound as a colorless oil with >20:1 dr. 1H NMR 
(400 MHz, CDCl3) δ 8.59–8.31 (m, 2 H), 7.77–6.76 (m, 12 H), 5.29–4.85 (m, 3 H), 4.30–
4.09 (m, 1 H), 3.67–3.27 (m, 1 H), 2.77–2.64 (m, 1 H), 2.35–2.24 (m, 1 H), 2.04–1.80 
(m, 2 H), 1.76–1.65 (m, 1 H); 13C NMR (125 MHz, CDCl3) δ 155.5, 150.5, 147.9, 143.6, 
136.7, 136.5, 134.3, 128.4, 128.3, 127.5, 127.3, 126.8, 125.6, 123.4, 66.7, 63.0, 61.1, 
38.1, 34.3, 28.6; IR (film) 1698 cm–1; MS (ESI): 395.1736 (395.1735 calculated for 
C24H24N2O2, M + Na+). 
The stereochemistry of the above compound was determined by 1H NMR nOe 
analysis of the product obtained through treatment of III-16 with 6N HCl, followed by 















   
(±)–(2R,5S)-3-(5-Phenylpyrrolidin-2-ylmethyl)pyridine (III-16a). A flask was 
charged with III-16 (40 mg, 0.11 mmol) and 6 N HCl (5 mL). The mixture was heated to 




mixture was washed with ether (3 x 10 mL), and the ether layers were discarded. The 
aqueous layer was then basified with 1M NaOH to pH 11 and extracted twice with ether 
(10 mL).  The combined ether layers were washed with brine, dried over anhydrous 
Na2SO4, filtered and concentrated in vacuo. The crude material was purified by flash 
chromatography using 5%  10% methanol/dichloromethane as the eluent to afford 22 
mg (87%) of the title compound as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 8.55–
8.42 (m, 2 H), 7.61–7.55 (m, 1 H), 7.43–7.36 (m, 2 H), 7.34–7.25 (m, 2 H), 7.24–7.17 
(m, 2 H), 4.19 (t, J = 8.0 Hz, 1 H), 3.56–3.43 (m, 1 H), 3.25–2.89 (m, 1 H), 2.82 (d, J = 
6.6 Hz, 2 H), 2.23–2.11 (m, 1 H), 2.02–1.90 (m, 1 H), 1.85–1.73 (m, 1 H), 1.72–1.60 (m, 
1 H); 13C NMR (100 MHz, CDCl3) δ 150.4, 147.7, 136.6, 135.1, 128.3, 127.1, 126.7, 
123.3, 62.3, 60.0, 39.7, 33.3, 30.6 (two aromatic carbons are incidentally equivalent); IR 
(film) 3410 cm-1; MS (ESI): 239.1537 (239.1548 calculated for C16H18N2, M + H+). 
 
(±)–(2R,3S)-tert-Butyl-2-(2-(Methoxycarbonyl)benzyl)-3-methylpyrrolidine-
1-carboxylate (III-17). General procedure A was employed for the reaction of methyl-2-
bromobenzoate (43 μL, 0.3 mmol) with II-7 (50 mg, 0.25 mmol). The 
diastereoselectivity of the transformation was assessed by TFA-mediated deprotection of 
the crude product obtained in a duplicate reaction, and was found to be 14:1 dr as judged 
by 1H NMR analysis. The minor diastereomer was separated upon chromatographic 
purification to afford 63 mg (75%) of the title compound as a colorless oil with >20:1 dr. 
This compound was found to exist as a ~2.5:1 mixture of rotamers as judged by 1H NMR 




7.44–7.33 (m, 1 H), 7.30–7.19 (m, 2 H), 3.89 (s, 3 H), 3.78–3.72 (m, 1 H), 3.60–3.50 (m, 
0.6 H), 3.47–3.17 (m, 2.8 H), 3.08–3.01 (m, 0.6 H), 2.10–1.96 (m, 2 H), 1.52–1.25 (m, 10 
H), 0.93–0.79 (m, 3 H); 13C NMR (125 MHz, CDCl3) δ 168.5, 168.1, 155.0, 154.7, 140.9, 
140.5, 131.8, 131.7, 131.6, 130.4, 130.2, 126.0, 125.9, 78.9, 65.8, 52.0, 45.1, 44.4, 37.6, 
37.4, 35.9, 30.9, 30.0, 28.5, 28.3, 19.4, 19.3; IR (film) 1723, 1691 cm–1. Anal calcd for 
C19H27NO4: C, 68.44; H, 8.16; N, 4.20. Found: C, 68.29; H, 8.12; N, 4.06. 
The stereochemistry of III-17 was assigned by 1H NMR nOe analysis of the 
corresponding derivative obtained from treatment of III-17 with TFA/CH2Cl2, followed 




1) TFA: CH2Cl2 (1:1), rt, 30 min












5(1H)-one (III-18).  A flame-dried flask was cooled under a stream of nitrogen and 
charged with III-17 (67 mg, 0.2 mmol), and methylene chloride (1 mL). The resulting 
solution was cooled to 0 °C, trifluoroacetic acid (1 mL) was then added slowly and the 
resulting mixture was stirred at rt for 30 min. The crude mixture was concentrated in 
vacuo. The crude product was dissolved in CH2Cl2 (5 mL), and solid Na2CO3 (636 mg, 4 
mmol) was added. The resulting mixture was stirred at rt for 3 h, filtered through a plug 
of celite, and the filtrate was concentrated in vacuo. This procedure afforded 37 mg 




CDCl3) δ 8.06 (dd, J = 1.2, 7.8, Hz, 1 H), 7.41 (td, J = 1.5, 7.3, Hz, 1 H), 7.34 (tt, J = 1.2, 
7.6, Hz, 1 H), 7.22–7.19 (m, 1 H), 3.86–3.80 (m, 1 H), 3.64–3.57 (m, 1 H), 3.41–3.34 (m, 
1 H), 3.05 (dd, J = 3.9, 15.1, Hz, 1 H), 2.78 (t, J = 3.9 Hz, 1 H), 2.22–2.15 (m, 1 H), 
2.09–1.99 (m, 1 H), 1.60–1.50 (m, 1 H), 1.17 (d, J = 6.3 Hz, 3 H); 13C NMR (125 MHz, 
CDCl3) δ 163.3, 137.3, 131.5, 130.3, 127.6, 127.2, 127.1, 63.0, 44.2, 41.6, 33.6, 31.7, 
15.9; IR (film) 1648 cm–1; MS (EI): 201.1151 (201.1153 calculated for C13H15NO, M +). 
 















(E)-tert-Butyl-5-d-pent-4-enylcarbamate (III-19). A flame-dried flask was 
cooled under a stream of nitrogen and charged with ammonium chloride (950 mg, 17.7 
mmol), and toluene (40 mL) and was cooled to 0 oC. A solution of trimethylaluminum 
(1.7 mL, 17.7 mmol) in toluene (20 mL) was then added slowly to the ammonium 
chloride solution.  The mixture was allowed to warm to rt and was stirred for 30 min 
(bubbling was observed). To another flame-dried flask cooled under a stream of nitrogen 
was added (E)-5-d-ethyl 4-pentenoate25 (745 mg, 5.8 mmol), and toluene (10 mL), and 
this solution was cooled to 0 oC. The trimethylaluminum solution was then added 
dropwise to this mixture slowly.  The resulting mixture was heated to 50 oC with stirring 
until the starting material was consumed as judged by TLC analysis (ca. 9h). The mixture 




acetate was added and the layers were separated. The organic layer was washed with a 
solution of saturated aqueous NaHCO3 (100 mL) and brine (100 mL). The organic layer 
was then dried over anhydrous Na2SO4, filtered and concentrated in vacuo to afford 50 
mg (9%) of (E)-5-d-pent-4-enylamide that was used without further purification. 1H 
NMR (500 MHz, CDCl3) δ 6.03 (s, br, 1 H), 5.91–5.78 (m, 1 H), 5.72 (s, br, 1 H), 5.14–
4.97 (m, 1 H), 2.45–2.24 (m, 4 H). 
A flame-dried round-bottom flask was cooled under a stream of nitrogen and 
charged with (E)-5-d-pent-4-enylamide (50 mg, 0.5 mmol). The flask was purged with 
nitrogen, THF (5 mL) was added, and the resulting solution was cooled to 0 oC. A 
solution of LiAlH4 in THF (4 mL, 4 mmol, 1.0 M) was added dropwise. The reaction 
mixture was warmed to rt, and stirred for 21 h, then was cooled to 0 oC, quenched with 
H2O (1 mL), and diluted with ether (5 mL).  An aqueous solution of NaOH (2 mL, 10 M) 
was added followed by H2O (0.2 mL), and an insoluble white material precipitated. The 
organic supernatant was decanted to a clean Erlenmeyer flask and the precipitate was 
washed with ether (15 mL).  The combined organic layers were dried over anhydrous 
sodium sulfate and filtered to afford a solution of (E)-5-d-pent-4-en-1-yl-amine in diethyl 
ether (ca 0.1 M), which was used without purification. 
A flame-dried round-bottom flask was cooled under a stream of nitrogen and 
charged with a solution of (E)-5-d-pent-4-en-1-yl-amine (5 mL, 0.5 mmol, 0.1M). Di-
tert-butyl dicarbonate (200 mg, 0.75 mmol) was added to the solution. The resulting 
mixture was stirred for 3 h, and then aqueous NaOH (20 mL, 1.0 M) was added.  The 




aqueous layer was extracted with diethyl ether (3 x 10 mL).  The combined organic layers 
were dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo.  The crude 
product was then purified by flash chromatography using 10% ethyl acetate/hexanes as 
the eluent to afford 27 mg (29%) of the title compound as a colorless oil with ~80% 
deuterium incorporation as judged by 1H NMR analysis. The data is for major compound. 
1H NMR (500 MHz, CDCl3) δ 5.85–5.75 (m, 1 H), 5.07–4.96 (m, 1 H), 4.56 (s, 1 H), 
3.18–3.05 (m, 2 H), 2.13–2.04 (m, 2 H), 1.58 (p, J = 7.6 Hz, 2 H), 1.49 (s, 9 H); 13C 
NMR (125 MHz, CDCl3) δ 155.9, 137.7, 114.8 (t, J = 23.9 Hz), 79.0, 40.1, 30.9, 29.2, 
28.4. MS (ESI): 209.1369 (209.1376 calculated for C10H18DNO2, M + Na+). 
(±)–(1R,2S)-tert-Butyl-[2d(2-(methoxycarbonyl)phenyl)methyl]pyrrolidine-1-
carboxylate (III-20). General procedure A was employed for the reaction of methyl 2-
bromobenzoate (38 mg, 0.17 mmol) with III-19 (27 mg, 0.14 mmol). This procedure 
afforded 30 mg (65%) of the title compound as a colorless oil with ~80% deuterium 
incorporation as judged by 1H NMR analysis and as a single stereoisomer. This 
compound was found to exist as a 2:1 mixture of rotamers, the data is for the mixture. 1H 
NMR (500 MHz, CDCl3) δ 7.91–7.78 (m, 1 H), 7.45–7.33 (m, 1.33 H), 7.30–7.18 (m, 
1.66 H), 4.20–4.10 (m, 1 H), 3.89 (s, 3 H), 3.49–3.20 (m, 2.66 H), 3.07–2.97 (m, 0.33 H), 
1.95–1.75 (m, 2.66 H), 1.74–1.61 (m, 1.33 H), 1.53–1.17 (m, 9 H). 
 
(±)–(10S,10aR)-10-d-2,3,10,10a-Tetrahydropyrrolo[1,2-b]isoquinolin-5(1H)-
one (III-21). A flame-dried flask was cooled under a stream of nitrogen and charged with 




cooled to 0 °C, trifluoroacetic acid (1 mL) was added slowly and the resulting mixture 
was stirred at rt for 30 min. The crude mixture was concentrated in vacuo. The crude 
product was dissolved in CH2Cl2 (5 mL), and solid Na2CO3 (636 mg, 4 mmol) was added. 
The resulting mixture was stirred at rt for 3 h, filtered through a plug of celite, and the 
filtrate was concentrated in vacuo. This procedure afforded 19 mg (100%) of the title 
compound as a colorless oil. 1H NMR (500 MHz, C6D6) δ 8.48–8.43 (m, 1 H), 7.15–7.12 
(m, 1 H), 7.10–7.04 (m, 1 H), 6.80–6.74 (m, 1 H), 3.61–3.54 (m, 1 H), 3.45–3.37 (m, 1 
H), 3.11–3.01 (m, 1 H), 2.18–2.10 (m, 1 H), 1.46–1.38 (m, 1 H), 1.39–1.27 (m, 1 H), 
1.16–1.05 (m, 1 H), 0.98–0.88 (m, 1 H). 
 
tert-Butyl-2-[2-(methoxycarbonyl)benzyl]pyrrolidine-1-carboxylate (III-22). 
General procedure A was employed for the reaction of methyl 2-bromobenzoate (65 mg, 
0.3 mmol) with II-5 (47 mg, 0.25 mmol). This procedure afforded 57 mg (71%) of the 
title compound as a colorless oil and as a 2:1 mixture of rotamers. The data is for the 
mixture. 1H NMR (500 MHz, CDCl3) δ 7.91–7.79 (m, 1 H), 7.45–7.34 (m, 1 H), 7.32–
7.19 (m, 2 H), 4.22–4.10 (m, 1 H), 3.90 (s, 3 H), 3.48–3.21 (m, 3.33 H), 3.09–2.99 (m, 
0.66 H), 1.95–1.75 (m, 2.66 H), 1.74–1.62 (m, 1.33 H), 1.52–1.23 (m, 9 H); 13C NMR 
(125 MHz, CDCl3) δ 168.1, 154.6, 141.0, 131.9, 131.8, 130.4, 130.3, 126.0, 78.9, 58.9, 
58.7, 52.0, 46.6, 45.9, 37.6, 36.1, 30.3, 28.5, 28.3, 23.5, 22.7; IR (film) 1719, 1694 cm–1; 
MS (EI): 342.1674 (342.1681 calculated for C18H25NO4, M +). 
 




dried flask was cooled under a stream of nitrogen and charged with III-22 (39 mg, 0.12 
mmol) and methylene chloride (1 mL). The resulting solution was cooled to 0 °C, 
trifluoroacetic acid (1 mL) was then added slowly and the resulting mixture was stirred at 
rt for 30 min. The crude mixture was concentrated in vacuo. The crude product was 
dissolved in CH2Cl2 (5 mL), and solid Na2CO3 (636 mg, 4 mmol) was added. The 
resulting mixture was stirred at rt for 3 h, filtered through a plug of celite, and the filtrate 
was concentrated in vacuo. This procedure afforded 16 mg (70%) of the title compound 
as a white solid; m.p. 102-104 oC (lit. m.p. 108 oC).26 1H NMR (500 MHz, C6D6) δ 8.50–
8.45 (m, 1 H), 7.09–7.04 (m, 2 H), 6.80–6.75 (m, 1 H), 3.62–3.54 (m, 1 H), 3.45–3.36 
(m, 1 H), 3.12–3.02 (m, 1 H), 2.25 (dd, J = 4.2, 15.1 Hz, 1 H), 2.19–2.11 (m, 1 H), 1.47–
1.39 (m, 1 H), 1.36–1.27 (m, 1 H), 1.16–1.04 (m, 1 H), 0.98–0.87 (m, 1 H). 
 
Synthesis of Functionalized Pyrrolidines via Coupling with Aryl Bromides (Tables 
8–9, Equations 21, 23 and 24) 
General Procedure B for Pd-Catalyzed Carboamination Reactions of Aryl Bromides. 
A flame-dried Schlenk tube equipped with a magnetic stirbar was cooled under a stream 
of nitrogen and charged with the aryl bromide (1.2 equiv), Pd(OAc)2 (5 mol %), 
Nixantphos (7.5 mol %) or (±)-BINAP (7.5 mol %) and Cs2CO3 (2.3 equiv). The tube 
was purged with nitrogen and a solution of the N-protected amine substrate (1.0 equiv) in 
dioxane (5 mL/mmol substrate) was then added. The resulting mixture was heated to 100 
°C with stirring until the starting material had been consumed as determined by GC 




NH4Cl (1 mL) and ethyl acetate (1 mL) were added. The layers were separated, the 
aqueous layer was extracted with ethyl acetate (3 x 5 mL), and the combined organic 
layers were dried over Na2SO4, filtered, and concentrated in vacuo. The crude product 
was then purified by flash chromatography on silica gel. 
 
(±)–(1R,2S)-tert-Butyl-2-[1-(naphthalen-2-yl)ethyl]pyrrolidine-1-carboxylate 
(II-50). General procedure B with Nixantphos as ligand was employed for the reaction of 
2-bromonaphthalene (63 mg, 0.3 mmol) with II-49 (50 mg, 0.25 mmol). This procedure 
afforded 49 mg (60%) of the title compound as a colorless oil. This compound was found 
to exist as a 1.5:1 mixture of rotamers as judged by 1H NMR analysis and as a single 
diastereoisomer; data are for the mixture of rotamers. 1H NMR (500 MHz, CDCl3) 
δ 7.84–7.74 (m, 3 H), 7.72–7.61 (m, 1 H), 7.54–7.34 (m, 3 H), 4.24–4.03 (m, 1 H), 3.85–
3.71 (m, 0.4 H), 3.66–3.43 (m, 1.6 H), 3.38–3.25 (m, 1 H), 1.87–1.66 (m, 3 H), 1.65–1.53 
(m, 1 H), 1.46 (s, 9 H), 1.32 (d, J = 6.8 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 154.9, 
153.0, 141.5, 133.4, 132.2, 127.7, 127.5, 126.9, 125.9, 125.3, 79.4, 62.6, 47.7, 47.2, 41.5, 
40.5, 28.5, 26.8, 25.9, 24.4, 23.6, 13.2, 12.9; IR (film) 1690 cm–1. MS (ESI): 348.1932 
(348.1939 calculated for C21H27NO2, M + Na+). 
The diastereoselectivity of the transformation was assessed by TFA-mediated 
deprotection of the crude product obtained in a duplicate reaction, and was found to be 














(±)–(1R-2S)-2-[1-(Naphthalen-2-yl)ethyl]pyrrolidine (II-50a).  A flame-dried 
flask was cooled under a stream of nitrogen and charged with II-50 (33 mg, 0.1 mmol), 
and methylene chloride (1 mL). The resulting solution was cooled to 0 °C, trifluoroacetic 
acid (1 mL) was then added slowly and the resulting mixture was stirred at rt for 30 min. 
The crude mixture was concentrated in vacuo. The crude product was dissolved in 
CH2Cl2 (5 mL), and solid Na2CO3 (636 mg, 4 mmol) was added. The resulting mixture 
was stirred at rt for 3 h, filtered through a plug of celite, and the filtrate was concentrated 
in vacuo. This procedure afforded 24 mg (100%) of the title compound as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 7.82–7.76 (m, 3 H), 7.67 (s, 1 H), 7.47–7.38 (m, 3 H), 
3.22–3.14 (m, 1 H), 2.98–2.92 (m, 1 H), 2.80–2.70 (m, 2 H), 2.06–1.98 (m, 1 H), 1.88–
1.72 (m, 2 H), 1.67–1.45 (m, 2 H), 1.34 (d, J = 7.1 Hz, 3 H); 13C NMR (125 MHz, 
CDCl3) δ 143.5, 133.6, 132.3, 128.1, 127.6, 127.6, 125.9, 125.8, 125.2, 65.1, 46.5, 46.1, 
30.0, 24.6, 19.7; IR (film) 3340 cm–1; MS (EI): 226.1591 (226.1596 calculated for 
C16H19N, M +). 
 
(±)–(1R,2S)-tert-Butyl-2-[1-(3-nitrophenyl)ethyl]pyrrolidine-1-carboxylate 
(III-24). General procedure B with Nixantphos as ligand was employed for the reaction 
of 1-bromo-3-nitrobenzene (61 mg, 0.3 mmol) with II-49 (50 mg, 0.25 mmol) except that 




the title compound as a colorless oil. NMR analysis indicated that the product was 
obtained as a single diastereoisomer and an 11:1 mixture of regioisomers. The NMR data 
is for the major regioisomer. 1H NMR (500 MHz, CDCl3) δ 8.14–8.02 (m, 2 H), 7.70–
7.42 (m, 2 H), 4.10–3.91 (m, 1 H), 3.67–3.39 (m, 2 H), 3.36–3.21 (m, 1 H), 1.88–1.59 
(m, 4 H), 1.42 (s, 9 H), 1.29 (d, J = 7.2 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 154.7, 
148.1, 146.1, 146.0, 140.3, 134.6, 134.3, 133.4, 133.3, 133.0, 130.3, 129.6, 129.2, 128.9, 
123.3, 122.5, 122.12, 122.08, 121.8, 121.7, 121.3, 121.1, 79.6, 79.2, 64.8, 62.3, 47.3, 
46.9, 41.5, 40.9, 39.8, 28.5, 28.4, 28.2, 26.9, 26.4, 24.7, 24.2, 23.4, 22.0, 13.5; IR (film) 
1691 cm–1. MS (ESI): 343.1638 (343.1634 calculated for C17H24N2O4, M + Na+). 
The diastereoselectivity of the transformation was assessed by TFA-mediated 
deprotection of the crude product obtained in a duplicate reaction, and was found to be 
>20:1 dr as judged by 1H NMR analysis. 
 
N








(±)–(1R,2S)-2-[1-(4-Nitrophenyl)ethyl]pyrrolidine (III-24a).  A flame-dried 
flask was cooled under a stream of nitrogen and charged with III-24 (18 mg, 0.06 mmol), 
and methylene chloride (1 mL). The resulting solution was cooled to 0 °C, trifluoroacetic 
acid (1 mL) was then added slowly and the resulting mixture was stirred at rt for 30 min. 
The crude mixture was concentrated in vacuo. The crude product was dissolved in 




was stirred at rt for 3 h, filtered through a plug of celite, and the filtrate was concentrated 
in vacuo. This procedure afforded 11 mg (89%) of the title compound as a colorless oil. 
NMR analysis indicated that the product was obtained as an 11:1 mixture of regioisomer. 
The NMR data is for the major regioisomer. 1H NMR (500 MHz, CDCl3) δ 8.11–8.03 (m, 
2 H), 7.60–7.54 (m, 1 H), 7.45 (t, J = 8.0 Hz, 1 H), 3.58–3.47 (m, 1 H), 3.18–3.08 (m, 1 
H), 2.95–2.80 (m, 2 H), 2.30–2.20 (m, 1 H), 2.12–2.00 (m, 1 H), 1.98–1.87 (m, 1 H), 
1.84–1.71 (m, 1 H), 1.33 (d, J = 7.0 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 148.4, 
144.6, 133.5, 129.8, 122.6, 122.2, 65.0, 44.8, 42.7, 29.5, 23.5, 19.8; IR (film) 1530 cm–1; 
MS (EI): 221.1290 (221.1290 calculated for C12H16N2O2, M +). 
 
(±)–(1R,2S)-tert-Butyl-2-[1-(4-(methoxycarbonyl)phenyl)ethyl]pyrrolidine-1-
carboxylate (III-25). General procedure B with (±)-BINAP as ligand was employed for 
the reaction of methyl 4-bromobenzoate (65 mg, 0.3 mmol) with II-49 (50 mg, 0.25 
mmol) except that the reaction was conducted at 100 oC for 48 h. This procedure afforded 
38 mg (46%) of the title compound as a colorless oil and as a 5:1 mixture of 
regioisomers. The NMR data is for the major regioisomer. 1H NMR (500 MHz, CDCl3) 
δ 8.01–7.92 (m, 2 H), 7.41–7.22 (m, 2 H), 4.11–3.95 (m, 1 H), 3.90 (s, 3 H), 3.67–3.54 
(m, 1 H), 3.50–3.40 (m, 1 H), 3.33–3.21 (m, 1 H), 1.81–1.55 (m, 4 H), 1.45 (s, 9 H), 1.24 
(d, J = 7.2 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 167.1, 166.9, 154.8, 149.4, 130.0, 
129.5, 127.9, 127.1, 79.4, 62.4, 52.0, 51.9, 47.5, 47.1, 41.6, 40.8, 28.5, 26.8, 26.1, 24.2, 
23.5, 13.1, 9.7; IR (film) 1724, 1693 cm–1. MS (ESI): 356.1838 (356.1838 calculated for 




The diastereoselectivity of the transformation was assessed by TFA-mediated 
deprotection of the crude product obtained in a duplicate reaction, and was found to be 
>20:1 dr as judged by 1H NMR analysis. 
 
N








(±)–(1S,2R)-Methyl-4-(1-pyrrolidin-2-yl)ethylbenzoate (III-25a).  A flame-
dried flask was cooled under a stream of nitrogen and charged with III-25 (15 mg, 0.04 
mmol), and methylene chloride (1 mL). The resulting solution was cooled to 0 °C, 
trifluoroacetic acid (1 mL) was then added slowly and the resulting mixture was stirred at 
rt for 30 min. The crude mixture was concentrated in vacuo. The crude product was 
dissolved in CH2Cl2 (5 mL), and solid Na2CO3 (636 mg, 4 mmol) was added. The 
resulting mixture was stirred at rt for 3 h, filtered through a plug of celite, and the filtrate 
was concentrated in vacuo. This procedure afforded 10 mg (95%) of the title compound 
as a colorless oil. NMR analysis indicated that the product was obtained as a mixture of 
5:1 mixture of regioisomers. The NMR data is for the major regioisomer. 1H NMR (500 
MHz, CDCl3) δ 7.94–7.85 (m, 2 H), 7.31–7.21 (m, 2 H), 3.87 (s, 3 H), 3.63–3.52 (m, 1 
H), 3.10–2.94 (m, 1 H), 2.82–2.69 (m, 2 H), 2.29–2.18 (m, 1 H), 2.05–1.94 (m, 1 H), 
1.93–1.82 (m, 1 H), 1.79–1.71 (m, 1 H), 1.27 (d, J = 6.8 Hz, 3 H); 13C NMR (125 MHz, 




(film) 1721 cm–1; MS (EI): 234.1485 (234.1494 calculated for C14H19NO2, M +). 
 
  (±)–(1R,2S)-Benzyl-2-[1-(4-(methoxycarbonyl)phenyl)ethyl]pyrrolidine-1-
carboxylate (III-27). General procedure B with (±)-BINAP as ligand was employed for 
the reaction of methyl 4-bromobenzoate (65 mg, 0.3 mmol) with III-26 (59 mg, 0.25 
mmol) except that the reaction was conducted at 100 oC for 72 h. This procedure afforded 
39 mg (43%) of the title compound as a colorless oil and as a single diastereoisomer. This 
compound exists as a 1.5:1 mixture of rotamers as judged by 1H NMR analysis; data are 
for the mixture. 1H NMR (500 MHz, CDCl3) δ 8.00–7.85 (m, 2 H), 7.41–7.28 (m, 6 H), 
7.20–7.13 (m, 1 H), 5.19–5.07 (m, 1.6 H), 5.01–4.93 (m, 0.4 H), 4.18–4.02 (m, 1 H), 3.90 
(s, 3 H), 3.71–3.51 (m, 1.6 H), 3.43–3.32 (m, 1.4 H), 1.85–1.57 (m, 4 H), 1.29–1.19 (m, 3 
H); 13C NMR (125 MHz, CDCl3) δ 167.1, 155.2, 149.2, 137.0, 136.6, 130.0, 129.4, 129.2, 
128.5, 128.1, 127.9, 127.7, 67.1, 66.5, 63.1, 62.6, 52.0, 47.5, 47.4, 41.8, 40.7, 29.7, 26.9, 
26.0, 24.3, 23.5, 13.4, 13.1; IR (film) 1719, 1702 cm–1. MS (ESI): 390.1670 (390.1681 
calculated for C22H25NO4, M + Na+). 
 
(±)–(1R,2S)-Benzyl-2-[1-(3-formylphenyl)ethyl]pyrrolidine-1-carboxylate 
(III-28). General procedure B with (±)-BINAP as ligand was employed for the reaction 
of 3-bromobenzaldehyde (93 mg, 0.5 mmol) with III-26 (59 mg, 0.25 mmol) except that 
10 mol % palladium and 15 mol % of ligand were used and the reaction was conducted at 
100 oC for 72 h. This procedure afforded 38 mg (45%) of the title compound as a 
colorless oil. NMR analysis indicated that the product was obtained as a single 




NMR analysis; data are for the mixture. 1H NMR (500 MHz, CDCl3) δ 10.05–9.84 (m, 1 
H), 7.83–7.54 (m, 3 H), 7.51–7.28 (m, 6 H), 5.16–4.89 (m, 2 H), 4.19–4.01 (m, 1 H), 
3.72–3.54 (m, 1.5 H), 3.46–3.32 (m, 1.5 H), 1.91–1.58 (m, 4 H), 1.32–1.20 (m, 3 H); 13C 
NMR (125 MHz, CDCl3) δ 192.6, 192.4, 155.2, 144.8, 136.3, 134.5, 134.1, 128.8, 128.5, 
128.1, 127.9, 127.7, 67.1, 66.6, 63.1, 62.7, 47.4, 47.3, 41.5, 40.4, 26.9, 26.0, 24.3, 23.5, 
13.6, 13.2; IR (film) 1698 cm–1. MS (ESI): 360.1584 (360.1576 calculated for 
C21H23NO3, M + Na+). 
 
(±)–(1R,2R)-tert-Butyl 2-[1-(naphthalen-2-yl)ethyl]pyrrolidine-1-carboxylate 
(III-31). General procedure B with (±)-BINAP as ligand was employed for the reaction 
of 2-bromonaphthalene (62 mg, 0.3 mmol) with III-30 (50 mg, 0.25 mmol). This 
procedure afforded 50 mg (61%) of the title compound as a colorless oil. NMR analysis 
indicated that the product was obtained as a single diastereoisomer. This compound exists 
as a 1:1 mixture of rotamers as judged by 1H NMR analysis; data are for the mixture. 1H 
NMR (500 MHz, CDCl3) δ 7.83–7.73 (m, 3 H), 7.64–7.58 (m, 1 H), 7.49–7.39 (m, 2 H), 
7.38–7.29 (m, 1 H), 4.19–4.03 (m, 1 H), 3.54–3.44 (m, 0.5 H), 3.43–3.33 (m, 0.5 H), 
3.31–3.18 (m, 1 H), 3.14–2.98 (m, 0.5 H), 2.93–2.82 (m, 0.5 H), 1.79–1.63 (m, 2.5 H), 
1.62–1.47 (m, 11 H), 1.39 (d, J = 7.0 Hz, 3 H), 1.31–1.10 (m, 1.5 H); 13C NMR (125 
MHz, CDCl3) δ 155.2, 141.2, 133.4, 132.3, 127.8, 127.6, 127.5, 127.4, 127.1, 126.7, 
126.6, 126.3, 125.9, 125.8, 125.3, 125.2, 79.4, 79.0, 62.6, 62.5, 46.7, 46.1, 42.6, 41.3, 
29.8. 29.7, 28.6, 28.4, 28.2, 27.6, 26.5, 25.5, 23.5; IR (film) 1690 cm–1. MS (ESI): 




The diastereoselectivity of the transformation was assessed by TFA-mediated 
deprotection of the crude product obtained in a duplicate reaction, and was found to be 
>20:1 dr as judged by 1H NMR analysis. 
 
N








(±)–(1R,2R)-2-[1-(Naphthalen-2-yl)ethyl]pyrrolidine (III-31a).  A flame-dried 
flask was cooled under a stream of nitrogen and charged with III-31 (40 mg, 0.1 mmol), 
and methylene chloride (1 mL). The resulting solution was cooled to 0 °C, trifluoroacetic 
acid (1 mL) was then added slowly and the resulting mixture was stirred at rt for 30 min. 
The crude mixture was concentrated in vacuo. The crude product was dissolved in 
CH2Cl2 (5 mL), and solid Na2CO3 (636 mg, 4 mmol) was added. The resulting mixture 
was stirred at rt for 3 h, filtered through a plug of celite, and the filtrate was concentrated 
in vacuo. This procedure afforded 28 mg (100%) of the title compound as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 7.83–7.77 (m, 3 H), 7.64 (s, 1 H), 7.48–7.41 (m, 2 H), 
7.38–7.34 (m, 1 H), 3.33–3.27 (m, 1 H), 3.15–3.08 (m, 1 H), 3.02–2.95 (m, 1 H), 2.92–
2.84 (m, 1 H), 2.28 (s br, 1 H), 1.81–1.72 (m, 1 H), 1.71–1.63 (m, 1 H), 1.61–1.53 (m, 1 
H), 1.48 (d, J = 7.1 Hz, 3 H) 1.40–1.31 (m, 1 H); MS (EI): 226.1591 (226.1596 
calculated for C16H19N, M +). 
 
(±)–(1R,2R)-tert-Butyl-2-[1-(4-(methoxycarbonyl)phenyl)ethyl]pyrrolidine-1-




the reaction of methyl 4-bromobenzoate (130 mg, 0.6 mmol) with III-30 (100 mg, 0.5 
mmol). This procedure afforded 98 mg (59%) of the title compound as a colorless oil. 
NMR analysis indicated that the product was obtained as a single diastereoisomer. This 
compound exists as a 1:1 mixture of rotamers as judged by 1H NMR analysis; data are for 
the mixture. 1H NMR (500 MHz, CDCl3) δ 7.99–7.93 (m, 2 H), 7.27–7.22 (m, 2 H), 
4.10–3.96 (m, 1 H), 3.91 (s, 3 H), 3.52–3.32 (m, 1 H), 3.29–3.13 (m, 1 H), 3.05–2.96 (m, 
0.5 H), 2.89–2.80 (m, 0.5 H), 1.81–1.69 (m, 1 H), 1.64–1.45 (m, 11 H), 1.30 (d, J = 7.2 
Hz, 3 H), 1.20–1.00 (m, 1 H); 13C NMR (125 MHz, CDCl3) δ 167.1, 155.0, 149.0, 129.4, 
129.2, 128.3, 128.1, 79.5, 79.1, 62.4, 62.3, 52.0, 46.7, 46.2, 42.4, 40.9, 28.5, 27.3, 26.1, 
23.4, 22.5, 17.9, 17.2; IR (film) 1724, 1694 cm–1. MS (ESI): 356.1837 (356.1838 
calculated for C19H27NO4, M + Na+). 
The diastereoselectivity of the transformation was assessed by TFA-mediated 
deprotection of the crude product obtained in a duplicate reaction, and was found to be 
>20:1 dr as judged by 1H NMR analysis. 
 
N








(±)–(1R,2R)-Methyl 4-(1-pyrrolidin-2-yl-ethyl)benzoate (III-32a).  A flame-
dried flask was cooled under a stream of nitrogen and charged with III-32 (60 mg, 0.18 
mmol), and methylene chloride (2 mL). The resulting solution was cooled to 0 °C, 




rt for 30 min. The crude mixture was concentrated in vacuo. The crude product was 
dissolved in CH2Cl2 (5 mL), and solid Na2CO3 (1.2 g, 8 mmol) was added. The resulting 
mixture was stirred at rt for 3 h, filtered through a plug of celite, and the filtrate was 
concentrated in vacuo. This procedure afforded 41 mg (98%) of the title compound as a 
colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.96 (d, J = 8.2 Hz, 2 H), 7.27 (d, J = 8.2  
Hz, 2 H), 3.90 (s, 3 H), 3.16–3.09 (m, 1 H), 3.05–2.98 (m, 1 H), 2.97–2.85 (m, 1 H), 
2.71–2.62 (m, 1 H), 2.00 (s br, 1 H), 1.77–1.58 (m, 2 H), 1.55–1.46 (m, 1 H), 1.35 (d, J = 
6.8 Hz, 3 H), 1.27–1.16 (m, 1 H); 13C NMR (125 MHz, CDCl3) δ 167.0, 151.2, 129.6, 
128.1, 127.6, 64.8, 51.9, 46.7, 46.2, 30.3, 25.2, 19.7; IR (film) 1721 cm–1; MS (EI): 
234.1496 (234.1494 calculated for C14H19NO2, M +). 
 
(±)–(1R,2R)-tert-Butyl-2-[1-(4-(acetoxymethyl)phenyl)ethyl]pyrrolidine-1-
carboxylate (III-33). General procedure B with (±)-BINAP as ligand was employed for 
the reaction of 4-bromobenzyl acetate (69 mg, 0.3 mmol) with III-30 (50 mg, 0.25 
mmol). 1H NMR analysis of the crude reaction mixture indicated that the reaction went to 
94% conversion. After purification, 52 mg (60%) of the title compound was obtained as a 
colorless oil and as a single diastereoisomer. This compound exists as a 1:1 mixture of 
rotamers as judged by 1H NMR analysis; data are for the mixture. 1H NMR (400 MHz, 
CDCl3) δ 7.30–7.24 (m, 2 H), 7.22–7.14 (m, 2 H), 5.08 (s, 2 H), 4.08–3.92 (m, 1 H), 
3.44–3.19 (m, 1.5 H), 3.15–2.85 (m, 1.5 H), 2.10 (s, 3 H), 1.78–1.66 (m, 1 H), 1.65–1.45 
(m, 11 H), 1.27 (d, J = 7.2 Hz, 3 H), 1.24–1.09 (m, 1 H); 13C NMR (100 MHz, CDCl3) 




46.1, 42.1, 41.0, 28.6, 27.5, 26.4, 23.4, 22.6, 21.0, 18.2, 17.7; IR (film) 1742, 1691 cm–1. 
MS (ESI): 370.1979 (370.1994 calculated for C20H29NO4, M + Na+). 
The diastereoselectivity of the transformation was assessed by TFA-mediated 
deprotection of the crude product obtained in a duplicate reaction, and was found to be 
>20:1 dr as judged by 1H NMR analysis. 
 
N









(±)–(1R,2R)-4-(1-Pyrrolidin-2-yl-ethyl)benzyl acetate (III-33a).  A flame-dried 
flask was cooled under a stream of nitrogen and charged with III-33 (25 mg, 0.07 mmol), 
and methylene chloride (1 mL). The resulting solution was cooled to 0 °C, trifluoroacetic 
acid (1 mL) was then added slowly, and the resulting mixture was stirred at rt for 30 min. 
The crude mixture was concentrated in vacuo. The crude product was dissolved in 
CH2Cl2 (5 mL), and solid Na2CO3 (636 mg, 4 mmol) was added. The resulting mixture 
was stirred at rt for 3 h, filtered through a plug of celite, and the filtrate was concentrated 
in vacuo. This procedure afforded 30 mg (100%) of the title compound as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 7.32 (d, J = 8.3 Hz, 2 H), 7.20 (d, J = 8.3 Hz, 2 H), 5.08 
(s, 2 H), 3.61–3.54 (m, 1 H), 3.41–3.30 (m, 2 H), 3.09–3.01 (m, 1 H), 2.11 (s, 3 H), 2.08–
1.99 (m, 1 H), 1.96–1.85 (m, 1 H), 1.80–1.72 (m, 1 H), 1.67–1.57 (m, 1 H), 1.44 (d, J = 
6.8 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 170.9, 142.6, 135.1, 128.8, 127.3, 66.2, 




(248.1651 calculated for C15H21NO2, M +). 
 
(±)–(1R,2R)-tert-Butyl-2-(1-pyridin-3-yl-ethyl)pyrrolidine-1-carboxylate (III-
34). General procedure B with (±)-BINAP as ligand was employed for the reaction of 
methyl 3-bromopyridine (48 mg, 0.3 mmol) with III-30 (50 mg, 0.25 mmol) except that 
this reaction was conducted at 100 oC for 48 h. This procedure afforded 39 mg (56%) of 
the title compound as a colorless oil. NMR analysis indicated that the product was 
obtained as a single diastereoisomer. This compound exists as a 1:1 mixture of rotamers 
as judged by 1H NMR analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) 
δ 8.54–8.37 (m, 2 H), 7.57–7.42 (m, 1 H), 7.25–7.19 (m, 1 H), 4.08–3.95 (m, 1 H), 3.53–
3.34 (m, 1 H), 3.31–3.21 (m, 0.5 H), 3.20–3.09 (m, 0.5 H), 3.05–2.95 (m, 0.5 H), 2.91–
2.81 (m, 0.5 H), 1.87–1.73 (m, 1.5 H), 1.68–1.48 (m, 11.5 H), 1.31 (d, J = 7.2 Hz, 3 H), 
1.23–1.13 (m, 0.5 H), 1.11–0.99 (m, 0.5 H); 13C NMR (100 MHz, CDCl3) δ 155.1, 150.1, 
149.6, 148.0, 147.8, 138.3, 135.5, 135.4, 123.1, 79.6, 79.3, 62.1, 46.8, 46.3, 40.1, 38.3, 
28.6, 28.4, 27.3, 25.9, 23.5, 22.6, 17.6, 16.8; IR (film) 1692 cm–1. MS (ESI): 277.1909 
(277.1916 calculated for C16H24N2O2, M + Na+). 
 
(±)–(1R,2R)-Benzyl-2-[1-(4-(methoxycarbonyl)phenyl)ethyl]pyrrolidine-1-
carboxylate (III-36). General procedure B with (±)-BINAP as ligand was employed for 
the reaction of methyl 4-bromobenzoate (65 mg, 0.3 mmol) with III-35 (59 mg, 0.25 
mmol). This procedure afforded 46 mg (50%) of the title compound as a colorless oil. 
NMR analysis indicated that the product was obtained as a single diastereoisomer. This 




the mixture. 1H NMR (400 MHz, CDCl3) δ 7.92 (d, J = 8.2 Hz, 2 H), 7.47–7.29 (m, 5 H), 
7.24–7.14 (m, 2 H), 5.31–5.14 (m, 2 H), 4.15–4.05 (m, 1 H), 3.91 (s, 3 H),  3.49–3.39 (m, 
1 H), 3.38–3.29 (m, 0.66 H), 3.26–3.17 (m, 0.33 H), 3.06–2.91 (m, 1 H), 1.83–1.71 (m, 1 
H), 1.67–1.50 (m, 2 H), 1.35–1.23 (m, 3 H), 1.20–1.04 (m, 1 H); 13C NMR (100 MHz, 
CDCl3) δ 167.1, 155.3, 148.6, 148.5, 137.1, 136.8, 129.4, 129.3, 128.5, 128.3, 128.12, 
128.06, 127.9, 127.8, 67.0, 66.6, 63.0, 62.4, 52.0, 46.8, 46.6, 42.1, 40.9, 27.2, 26.1, 23.4, 
22.6, 17.7, 17.4; IR (film) 1721, 1702 cm–1. MS (ESI): 390.1670 (390.1681 calculated for 
C22H25NO4, M + Na+). 
 
(±)–(1R,2R)-Benzyl-2-[1-(3-formylphenyl)ethyl]pyrrolidine-1-carboxylate 
(III-37). General procedure B with (±)-BINAP as ligand was employed for the reaction 
of 3-bromobenzaldehyde (93 mg, 0.5 mmol) with III-35 (59 mg, 0.25 mmol) except that 
the amounts of palladium and ligand were doubled and that this reaction was conducted 
at 100 oC for 72 h. This procedure afforded 39 mg (46%) of the title compound as a 
colorless oil. NMR analysis indicated that the product was obtained as a single 
diastereoisomer. This compound exists as a 2:1 mixture of rotamers as judged by 1H 
NMR analysis; data are for the mixture. 1H NMR (500 MHz, CDCl3) δ 9.95 (s, 1 H), 
7.78–7.61 (m, 2 H), 7.49–7.30 (m, 6 H), 5.33–5.12 (m, 2 H), 4.17–4.07 (m, 1 H), 3.54–
3.43 (m, 1 H), 3.42–3.31 (m, 0.66 H), 3.30–3.19 (m, 0.33 H), 3.03–2.88 (m, 1 H), 1.86–
1.74 (m, 1 H), 1.67–1.52 (m, 2 H), 1.39–1.25 (m, 3 H), 1.23–1.09 (m, 1 H); 13C NMR 
(125 MHz, CDCl3) δ 192.6, 155.4, 144.2, 137.1, 136.3, 134.7, 129.2, 128.9, 128.8, 128.7, 




27.3, 26.1, 23.4, 22.6, 17.7, 17.4; IR (film) 1698 cm–1. MS (ESI): 360.1578 (360.1576 
calculated for C21H23NO3, M + Na+). 
 
tert-Butyl-2-(2-chlorophenethyl)pyrrolidine-1-carboxylate (III-38). General 
procedure B with (±)-BINAP as ligand was employed for the reaction of 2-bromo 
chlorobenzene (48 mg, 0.3 mmol) with III-30 (50 mg, 0.25 mmol) except that this 
reaction was conducted at 100 oC for 35 h. This procedure afforded 58 mg (75%) of the 
title compound as a colorless oil that contained ~8% of an unidentified impurity. 1H 
NMR (500 MHz, CDCl3) δ 7.40–7.02 (m, 4 H), 4.00–3.73 (m, 1 H), 3.48–3.25 (m, 2 H), 
2.79–2.62 (m, 2 H), 2.13–1.72 (m, 5 H), 1.69–1.54 (m, 1 H), 1.49–1.37 (m, 9 H); 13C 
NMR (125 MHz, CDCl3) δ 154.6, 139.5, 133.8, 130.2, 129.5, 127.2, 126.8, 79.1, 56.8, 
46.5, 46.1, 34.7, 34.1, 30.5, 29.9, 28.5, 28.4, 23.8, 23.1; IR (film) 1693 cm–1. MS (ESI): 
332.1398 (332.1393 calculated for C17H24ClNO2, M + Na+). 
 
(±)–(10S,10aR)-10-Methyl-2,3,10,10a-tetrahydropyrrolo[1,2-b]isoquinolin-
5(1H)-one (III-39). A flame-dried flask was cooled under a stream of nitrogen and 
charged with II-50 (70 mg, 0.22 mmol), P2O5 (184 mg, 0.65 mmol) and POCl3 (2 mL). 
The resulting mixture was heated to 100 °C for 13 h. The crude mixture was concentrated 
in vacuo and cooled to 0 °C. The crude material was diluted with water, and aqueous 
Na2CO3 was added until bubbling stopped. The aqueous phase was extracted with ethyl 
acetate (3 x 10 mL). The combined organic layers were then washed with saturated 
Na2CO3, brine and dried over anhydrous Na2SO4, filtered and concentrated in vacuo to 




(400 MHz, CDCl3) δ 9.39 (d, J = 8.8 Hz, 1 H), 7.94 (d, J = 8.6 Hz, 1 H), 7.81 (dd, J = 
8.2, 0.6 Hz, 1 H), 7.60–7.55 (m, 1 H), 7.50–7.44 (m, 2 H), 3.93–3.85 (m, 1 H), 3.79–3.70 
(m, 1 H), 3.53–3.44 (m, 1 H), 3.02–2.92 (m, 1 H), 2.44–2.35 (m, 1 H), 2.18–2.09 (m, 1 
H), 1.96–1.73 (m, 2 H), 1.46 (d, J = 7.0 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 141.8, 
132.8, 132.2, 131.3, 127.8, 127.5, 127.0, 125.7, 121.6, 61.6, 45.6, 39.4, 33.3, 23.3, 14.6 
(two aromatic carbons are accidentally equivalent); IR (film) 1639 cm–1. MS (ESI): 














5(1H)-one (III-40). A flame-dried flask was cooled under a stream of nitrogen and 
charged with III-31 (64 mg, 0.20 mmol), P2O5 (168 mg, 0.59 mmol) and POCl3 (2 mL). 
The resulting mixture was heated to 100 °C for 13 h. The crude mixture was concentrated 
in vacuo and cooled to 0 °C. The crude material was diluted with water, and aqueous 
Na2CO3 was added until bubbling stopped. The aqueous phase was extracted with ethyl 
acetate (3 x 10 mL). The combined organic layers were then washed with sat. Na2CO3 (5 
mL), brine (5 mL) and dried over anhydrous Na2SO4, filtered and concentrated in vacuo 
to afford 12 mg (24%) of the title compound as colorless oil. 1H NMR (400 MHz, CDCl3) 
δ 9.45 (d, J = 8.8 Hz, 1 H), 7.89 (d, J = 8.3 Hz, 1 H), 7.80 (dd, J = 8.3, 0.7 Hz, 1 H), 
7.60–7.55 (m, 1 H), 7.49–7.45 (m, 1 H), 7.30–7.27 (m, 1 H), 4.09–4.02 (m, 1 H), 3.91–
3.84 (m, 1 H), 3.71–3.63 (m, 1 H), 3.10–3.04 (m, 1 H), 2.16–2.07 (m, 2 H), 2.04–1.95 
(m, 1 H), 1.94–1.86 (m, 1 H), 1.17 (dd, J = 7.1, 0.7, Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 144.8, 133.1, 132.4, 131.6, 128.0, 127.5, 126.8, 125.7, 125.1, 58.3, 45.8, 37.7, 
28.6, 23.7, 14.9 (two aromatic carbons are incidentally equivalent); IR (film) 1638 cm–1. 
MS (ESI): 252.1388 (252.1393 calculated for C17H17NO, M + H+). 
 
Synthesis of Functionalized Pyrrolidines via Coupling with Aryl Bromides (Table 10) 
General Procedure C for Pd-Catalyzed Carboamination Reactions of Aryl 
Bromides. A flame-dried Schlenk tube equipped with a magnetic stirbar was cooled 
under a stream of nitrogen and charged with the aryl bromide (1.2 equiv), Pd(OAc)2 (2 
mol %), Nixantphos (4 mol %) and Cs2CO3 (2.3 equiv). The tube was purged with 




mL/mmol substrate) was then added. The resulting mixture was heated to 100 °C with 
stirring until the starting material had been consumed as determined by GC analysis. The 
reaction mixture was cooled to room temperature and saturated aqueous NH4Cl (1 mL) 
and ethyl acetate (1 mL) were added. The layers were separated, the aqueous layer was 
extracted with ethyl acetate (3 x 5 mL), and the combined organic layers were dried over 
Na2SO4, filtered, and concentrated in vacuo. The crude product was then purified by flash 
chromatography on silica gel. 
 
tert-Butyl-2-methyl-2-(naphthalen-2-ylmethyl)pyrrolidine-1-carboxylate (III-
43). General procedure C was employed for the reaction of 2-bromonapthalene (63 mg, 
0.30 mmol) with III-41 (50 mg, 0.25 mmol). This procedure afforded 62 mg (77%) of the 
title compound as a colorless oil. This compound was found to exist as a 1:1 mixture of 
rotamers as judged by 1H NMR analysis; data are for the mixture. 1H NMR (500 MHz, 
CDCl3) δ 7.84–7.70 (m, 3 H), 7.65–7.56 (m, 1 H), 7.48–7.39 (m, 2 H), 7.36–7.26 (m, 1 
H), 3.70–3.64 (m, 0.5 H), 3.47–3.37 (m, 1 H), 3.35–3.26 (m, 0.5 H), 3.19–3.11 (m, 0.5 
H), 2.98–2.89 (m, 1.5 H), 2.12–2.03 (m, 1 H), 1.65–1.48 (m, 14 H), 1.23–1.11 (m, 1 H); 
13C NMR (125 MHz, CDCl3) δ 154.4, 153.8, 136.6, 136.3, 133.4, 132.0, 129.2, 128.9, 
128.8, 128.7, 127.6, 127.5, 127.2, 125.8, 125.7, 125.4, 125.2, 79.6, 78.6, 63.6, 63.1, 
48.50, 48.46, 44.5, 43.2, 39.0, 37.8, 28.8, 28.7, 27.1, 26.1, 21.7, 21.3; IR (film) 1690 cm–
1. MS (ESI): 348.1940 (348.1939 calculated for C21H27NO2, M + Na+). 
 
tert-Butyl-2-methyl-2-(pyridin-3-ylmethyl)pyrrolidine-1-carboxylate (III-44). 




mmol) with III-41 (50 mg, 0.25 mmol) except that 10 mol % palladium and 15 mol % 
ligand were used. This procedure afforded 55 mg (80%) of the title compound as a 
colorless oil. This compound was found to exist as a 1.5:1 mixture of rotamers as judged 
by 1H NMR analysis; data are for the mixture. 1H NMR (500 MHz, CDCl3) δ 8.49–8.40 
(m, 2 H), 7.51–7.42 (m, 1 H), 7.23–7.16 (m, 1 H), 3.56–3.50 (m, 0.6 H), 3.48–3.41 (m, 
0.4 H), 3.38–3.31 (m, 0.6 H), 3.28–3.21 (m, 0.4 H), 3.18–3.11 (m, 0.4 H), 3.00–2.93 (m, 
0.6 H), 2.82–2.73 (m, 1 H), 1.99–1.88 (m, 1 H), 1.70–1.45 (m, 14 H), 1.26–1.15 (m, 1 H); 
13C NMR (125 MHz, CDCl3) δ 154.2, 153.7, 151.4, 151.3, 147.8, 147.5, 137.7, 137.3, 
135.7, 134.2, 134.0, 123.2, 123.0, 121.7, 79.8, 78.9, 63.2, 62.7, 48.5, 48.4, 41.6, 40.4, 
39.0, 37.6, 29.7, 28.7, 28.6, 28.39, 28.36, 26.9, 25.8, 21.6, 21.2; IR (film) 1687 cm–1. MS 
(ESI): 299.1738 (299.1735 calculated for C16H24N2O2, M + Na+). 
 
tert-Butyl-2-(3-methoxybenzyl)-2-methylpyrrolidine-1-carboxylate (III-45). 
General procedure C was employed for the reaction of 3-bromoanisole (57 mg, 0.30 
mmol) with III-41 (50 mg, 0.25 mmol). This procedure afforded 52 mg (68%) of the title 
compound as a colorless oil. This compound was found to exist as a 1:1 mixture of 
rotamers as judged by 1H NMR analysis; data are for the mixture. 1H NMR (500 MHz, 
CDCl3) δ 7.17 (q, J = 7.8 Hz, 1 H), 6.79–6.67 (m, 3 H), 3.78 (s, 3 H), 3.46–3.38 (m, 1 H), 
3.36–3.29 (m, 0.5 H), 3.28–3.23 (m, 0.5 H), 3.21–3.13 (m, 0.5 H), 3.09–3.01 (m, 0.5 H), 
2.80–2.69 (m, 1 H), 2.06–1.97 (m, 1 H), 1.60–1.45 (m, 14 H), 1.27–1.13 (m, 1 H); 13C 
NMR (125 MHz, CDCl3) δ 159.4, 159.3, 154.3, 153.7, 140.6, 140.3, 129.0, 128.7, 123.0, 




37.8, 28.73, 28.69, 27.2, 26.0, 21.7, 21.3, 18.6; IR (film) 1693 cm–1. MS (ESI): 328.1881 
(328.1889 calculated for C18H27NO3, M + Na+). 
 
Benzyl 2-(4-tert-butylbenzyl)-2-methylpyrrolidine-1-carboxylate (III-46). 
General procedure C was employed for the reaction of 4-tert-butyl bromobenzene (64 
mg, 0.30 mmol) with III-42 (50 mg, 0.21 mmol). This procedure afforded 58 mg (74%) 
of the title compound as a colorless oil. This compound was found to exist as a 1.5:1 
mixture of rotamers as judged by 1H NMR analysis; data are for the mixture. 1H NMR 
(500 MHz, CDCl3) δ 7.46–7.30 (m, 5 H), 7.27–7.18 (m, 2 H), 7.05–6.95 (m, 2 H), 5.28–
5.22 (m, 1.4 H), 5.13–5.05 (m, 0.6 H), 3.53–3.40 (m, 1 H), 3.37–3.31 (m, 0.6 H), 3.26–
3.12 (m, 1.4 H), 2.88–2.82 (m, 0.6 H), 2.79–2.73 (m, 0.4 H), 2.08–1.98 (m, 1 H), 1.64–
1.53 (m, 2 H), 1.48 (s, 2 H), 1.40 (s, 1 H), 1.34–1.24 (m, 10 H); 13C NMR (125 MHz, 
CDCl3) δ 155.0, 153.8, 149.1, 148.9, 137.5, 135.4, 135.2, 130.1, 129.9, 128.5, 128.4, 
128.2, 128.0, 127.8, 127.7, 125.0, 124.8, 67.0, 65.9, 64.2, 63.6, 49.1, 48.1, 43.9, 42.5, 
38.9, 37.6, 34.3, 31.4, 31.4, 26.9, 25.7, 21.8, 21.4; IR (film) 1701 cm–1. MS (ESI): 
388.2256 (388.2252 calculated for C24H31NO2, M + Na+). 
 
Benzyl-2-(4-(methoxycarbonyl)benzyl)-2-methylpyrrolidine-1-carboxylate 
(III-47). General procedure C was employed for the reaction of methyl 4-bromobenzoate 
(65 mg, 0.30 mmol) with III-42 (59 mg, 0.25 mmol). This procedure afforded 63 mg 
(68%) of the title compound as a colorless oil. This compound was found to exist as a 3:1 
mixture of rotamers as judged by 1H NMR analysis; data are for the mixture. 1H NMR 




5.20 (m, 1.25 H), 5.12–5.06 (m, 0.75 H), 3.90 (s, 3 H), 3.57–3.51 (m, 0.75 H), 3.50–3.39 
(m, 1 H), 3.30–3.25 (m, 0.25 H), 3.23–3.16 (m, 0.25 H), 3.12–3.05 (m, 0.75 H), 2.86–
2.79 (m, 1 H), 2.04–1.93 (m, 1 H), 1.67–1.54 (m, 2 H), 1.51 (s, 2.25 H), 1.42 (s, 0.75 H), 
1.27–1.13 (m, 1 H); 13C NMR (125 MHz, CDCl3) δ 167.1, 153.9, 144.1, 143.8, 137.3, 
130.4, 130.2, 129.4, 129.2, 128.54, 128.45, 128.4, 128.3, 128.1, 128.1, 127.9, 127.8, 67.1, 
66.1, 64.0, 63.4, 52.0, 49.1, 48.1, 44.4, 43.0, 39.0, 37.6, 27.2, 26.0, 21.8, 21.4, 18.9; IR 
(film) 1721, 1698 cm–1. MS (ESI): 390.1683 (390.1681 calculated for C22H25NO4, M + 
Na+). 
 
Synthesis of Functionalized Pyrrolidines via Coupling with Aryl Triflates (Table 11) 
General Procedure D for Pd-Catalyzed Carboamination Reactions of Aryl Triflates. 
A flame-dried Schlenk tube equipped with a magnetic stirbar was cooled under a stream 
of nitrogen and charged with the aryl bromide (1.2 equiv), Pd(OAc)2 (4 mol %), dpe-phos 
(8 mol %) and K3PO4 (2.3 equiv). The tube was purged with nitrogen and a solution of 
the N-protected amine substrate (1.0 equiv) in dioxane (4 mL/mmol substrate) was then 
added. The resulting mixture was heated to 100 °C with stirring until the starting material 
had been consumed as determined by GC analysis. The reaction mixture was cooled to 
room temperature and saturated aqueous NH4Cl (1 mL) and ethyl acetate (1 mL) were 
added. The layers were separated, the aqueous layer was extracted with ethyl acetate (3 x 
5 mL), and the combined organic layers were dried over Na2SO4, filtered, and 






2-(4-Formylbenzyl)pyrrolidine-1-carboxylic acid tert-butyl ester (III-49). 
General procedure D was employed for the reaction of 4-formylphenyl 
trifluoromethanesulfonate (82 mg, 0.30 mmol) with II-5 (47 mg, 0.25 mmol). This 
procedure afforded 49 mg (68%) of the title compound as a colorless oil. This material 
gave spectral data to those obtained for the synthesis of this product from the analogous 
aryl bromide (see above).   1H NMR (400 MHz, CDCl3) δ 9.98–9.96 (s, 1 H), 7.83–7.77 
(d, J = 8.0 Hz, 2 H), 7.41–7.29 (m, 2 H), 4.13–3.92 (m, 1 H), 3.46–3.01 (m, 3 H), 2.74–
2.58 (m, 1 H), 1.85-1.60 (m, 4 H), 1.52–1.45 (s, 9 H).  
 
2-(2-Methylbenzyl)pyrrolidine-1-carboxylic acid benzyl ester (III-50). 
General procedure D was employed for the reaction of o-tolyl trifluoromethanesulfonate 
(145 mg, 0.3 mmol) with III-11 (110 mg, 0.5 mmol). This procedure afforded 120 mg 
(78%) of the title compound as a pale yellow oil. This compound was found to exist as a 
1:1 mixture of rotamers as judged by 1H NMR analysis; data are for the mixture. 1H 
NMR (400 MHz, CDCl3) δ 7.44–7.27 (m, 5 H), 7.20–6.98 (m, 4 H), 5.23–5.07 (m, 2 H), 
4.17–4.00 (m, 1 H), 3.56–3.31 (m, 2.5 H), 3.15–3.03 (m, 0.5 H), 2.52–2.38 (m, 2.5 H), 
2.14 (s, 1.5 H), 2.01–1.78 (m, 2 H), 1.77–1.68 (m, 2 H); 13C NMR (100 MHz, CDCl3) 
δ 154.9, 137.2, 137.0, 136.6, 130.4, 130.33, 130.28, 128.5, 128.4, 128.1, 127.8, 127.7, 
126.4, 125.73, 125.67, 67.1, 66.5, 58.1, 57.3, 46.7, 46.5, 37.8, 36.9, 29.4, 28.6, 23.4, 22.6, 
19.5, 19.2; IR (film) 1698 cm–1. MS (ESI): 332.1618 (332.1626 calculated for 





(±)– (2R,3S)-2-(4-Acetylbenzyl)-3-methylpyrrolidine-1-carboxylic acid benzyl 
ester (III-51). General procedure D was employed for the reaction of 4-acetylphenyl 
trifluoromethanesulfonate (41 mg, 0.15 mmol) with III-15 (30 mg, 0.125 mmol). The 
diastereoselectivity of the transformation was assessed by HCl-mediated deprotection of 
the crude product obtained in a duplicate reaction, and was found to be 12:1 dr as judged 
by 1H NMR analysis. The minor diastereomer was separated upon chromatographic 
purification to afford 31 mg (71%) of the title compound as a colorless oil with >20:1 dr. 
This compound was found to exist as a 1:1 mixture of rotamers as judged by 1H NMR 
analysis; data are for the mixture. 1H NMR (300 MHz, CDCl3) δ 7.91–7.78 (m, 2 H), 
7.44–7.30 (m, 5 H), 7.29–7.23 (m, 1 H), 7.20–7.10 (m, 1 H), 5.26–5.08 (m, 2 H), 3.76–
3.49 (m, 2 H), 3.35–3.12 (m, 1.5 H), 3.07–2.97 (m, 0.5 H), 2.92–2.82 (m, 0.5 H), 2.78–
2.68 (m, 0.5 H), 2.62–2.53 (m, 3 H), 2.11–1.96 (m, 1 H), 1.95–1.76 (m, 1 H), 1.51–1.36 
(m, 1 H), 0.88 (d, J = 6.8 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 197.9, 197.8, 155.0, 
154.9, 144.5, 144.4, 137.0, 136.6, 135.3, 129.8, 129.6, 128.5, 128.42, 128.37, 128.0, 
127.9, 127.8, 67.0, 66.6, 65.7, 65.5, 45.4, 45.3, 40.2, 38.6, 37.0, 36.1, 31.1, 30.2, 26.5, 
19.2, 19.0; IR (film) 1698 cm–1. MS (EI): 374.1728 (374.1732 calculated for C22H25NO3, 
M + Na+). 
The stereochemistry of the above compound was determined by 1H NMR nOe 
analysis of the product obtained through treatment of III-51 with 6N HCl, followed by 

















   
(±)– (2S,3R)-2-(4-Acetylbenzyl)-3-methylpyrrolidine (III-51a). The product 
III-51 (70 mg, 0.20 mmol) was deprotected with 6 N HCl (10 mL) using a procedure 
analogous to that described above for the preparation of III-21a. This procedure afforded 
40 mg (92%) of the title compound as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.88 
(d, J = 8.1 Hz, 2 H), 7.31 (d, J = 8.1 Hz, 2 H), 2.98–2.91 (m, 2 H), 2.88–2.81 (m, 1 H), 
2.78–2.71 (m, 1 H), 2.67–2.59 (m, 1 H), 2.57 (s, 3 H), 2.06–1.97 (m, 1 H), 1.91 (s, br, 1 
H), 1.77–1.68 (m, 1 H), 1.41–1.32 (m, 1 H), 0.99 (d, J = 6.6 Hz, 3 H); 13C NMR (125 
MHz, CDCl3) δ 197.8, 146.1, 135.2, 129.2, 128.5, 67.2, 44.7, 41.2, 39.1, 34.0, 26.5, 18.1; 




butyl ester (III-52). General procedure D was employed for the reaction of 4-
formylphenyl trifluoromethanesulfonate (82 mg, 0.30 mmol) with II-21 (66 mg, 0.25 
mmol). The diastereoselectivity of the transformation was assessed by LAH reduction of 
the crude product obtained in a duplicate reaction, and was found to be >20:1 dr as 
judged by 1H NMR analysis. Chromatographic purification afforded 63 mg (69%) of the 
title compound as a colorless oil with >20:1 dr. 1H NMR (500 MHz, CDCl3) δ 9.99 (s, 1 




5.05–4.60 (m, 1 H), 4.30–4.08 (m, 1 H), 3.71–3.44 (m, 1 H), 2.82–2.69 (m, 1 H), 2.33–
2.23 (m, 1 H), 2.00–1.90 (m, 1 H), 1.88–1.77 (m, 1 H), 1.73–1.66 (m, 1 H), 1.60–1.03 
(m, 9 H); 13C NMR (100 MHz, CDCl3) δ 192.0, 154.9, 146.6, 144.5, 134.8, 130.1, 130.0, 
128.3, 126.6, 125.5, 79.7, 63.1, 60.6, 41.3, 34.6, 28.2 (two aliphatic carbons are 
incidentally equivalent); IR (film) 1690, 1606 cm–1. MS (EI): 388.1886 (388.1889 
calculated for C23H27NO3, M + Na+). 
The stereochemistry of the above compound was determined by 1H NMR nOe 
















52a). A flame-dried flask was cooled under a steam of nitrogen and charged with III-52 
(95 mg, 0.26 mmol) and tetrahydrofuran (3 mL). The resulting solution was cooled to 0 
°C and LiAlH4 (2.6 mL, 2.6 mmol, 1 M in tetrahydrofuran) was added dropwise via 
syringe. The resulting mixture was heated to reflux until the starting material was 
consumed as judged by TLC analysis (ca. 21 h). The reaction mixture was cooled to 0 °C, 
slowly quenched with water (0.3 mL) and diluted with diethyl ether (5 mL). Aqueous 
NaOH (0.3 mL, 10 M) and water (0.3 mL) were added sequentially and an insoluble 
white precipitate formed. The organic supernatant was decanted to a clean Erlenmeyer 




were dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The crude oil 
obtained was purified by flash chromatography using 10%  20% 
methanol/dichloromethane as the eluent to afford 54 mg (74%) of the title compound as a 
colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.37–7.27 (m, 6 H), 7.26–7.21 (m, 3 H), 4.66 
(s, 2 H), 3.23 (t, J = 7.8 Hz, 1 H), 3.10–3.02 (m, 1 H), 2.66–2.56 (m, 2 H), 2.20 (s, 3 H), 
2.03–1.95 (m, 1 H), 1.88 (s, br 1 H), 1.79–1.70 (m, 1 H), 1.66–1.56 (m, 2 H); 13C NMR 
(125 MHz, CDCl3) δ 144.0, 139.4, 138.5, 129.6, 128.3, 127.4, 127.0, 126.9, 72.4, 68.1, 
65.2, 40.7, 39.1, 33.2, 29.3 (two aromatic carbons are incidentally equivalent); IR (film) 
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Palladium-Catalyzed Synthesis of Cyclopentane-Fused Benzocyclobutenes via 
Tandem Directed Carbopalladation/C-H Bond Functionalization1 
 During the course of our studies on Pd-catalyzed carboamination reactions of N-
protected γ-aminoalkenes, 2  we observed that the use of the weak base Cs2CO3 in 
transformations of terminal alkene substrates provided 2-benzylpyrrolidine derivatives in 
yields that were comparable to those obtained with the stronger base NaOt-Bu (Chapters 
II and III).3 However, when the Cs2CO3 conditions were employed with cyclopentene-
derived substrate II-14, a surprising result was obtained. As shown in equation 27, the 
Pd-catalyzed reaction of II-14 with 4-bromobiphenyl in the presence of Cs2CO3 did not 
provide the expected product IV-1, but instead generated benzocyclobutene derivative4 
IV-2 in 72% yield and >20:1 dr. This result is in marked contrast with the reaction of II-
14 with 4-bromobiphenyl in the presence of NaOt-Bu,2b which affords the expected 







































The generation of benzocyclobutene IV-2 is both synthetically and 
mechanistically interesting.5 Benzocyclobutenes are widely employed as precursors to 
ortho-quinodimethides, which are known to undergo facile [4+2] cycloaddition 
reactions,6 and can also be employed in polymerizations.7 Moreover, the surprising effect 
of base on the reactivity of II-14 raises questions about the mechanistic relationship 
between the reactions shown in equations 26-27 and the carboamination reactions of 
acyclic N-protected aminoalkene substrates. This chapter contains a description of our 
studies in the preparation of benzocyclobutenes via coupling of II-14 with aryl bromides, 
preliminary studies in expanding the scope of this new transformation and a presentation 
of a mechanistic hypothesis that accounts for the observed effect of base. 
 
Scope and Diastereoselectivity 
 To explore the scope of the Pd-catalyzed benzocyclobutene forming process, we 
examined reactions of II-14 with various p-, m- and o-substituted aryl bromides. As 




substituted exclusively at the 2-position of the aromatic ring (entries 1–4). Similarly high 
regioselectivity was obtained in reactions of o-substituted aryl bromides, which afforded 
products bearing substituents at the 5-position (entries 5–6). The regioselectivities 
observed in reactions of m-substituted aryl bromides were dependent on the nature of the 
substituent. Although the reaction of II-14 with m-bromotoluene proceeded with good 
regioselectivity (entry 7), the coupling of II-14 with m-bromoanisole afforded a 2:1 

















R = CH2OAc: 74, IV-3
R = Cl: 70, IV-4
R = OMe: 58, IV-5
R = Me: 85, IV-6
Br
Br














































aConditions: 1.0 equiv II-14, 1.2. equiv ArBr, 2.3 equiv Cs2CO3, 4 mol % Pd(OAc)2, 8 mol % Dpe-phos, 
dioxane (0.25 M), 100 °C. bYields refer to average isolated yields obtained in two or more experiments. 
cAll products were obtained with >20:1 dr and >20:1 regioselectivity unless otherwise noted. 
 
 
The major side products formed in reactions between II-14 and either electron-
rich or -neutral aryl bromides were arylated cyclopentanes (IV-10), although in many 
reactions trace amounts of bicyclic products IV-11–IV-13 were detected by 1H NMR 
















IV-10 IV-11 IV-12 IV-13  
Figure 5. Side-products. 
 
Although the benzocyclobutene-forming reactions proceeded smoothly with many 
aryl bromides, the Pd-catalyzed coupling of II-14 with the electron-poor substrate 3-
bromobenzotrifluoride afforded a 26:39:23 mixture of IV-14:IV-11:IV-12 (eq 28);9 upon 
purification IV-14 was obtained in 24% yield. In addition, the Pd-catalyzed reaction of 
II-14 with 1-bromo-2-methylnaphthalene proceeded slowly and in low conversion (ca. 
40%) to afford 5-aryl azabicyclo[3.3.0]octane IV-15 in 26% isolated yield (eq 29). A 
similar result was obtained with 2-bromo-m-xylene, which afforded a 5-aryl 
azabicyclo[3.3.0]octane IV-16 in 30% yield (ca. 40% conversion, eq 30). Efforts to 
extend this transformation to cyclohexene-derived substrate IV-17 were unsuccessful (eq 
31).10 In addition, when the reaction of II-14 with 4-bromobiphenyl was conducted under 

































































not observed  
 
Mechanistic Considerations 
  The dependence of base on the outcome of Pd-catalyzed reactions of II-14 with 
aryl bromides (Scheme 18) likely results from differences in reactivity of palladium 
amino complexes vs. palladium amido complexes.11 As shown in Scheme 18, oxidative 
addition of the aryl bromide to Pd(0) would generate IV-19, which can bind the 
carbamate to provide IV-20. In the presence of a base, amino complex IV-20 can 
potentially be converted to amido complex IV-25. However, with the weak base Cs2CO3 
this process should be relatively slow due to the low solubility of Cs2CO3,11 and the 
equilibrium between IV-20 and IV-25 may favor IV-20. In contrast, when the relatively 
strong, soluble base NaOt-Bu is employed, the conversion of IV-20 to IV-25 is relatively 































































The benzocyclobutene products formed when Cs2CO3 is used as base are likely 
generated via directed carbopalladation13 , 14  of amino complex IV-20 to provide the 
sterically hindered alkylpalladium intermediate IV-21, which lacks β−hydrogen atoms 
syn to the metal. Intramolecular aryl C–H bond activation5,15 of IV-21 provides IV-22 
and an equivalent of HBr, which is neutralized by Cs2CO3. Complex IV-22 is then 
converted to benzocyclobutene IV-23 via C–C bond-forming reductive elimination.5,16 




the Pd–C bond(s) of IV-21 or IV-22. 
The conversion of the electron-poor m-bromobenzotrifluoride to a mixture of IV-
14, IV-11, and IV-12 is likely due to enhancement of the N–H proton acidity of IV-20 
when the complex bears an electron-withdrawing aryl substituent, which would shift the 
IV-20/IV-25 equilibrium towards IV-25. Under conditions that facilitate rapid and/or 
thermodynamically favorable formation of amido complex IV-25, the reactions likely 
proceed via syn-amidopalladation as described previously to generate IV-26,2 which is 
converted to IV-11 via C–C bond-forming reductive elimination. Alternatively, IV-26 
can also be transformed to IV-12 via β-hydride elimination/reinsertion processes.2a,c 
The differences in reactivity observed between substrates bearing terminal 
alkenes (e.g., II-5) and cycloalkene substrate II-14 may be due either to the influence of 
alkene size on the position of the IV-25/IV-26 equilibrium, the influence of substrate 
sterics on the rate of C–C bond-forming reductive elimination from IV-26, or the 
influence of alkene substitution on the relative rates of alkene insertion into the Pd–C 
bond of IV-20 vs. the Pd–N bond of IV-25. In addition, the fact that Pd-catalyzed 
reactions of II-14 with aryl halides lacking o-hydrogen atoms are converted to 
azabicyclooctanes (e.g., IV-15) in the presence of Cs2CO3 suggests that the 
carbopalladation of IV-20 is either reversible,17 or very slow with bulky aryl groups. Our 
current data do not allow us to differentiate between these two possibilities. 
 
Studies Towards the Development of Non-Directed Benzocyclobutene-Forming 
Reactions and Other Tandem Reactions 
 




expand the scope of this chemistry in two manners. First of all, it could be possible to 
employ other alkene substrates that lack a directing group, provided that the intermediate 
generated upon carbopalladation lacks syn β-hydrogen atoms. To probe this hypothesis, 
olefin substrates IV-28, IV-30, IV-31, IV-32, IV-33, IV-35 and IV-37 were treated with 
4-bromobiphenyl and Cs2CO3 using several Pd-catalysts (eqs 32-35).21 Unfortunately, 
none of these reactions provided the desired benzocyclobutene products, and starting 
material was recovered in all cases. The absence of a directing group such as a Boc-









































IV-30, X = O






















A second study that would expand the scope of this process would involve 
capture of intermediate IV-21 by a pendant alkene, nitrile or heteroatom present on the 
aryl bromide substrate. As shown in eq 36, treatment of II-14 with ortho-vinyl 
bromobenzene under the optimized reaction conditions afforded product IV-39 in 69% 
yield and high diastereoselectivity.18 However, use of ortho-allyl bromobenzene under 
the same reaction conditions led to a complex mixture of products and IV-40 was not 
observed (eq 37), presumably due to relatively slow formation of the six-membered ring. 
Similarly, reaction of II-14 with 2-bromobenzonitrile did not afford any of the ketone 
product IV-41 but instead lead to the formation of bicyclic structure IV-42 as a major 
product (eq 38).19 Pyrrole-containing aryl bromide IV-43 was recently used in a similar 
C-H activation/annulation reaction by Lautens and coworkers (eq 39).20 Unfortunately, 
use of the substrate also failed to produce IV-44, and all starting material was recovered. 
Attempts to extend the methodology to heteroatom nucleophiles (IV-45, IV-47 and IV-
48) did not produce any of the desired products; starting material was usually recovered 
(eqs 40-41).21 It is possible that heteroatom chelation to the palladium catalyst could 





































































































not observedIV-47, X = Br






In conclusion, we have developed a new transformation for the conversion of II-
14 to cyclopentane-fused benzocyclobutenes via an unprecedented sequence of 




activation. These are the first examples of reactions that exploit directed carbopalladation 
for the generation and functionalization of alkylpalladium intermediates that lack syn-β-
hydrogen atoms. Importantly, the results described above illustrate that differences in 
reactivity between Pd-amino and Pd-amido complexes can be exploited to allow the 
construction of strikingly different products from common starting materials. 
 
Experimental Section 
General Considerations. All reactions were carried out under an argon or 
nitrogen atmosphere in oven- or flame-dried glassware. Pd(OAc)2, Dpe-phos, anhydrous 
dioxane, and all starting materials were obtained from commercial sources and used 
without further purification except 2-cyclopent-2-enylethyl carbamic acid tert-butyl ester 
(II-14), 22  IV-17, 23  2-allyl bromobenzene, 24  IV-43, 25  IV-45, 26  and 4-bromobenzyl 
acetate,27 which were prepared according to published procedures. Ratios of regioisomers 
and/or diastereomers were determined by 1H NMR and/or capillary GC analysis of crude 
reaction mixtures. Yields refer to isolated yields of compounds estimated to be ≥95% 
pure as determined by 1H NMR, GC, and/or combustion analysis. The yields reported in 
the supporting information describe the result of a single experiment, whereas the yields 
reported in Table 12 are the average yields of two or more experiments. Thus, the yields 
reported in the supporting information may differ from those shown in Table 12. The 
stereochemistry of IV-2 was assigned by x-ray crystallographic analysis. The 





Synthesis of Benzocyclobutene Derivatives and Cyclized Products via Coupling with 
Aryl Bromides (Table 12, eqs 28–30) 
General Procedure. A flame-dried Schlenk tube equipped with a magnetic 
stirbar was cooled under a stream of nitrogen and charged with the aryl bromide (1.2 
equiv), Pd(OAc)2 (4 mol %), Dpe-phos (8 mol %) and Cs2CO3 (2.3 equiv). The tube was 
purged with nitrogen and a solution of the N-protected amine substrate II-14 (1.0 equiv) 
in dioxane (4 mL/mmol II-14) was then added via syringe. The resulting mixture was 
heated to 100 °C with stirring until the starting material had been consumed as 
determined by GC analysis. The reaction mixture was cooled to room temperature and 
saturated aqueous NH4Cl (1 mL) and ethyl acetate (1 mL) were added. The layers were 
separated, the aqueous layer was extracted with ethyl acetate (3 x 5 mL), and the 
combined organic layers were dried over Na2SO4, filtered, and concentrated in vacuo. 
The crude product was then purified by flash chromatography on silica gel. All reactions 
provided the benzocyclobutene derivatives with >20:1 dr. 
 
(±)-(3aR,6S,6aS)-6-Biphenyl-4-yl-hexahydrocyclopenta[b]pyrrole-1-
carboxylic acid tert-butyl ester (IV-1).22 The general procedure was employed for the 
reaction of 4-bromobiphenyl (140 mg, 0.60 mmol) with II-14 (106 mg, 0.50 mmol) 
except that NaOt-Bu (111 mg, 1.15 mmol) was used as a base instead of Cs2CO3. This 
procedure afforded 92 mg (51%) of the title compound as a white solid, m.p. 126–128 
°C. This compound was found to exist as a ~2:1 mixture of rotamers as judged by 1H 




7.42 (t, J = 7.6 Hz, 2 H), 7.28–7.20 (m, 3 H), 4.58–4.48 (m, 0.3 H), 4.43–4.34 (m, 0.7 H), 
3.86–3.75 (m, 0.7 H), 3.57–3.45 (m, 0.3 H), 3.39–3.19 (m, 1.3 H), 3.12–3.01 (m, 0.7 H), 
3.00–2.81 (m, 1 H), 2.16–2.02 (m, 1 H), 2.01–1.77 (m, 3 H), 1.76–1.62 (m, 2 H), 1.21–
0.93 (m, 9 H). 
 
(±)-(1R,3aR,7bS)-2-[6-Phenyl-2,3,3a,7b-tetrahydro-1H-
cyclopenta[3,4]cyclobuta[1,2]benzen-1-yl]ethyl-carbamic acid tert-butyl ester (IV-2). 
The general procedure was employed for the reaction of 4-bromobiphenyl (70 mg, 0.30 
mmol) with II-14 (53 mg, 0.25 mmol). This procedure afforded 71 mg (75%) of the title 
compound as a white solid, m.p. 125–127 °C. 1H NMR (400 MHz, CDCl3) δ 7.59–7.53 
(m, 2 H), 7.46–7.38 (m, 3 H), 7.34–7.27 (m, 2 H), 7.07 (d, J = 7.6 Hz, 1 H), 4.56 (s, br, 1 
H), 3.85 (d, J = 4.6 Hz, 2 H), 3.41–3.28 (m, 1 H), 3.29–3.17 (m, 1 H), 1.95–1.83 (m, 2 
H), 1.81–1.59 (m, 4 H), 1.46 (s, 9 H), 1.13–1.02 (m, 1 H); 13C NMR (100 MHz, CDCl3) 
δ 155.9, 146.3, 144.4, 142.2, 140.4, 128.6, 127.2, 126.8, 122.2, 121.8, 79.0, 50.7, 47.6, 
40.2, 38.6, 32.1, 30.2, 28.7, 28.4 (two aromatic carbons are incidentally equivalent); IR 










(±)-(1S,3R)-2-[3-Biphenyl-4-yl-cyclopentyl)-ethyl]-carbamic acid tert-butyl 
ester (IV-10, Ar = p-biphenyl). This compound was isolated as a side-product formed in 
the reaction of II-14 with 4-bromobiphenyl described above (10 mg, 5% yield, ca. 90% 
purity). 1H NMR (500 MHz, CDCl3) δ 7.61–7.56 (m, 2 H), 7.51 (d, J = 8.2 Hz, 2 H), 7.42 
(t, J = 7.3 Hz, 2 H), 7.35–7.28 (m, 3 H), 4.52 (s, br, 1 H), 3.21–3.04 (m, 3 H), 2.29–2.21 
(m, 1 H), 2.16–1.92 (m, 3 H), 1.77–1.68 (m, 1 H), 1.66–1.54 (m, 3 H), 1.45 (s, 9 H), 
1.35–1.24 (m, 1 H); 13C NMR (100 MHz, CDCl3) δ 155.9, 145.2, 141.1, 138.8, 128.7, 
127.4, 127.1, 127.0, 126.8, 79.1, 45.4, 42.1, 39.9, 37.7, 36.7, 33.3, 31.8, 28.4; IR (film) 
1699 cm–1.  MS (ESI): 388.2247 (388.2252 calculated for C24H31NO2, M + Na+).  
















cyclopenta[3,4]cyclobuta[1,2]benzen-5-yl-acetic acid methyl ester (IV-3). The general 
procedure was employed for the reaction of 4-bromobenzyl acetate (69 mg, 0.30 mmol) 
with II-14 (53 mg, 0.25 mmol). This procedure afforded 68 mg (76%) of the title 
compound as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.24–7.17 (m, 1 H), 7.07–
6.97 (m, 2 H), 5.05 (q, J = 11.9 Hz, 2 H), 4.58 (s, br, 1 H), 3.79 (d, J = 6.6 Hz, 2 H), 
3.35–3.17 (m, 2 H), 2.09 (s, 3 H), 1.93–1.79 (m, 2 H), 1.78–1.51 (m, 4 H), 1.46 (s, 9 H), 
1.08–0.94 (m, 1 H); 13C NMR (125 MHz, CDCl3) δ 170.9, 155.9, 147.5, 144.3, 134.7, 
128.1, 123.6, 121.8, 79.1, 67.1, 50.9, 47.6, 40.3, 38.7, 32.0, 30.1, 28.7, 28.4, 21.1; IR 
(film) 1740, 1713 cm–1. Anal calcd for C21H29NO4: C, 70.17; H, 8.13; N, 3.90. Found: C, 
70.31; H, 8.21; N, 3.88. 
 
(±)-(1R,3aR,7bS)-2-[6-Chloro-2,3,3a,7b-tetrahydro-1H-
cyclopenta[3,4]cyclobuta[1,2]benzen-1-yl] ethyl-carbamic acid tert-butyl ester (IV-
4). The general procedure was employed for the reaction of 4-bromochlorobenzene (115 
mg, 0.60 mmol) with II-14 (106 mg, 0.50 mmol). This procedure afforded 120 mg (71%) 
of the title compound as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.18 (dd, J = 1.7, 
7.8 Hz, 1 H), 7.03 (s, 1 H), 6.91 (d, J = 7.6 Hz, 1 H), 4.63 (s, br, 1 H), 3.76 (p, J = 3.9 Hz, 




1.46 (s, 9 H), 1.04–0.94 (m, 1 H); 13C NMR (125 MHz, CDCl3) δ 155.9, 145.2, 132.7, 
127.9, 123.7, 123.1, 79.1, 50.8, 47.3, 40.1, 38.6, 31.9, 30.0, 28.6, 28.4 (two aromatic 
carbons are incidentally equivalent); IR (film) 1695 cm–1. Anal calcd for C18H24ClNO2: 
C, 67.17; H, 7.52; N, 4.35. Found: C, 67.10; H, 7.55; N, 4.38. 
 
(±)-(1R,3aR,7bS)-2-6-Methoxy-2,3,3a,7b-tetrahydro-1H-
cyclopenta[3,4]cyclobuta[1,2]benzen-1-yl]ethyl-carbamic acid tert-butyl ester (IV-5). 
The general procedure was employed for the reaction of 4-bromoanisole (113 mg, 0.60 
mmol) with II-14 (106 mg, 0.50 mmol). This procedure afforded 98 mg (62%) of the title 
compound as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 6.90 (d, J = 8.1 Hz, 1 H), 
6.75 (dd, J = 2.2, 8.1Hz, 1 H), 6.71 (s, 1 H), 4.60 (s, br, 1 H), 3.78 (s, 3 H), 3.73 (d, J = 
6.3 Hz, 2 H), 3.38–3.27 (m, 1 H), 3.24–3.15 (m, 1 H), 1.89–1.76 (m, 2 H), 1.75–1.62 (m, 
2 H), 1.61–1.52 (m, 2 H), 1.45 (s, 9 H), 1.07–0.96 (m, 1 H); 13C NMR (125 MHz, CDCl3) 
δ 159.4, 155.9, 144.7, 138.8, 122.6, 114.0, 109.3, 79.1, 55.4, 50.2, 47.0, 40.3, 38.6, 32.1, 
30.2, 28.9, 28.4; IR (film) 1700 cm–1. Anal calcd for C19H27NO3: C, 71.89; H, 8.57; N, 
4.41. Found: C, 72.06; H, 8.59; N, 4.36. 
 
(±)-(1R,3aR,7bS)-2-[4-Methyl-2,3,3a,7b-tetrahydro-1H-
cyclopenta[3,4]cyclobuta[1,2]benzen-1-yl]ethyl-carbamic acid tert-butyl ester (IV-6). 
The general procedure was employed for the reaction of 2-bromotoluene (103 mg, 0.60 
mmol) with II-14 (106 mg, 0.50 mmol). This procedure afforded 130 mg (87%) of the 
title compound as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.09 (t, J = 7.6 Hz, 1 H), 




3.36–3.16 (m, 2 H), 2.17 (s, 3 H), 1.90–1.79 (m, 2 H), 1.75–1.62 (m, 2 H), 1.61–1.51 (m, 
2 H), 1.45 (s, 9 H), 1.07–0.95 (m, 1 H); 13C NMR (100 MHz, CDCl3) δ 155.9, 145.2, 
143.5, 131.9, 128.2, 127.3, 120.5, 79.1, 50.4, 47.0, 40.3, 38.5, 31.9, 30.2, 28.4, 27.6, 
16.2; IR (film) 1696 cm–1. Anal calcd for C19H27NO2: C, 75.71; H, 9.03; N, 4.65. Found: 
C, 75.61; H, 9.04; N, 4.64. 
 
(±)-(1R,3aR,7bS)-2-[4-Phenyl-2,3,3a,7b-tetrahydro-1H-
cyclopenta[3,4]cyclobuta[1,2]benzen-1-yl]ethyl-carbamic acid tert-butyl ester (IV-7). 
The general procedure was employed for the reaction of 2-bromobiphenyl (70 mg, 0.30 
mmol) with II-14 (53 mg, 0.25 mmol). This procedure afforded 68 mg (75%) of the title 
compound as a white solid (m.p. 118–120 °C). 1H NMR (400 MHz, CDCl3) δ 7.67 (d, J = 
7.4 Hz, 2 H), 7.48 (d, J = 8.2 Hz, 1 H), 7.41 (t, J = 7.6 Hz, 2 H), 7.33–7.23 (m, 2 H), 6.98 
(d, J = 7.2 Hz, 1 H), 4.58 (s, br, 1 H), 4.18–4.10 (m, 1 H), 3.89–3.81 (m, 1 H), 3.37–3.17 
(m, 2 H), 1.96–1.86 (m, 1 H), 1.85–1.79 (m, 1 H), 1.78–1.70 (m, 1 H), 1.69–1.54 (m, 3 
H), 1.46 (s, 9 H), 1.09–0.96 (m, 1 H); 13C NMR (100 MHz, CDCl3) δ 155.9, 144.7, 
143.8, 138.0, 134.4, 128.7, 128.0, 127.2, 126.9, 125.2, 122.2, 79.1, 50.6, 48.9, 40.3, 38.8, 
31.8, 30.2, 28.4, 27.7; IR (film) 1699 cm–1. Anal calcd for C24H29NO2: C, 79.30; H, 8.04; 
N, 3.85. Found: C, 79.01; H, 8.05; N, 3.84. 
 
(±)-[(1R,3aR,7bS)-2-[5-Methyl-2,3,3a,7b-tetrahydro-1H-
cyclopenta[3,4]cyclobuta[1,2]benzen-1-yl]ethyl-carbamic acid tert-butyl ester (IV-8). 
The general procedure was employed for the reaction of 3-bromotoluene (52 mg, 0.30 




compound as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 6.96 (d, J = 7.6 Hz, 1 H), 
6.87 (d, J = 7.2 Hz, 1 H), 6.79 (s, 1 H), 4.51 (s, br, 1 H), 3.72 (m, 2 H), 3.31–3.11 (m, 2 
H), 2.28 (s, 3 H), 1.86–1.73 (m, 2 H), 1.71–1.48 (m, 4 H), 1.41 (s, 9 H), 1.03–0.90 (m, 1 
H); 13C NMR (100 MHz, CDCl3) δ 155.9, 147.3, 140.6, 137.1, 127.7, 123.0, 122.4, 79.1, 
50.5, 47.6, 40.3, 38.6, 32.0, 30.1, 28.7, 28.4, 22.1; IR (film) 1699 cm–1. Anal calcd for 
C19H27NO2: C, 75.71; H, 9.03; N, 4.65. Found: C, 75.53; H, 9.02; N, 4.47. 
 
(±)-(1R,3aR,7bS)-2-[5-Methoxy-2,3,3a,7b-tetrahydro-1H-
cyclopenta[3,4]cyclobuta[1,2]benzen-1-yl]ethyl-carbamic acid tert-butyl ester (IV-9). 
The general procedure was employed for the reaction of 3-bromoanisole (113 mg, 0.6 
mmol) with II-14 (106 mg, 0.5 mmol). This procedure afforded 107 mg (67%) of the title 
compound as an inseparable 2:1 mixture of regioisomers (colorless oil). Data are for the 
mixture 1H NMR (400 MHz, CDCl3) δ 7.19 (t, J = 7.6 Hz, 0.33 H), 6.93 (d, J = 8.0 Hz, 
0.67 H), 6.77–6.70 (m, 1 H), 6.69–6.63 (m, 0.33 H), 6.62–6.58 (m, 0.67 H), 5.02 (s, br, 
0.33 H), 4.62 (s, br, 0.67 H), 3.89–3.83 (m, 0.33 H), 3.82–3.68 (m, 4.67 H), 3.39–3.14 
(m, 2 H), 1.89–1.75 (m, 2 H), 1.74–1.51 (m, 4 H), 1.46 (s, 9 H), 1.18–1.07 (m, 0.33 H), 
1.06–0.94 (m, 0.67 H); 13C NMR (100 MHz, CDCl3) δ 159.8, 156.1, 155.9, 154.0, 149.1, 
148.0, 135.4, 129.7, 129.2, 124.2, 114.6, 113.4, 109.4, 107.5, 79.0, 78.7, 55.3, 55.0, 50.0, 
49.9, 47.7, 47.1, 40.6, 40.2, 40.0, 38.6, 31.9, 30.5, 30.1, 28.6, 28.43, 28.39, 28.0 (two 
aliphatic carbons are incidentally equivalent); IR (film) 1699 cm–1. Anal calcd for 






cyclopenta[3,4]cyclobuta[1,2]benzen-1-yl]ethyl-carbamic acid tert-butyl ester (IV-
14). The general procedure was employed for the reaction of 3-bromobenzotrifluoride 
(270 mg, 1.2 mmol) with II-14 (212 mg, 1.0 mmol). This procedure afforded 84 mg 
(24%) of the title compound as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.46 (d, J = 
7.6 Hz, 1 H), 7.25 (s, 1 H), 7.16 (d, J = 7.3 Hz, 1 H), 4.60 (s, br, 1 H), 3.85 (d, J = 6.3 Hz, 
2 H), 3.37–3.27 (m, 1 H), 3.26–3.15 (m, 1 H), 1.97–1.83 (m, 2 H), 1.76–1.61 (m, 3 H), 
1.60–1.51 (m, 1 H), 1.46 (s, 9 H), 1.04–0.92 (m, 1 H); 13C NMR (125 MHz, CDCl3) 
δ 155.9, 148.2, 147.7, 129.8 (q, J = 31.8 Hz), 124.6 (q, J = 272.5 Hz), 124.3, 123.5, 
118.7, 79.2, 51.2, 47.8, 40.2, 38.6, 32.0, 30.1, 28.6, 28.4; IR (film) 1699 cm–1. Anal calcd 
for C19H24F3NO2: C, 64.21; H, 6.81; N, 3.94. Found: C, 64.19; H, 7.00; N, 3.94. 
 
(±)-(3aR,5R,6aR)-5-(2-Methylnaphthalen-1-
yl)hexahydrocyclopenta[b]pyrrole-1-carboxylic acid tert-butyl ester (IV-15). The 
general procedure was employed for the reaction of 1-bromo-2-methylnaphthalene (67 
mg, 0.30 mmol) with II-14 (53 mg, 0.25 mmol). This procedure afforded 23 mg (26%) of 
the title compound as a colorless oil and as a ~2:1 mixture of rotamers. 1H NMR (500 
MHz, CDCl3) δ 8.12 (d, J = 8.3 Hz, 1 H), 7.79 (d, J = 7.8 Hz, 1 H), 7.64–7.57 (m, 1 H), 
7.48–7.34 (m, 2 H), 7.30–7.23 (m, 1 H), 4.36–4.21 (m, 1 H), 4.02–3.87 (m, 1 H), 3.84–
3.77 (m, 0.7 H), 3.74–3.67 (m, 0.3 H), 3.65–3.55 (m, 1 H), 2.92–2.82 (m, 1 H), 2.57–2.42 
(m, 5 H), 2.30–2.16 (m, 1 H), 2.10–1.97 (m, 2 H), 1.87–1.79 (m, 1 H), 1.54–1.36 (m, 9 
H); 13C NMR (125 MHz, CDCl3) δ 154.5, 135.1, 133.6, 133.4, 131.7, 129.7, 129.2, 




41.3, 39.5, 38.1, 36.3, 29.4, 28.8, 28.6, 28.5, 21.8; IR (film) 1692 cm–1.  MS (ESI): 




1-carboxylic acid tert-butyl ester (IV-16). The general procedure was employed for the 
reaction of 2-bromomesitylene (60 mg, 0.30 mmol) with II-14 (53 mg, 0.25 mmol). This 
procedure afforded 25 mg (30%) of the title compound as a colorless oil and as a ~2:1 
mixture of rotamers. 1H NMR (500 MHz, CDCl3) δ 6.86–6.78 (m, 2 H), 4.23–4.10 (m, 1 
H), 3.73–3.65 (m, 0.7 H), 3.62–3.55 (m, 0.3 H), 3.52–3.36 (m, 2 H), 2.79–2.67 (m, 1 H), 
2.42–2.29 (m, 7 H), 2.23 (s, 3 H), 2.11–1.82 (m, 4 H), 1.78–1.70 (m, 1 H), 1.52–1.39 (m, 
9 H); 13C NMR (125 MHz, CDCl3) δ 154.4, 136.7, 135.4, 135.3, 130.3, 130.2, 79.0, 62.6, 
62.3, 45.5, 44.9, 44.3, 43.3, 41.4, 39.0, 37.4, 35.1, 29.7, 28.9, 28.5, 21.4, 21.2, 20.6; IR 
(film) 1695 cm–1.  MS (ESI): 352.2249 (352.2252 calculated for C21H31NO2, M + Na+). 
 
tert-butyl 2-((1R,3aR,8aS)-8-methylene-1,2,3,3a,8,8a-
hexahydrocyclopenta[a]inden-1-yl)ethylcarbamate (IV-39). The general procedure 
was employed for the reaction of 2-bromostyrene (55 mg, 0.30 mmol) with II-14 (53 mg, 
0.25 mmol). This procedure afforded 58.4 mg (74%) of the title compound as a colorless 
oil and as a single diastereoisomer. 1H NMR (500 MHz, CDCl3) δ 7.43–7.38 (m, 1 H), 
7.25–7.14 (m, 3 H), 5.56 (s, 1 H), 4.96 (s, 1 H), 4.48 (s, 1 H), 3.75–3.68 (m, 1 H), 3.39–
3.32 (m, 1 ), 3.23–3.04 (m, 2 H), 2.07–1.97 (m, 1 H), 1.92–1.86 (m, 2 H), 1.85–1.77 (m, 




NMR (125 MHz, CDCl3) δ 155.9, 150.4, 149.8, 142.1, 128.6, 126.6, 124.5, 119.6, 105.5, 
79.0, 50.3, 48.5, 41.4, 40.3, 33.0, 31.9, 30.3, 28.4; IR (film) 1699, 1636 cm–1.  MS (ESI): 
313.2036 (313.2042 calculated for C20H27NO2, M + Na+). 
The stereochemistry of the above compound was determined by 1H NMR nOe 
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Stereoselective Synthesis of Preussin via Pd-Catalyzed Carboamination Reaction1 
With the aim of demonstrating an application of the carboamination methodology 
described in Chapter II, the synthesis of an alkaloid natural product alkaloid was 
undertaken. Preussin (V-1), a 2-benzyl pyrrolidine derivative, was chosen as a target to 
accomplish this task. In this chapter our two routes for the synthesis of preussin and 
analogs are described. 
Background 
The natural product preussin (V-1) was first isolated in 1988 by Schwartz and 
coworkers from the fermentation extracts of Preussia sp. and Aspergillus ochraceus 
(Figure 6). 2  Initial screens revealed that this compound had significant antifungal 
activity,2,3 and more recent work has demonstrated that preussin induces apoptosis in a 
number of human cancer cell lines and is a potent (IC50 = 500 nm) inhibitor of cyclin-E 
kinase.4 Preussin has also shown antiviral activity, and is believed to inhibit –1 ribosomal 
frameshifting of RNA-based viruses.5 Interestingly, all eight stereoisomers of preussin 















Preussin (V-1) Anisomycin (V-2)  
Figure 6. Preussin and Anisomycin 
 
Owing to its interesting biological properties, preussin has been a popular target 
for total synthesis, and has been prepared via 23 different routes ranging from five steps 
to over 23 steps.7,8,9,10 We felt that the majority of these routes were limited in that the 
synthetic sequences were not easily amenable to the preparation of analogs. In particular, 
introduction of the C5 alkyl side-chain is generally accomplished by addition of the 
corresponding organometallic reagent to an electrophilic site8 towards the beginning of 
the sequence.11 Additionally, a large majority of these syntheses employ phenylalanine as 
the source of the C1’-phenyl group, and most other routes also install this group early in 
the synthetic sequence.7 Three strategies allow installation of the aryl moiety within 1–3 
steps of the final target. As shown in Scheme 19, equation 42, Davis generated the C1’-
phenyl group as the final step in his asymmetric synthesis of preussin via reaction of 
lithium diphenyl cuprate with a pyrrolidinylmethyl iodide (40% yield, single 
diastereomer; 10 steps total, 9% overall yield).10c In the second example presented in 
equation 43, Bach employed a Paternò-Büchi reaction of benzaldehyde with 
dihydropyrrole V-6 (4:1 dr, 53% yield after separation of diastereomers) followed by a 
two-step deprotection sequence to generate the C1’-phenyl substituent (39% yield over 3 
steps; 9 steps total, 11% overall yield).12 More recently, Davis and coworkers described 




Horner-Wadsworth-Emmons reaction between phosphonate V-9 and benzaldehyde (85% 
yield, eq 44).10a This strategy allowed the authors to synthesize a p-methoxy aryl analog 
of preussin by using p-anisaldehyde in this key transformation (70% yield). The final two 
steps of the synthesis involved hydrogenation and LiAlH4 reduction of enone V-10 (55% 
over three steps; 9 steps total, 28% overall yield). 
 
























































V-3 V-4 2 steps, 41%










































group towards the end of the synthetic sequence, they are limited by the need for highly 
reactive reagents (e.g. LiAlH4 or aryllithium reagents) in the final steps that limit 
functional group tolerance. A concise approach to preussin that involves the installation 
of the alkyl side-chain or aryl group near the end of the synthetic route under mild 
conditions would be of great value, particularly if the alkyl group or arene could be 
incorporated in a manner that would permit synthesis of functionalized and/or heteroaryl 
analogs from readily available precursors.  
Due to the limitations of existing synthetic routes, very little work has been 
conducted on the synthesis and study of preussin analogs.13 Schaumann14 and Bach15 
have reported the synthesis of analogs where the C5 alkyl chain was replaced with a (Z)-
non-1-enyl group or a benzyl group, but the testing of these compounds in biological 
assays was not reported. Other than the p-methoxyphenyl analog reported recently by 
Davis,10a no aryl analogs of preussin have been prepared that are modified on the 
aromatic ring. However, limited studies on the effect of arene substitution on the activity 
of the related alkaloid anisomycin (V-2) have been performed. These studies 
demonstrated that the nature of the C1’ aryl group has a profound effect on biological 
activity.16,17 For example, an anisomycin analog bearing a phenyl group in place of the p-
methoxyphenyl moiety showed 40-fold less cytotoxic potency than V-2 against a human 
KB cell line.17 For these reasons we felt that a short synthetic route to preussin that would 








We envisioned that the trisubstituted pyrrolidine alkaloid preussin (V-1) could be 
potentially generated via two different carboamination disconnections: route A and route 
B (Scheme 20). Route A would involve coupling of a 1,2-amino alcohol derivative (V-
11) with (E)-1-bromooct-1-ene. Route B, on the other hand, would involve coupling of a 
1,3-amino alcohol derivative (V-12) with bromobenzene. 


























The key steps proposed for the synthesis of trisubstituted pyrrolidines V-14 and 
V-16 would challenge our previously developed methodology as well as our proposed 
stereochemical model (Scheme 21). In the vinyl bromide route (A), analysis of transition 
state model V-13 for the formation of the required 2,5-cis pyrrolidine V-14 revealed a O-
Pg substituent at C3 lying in the pseudoequatorial position. The effects of this polar side 
chain on the cyclization yield and selectivity were unknown at the time of our study.18 In 
the aryl bromide route (B), analysis of transition state V-15 required to afford the desired 
2,5-cis pyrrolidine product V-16 revealed an O-Pg at C3 that would lie in the pseudoaxial 
position. It is possible that this O-Pg substituent at C3 and the alkyl side chain at C5 




and/or selectivity for the key reaction. Thus, we opted to start our synthetic studies with 
the vinyl bromide route (A). 
 

























































Vinyl Bromide Route (A) 
 
Our synthetic plan involved a five-step sequence to preussin (Scheme 22), which 
would be equal in length to the shortest reported synthesis of the natural product.20 
Additionally, it would enable the installation of various alkyl side chains at C5 two steps 
from the end of the sequence, which would permit the facile construction of a number of 
preussin analogs. Following a literature procedure,21 oxidation of commercially available 
(S)-2-[(tert-butoxycarbonyl)amino]-3-phenyl-1-propanol (V-17) followed by in situ 




18:V-19 that were separable by column chromatography. Protection of V-19 with TBS-Cl 
afforded substrate V-20 that was used in the key cyclization. Under optimized reaction 
conditions,22 the Pd-catalyzed carboamination reaction of V-20 afforded only 6% of V-22 
as a single diastereomer. The majority of the starting material was converted to Heck-
type side-product V-21. Other reaction parameters that could influence the 
carboamination reaction such as solvent and base were investigated, but none provided 
significant improvements in the key reaction. Pyrrolidine V-22 was then converted in two 
steps to preussin (V-1) via hydrogenation of the internal olefin and reduction of the Boc 
protecting group with concomitant TBS deprotection.21 The 1H NMR spectra obtained for 
V-1 matched the literature data available for preussin.15 Thus, the key reaction was found 
to be selective for the formation of 2,5-cis pyrrolidine V-22, albeit in low yield.  

































































With the anti 1,2-aminoalcohol substrate V-18 in hand, we were interested in 
examining the outcome of its cyclization, as this would lead to the generation of a 
biologically active stereoisomer of the natural product, and would also indicate the 
importance of the C3 stereochemical configuration on the yield and selectivity of the 
carboamination. Interestingly, the use of anti 1,2-aminoalcohol substrate V-24 in the key 
cyclization step afforded product V-26 in 28% isolated yield, although the reaction 
proceeded to only ~50% conversion (Scheme 23).23 The minor product observed resulted 
from a Heck-type side-reaction (V-25). 24  The pyrrolidine product V-26 was then 
converted in two steps (hydrogenation and LiAlH4 reduction) to 3-epi-preussin (V-28), 
and the 1H NMR spectra obtained matched the literature data.6,9d Thus, the key reaction 
of V-24 was found to be highly selective for the formation of the 2,5-cis pyrrolidine 
isomer. Additionally, a much higher yield of the pyrrolidine V-26 was obtained (28% 
yield, 50% conversion), which is in sharp contrast to the cyclization of V-20 where 
pyrrolidine V-22 was obtained in only 6% yield. 
















































The different product distribution observed in the reaction of syn substrate V-20 
and anti substrate V-24 could be due to differences in the relative rates of 
aminopalladation versus Heck arylation (Scheme 24). Transition state analysis for the 
cyclization of syn substrate V-30 via the Newman projection V-31 reveals a gauche 
interaction between the pseudoaxial benzyl group and the pseudoequatorial TBS-
protected oxygen, which would result in a higher energy transition state V-30 and thus a 
slower cyclization. Conversely, transition state analysis of the anti substrate V-34 reveals 
both Bn and OTBS groups in a pseudoaxial position, and a Newman projection of this 
configuration (V-35) reveals a gauche interaction between the OTBS group and N-Boc 
group. However, since a higher ratio of pyrrolidine V-26 to Heck product was obtained 
with V-24, it is believed that this gauche interaction was not as severe as in V-31 and 
rendered olefin insertion faster for this particular stereoisomer. This hypothesis implied 
that reducing the steric bulk on the oxygen substituent (V-31) could facilitate the 


























































































This idea was tested by studying the carboamination of substrates containing 
various oxygen protecting groups TBS, TMS and MOM (V-20, V-36 and V-38, Scheme 
25). The trend observed was consistent with the hypothesis: the smallest oxygen 
protecting group (V-38) provided the highest yield of V-39. Although this result was 




number of steps to the final target molecule, as an extra deprotection step would be 
necessary. 25  Additionally, removal of a MOM group often requires harsh acidic 
conditions incompatible with numerous functional groups.26 It is important to note that 
when no protecting groups were used on the substrate, some conversion to a ketone 
product was observed, presumably via Pd(II)-catalyzed oxidation of the secondary 
alcohol functionality.27 































In order to better understand the reasons behind the low yields and different 
chemoselectivities obtained in the coupling of V-20 with V-24, we examined the 
reactions of unsaturated amines V-20, V-24, II-5 and II-21 with 4-t-butyl bromobenzene 
and (E)-1-bromooct-1-ene (Scheme 26). As shown in eqs 45 and 46, treatment of 
substrates V-20 and V-24 with 4-t-butyl bromobenzene and NaOt-Bu in the presence of 




products V-40 and V-41 with excellent diastereoselectivity. Surprisingly, contrary to their 
reaction with (E)-1-bromooct-1-ene, the two substrates V-20 and V-24 afforded similar 
product yields with 4-t-butyl bromobenzene. The coupling of (E)-1-bromooct-1-ene with 
less substituted substrates II-5 and II-21 provided moderate but comparable yields of the 
pyrrolidine products V-42 and V-43 under the same reaction conditions (eqs 47 and 48). 
The major side-product observed resulted from N-vinylation of the substrates. This side-
reaction was previously observed in the reaction of II-5 and β-bromostyrene under the 
same condition.  Use of dppe as a ligand improved the yield of II-35 to 75% (Chapter 
II).28  Together these results suggested that the low yields originally obtained in the 
preussin synthesis (Schemes 22 and 23) could be attributed to a combination of two 
factors: use of a vinyl bromide and the reactant’s high degree of substitution. It was more 
difficult to identify the reason behind the different chemoselectivities that were observed 
with the use of (E)-1-bromooct-1-ene (6% vs 56% yields) but that were not observed with 
the use of an aryl bromide (yields: 68% and 62%). Such results suggested that the energy 
of transition states V-30 and V-34 in Scheme 24 was closer when R = aryl than when R = 
vinyl. These results also implied that olefin insertion in the Pd-N bond was in general 
faster when R = aryl, since higher yields of pyrrolidine products were obtained, although 











































































Aryl Bromide Route (B) 
 
Since our first approach to preussin was not satisfying, we decided to investigate 
the aryl bromide route (B) (Scheme 27). The key disconnection in this route is the 
retrosynthetic cleavage of both the C–N bond and C1’–aryl bond to yield starting amino 
alcohol V-47 and aryl bromide. This strategy had two significant implications for the 
construction of the molecule. It would allow the installation of a variety of different 
functionalized arenes one step from the end of the sequence, which would permit the 
facile construction of a number of preussin analogs. It could also allow control of the 
relative stereochemistry at C2 through use of A(1,3)-strain 29  in conjunction with a 




stereochemistry determining step of the carboamination reaction to afford 2,5-cis 
pyrrolidine V-44. The cyclization would occur through transition state V-45 in which the 
C3 O-Pg substituent and C5 alkyl chain are oriented in a pseudoaxial position. Although 
we favored transition state V-45 on the basis of minimizing A(1,3)-strain, we were 
concerned that the two axial substituents would suffer from unfavorable 1,3-diaxial 
interactions19 thus leading to lower yields and/or selectivity. 



































In order to probe the feasibility of the key Pd-catalyzed carboamination reaction, 
our initial studies focused on the development of a synthesis of (±)-preussin (V-1). As 
outlined in Scheme 28, aldol reaction between commercially available 2-undecanone and 
acrolein provided keto-alcohol V-48 in 78% yield. Conversion of V-48 to the O-benzyl 
oxime V-49 proceeded smoothly, and was followed by a one-pot sequence of LiAlH4 
reduction and Boc-protection to provide an 86% yield of a 1:1.2 mixture of readily 
separable amino alcohol diastereomers V-50 and V-51. Although stereoselective 




employ non-selective conditions to allow access to both syn- and anti-amino alcohol 
substrates V-50 and V-51 for the Pd-catalyzed cyclization reactions, which would 
ultimately provide two different biologically active pyrrolidine derivatives (V-1 and V-
28).  
TBS-protection of amino alcohol V-51 provided V-47, the substrate for the key 
Pd-catalyzed carboamination reaction. In the event, treatment of V-47 with 
bromobenzene and NaOt-Bu in the presence of catalytic Pd(OAc)2/Dpe-phos provided 
pyrrolidine V-23 in 62% isolated yield with >20:1 diastereoselectivity. A major side-
product observed was V-52, which likely derives from competing β-hydride elimination 
from intermediate II-54 (Scheme 10). One-pot reduction and deprotection of V-23 
afforded (±)–Preussin (V-1) in 90% yield as a single diastereomer. This six-step sequence 
proceeded with an overall yield of 15% from 2-undecanone. 
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Amino alcohol V-50 was converted to (±)-3-epi-preussin (V-28)9a,c using a 
sequence of reactions analogous to that described above (Scheme 29). The 
stereoselectivity of the Pd-catalyzed cyclization of V-53 was high, although the chemical 
yield obtained in the reaction of V-53 (54%) was slightly lower than that achieved for the 
reaction of V-47 (62%). This route provided the desired pyrrolidine V-28 as a single 
isomer in an overall yield of 15%. Thus, the strategy described herein provides 
straightforward access to both racemic preussin diastereomers in comparable yields and 
stereoselectivities.31 
 









2 mol % Pd(OAc)2





















We were encouraged by these results, as our initial stereochemical hypothesis was 
confirmed (Scheme 27). Additionally, the stereochemistry at C3 did not appear to have 
an important effect on the yield and selectivity of the key reaction. However, these 
overall results differ greatly from the vinyl bromide route (A) where the cyclization 
yields where much lower, and a substantial difference in chemoselectivity was observed 




47 and V-53 were treated with vinyl bromide (E)-1-bromooct-1-ene under the same 
reaction conditions as with V-20 and V-24, moderate but similar GC yields of products 
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45% GC yield, >15:1 dr
38% GC yield, >15:1 dr  
 
Having demonstrated the feasibility of the Pd-catalyzed carboamination for the 
construction of preussin, we turned our attention towards the development of an 
asymmetric synthesis of the naturally occurring (+)-enantiomer. As shown in Scheme 30, 
addition of allylmagnesium bromide to enantiopure sulfinylimine V-56 under Ellman’s 
conditions33 afforded V-57, which was isolated in 77% yield as a single diastereomer 
upon purification. 34  Cleavage of the chiral auxiliary and protection of the resulting 
primary amine afforded V-58 in 85% yield. Ozonolysis of V-58 (63%) followed by 
vinylcuprate addition35 to the resulting β-amino aldehyde V-59 generated (+)-V-51 with 
3:1 diastereoselectivity; the desired pure anti-diastereomer was obtained in 54% yield 
after chromatographic separation. The remaining three steps proceeded with similar 




preussin (V-1) {[α]23D +21.2° (c 1.0, CHCl3) [lit.3 [α]25D +22.0° (c 1.0, CHCl3)]} with an 
overall yield of 12% in nine steps from commercially available decanal. 
 
Scheme 30. Synthesis of (+)-Preussin (V-1) 





























































4 mol % Dpe-phos




In order to demonstrate the amenability of this strategy toward the synthesis of 
differentially arylated preussin analogs, Pd-catalyzed reactions of V-47 and V-53 were 
conducted with a variety of different aryl bromide coupling partners. To illustrate the 
utility of this method for the rapid generation of useful quantities of analogs, the 
Pd(OAc)2/Dpe-phos catalyst was employed for all substrate combinations. Previous 
studies indicated that other ligands may provide superior results for certain aryl bromide 




on a case-by-case basis. As shown in Tables 13 and 14, the cyclization reactions 
proceeded in moderate to good yields for a variety of different aryl bromides including 
substrates that are electron-rich (Table 13, entries 3–4),36 electron-poor (Table 13, entries 
1–2, 5–6 and Table 14, entries 3–6), or sterically hindered (Table 14, entry 2). Several 
functional groups were tolerated, and heterocyclic aryl bromides could also be employed 
(Table 14, entries 4–5). In most cases examined, the cyclizations of amino alcohol 
derivative V-47 proceeded in higher yield than the analogous reactions of amino alcohol 
derivative V-53. In all cases the reactions proceeded with >20:1 diastereoselectivity as 
judged by 1H and 13C NMR analysis. 
Substrate V-47 was also efficiently transformed to the corresponding pyrrolidine 
product using the mild reaction conditions described in Chapter III. As shown in Table 14 
(entries 7–8), Pd-catalyzed reactions of V-47 with bromobenzene or methyl-4-
bromobenzoate with Cs2CO3 as a base proceeded smoothly to provide preussin 





Table 13. Synthesis of N-Boc-O-TBS-Preussin and N-Boc-O-TBS-3-epi-Preussin 
Analogsa  
 






























































aConditions: 1.0 equiv substrate, 1.2 equiv ArBr, 2.3 equiv NaOt-Bu, 2 mol % Pd(OAc)2, 4 mol % Dpe-









Table 14. Synthesis of N-Boc-O-TBS-Preussin Analogsa  
 





































































aConditions: 1.0 equiv substrate V-47, 1.2 equiv ArBr, 2.3 equiv NaOt-Bu, 2 mol % Pd(OAc)2, 4 mol % 
Dpe-phos, toluene, 90 °C. bYield refers to average isolated yield obtained in two or more experiments. 
cConditions: 1.0 equiv substrate, 1.2 equiv ArBr, 2.3 equiv Cs2CO3, 2 mol % Pd(OAc)2, 4 mol % Dpe-phos, 




To illustrate that the N-Boc-O-TBS-preussin and N-Boc-O-TBS-3-epi-preussin 
analogs could be converted to N-methyl-3-hydroxy-2-(arylmethyl)pyrrolidines that are 
closely related to the natural product, the products shown in Table 13 were deprotected in 
a 1–2 step sequence. As shown in Table 15, deprotection was effected using LiAlH4 
followed by treatment with aqueous base or TBAF for products bearing unreactive 
aromatic functionality. Alternatively, deprotection was also achieved through one-pot 
Boc-cleavage and reductive amination with formic acid/formaldehyde followed by 
treatment with TBAF. The latter conditions tolerate functional groups (e.g., ketones, 
trifluoromethyl substituents) that would be reduced by LiAlH4. Both deprotection 




Table 15. Deprotection of N-Boc-O-TBS-Preussin and N-Boc-O-TBS-3-epi-Preussin 
Analogsa 
 























































aConditions: Method A: i) LiAlH4, THF, 60 °C; ii) H2O or TBAF. Method B: i) HCO2H, HCHO; ii) TBAF, 




In conclusion, application of the carboamination methodology to the synthesis of 




successful. A concise, stereoselective route to (+)-preussin, (±)-preussin and (±)-3-epi-
preussin was developed. This route features a new strategy for the synthesis of 2-
benzylpyrrolidine alkaloids that allows the construction of both the C-N and the C1’-Ar 
bonds in a single step near the end of the synthetic sequence. It also allows the facile 
synthesis of differentially arylated preussin analogs, and provides straightforward access 
to derivatives that cannot be easily and rapidly prepared using previously developed 
routes. This strategy is potentially applicable to the synthesis of other pyrrolidine alkaloid 
natural products, and further studies in this area are presented in Chapter VI. 
 
Experimental section 
General Considerations. All reactions were carried out under an argon or 
nitrogen atmosphere in oven- or flame-dried glassware. Palladium acetate and all 
phosphine ligands were purchased from Strem Chemical Co. and used without further 
purification. All aryl bromides were obtained from commercial sources (Aldrich 
Chemical CO or Acros Chemical CO) and were used as obtained except (E)-1-bromooct-
1-ene,37 which were prepared according to published procedures. Toluene, ether, and 
THF were purified using a GlassContour solvent purification system. Ratios of 
regioisomers and/or diastereomers were determined by either 1H NMR or capillary GC 
analysis of crude reaction mixtures. Yields refer to isolated yields of compounds 
estimated to be ≥95% pure as determined by 1H NMR, and either capillary GC (known 
compounds), combustion analysis (new compounds). The yields reported in the 




reported in Tables 13–15 are average yields of two or more experiments. Thus, the yields 
reported in the experimental section may differ from those shown in Tables 13–15. 
 
Vinyl Bromide Route (A) (Schemes 22, 23, 25 and 26) 
 
(2S,3R)-tert-Butyl-3-hydroxy-1-phenylhex-5-en-2-ylcarbamate (V-18).21 
Following a literature procedure, this product was obtained as a white solid (m.p.: 137–
139 oC, lit m.p.: 136–138 oC) and was the second diastereoisomer to elute from 
purification by column chromatography (10% ethyl acetate/hexanes). 1H NMR (400 
MHz, CDCl3) δ 7.31–7.26 (m, 3 H), 7.23–7.20 (m, 2 H), 5.90–5.82 (m, 1 H), 5.20–5.16 
(m, 2 H), 4.58 (s, br, 1 H), 3.82 (s, 1 H), 3.72 (s, 1 H), 3.00–2.91 (m, 1 H), 2.84–2.78 (m, 
1 H), 2.60 (s, 1 H), 2.40–2.36 (m, 1 H), 2.28–2.23 (m, 1 H), 1.35 (s, 9 H). 
 
(2S,3S)-tert-Butyl-3-hydroxy-1-phenylhex-5-en-2-ylcarbamate (V-19).21 
Following a literature procedure, this product was obtained as an oil and was the first 
diastereoisomer to elute from purification by column chromatography (10% ethyl 
acetate/hexanes). 1H NMR (400 MHz, CDCl3) δ 7.31–7.19 (m, 5 H), 7.81–5.70 (m, 1 H), 
5.14–5.10 (m, 2 H), 4.87–4.84 (m, 1 H), 3.79–3.74 (m, 1 H), 3.61–3.57 (m, 1 H), 2.96–
2.85 (m, 2 H), 2.28–2.22 (m, 2 H), 2.05–1.92 (m, 1 H), 1.44–1.28 (m, 9 H). 
 
(2S,3S)-tert-Butyl-3-(tert-butyldimethylsilyloxy)-1-phenylhex-5-en-2-
ylcarbamate (V-20).  A flame-dried flask was cooled under a steam of nitrogen and 




6.8 mmol) and TBS-Cl (820 mg, 5.4 mmol). The resulting mixture was stirred at rt until 
the starting material was consumed as judged by TLC analysis (ca. 24 h). The reaction 
mixture was diluted with water (20 mL) and ethyl acetate (20 mL). The layers were 
separated and the aqueous layer was extracted with ethyl acetate (3 x 20 mL). The 
combined organic layers were dried over anhydrous Na2SO4, filtered, and concentrated in 
vacuo. The crude product was purified by flash chromatography using 5% ethyl 
acetate/hexanes as the eluent to afford 1.5 g (74%) of the title compound as a colorless 
oil. This compound was found to exist as a 2:1 mixture of rotamers as judged by 1H NMR 
analysis; data are for the mixture. 1H NMR (500 MHz, CDCl3) δ 7.32–7.23 (m, 2 H), 
7.22–7.13 (m, 3 H), 5.74–5.60 (m, 1 H), 5.08–4.98 (m, 2 H), 4.78–4.72 (m, 0.66 H), 
4.66–4.59 (m, 0.33 H), 3.96–3.87 (m, 0.66 H), 3.80–3.72 (m, 0.33 H), 3.70–3.64 (m, 1 
H), 2.79–2.74 (m, 1.33 H), 2.72–2.66 (m, 0.66 H), 2.39–2.24 (m, 1 H), 2.23–2.14 (m, 1 
H), 1.37 (s, 6 H), 1.21 (s, 3 H), 0.95 (s, 9 H), 0.10 (d, J = 11.0 Hz, 6 H). 
 
(E)-(2S,3S,5R)-tert-Butyl-2-benzyl-3-(tert-butyldimethylsilyloxy)-5-(non-2-
enyl)pyrrolidine-1-carboxylate (V-22). A flame-dried Schlenk tube equipped with a 
magnetic stirbar was cooled under a stream of nitrogen and charged with V-20 (102 mg, 
0.25 mmol), Pd2(dba)3 (4.8 mg, 0.005 mmol, 2 mol %), Dpe-phos (5.6 mg, 0.01 mmol, 4 
mol %), NaOt-Bu (30 mg, 0.30 mmol) and (E)-1-bromooct-1-ene (60 mg, 0.30 mmol). 
The tube was purged with nitrogen and toluene was added (1 mL). The resulting mixture 
was heated to 110 °C with stirring for 16 hours until the starting material had been 
consumed as determined by GC analysis. The reaction mixture was cooled to room 




The layers were separated, the aqueous layer was extracted with ethyl acetate (3 x 5 mL), 
and the combined organic layers were dried over Na2SO4, filtered, and concentrated in 
vacuo. The crude product was then purified by flash chromatography using 2.5% 
ethyl/hexanes as the eluent to afford 7.7 mg (6%) of the title compound as a colorless oil 
in ~60% purity. This compound was identified by comparison of 1H NMR data to that 
reported for the known pyrrolidine compound V-23.38 Also isolated from this reaction 
was Heck product V-21; data are provided below. 
 
(E)-(2S,3S)-tert-Butyl-3-(tert-butyldimethylsilyloxy)-1-phenyldodec-5-en-2-
ylcarbamate (V-21). The title compound was isolated as an oil in ~80% purity and was 
found to exist as a 1:1 mixture of rotamers. The data is for the mixture. 1H NMR (400 
MHz, CDCl3) δ 7.31–7.11 (m, 5 H), 6.05–5.91 (m, 1 H), 5.71–5.30 (m, 2 H), 4.77–4.57 
(m, 1 H), 3.96–3.84 (m, 1 H), 3.79–3.62 (m, 1 H), 2.81–2.65 (m, 2 H), 2.38–2.12 (m, 1.5 
H), 2.10–1.98 (m, 1.5 H), 1.43–1.09 (m, 21 H), 0.99–0.79 (m, 9 H), 0.16–-0.02 (m, 6 H). 
 
(2S,3S,5R)–2-Benzyl-3-(tert-butyldimethylsilyloxy)-5-nonylpyrrolidine-1-
carboxylic acid tert-butyl ester (V-23).38 A flame-dried flask was cooled under a stream 
of nitrogen and charged with 5% Pd/C (33 mg) followed by V-22 (7.7 mg, 0.015 mmol) 
and EtOH (1 mL). The resulting mixture was purged with H2 and, a balloon filled with H2 
was attached. The reaction was stirred at rt until the starting material was consumed as 
judged by crude 1H NMR analysis (ca. 2 h). The reaction mixture was then filtered 
through a pad of celite/sand and the pad was washed with EtOH (3 x 5 mL). The 




~60% purity and was identified by comparison of 1H NMR data to that reported of 
known compound V-23. This mixture was used in the following transformation without 
further purification. 
(±)–Preussin (V-1).15  A flame-dried flask was cooled under a stream of nitrogen 
and charged with V-23 (16 mg, 0.031 mmol) and tetrahydrofuran (4 mL). The resulting 
solution was cooled to 0 °C and LiAlH4 (1 mL, 0.1 mmol, 1 M in tetrahydrofuran) was 
added dropwise. The resulting mixture was heated to reflux with stirring until the starting 
material was consumed as judged by TLC analysis (ca. 15h). The reaction mixture was 
cooled to 0 °C, slowly quenched with water (0.2 mL) and diluted with diethyl ether (5 
mL). Aqueous NaOH (0.2 mL, 10 M) and water (0.2 mL) were added sequentially and an 
insoluble white precipitate formed. The organic supernatant was decanted to a clean 
Erlenmeyer flask and the precipitate was washed with diethyl ether. The combined 
organic extracts were dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. 
The crude oil obtained contained ~60% of the title compound that was identified by 
comparison of 1H NMR data with 1H NMR data previously reported in the literature. 
 
(2S,3R)-tert-Butyl-3-(tert-butyldimethylsilyloxy)-1-phenylhex-5-en-2-
ylcarbamate (V-24). A flame-dried flask was cooled under a stream of nitrogen and 
charged with V-18 (400 mg, 1.4 mmol), dimethylformamide (10 mL), imidazole (191 
mg, 2.8 mmol) and TBS-Cl (338 mg, 2.2 mmol). The resulting mixture was stirred at rt 
until the starting material was consumed as judged by TLC analysis (ca. 24 h). The 




were separated and the aqueous layer was extracted with ethyl acetate (3 x 10 mL). The 
combined organic layers were dried over anhydrous Na2SO4, filtered, and concentrated in 
vacuo. The crude product was purified by flash chromatography using 5%  10% ethyl 
acetate/hexanes as the eluent to afford 460 mg (83%) of the title compound as a colorless 
oil. This compound was found to exist as a 2:1 mixture of rotamers as judged by 1H NMR 
analysis; data are for the mixture. 1H NMR (500 MHz, CDCl3) δ 7.29–7.23 (m, 2 H), 
7.21–7.14 (m, 3 H), 5.88–5.78 (m, 1 H), 5.16–5.06 (m, 2 H), 4.56–4.43 (m, 1 H), 3.98–
3.91 (m, 1 H), 3.90–3.83 (m, 1 H), 2.96 (dd, J = 4.4, 14.4 Hz, 1 H), 2.65–2.55 (m, 1 H), 
2.38–2.24 (m, 2 H), 1.37–1.15 (m, 9 H), 0.92 (s, 9 H), 0.07 (s, 6 H). 
 
(E)-(2S,3R,5R)-tert-Butyl 2-benzyl-3-(tert-butyldimethylsilyloxy)-5-(non-2-
enyl)pyrrolidine-1-carboxylate (V-26). A flame-dried Schlenk tube equipped with a 
magnetic stirbar was cooled under a stream of nitrogen and charged with V-24 (128 mg, 
0.32 mmol), Pd2(dba)3 (7.4 mg, 0.008 mmol, 2.5 mol %), Dpe-phos (9 mg, 0.016 mmol, 5 
mol %), NaOt-Bu (37 mg, 0.384 mmol) and (E)-1-bromooct-1-ene (74 mg, 0.384 mmol). 
The tube was purged with nitrogen and toluene was added (1 mL). The resulting mixture 
was heated to 110 °C with stirring for 19 h, 50% of the starting material had been 
consumed as determined by GC analysis. The reaction mixture was cooled to room 
temperature and saturated aqueous NH4Cl (1 mL) and ethyl acetate (1 mL) were added. 
The layers were separated, the aqueous layer was extracted with ethyl acetate (3 x 5 mL), 
and the combined organic layers were dried over Na2SO4, filtered, and concentrated in 
vacuo. The crude product was then purified by flash chromatography using 2.5% 




oil. This compound was found to exist as a 1.5:1 mixture of rotamers as judged by 1H 
NMR analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.34–7.09 (m, 5 
H), 5.54– 5.40 (m, 1 H), 5.38–5.22 (m, 1 H), 4.06–3.75 (m, 2 H), 3.12–2.98 (m, 0.4 H), 
2.97–2.81 (m, 0.6 H), 2.74–2.56 (m, 0.6 H), 2.50–2.28 (m, 1.4 H), 2.26–2.08 (m, 1 H), 
2.07–1.92 (m, 2 H), 1.91–1.71 (m, 1 H), 1.55–1.41 (m, 9 H), 1.40–1.02 (m, 10 H), 0.96–
0.79 (m, 3 H), 0.74 (s, 9 H), -0.12–-0.34 (m, 6 H). 
 
(±)–(2S,3R,5R)–2-Benzyl-3-(tert-butyldimethylsilyloxy)-5-nonylpyrrolidine-1-
carboxylic acid tert-butyl ester (V-27). Protected pyrrolidine V-26 (29.4 mg, 0.057 
mmol) was converted to the title compound using a procedure analogous to that 
employed for the conversion of V-22 to V-23 to afford 25 mg (86%) as a colorless oil. 
The compound obtained gave 1H and 13C NMR spectrum identical to those reported 
above. This mixture was used in the following transformation without purification. 
 
(±)–3-epi-Preussin (V-28).6,9d Protected pyrrolidine V-27 (25 mg, 0.005 mmol) 
was converted to the title compound using a procedure analogous to that employed for 
the conversion of V-23 to V-1 to afford 17 mg (quantitative) of a colorless oil in ~70% 
purity. The compound obtained was identified as the title compound by comparison of 1H 






36). A flame-dried flask was cooled under a stream of nitrogen and charged with V-19 
(500 mg, 1.72 mmol), tetrahydrofuran (12 mL), and triethylamine (0.53 mL, 3.8 mmol). 
TMS-Cl (0.52 mL, 3.4 mmol) was then added dropwise. The resulting mixture was 
stirred at rt until the starting material was consumed as judged by TLC analysis (ca. 24 
h). The crude mixture was then concentrated in vacuo. The crude residue was diluted 
with methylene chloride (10 mL) and washed with saturated NaHCO3 solution. The 
aqueous layer was then extracted with methylene chloride (2 x 10 mL), and the combined 
organic layers were dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. 
The crude product was purified by flash chromatography using 5% ethyl acetate/hexanes 
as the eluent to afford 494 mg (79%) of the title compound as a colorless oil. This 
compound was found to exist as a 4:1 mixture of rotamers as judged by 1H NMR 
analysis; data are for the mixture. 1H NMR (500 MHz, CDCl3) δ 7.31–7.24 (m, 2 H), 
7.25–7.14 (m, 3 H), 5.76–5.61 (m, 1 H), 5.07–4.98 (m, 2 H), 4.90–4.68 (m, 1 H), 3.94–
3.83 (m, 0.8 H), 3.78–3.69 (m, 0.4 H), 3.68–3.62 (m, 0.8 H), 2.85–2.75 (m, 1 H), 2.74–
2.64 (m, 1 H), 2.35–2.13 (m, 2 H), 1.43–1.19 (m, 9 H), 0.14 (s, 9 H). 
 
(E)-(2S,3S,5R)-tert-Butyl-2-benzyl-5-(non-2-enyl)-3-
(trimethylsilyloxy)pyrrolidine-1-carboxylate (V-37). A flame-dried Schlenk tube 
equipped with a magnetic stirbar was cooled under a stream of nitrogen and charged with 
V-36 (65 mg, 0.18 mmol), Pd2(dba)3 (3.3 mg, 0.0036 mmol, 2 mol %), dpe-phos (3.9 mg, 
0.0072 mmol, 4 mol %), NaOt-Bu (21 mg, 0.22 mmol) and (E)-1-bromooct-1-ene (42 
mg, 0.22 mmol). The tube was purged with nitrogen and toluene was added (1 mL). The 




consumed as determined by GC analysis. The reaction mixture was cooled to room 
temperature and saturated aqueous NH4Cl (1 mL) and ethyl acetate (1 mL) were added. 
The layers were separated, the aqueous layer was extracted with ethyl acetate (3 x 5 mL), 
and the combined organic layers were dried over Na2SO4, filtered, and concentrated in 
vacuo. The crude product was then purified by flash chromatography using 2.5%  5% 
ethyl/hexanes as the eluent to afford 25 mg (30%) of the title compound as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ 7.34–7.09 (m, 5 H), 5.55– 5.42 (m, 1 H), 5.39–5.27 (m, 1 
H), 4.25–4.15 (m, 1 H), 4.14–3.95 (m, 1 H), 3.77–3.57 (m, 1 H), 3.02–2.91 (m, 1 H), 
2.87–2.74 (m, 1 H), 2.72–2.53 (m, 1 H), 2.23–2.03 (m, 2 H), 2.02–1.94 (m, 2 H), 1.78–
1.67 (m, 1 H), 1.54–1.10 (m, 17 H), 0.88 (t, J = 9.0 Hz, 3 H), 0.18–-0.09 (m, 9 H). 
 
(2S,3S)-tert-Butyl-3-(methoxymethoxy)-1-phenylhex-5-en-2-ylcarbamate (V-
38). A flame-dried flask was cooled under a stream of nitrogen and charged with V-19 
(500 mg, 1.72 mmol), CH2Cl2 (5 mL) and diisopropylamine (2.8 mL, 16.0 mmol). The 
resulting mixture was cooled to 0 oC and MOM-Cl (0.6 mL, 7.7 mmol) was added 
dropwise. The resulting mixture was stirred at rt until the starting material was consumed 
as judged by TLC analysis (ca. 24 h). The reaction mixture was diluted with water (10 
mL) and CH2Cl2 (10 mL). The layers were separated and the aqueous layer was extracted 
with CH2Cl2 (3 x 10 mL). The combined organic layers were washed with 1 M HCl, 
water, and brine, and then were dried over anhydrous Na2SO4, filtered, and concentrated 
in vacuo. The crude product was purified by flash chromatography using 10% ethyl 
acetate/hexanes as the eluent to afford 343 mg (60%) of the title compound as a colorless 




analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.33–7.15 (m, 5 H), 
5.76–5.60 (m, 1 H), 5.10–4.99 (m, 2 H), 4.95–4.83 (m, 1 H), 4.77–4.70 (m, 1 H), 4.67–
4.60 (m, 1 H), 4.01–3.91 (m, 0.8 H), 3.85–3.75 (m, 0.2 H), 3.60–3.51 (m, 1 H), 3.43 (s, 3 
H), 2.90–2.73 (m, 2 H), ), 2.44–2.30 (m, 1 H), 2.29–2.20 (m, 1 H), 1.46–1.18 (m, 9 H). 
 
(E)-(2S,3S,5R)-tert-Butyl-2-benzyl-3-(methoxymethoxy)-5-(non-2-
enyl)pyrrolidine-1-carboxylate (V-39). A flame-dried Schlenk tube equipped with a 
magnetic stirbar was cooled under a stream of nitrogen and charged with V-38 (42 mg, 
0.13 mmol), Pd2(dba)3 (2.3 mg, 0.0025 mmol, 2 mol %), Dpe-phos (2.7 mg, 0.005 mmol, 
4 mol %), NaOt-Bu (15 mg, 0.15 mmol) and (E)-1-bromooct-1-ene (29 mg, 0.15 mmol). 
The tube was purged with nitrogen and toluene was added (1 mL). The resulting mixture 
was heated to 110 °C with stirring until the starting material had been consumed as 
determined by GC analysis. The reaction mixture was cooled to room temperature and 
saturated aqueous NH4Cl (1 mL) and ethyl acetate (1 mL) were added. The layers were 
separated, the aqueous layer was extracted with ethyl acetate (3 x 5 mL), and the 
combined organic layers were dried over Na2SO4, filtered, and concentrated in vacuo. 
The crude product was then purified by flash chromatography using 5%  10% 
ethyl/hexanes as the eluent to afford 32 mg (60%) of the title compound as a colorless oil 
in ~60% purity (36% yield of V-39). 1H NMR (400 MHz, CDCl3) δ 7.32–7.10 (m, 5 H), 
5.58– 5.44 (m, 1 H), 5.41–5.28 (m, 1 H), 4.55–4.17 (m, 2 H), 4.16–4.07 (m, 1 H), 3.80–
3.62 (m, 1 H), 3.37–3.20 (m, 3 H), 3.00–2.89 (m, 1 H), 2.88–2.76 (m, 1 H), 2.32–2.19 




H), 0.88 (t, J = 6.2 Hz, 3 H). 
 
(2S,3S,5R)-tert-Butyl-2-benzyl-5-(4-tert-butylbenzyl)-3-(tert-
butyldimethylsilyloxy)pyrrolidine-1-carboxylate (V-40). A flame-dried Schlenk tube 
equipped with a magnetic stirbar was cooled under a stream of nitrogen and charged with 
V-20 (37.1 mg, 0.09 mmol), Pd2(dba)3 (1.7 mg, 0.0018 mmol, 2 mol %), Dpe-phos (2.0 
mg, 0.0037 mmol, 4 mol %), NaOt-Bu (11 mg, 0.11 mmol) and 4-bromo-t-butylbenzene 
(24 mg, 0.11 mmol). The tube was purged with nitrogen and toluene was added (1 mL). 
The resulting mixture was heated to 110 °C with stirring until the starting material had 
been consumed as determined by GC analysis. The reaction mixture was cooled to room 
temperature and saturated aqueous NH4Cl (1 mL) and ethyl acetate (1 mL) were added. 
The layers were separated, the aqueous layer was extracted with ethyl acetate (3 x 5 mL), 
and the combined organic layers were dried over Na2SO4, filtered, and concentrated in 
vacuo. The crude product was then purified by flash chromatography using 5%  10% 
ethyl/hexanes as the eluent to afford 37 mg (68%) of the title compound as a colorless oil 
in ~90% purity. This compound was found to exist as a 1:1 mixture of rotamers as judged 
by 1H NMR analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.39–6.97 
(m, 9 H), 4.32–4.14 (m, 1 H), 4.13–3.93 (m, 0.5 H), 3.92–3.69 (m, 1 H), 3.57–3.25 (m, 
0.5 H), 3.06–2.83 (m, 1 H), 2.82–2.67 (m, 1 H), 2.58–2.29 (m, 1 H), 2.16–1.89 (m, 1 H), 
1.77–1.62 (m, 1 H), 1.52–1.08 (m, 19 H), 1.01–0.67 (m, 9 H), 0.17–-0.13 (m, 6 H). 
 
(2S,3R,5R)-tert-Butyl-2-benzyl-5-(4-tert-butylbenzyl)-3-(tert-




equipped with a magnetic stirbar was cooled under a stream of nitrogen and charged with 
V-24 (41 mg, 0.1 mmol), Pd2(dba)3 (1.9 mg, 0.002 mmol, 2 mol %), Dpe-phos (2.2 mg, 
0.004 mmol, 4 mol %), NaOt-Bu (12 mg, 0.12 mmol) and 4-bromo-t-butylbenzene (26 
mg, 0.11 mmol). The tube was purged with nitrogen and toluene was added (1 mL). The 
resulting mixture was heated to 110 °C with stirring until the starting material had been 
consumed as determined by GC analysis. The reaction mixture was cooled to room 
temperature and saturated aqueous NH4Cl (1 mL) and ethyl acetate (1 mL) were added. 
The layers were separated, the aqueous layer was extracted with ethyl acetate (3 x 5 mL), 
and the combined organic layers were dried over Na2SO4, filtered, and concentrated in 
vacuo. The crude product was then purified by flash chromatography using 5%  10% 
ethyl/hexanes as the eluent to afford 33.2 mg (62%) of the title compound as a colorless 
oil. This compound was found to exist as a 1.5:1 mixture of rotamers as judged by 1H 
NMR analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.35–7.02 (m, 9 
H), 4.30– 4.15 (m, 0.6 H), 4.14–4.05 (m, 0.6 H), 4.01–3.93 (m, 0.4 H), 3.92–3.85 (m, 1 
H), 3.84–3.75 (m, 0.4 H), 3.29–3.18 (m, 0.6 H), 3.17–3.06 (m, 0.4 H), 2.97–2.87 (m, 0.4 
H), 2.81–2.65 (m, 1 H), 2.57–2.43 (m, 0.6 H), 2.09–1.96 (m, 0.6 H), 1.92–1.80 (m, 1.4 
H), 1.79–1.68 (m, 1 H), 1.64–1.42 (m, 9 H), 1.30 (s, 9 H), 0.72 (s, 9 H), -0.28 (d, J = 9.5 
Hz, 6 H). 
 
(E)-tert-Butyl 2-(non-2-enyl)pyrrolidine-1-carboxylate (V-42). A flame-dried 
Schlenk tube equipped with a magnetic stirbar was cooled under a stream of nitrogen and 
charged with II-5 (19 mg, 0.1 mmol), Pd2(dba)3 (1.0 mg, 0.001 mmol, 1 mol %), Dpe-




1-ene (23 mg, 0.12 mmol). The tube was purged with nitrogen and toluene was added (1 
mL). The resulting mixture was heated to 110 °C with stirring until the starting material 
had been consumed as determined by GC analysis. The reaction mixture was cooled to 
room temperature and saturated aqueous NH4Cl (1 mL) and ethyl acetate (1 mL) were 
added. The layers were separated, the aqueous layer was extracted with ethyl acetate (3 x 
5 mL), and the combined organic layers were dried over Na2SO4, filtered, and 
concentrated in vacuo. The crude product was then purified by flash chromatography 
using 2.5%  5% ethyl/hexanes as the eluent to afford 16.2 mg (55%) of the title 
compound as a colorless oil. This compound was found to exist as a 1:1 mixture of 
rotamers as judged by 1H NMR analysis; data are for the mixture. 1H NMR (400 MHz, 
CDCl3) δ 5.49–5.39 (m, 1 H), 5.38– 5.24 (m, 1 H), 3.87–3.63 (m, 1 H), 3.44–3.21 (m, 2 
H), 2.53–2.41 (m, 0.5 H), 2.40–2.28 (m, 0.5 H), 2.09–2.01 (m, 0.5 H), 2.00–1.93 (m, 2.5 
H), 1.91–1.66 (m, 4 H), 1.47 (s, 9 H), 1.39–1.14 (m, 8 H), 0.88 (d, J = 6.6 Hz, 3 H). 
 
(E)-(2S,5R)-tert-Butyl 2-(non-2-enyl)-5-phenylpyrrolidine-1-carboxylate (V-
43). A flame-dried Schlenk tube equipped with a magnetic stirbar was cooled under a 
stream of nitrogen and charged with II-21 (26 mg, 0.1 mmol), Pd2(dba)3 (1.0 mg, 0.001 
mmol, 1 mol %), Dpe-phos (1.1 mg, 0.002 mmol, 2 mol %), NaOt-Bu (12 mg, 0.12 
mmol) and (E)-1-bromooct-1-ene (23 mg, 0.12 mmol). The tube was purged with 
nitrogen and toluene was added (1 mL). The resulting mixture was heated to 110 °C with 
stirring until the starting material had been consumed as determined by GC analysis. The 
reaction mixture was cooled to room temperature and saturated aqueous NH4Cl (1 mL) 




extracted with ethyl acetate (3 x 5 mL), and the combined organic layers were dried over 
Na2SO4, filtered, and concentrated in vacuo. The product was observed through 1H NMR 
analysis of the crude material, and was identified by comparison to 1H NMR data 
previously reported for pyrrolidine II-41. 
 
 
Aryl Bromide Route (B) 
Synthesis of (±)-Preussin (Scheme 28) 
 
3-Hydroxytetradec-1-en-5-one (V-48). A flame-dried flask was cooled under a 
stream of nitrogen and charged with diisopropylamine (7.4 mL, 52.5 mmol) and 
tetrahydrofuran (300 mL). The resulting solution was cooled to -78 °C and n-butyllithium 
(20.8 mL, 52 mmol, 2.5 M in hexanes) was added dropwise. The reaction mixture was 
stirred at -78 °C for 30 min and then a solution of 2-undecanone (8.52g, 50 mmol) in 
tetrahydrofuran (30 mL) was added dropwise. The reaction mixture was stirred at -78 °C 
for 1h then a solution of acrolein (3.5 mL, 52.5 mmol) in tetrahydrofuran (30 mL) was 
then slowly added dropwise. The resulting mixture was stirred at -78 °C for 35 min and 
then warmed to rt. Saturated aqueous NH4Cl (25 mL) and diethyl ether (200 mL) were 
added, the layers were separated and the aqueous layer was extracted with diethyl ether 
(3 x 150 mL). The combined organic extracts were dried over anhydrous Na2SO4, 
filtered, and concentrated in vacuo. The crude product was purified by flash 
chromatography using 5%  10% ethyl acetate/hexanes as the eluent to afford 8.88 g 




(m, 1 H), 5.32–5.27 (m, 1 H), 5.15–5.12 (m, 1 H), 4.60–4.55 (m, 1 H), 3.06 (s, br, 1 H), 
2.68–2.59 (m, 2 H), 2.45– 2.40 (m, 2 H), 1.62–1.49 (m, 2 H), 1.33–1.20 (m, 12 H), 0.88 
(t, J = 6.8 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 211.7, 139.0, 115.0, 68.6, 48.5, 43.7, 
31.8, 29.39, 29.36, 29.2, 29.1, 23.6, 22.7, 14.1; IR (film) 3432, 1710 cm-1. Anal calcd for 
C14H26O2: C, 74.29; H, 11.58. Found: C, 74.25; H, 11.47. 
 
3-Hydroxytetradec-1-en-5-one-O-benzyl oxime (V-49). A flame-dried flask 
was cooled under a stream of nitrogen and charged with V-48 (11.9 g, 52.6 mmol), 
methanol (190 mL), O-benzylhydroxylamine (10.1 g, 63.2 mmol) and pyridine (11 mL). 
The resulting mixture was refluxed until the starting material was consumed as judged by 
TLC analysis (ca. 1h). The mixture was cooled to rt and concentrated in vacuo. The 
resulting residue was diluted with water (100 mL) and dichloromethane (100 mL). The 
layers were separated and the aqueous layer was extracted with dichloromethane (3 x 100 
mL). The combined organic extracts were dried over anhydrous Na2SO4, filtered, and 
concentrated in vacuo. The resulting oil was purified by flash chromatography using 5% 
 10% ethyl acetate/hexanes as the eluent to afford 16.9 g (98%) of the title compound 
as a colorless oil. This compound was judged to be a 1:1 mixture of oxime isomers as 
judged by 1H NMR and 13C NMR. Data are for the mixture. 1H NMR (500 MHz, CDCl3) 
δ 7.37– 7.27 (m, 5 H), 5.90–5.81 (m, 1 H), 5.28–5.20 (m, 1 H), 5.12–5.04 (m, 3 H), 4.46–
4.38 (m, 1 H), 2.71–2.65 (m, 0.5 H), 2.50–2.45 (m, 0.5 H), 2.40–2.28 (m, 2 H), 2.24–2.20 
(m, 1 H), 1.54–1.41 (m, 2 H), 1.33–1.19 (m, 13 H), 0.88 (t, J = 7.1 Hz, 3 H); 13C NMR 




128.06, 127.82, 127.79, 114.8, 114.7, 75.7, 75.6, 70.7, 69.4, 41.0, 36.5, 35.3, 31.9, 29.6, 
29.5, 29.48, 29.43, 29.36, 29.31, 29.27, 29.23, 26.3, 25.5, 22.7, 14.1 (4 sets of aliphatic 
carbons are incidentally equivalent); IR (film) 3414, 1631 cm-1. Anal calcd for 
C21H33NO3: C, 76.09; H, 10.03; N, 4.23. Found: C, 75.92; H, 10.02; N, 4.30. 
 
3-Hydroxy-1-nonylpent-4-enylcarbamic acid tert-butyl ester. A flame-dried 
flask was cooled under a stream of nitrogen and charged with V-49 (16.6 g, 50 mmol) 
and diethyl ether (100 mL). The resulting solution was cooled to 0 °C and LiAlH4 (200 
mL, 200 mmol, 1 M in diethyl ether) was added dropwise via cannula. The resulting 
mixture was heated to reflux until the starting material was consumed as judged by TLC 
analysis (ca. 1h). The reaction mixture was cooled to 0 °C, slowly quenched with water 
(30 mL) and diluted with diethyl ether (100 mL). Aqueous NaOH (16 mL, 10 M) and 
water (16 mL) were added sequentially and an insoluble white precipitate formed. The 
organic supernatant was decanted to a clean Erlenmeyer flask and the precipitate was 
washed with diethyl ether. The combined organic extracts were dried over anhydrous 
Na2SO4 and filtered to afford a solution of 3-hydroxy-1-nonylpent-4-enylamine in diethyl 
ether (ca. 0.1 M). A portion of this solution was concentrated in vacuo and 1H NMR 
analysis of this sample indicated that the product was obtained as a 54:46 mixture of 
syn:anti diastereomers.  
 
A flame-dried flask was cooled under a stream of nitrogen and charged with a 
solution of 3-hydroxy-1-nonylpent-4-enylamine in diethyl ether (500 mL, 50 mmol, 0.1 




resulting mixture was stirred until the starting material was consumed as judged by TLC 
analysis (ca. 2h). Aqueous NaOH (200 mL, 1 M) was added and the resulting biphasic 
mixture was vigorously stirred for 8h. The layers were separated and the aqueous layer 
was extracted with diethyl ether (3 x 150 mL). The combined organic extracts were dried 
over anhydrous Na2SO4, filtered, and concentrated in vacuo. The crude product was 
purified by flash chromatography using 10%  20% ethyl acetate/hexanes as the eluent 
to afford 6.31 g (40%) of V-50 and 7.62 g (46%) of V-51 as colorless oils. 
 
(±)–(1R,3S)-3-Hydroxy-1-nonylpent-4-enylcarbamic acid tert-butyl ester (V-
50): 1H NMR (400 MHz, CDCl3) δ 5.89–5.81 (m, 1 H), 5.27–5.22 (m, 1 H), 5.06–5.02 
(m, 1 H), 4.56–4.46 (m, 1 H), 4.18–4.08 (m, 2 H), 3.81–3.69 (m, 1 H), 1.61–1.53 (m, 
1H), 1.50– 1.16 (m, 26 H), 0.88 (t, J = 6.3 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 
157.2, 140.3, 113.6, 79.8, 68.4, 47.4, 44.2, 35.6, 31.8, 29.45, 29.43, 29.3, 29.2, 28.3, 26.1, 
22.6, 14.0; IR (film) 3342, 1690 cm-1. Anal calcd for C19H37NO3: C, 69.68; H, 11.39; N, 
4.28. Found: C, 69.84; H, 11.46; N, 4.34. 
 
(±)–(1R,3R)-3-Hydroxy-1-nonylpent-4-enylcarbamic acid tert-butyl ester 
(51): 1H NMR (400 MHz, CDCl3) δ 5.90–5.81 (m, 1 H), 5.25–5.20 (m, 1 H), 5.08–5.05 
(m, 1 H), 4.58–4.44 (m, 1 H), 4.23–4.14 (m, 1 H), 3.72–3.54 (m, 1 H), 3.06–2.90 (m, 1 
H), 1.72–1.53 (m, 2 H), 1.52–1.14 (m, 25 H), 0.85 (t, J = 6.6 Hz, 3 H); 13C NMR (100 
MHz, CDCl3) δ 155.9, 140.9, 114.3, 79.2, 70.9, 48.3, 43.1, 36.0, 31.8, 29.51, 29.46, 




C, 69.68; H, 11.39; N, 4.28. Found: C, 69.79; H, 11.54; N, 4.31. 
 
(±)–(1R,3S)-3-(tert-Butyldimethylsilyloxy)-1-nonylpent-4-enylcarbamic acid 
tert-butyl ester (V-47). A flame-dried flask was cooled under a steam of nitrogen and 
charged with V-51 (6.0 g, 18.3 mmol), dimethylformamide (36 mL), imidazole (2.50 g, 
36.6 mmol) and TBS-Cl (4.42 g, 29.3 mmol). The resulting mixture was stirred at rt until 
the starting material was consumed as judged by TLC analysis (ca. 24 h). The reaction 
mixture was diluted with water (50 mL) and ethyl acetate (50 mL). The layers were 
separated and the aqueous layer was extracted with ethyl acetate (3 x 50 mL). The 
combined organic layers were dried over anhydrous Na2SO4, filtered, and concentrated in 
vacuo. The crude product was purified by flash chromatography using 5% ethyl 
acetate/hexanes as the eluent to afford 7.6 g (94%) of the title compound as a white solid, 
m.p. 64–66 °C. 1H NMR (400 MHz, CDCl3) δ 5.84–5.75 (m, 1 H), 5.17–5.11 (m, 1 H), 
5.05–5.01 (m, 1 H), 4.93 (s, br, 1 H), 4.30–4.22 (m, 1 H), 3.69–3.54 (m, 1 H), 1.74–1.62 
(m, 1 H), 1.54–1.36 (m, 12 H), 1.34–1.15 (m, 14 H), 0.94–0.83 (m, 12 H), 0.10–0.01 (m, 
6 H); 13C NMR (100 MHz, CDCl3) δ 155.4, 141.4, 114.1, 78.4, 71.8, 48.1, 42.0, 35.5, 
31.9, 29.58, 29.55, 29.50, 29.3, 28.4, 25.9, 25.8, 22.6, 18.0, 14.1, -4.1, -5.1; IR (film) 
3339, 1677 cm-1. Anal calcd for C25H51NO3Si: C, 67.97; H, 11.64; N, 3.17. Found: C, 
68.09; H, 11.76; N, 3.18. 
 
(±)–(2S,3S,5R)–2-Benzyl-3-(tert-butyldimethylsilyloxy)-5-nonylpyrrolidine-1-
carboxylic acid tert-butyl ester (V-23).38 A flame-dried Schlenk tube equipped with a 




0.25 mmol), Pd(OAc)2 (1.2 mg, 0.005 mmol, 2 mol %), Dpe-phos (5.4 mg, 0.01 mmol, 4 
mol %), NaOtBu (56 mg, 0.575 mmol) and bromobenzene (32 µL, 0.3 mmol). The tube 
was purged with nitrogen and toluene was added (1 mL). The resulting mixture was 
heated to 90 °C with stirring for 5 hours until the starting material had been consumed as 
determined by GC analysis. The reaction mixture was cooled to room temperature and 
saturated aqueous NH4Cl (1 mL) and ethyl acetate (1 mL) were added. The layers were 
separated, the aqueous layer was extracted with ethyl acetate (3 x 5 mL), and the 
combined organic layers were dried over Na2SO4, filtered, and concentrated in vacuo. 
The crude product was then purified by flash chromatography using 2.5% ethyl 
acetate/hexanes as the eluent to afford 85.4 mg (66%) of the title compound as a colorless 
oil. This compound was found to exist as a 3:1 mixture of rotamers as judged by 1H NMR 
analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.35–7.13 (m, 5 H), 
4.34– 4.22 (m, 1.25 H), 4.12–3.97 (m, 0.75 H), 3.74–3.50 (m, 1 H), 3.09–2.98 (m, 1 H), 
2.88–2.73 (m, 0.25 H), 2.64–2.49 (m, 0.75 H), 2.36–2.13 (m, 1.75 H), 2.07–1.92 (m, 0.25 
H), 1.74–1.58 (m, 1 H), 1.50–1.06 (m, 24 H), 1.00–0.84 (m, 12 H), 0.17– -0.08 (m, 6 H); 
13C NMR (100 MHz, CDCl3) δ 154.9, 140.0, 129.8, 128.0, 125.6, 78.9, 71.3, 62.3, 55.6, 
37.9, 37.2, 35.9, 31.9, 29.6, 29.5, 29.3, 28.0, 26.5, 25.8, 22.7, 18.1, 14.1, -4.8, -5.0. 
 
(±)–Preussin (V-1).15  A flame-dried flask was cooled under a steam of nitrogen 
and charged with V-23 (200 mg, 0.39 mmol) and tetrahydrofuran (5 mL). The resulting 
solution was cooled to 0 °C and LiAlH4 (2.4 mL, 2.4 mmol, 1 M in tetrahydrofuran) was 
added dropwise. The resulting mixture was heated to reflux with stirring until the starting 




cooled to 0 °C, slowly quenched with water (1 mL) and diluted with diethyl ether (5 mL). 
Aqueous NaOH (1 mL, 10 M) and water (1 mL) were added sequentially and an 
insoluble white precipitate formed. The organic supernatant was decanted to a clean 
Erlenmeyer flask and the precipitate was washed with diethyl ether. The combined 
organic extracts were dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. 
The crude oil obtained was purified by flash chromatography using 10% 
methanol/dichloromethane as the eluent to afford 106.2 mg (85%) of the title compound 
as a colorless oil.  1H NMR (400 MHz, CDCl3) δ 7.29–7.21 (m, 4 H), 7.20–7.12 (m, 1 H), 
3.80–3.69 (m, 1 H), 2.90–2.76 (m, 2 H), 2.29 (s, 3 H), 2.26–2.19 (m, 1 H), 2.18–2.11 (m, 
1 H), 2.10–2.02 (m, 1 H), 1.74–1.62 (m, 1 H), 1.41–1.34 (m, 1 H), 1.33–1.13 (m, 16 H), 
0.85 (t, J = 7.0 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 139.5, 129.3, 128.3, 126.0, 73.6, 
70.3, 65.8, 39.4, 38.6, 34.9, 33.6, 31.9, 29.9, 29.6, 29.5, 29.3, 26.3, 22.7, 14.1 
 
Synthesis of (±)-3-epi-Preussin (Scheme 29) 
 
(±)–(1R,3R)-3-(tert-Butyldimethylsilyloxy)-1-nonylpent-4-enylcarbamic acid 
tert-butyl ester (V-53). Syn amino-alcohol derivative V-50 (3.27 g, 10 mmol) was 
converted to the title compound (4.0 g, 91 % yield) using a procedure analogous to that 
employed for the conversion of V-51 to V-47. 1H NMR (400 MHz, CDCl3) δ 5.85–5.77 
(m, 1 H), 5.18–5.14 (m, 1 H), 5.05–5.01 (m, 1 H), 4.51–4.41 (m, 1 H), 4.20–4.10 (m, 1 
H), 3.60–3.46 (m, 1 H), 1.63–1.53 (m, 2 H), 1.40–1.32 (m, 11 H), 1.31–1.18 (m, 14 H), 
0.95–0.79 (m, 12 H), 0.02 (d, J = 9.2 Hz, 6 H); 13C NMR (100 MHz, CDCl3) δ 155.3, 




22.6, 18.1, 14.1, -4.3, -4.9; IR (film) 3362, 1703 cm-1. Anal calcd for C25H51NO3Si: C, 
67.97; H, 11.64; N, 3.17. Found: C, 68.07; H, 11.79; N, 3.20. 
 
(±)–(2S,3R,5R)–2-Benzyl-3-(tert-butyldimethylsilyloxy)-5-nonylpyrrolidine-1-
carboxylic acid tert-butyl ester (V-27). Silyl ether V-53 (111 mg, 0.25 mmol) was 
converted to the title compound using a procedure analogous to that employed for the 
conversion of V-47 to V-23 to afford 71.6 mg (55%) of the title compound as a colorless 
oil. This compound was found to exist as a ~2:1 mixture of rotamers as judged by 1H 
NMR analysis; data are for the mixture.  1H NMR (400 MHz, CDCl3) δ 7.35–7.12 (m, 5 
H), 4.02–3.77 (m, 3 H), 3.09–3.01 (m, 0.3 H), 2.93–2.83 (m, 0.7 H), 2.44–2.36 (m, 1 H), 
2.18–2.08 (m, 0.6 H), 2.03–1.91 (m, 1.4 H), 1.78–1.69 (m, 1 H), 1.51–1.38 (m, 9 H), 
1.35–1.14 (m, 15 H), 0.88 (t, J = 7.0 Hz, 3 H), 0.75 (s, 9 H), -0.20– -0.28 (m, 6 H); 13C 
NMR (100 MHz, CDCl3) δ 155.3, 138.7, 129.3, 128.3, 126.2, 78.8, 73.2, 72.2, 69.7, 69.1, 
57.2, 40.5, 39.7, 39.3, 38.9, 36.0, 31.9, 29.7, 29.5, 29.4, 29.3, 28.4, 26.1, 25.8, 25.6, 22.6, 
17.7, 14.1, -5.18, -5.23. IR (film) 1697 cm-1. Anal calcd for C31H55NO3Si: C, 71.90; H, 
10.70; N, 2.70. Found: C, 72.15; H, 10.75; N, 2.78. 
 
(±)–3-epi-Preussin (V-28).6,9d Protected pyrrolidine V-27 (200 mg, 0.39 mmol) 
was converted to the title compound using a procedure analogous to that employed for 
the conversion of V-23 to V-1 to afford 105 mg (86%) of a colorless oil. 1H NMR (400 
MHz, CDCl3) δ 7.33–7.17 (m, 5 H), 4.02–3.95 (m, 1 H), 3.08–3.00 (m, 1 H), 2.59–2.50 
(m, 1 H), 2.49–2.38 (m, 2 H), 2.35 (s, 3 H), 1.79–1.71 (m, 1 H), 1.70–1.59 (m, 2 H), 




129.3, 128.6, 126.4, 77.3, 74.7, 64.9, 39.4, 39.14, 39.05, 33.8, 31.9, 30.0, 29.6, 29.5, 29.3, 
26.4, 22.7, 14.1.  
 
Asymmetric Synthesis of (+)–Preussin (Scheme 30) 
 
(–)-(R)-N-Decylidene-2-methylpropanesulfinamide (V-56). A flame-dried flask 
was cooled under a stream of nitrogen and charged with decanal (1.7 mL, 9.1 mmol), 
titanium ethoxide (3.5 mL, 16.5 mmol) and tetrahydrofuran (33 mL). Solid (R)-tert-
butanesulfinamide (1.0 g, 8.25 mmol) was added in one portion and the mixture was 
stirred at rt for 3 h. The reaction mixture was poured into a vigorously stirred solution of 
saturated aqueous NaCl (33 mL), the mixture was filtered through celite, and the celite 
was washed with ethyl acetate (100 mL). The aqueous phase was extracted with ethyl 
acetate (3 x 30 mL) and the combined organic extracts were dried over anhydrous 
Na2SO4, filtered, and concentrated in vacuo. The crude material was purified by flash 
chromatography on silica gel to afford 1.91g (90%) of the title compound as a colorless 
oil: [α]23D –212.7° (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 8.06 (t, J = 5.0 Hz, 1 
H), 2.53–2.49 (m, 2 H), 1.62 (p, J = 8.0 Hz, 2 H), 1.39–1.20 (m, 12 H), 1.19 (s, 9 H), 0.88 
(t, J = 7.0 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 169.8, 56.4, 36.1, 31.8, 29.4, 29.3, 
29.20, 29.18, 25.5, 22.6, 22.3, 14.1; IR (neat, cm–1) 1623. Anal calcd for C14H29NOS: C, 
64.81; H, 11.27; N, 5.40. Found: C, 64.93; H, 11.33; N, 5.36. 
 
(–)-(RS,4R)-4-(2-Methylpropane-2-sulfinylamino)tridecene (V-57). A flame-
dried flask was cooled under a stream of nitrogen and charged with (–)-(R)-N-decylidene-




flask was cooled to 0 °C and a solution of allylmagnesium bromide (5.2 mL, 5.2 mmol, 
1.0 M in diethyl ether) was added slowly dropwise. The mixture was stirred at 0 °C for 
30 min then a solution of saturated aqueous ammonium chloride (20 mL) was added. The 
mixture was warmed to rt, the layers were separated, and the aqueous layer was extracted 
with ethyl acetate (3 x 20 mL). The combined organic layers were dried over anhydrous 
sodium sulfate, filtered, and concentrated in vacuo. Analysis of the crude product by 1H 
NMR indicated that a 10:1 mixture of diastereomers had formed. The crude material was 
purified by flash chromatography on silica gel to afford 824 mg (79%) of the title 
compound (a colorless oil) as a single pure diastereomer: [α]23D –53.0° (c 1.0, CHCl3); 
1H NMR (500 MHz, CDCl3) δ 5.83–5.73 (m, 1 H), 5.14 (d, J = 15.0 Hz, 2 H), 3.34–3.26 
(m, 1 H), 3.19 (d, J = 7.5 Hz, 1 H), 2.44–2.39 (m, 1 H), 2.33–2.27 (m, 1 H), 1.51–1.45 
(m, 2 H), 1.36–1.22 (m, 14 H), 1.20 (s, 9 H), 0.88 (t, J = 8.5 Hz, 3 H); 13C NMR (125 
MHz, CDCl3) δ 134.2, 118.8, 55.7, 54.8, 40.4, 34.9, 31.8, 29.50, 29.48, 29.4, 29.2, 25.4, 
22.6, 14.1; IR (neat, cm–1) 3216, 1640. Anal calcd for C17H35NOS: C, 67.72; H, 11.70; N, 
4.65. Found: C, 67.43; H, 11.82; N, 4.62. 
 
(+)-(1R)-1-Nonylpent-4-enylcarbamic acid tert-butyl ester (V-58). A round-
bottom flask was charged with (–)-(RS,4R)-4-(2-methylpropane-2-
sulfinylamino)tridecene (1.25 g, 4.15 mmol) and methanol (5 mL). A solution of 
anhydrous hydrochloric acid (5 mL, 10 mmol, 2 M in diethyl ether) was added and the 
mixture was stirred at rt for 30 min, at which time TLC analysis indicated that the starting 
material had been completely consumed. The mixture was concentrated in vacuo, and the 




aqueous NaOH (16 mL, 16 mmol). Solid di-tert-butyldicarbonate was added in one 
portion and the reaction mixture was stirred at rt for 2 h, at which time TLC analysis 
indicated the primary amine intermediate had been completely consumed. 
Tetrahydrofuran (7 mL) and additional 1 M NaOH (7 mL) were added and the resulting 
mixture was stirred at rt for 12 h. The reaction mixture was then extracted with ether (3 x 
40 mL) and the combined organic extracts were dried over anhydrous Na2SO4, filtered, 
and concentrated in vacuo. The crude product was purified by flash chromatography on 
silica gel to afford the title compound (1.10 g, 89%) as a white solid, m.p. 41–42 °C: 
[α]23D +19.7° (c 1.0, CHCl3); 1H NMR (500 MHz, CDCl3) δ 5.80–5.74 (m, 1 H), 5.09–
5.05 (m, 2 H), 4.34–4.28 (m, br, 1 H), 3.62 (s, br, 1 H), 2.28–2.12 (m, 2 H), 1.43 (s, 9 H), 
1.33–1.25 (m, 16 H), 0.88 (t, J = 6.5 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 155.6, 
134.6, 117.5, 78.9, 50.1, 39.5, 34.7, 31.9, 29.6, 29.5, 29.3, 28.4, 25.9, 22.7, 14.1; IR 
(neat, cm–1) 3345, 1690. Anal calcd for C17H35NO2: C, 72.68; H, 11.86; N, 4.71. Found: 
C, 72.91; H, 11.92; N, 4.75. 
 
(+)-(1R)-1-(2-Oxoethyl)decylcarbamic acid tert-butyl ester (V-59). A round-
bottom flask was charged with (+)-(1R)-1-nonylpent-4-enylcarbamic acid tert-butyl ester 
(594 mg, 2.0 mmol) and dichloromethane (80 mL). The solution was cooled to –78 °C 
and ozone was bubbled through the mixture until a blue color persisted. Dry nitrogen was 
then bubbled through the solution until the blue color dissipated. Solid 
triphenylphosphine (1.05 g, 4.0 mmol) was added in one portion and the flask was 
warmed to rt and stirred for 2h. The reaction mixture was then concentrated in vacuo and 




compound (381 mg, 63%) as a colorless oil: [α]23D +30.8° (c 1.0, CHCl3); 1H NMR (500 
MHz, CDCl3) δ 9.70 (t, J = 2.5 Hz, 1 H), 4.71 (d, J = 9.0 Hz, 1 H), 4.00–3.93 (m, 1 H), 
2.60–2.46 (m, 2 H), 1.48–1.43 (m, 2 H), 1.37 (s, 9 H), 1.26–1.20 (m, 14 H), 0.82 (t, J = 
7.0 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 201.1, 155.3, 79.3, 49.1, 46.4, 35.0, 31.8, 
29.4, 29.20, 29.16, 28.4, 25.9, 22.5, 14.0; IR (neat, cm–1) 3343, 1716; MS (ESI): 
322.2352 (322.2358 calculated for C17H33NO3, M + Na+). 
 
(+)–(1R,3S)-3-Hydroxy-1-nonylpent-4-enylcarbamic acid tert-butyl ester (V-
51). A flame-dried flask was charged with CuBr2•Me2S (1.30g, 6.3 mmol) and ether (23 
mL). The resulting suspension was cooled to –20 °C and vinyllithium39 (12.6 mL, 12.6 
mmol, 1.0 M in ether) was added dropwise. The resulting dark-colored solution was 
cooled to –78 °C and a solution of V-59 (381 mg, 1.26 mmol) in ether (4 mL) was added 
dropwise. The resulting mixture was stirred at –78 °C for 2 h then methanol (4 mL) was 
added and the mixture was warmed to rt. Saturated aqueous ammonium chloride (30 mL) 
was added, the layers were separated, and the aqueous layer was extracted with ether (3 x 
30 mL). The combined organic layers were dried over anhydrous Na2SO4, filtered and 
concentrated in vacuo. Analysis of the crude material by 1H NMR revealed that the 
product had been formed as a 3:1 mixture of diastereomers. The crude product was 
purified by flash chromatography on silica gel to afford 230 mg (56%) of the title 
compound as a white solid, m.p. 49–50 °C, [α]23D +6.1° (c 1.0, CHCl3). Spectral data 
were identical to the racemic compound V-51 described above. This material was judged 




The enantiomeric purity of V-51 was determined through HPLC analysis of the 
O-benzoyl derivative, which was prepared as follows: A flame-dried flask cooled under a 
stream of nitrogen was charged with (±)V-51 (40 mg, 0.122 mmol), pyridine (2 mL) and 
cooled to 0 °C. Neat benzoyl chloride (90 μL, 0.78 mmol) was added dropwise.  The 
resulting mixture was stirred at 0 °C until the starting material was consumed as judged 
by TLC analysis (ca. 1h). The reaction mixture was then diluted with water (3 mL) and 
ethyl acetate (5 mL). The layers were separated and the remaining aqueous phase was 
extracted with ethyl acetate (3 x 3 mL). The combined organic extracts were dried over 
anhydrous Na2SO4, filtered and concentrated in vacuo. The crude product was purified by 
flash chromatography using 10% ethyl acetate/hexanes as the eluent to afford 47.5 mg 
(90 %) of a colorless oil. 1H NMR (500 MHz, CDCl3) δ 8.06 (d, J = 7.3 Hz, 2 H), 7.55 (t, 
J = 7.3 Hz, 1 H), 7.44 (t, J = 7.8 Hz, 2 H), 5.96–5.85 (m, 1 H), 5.63–5.55 (m, 1 H), 5.33 
(d, J = 17.1 Hz, 1 H), 5.20 (d, J = 10.5 Hz, 1 H), 4.45 (s, br, 1 H), 3.80–3.61 (m, br, 1 H), 
2.04–1.91 (m, 1 H), 1.85–1.75 (m, 1 H), 1.57–1.15 (m, 25 H), 0.88 (t, J = 6.8 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) δ 206.1, 165.6, 155.2, 136.3, 132.9, 130.4, 129.6, 128.3, 
116.8, 78.9, 72.6, 48.5, 47.6, 40.8, 39.5, 36.5, 35.4, 31.9, 29.6, 29.5, 29.3, 28.4, 25.8, 
22.6, 14.1. 
 
Assay for determination of enantiomeric excess (ee):  The O-benzoyl 
derivative of (±)V-51 (10 mg) was dissolved in isopropanol (50 μL) and hexanes (1 mL) 
and injected in an HPLC apparatus equipped with chiral column (R,R) WHELK-O 1 




6.733min) was found to be 5 % isopropanol/hexanes, flow rate = 1 mL/min at 
wavelength of 231 nm.  The HPLC analysis indicated the material was of 97 % ee. 
 
(–)–(1R,3S)-3-(tert-Butyldimethylsilyloxy)-1-nonylpent-4-enylcarbamic acid 
tert-butyl ester (V-47). Treatment of V-51 (180 mg, 0.55 mmol) with TBS-Cl (133 mg, 
0.88 mmol) and imidazole (75 mg, 1.1 mmol) using a procedure analogous to that 
described above for the synthesis of racemic compound V-47 afforded the nonracemic 
title compound (226 mg, 93%) as a colorless oil, [α]23D –1.3° (c 1.0, CHCl3). Spectral 
data were identical to the racemic compound V-47 described above. 
 
(–)–(2S,3S,5R)–2-Benzyl-3-(tert-butyldimethylsilyloxy)-5-nonylpyrrolidine-1-
carboxylic acid tert-butyl ester (V-23).38 Treatment of (–)–(1R,3S)-3-(tert-
butyldimethylsilyloxy)-1-nonylpent-4-enylcarbamic acid tert-butyl ester V-47 (110 mg, 
0.25 mmol) with bromobenzene (32 µL, 0.3 mmol) using a procedure analogous to that 
described above for the synthesis of racemic compound V-23 afforded the nonracemic 
title compound (80.2 mg, 62 %) as a colorless oil, [α]23D –51.8° (c 1.1, CHCl3) [lit.38 
[α]20D –48.6° (c 1.1, CHCl3)]. Spectral data were identical to the racemic compound V-23 
described above. This material was judged to be of 96% ee using the method described 
below. 
Assay for determination of enantiomeric excess (ee):  Compound V-23 (10 mg) 
was dissolved in isopropanol (50 μL) and hexanes (1 mL) and injected in an HPLC 




permitting separation of enantiomers (RT = 8.350 min and 9.433 min) was found to be 
2.5 % isopropanol/hexanes, flow rate = 0.5 mL/min at wavelength of 254 nm.  The HPLC 
analysis indicated the material was of 96% ee. 
 
(+)–Preussin (V-1).3 Treatment of (–)–(2S,3S,5R)–2-benzyl-3-(tert-
butyldimethylsilyloxy)-5-nonylpyrrolidine-1-carboxylic acid tert-butyl ester (27 mg, 0.05 
mmol) with LiAlH4 (313 µL, 0.313 mmol) using a procedure analogous to that described 
above for the synthesis of racemic compound V-1 afforded the nonracemic title 
compound (16 mg, 95 %) as a colorless oil, [α]23D +21.2° (c 1.0, CHCl3) [lit.3 [α]25D 
+22.0° (c 1.0, CHCl3)]. Spectral data were identical to the racemic compound V-1 
described above. 
 
Synthesis of N-Boc-O-TBS Preussin and 3-epi-Preussin Analogs (Tables 13–14).  
 
(±)–(2S,3S,5R)–2-(4-Benzoylbenzyl)-3-(tert-butyldimethylsilyloxy)-5-
nonylpyrrolidine-1-carboxylic acid tert-butyl ester (V-60). This compound was 
prepared on a 0.5 mmol scale using a procedure analogous to that employed for the 
synthesis of V-23 except 4-bromobenzophenone (157 mg, 0.6 mmol) was used in place 
of bromobenzene. This procedure afforded 208 mg (67%) of the title compound as a 
colorless oil. This compound was found to exist as a 1.5:1 mixture of rotamers as judged 
by 1H NMR analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.81–7.66 
(m, 4 H), 7.59–7.52 (m, 1 H), 7.49–7.42 (m, 2 H), 7.40–7.29 (m, 2 H), 4.34–4.18 (m, 1.4 
H), 4.15–4.00 (m, 0.6 H), 3.74–3.50 (m, 1 H), 3.15–3.03 (m, 1 H), 2.89–2.75 (m, 0.4 H), 




1.43–1.11 (m, 24 H), 0.95–0.82 (m, 12 H), 0.13–0.07 (m, 6 H); 13C NMR (100 MHz, 
CDCl3) δ 196.3, 154.7, 145.6, 138.0, 135.0, 132.0, 130.0, 129.8, 129.7, 128.1, 79.1, 71.3, 
62.0, 61.5, 55.6, 38.7, 38.0, 37.1, 36.2, 31.8, 29.6, 29.5, 29.2, 28.1, 26.5, 25.8, 22.6, 18.1, 
14.1, -4.7, -5.0. IR (film) 1693, 1661 cm–1. Anal calcd for C38H59NO4Si: C, 73.38; H, 
9.56; N, 2.25. Found: C, 73.23; H, 9.67; N, 2.32. 
 
(±)–(2S,3R,5R)–2-(4-Benzoylbenzyl)-3-(tert-butyldimethylsilyloxy)-5-
nonylpyrrolidine-1-carboxylic acid tert-butyl ester (V-61). This compound was 
prepared on a 0.5 mmol scale using a procedure analogous to that employed for the 
synthesis of V-27 except 4-bromobenzophenone (157 mg, 0.6 mmol) was used in place 
of bromobenzene. This procedure afforded 194.8 mg (63%) of the title compound as a 
colorless oil. This compound was found to exist as a 1.5:1 mixture of rotamers as judged 
by 1H NMR analysis and contained a small amount (ca 3–5%) of an inseparable aromatic 
impurity; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.75–7.67 (m, 4 H), 
7.56–7.48 (m, 1 H), 7.45–7.38 (m, 2 H), 7.34–7.21 (m, 2 H), 4.02–3.74 (m, 3 H), 3.13–
3.00 (m, 0.4 H), 2.96–2.81 (m, 0.6 H), 2.56–2.45 (m, 1 H), 2.18–2.03 (m, 0.4 H), 2.02–
1.88 (m, 1.6 H), 1.85–1.66 (m, 1 H), 1.49–1.33 (m, 10 H), 1.31–1.10 (m, 14 H), 0.83 (t, J 
= 6.6 Hz, 3 H), 0.75–0.69 (m, 9 H), -0.17–-0.27 (m, 6 H); 13C NMR (100 MHz, CDCl3) 
δ 196.1, 195.5, 159.9, 155.2, 143.7, 137.9, 137.6, 135.6, 132.1, 131.8, 131.6, 130.2, 
129.8, 129.6, 129.2, 128.1, 128.0, 122.0, 79.4, 79.0, 73.3, 72.4, 69.3, 68.8, 57.2, 40.4, 
39.6, 39.2, 38.8, 36.0, 38.0, 31.8, 29.6, 29.4, 29.2, 28.8, 28.3, 25.5, 22.5, 17.7, 14.0, -5.1, 




Found: C, 73.68; H, 9.48; N, 2.16. 
 
(±)–(2S,3S,5R)–2-(4-Methoxybenzyl)-3-(tert-butyldimethylsilyloxy)-5-
nonylpyrrolidine-1-carboxylic acid tert-butyl ester (V-62). This compound was 
prepared on a 0.5 mmol scale using a procedure analogous to that employed for the 
synthesis of V-23 except 4-bromoanisole (76 µL, 0.6 mmol) was used in place of 
bromobenzene. This procedure afforded 149.7 mg (55%) of the title compound as a 
colorless oil. This compound was found to exist as a 1.5:1 mixture of rotamers as judged 
by 1H NMR analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.20–7.04 
(m, 2 H), 6.84–6.75 (m, 2 H), 4.30–4.18 (m, 1 H), 4.17–4.08 (m, 0.4 H), 4.01–3.90 (m, 
0.6 H), 3.77 (s, 3 H), 3.70–3.46 (m, 1 H), 2.99–2.89 (m, 1 H), 2.78–2.62 (m, 0.4 H), 
2.56–2.41 (m, 0.6 H), 2.32–2.09 (m, 1.6 H), 2.01–1.86 (m, 0.4 H), 1.63–1.50 (m, 1 H), 
1.48–1.02 (m, 24 H), 0.97–0.79 (m, 12 H), 0.13– -0.08 (m, 6 H); 13C NMR (100 MHz, 
CDCl3) δ 157.8, 154.9, 132.1, 130.7, 113.5, 78.9, 71.4, 62.4, 61.7, 55.6, 55.3, 38.7, 38.0, 
37.2, 34.9, 31.9, 29.7, 29.5, 29.3, 28.1, 26.5, 25.8, 22.7, 18.1, 14.1, -4.7, -5.0. IR (film) 
1692 cm-1. Anal calcd for C32H57NO4Si: C, 70.15; H, 10.49; N, 2.56. Found: C, 70.08; H, 
10.30; N, 2.52. 
 
(±)–(2S,3S,5R)–2-(4-Methoxybenzyl)-3-(tert-butyldimethylsilyloxy)-5-
nonylpyrrolidine-1-carboxylic acid tert-butyl ester (V-63). This compound was 
prepared on a 0.5 mmol scale using a procedure analogous to that employed for the 
synthesis of V-27 except 4-bromoanisole (76 µL, 0.6 mmol) was used in place of 




colorless oil. This compound was found to exist as a ~1.5:1 mixture of rotamers as 
judged by 1H NMR analysis; data are for the mixture. 1H NMR (500 MHz, CDCl3) 
δ 7.19–7.03 (m, 2 H), 6.86–6.78 (m, 2 H), 4.00–3.96 (m, 1 H), 3.95–3.85 (m, 1 H), 3.84–
3.73 (m, 4 H), 3.04–2.93 (m, 0.35 H), 2.86–2.76 (m, 0.65 H), 2.40–2.31 (m, 1 H), 2.17–
2.05 (m, 0.65 H), 2.00–1.86 (m, 1 H), 1.85–1.77 (m, 0.35 H), 1.76–1.67 (m, 1 H), 1.53–
1.37 (m, 10 H), 1.35–1.12 (m, 14 H), 0.88 (t, J = 6.3 Hz, 3 H), 0.75 (s, 9 H), -0.17– -0.26 
(m, 6 H); 13C NMR (125 MHz, CDCl3) δ 158.1, 155.4, 130.9, 130.2, 113.8, 78.8, 73.2, 
72.3, 69.8, 69.2, 57.2, 55.3, 39.5, 38.9, 38.7, 36.0, 31.9, 29.7, 29.5, 29.3, 28.5, 26.1, 25.9, 
25.6, 22.7, 17.8, 14.1, -5.08, -5.13. IR (film) 1694 cm-1. Anal calcd for C32H57NO4Si: C, 
70.15; H, 10.49; N, 2.56. Found: C, 70.01; H, 10.64; N, 2.53. 
 
(±)–(2S,3S,5R)–2-(4-Trifluoromethylbenzyl)-3-(tert-butyldimethylsilyloxy)-5-
nonylpyrrolidine-1-carboxylic acid tert-butyl ester (V-64). This compound was 
prepared on a 0.5 mmol scale using a procedure analogous to that employed for the 
synthesis of V-23 except 4-bromobenzotrifluoride (85 µL, 0.6 mmol) was used in place 
of bromobenzene. This procedure afforded 201.3 mg (69%) of the title compound as a 
colorless oil. This compound was found to exist as a 1.5:1 mixture of rotamers as judged 
by 1H NMR analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.56–7.43 
(m, 2 H), 7.41–7.25 (m, 2 H), 4.32–4.15 (m, 1.4 H), 4.06–3.93 (m, 0.6 H), 3.72–3.45 (m, 
1 H), 3.10–3.00 (m, 1 H), 2.86–2.72 (m, 0.4 H), 2.65–2.51 (m, 0.6 H), 2.36–2.11 (m, 1.6 
H), 2.05–1.90 (m, 0.4 H), 1.65–1.54 (m, 1 H), 1.45–1.00 (m, 24 H), 0.99–0.78 (m, 12 H), 




25.0 Hz), 124.9, 124.4 (q, J = 271.8 Hz), 79.2, 71.3, 62.2, 61.3, 56.5, 55.7, 38.8, 38.0, 
37.3, 36.0, 31.9, 29.6, 29.5, 29.3, 28.3, 28.0, 26.5, 25.8, 22.7, 18.1, 14.1, -4.7, -5.0; IR 
(film) 1695 cm-1. Anal calcd for C32H54F3NO3Si: C, 65.60; H, 9.29; N, 2.39. Found: C, 
65.57; H, 9.40; N, 2.37. 
 
(±)–(2S,3R,5R)–2-(4-Trifluoromethylbenzyl)-3-(tert-butyldimethylsilyloxy)-5-
nonylpyrrolidine-1-carboxylic acid tert-butyl ester (V-65). This compound was 
prepared on a 0.5 mmol scale using a procedure analogous to that employed for the 
synthesis of V-27 except 4-bromobenzotrifluoride (85 µL, 0.6 mmol) was used in place 
of bromobenzene. This procedure afforded 152 mg (52%) of the title compound as a 
colorless oil. This compound was found to exist as a 1.5:1 mixture of rotamers as judged 
by 1H NMR analysis; data are for the mixture. 1H NMR (500 MHz, CDCl3) δ 7.58–7.50 
(m, 2 H), 7.38–7.24 (m, 2 H), 4.03–3.77 (m, 3 H), 3.13–3.04 (m, 0.4 H), 2.89–2.79 (m, 
0.6 H), 2.58–2.51 (m, 1 H), 2.17–2.07 (m, 0.6 H), 2.09–1.90 (m, 1.4 H), 1.80–1.70 (m, 1 
H), 1.55–1.11 (m, 24 H), 0.88 (t, J = 6.6 Hz, 3 H), 0.75 (s, 9 H), -0.13– -0.27 (m, 6 H); 
13C NMR (125 MHz, CDCl3) δ 155.3, 142.9, 129.7, 128.7 (q, J = 32.2 Hz), 125.2, 124.3 
(q, J = 272.0 Hz), 79.1, 73.6, 72.4, 69.3, 68.7, 57.4, 57.1, 40.3, 39.3, 39.0, 36.3, 31.9, 
29.7, 29.5, 29.3, 28.4, 26.2, 25.9, 25.5, 22.7, 17.8, 14.1, -5.0, -5.2; IR (film) 1694 cm-1. 








prepared on a 0.5 mmol scale using a procedure analogous to that employed for the 
synthesis of V-23 except 2-bromonaphthalene (125 mg, 0.6 mmol) was used in place of 
bromobenzene. This procedure afforded 187.9 mg (66%) of the title compound as a pale 
orange oil. This compound was found to exist as a 3:1 mixture of rotamers as judged by 
1H NMR analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.82–7.71 (m, 
3 H), 7.69–7.59 (m, 1 H), 7.51–7.31 (m, 3 H), 4.36–4.23 (m, 1.25 H), 4.18–4.02 (m, 0.75 
H), 3.76–3.50 (m, 1 H), 3.24–3.14 (m, 1 H), 3.06–2.88 (m, 0.25 H), 2.81–2.64 (m, 0.75 
H), 2.38–2.11 (m, 1.75 H), 2.03–1.90 (m, 0.25 H), 1.71–1.58 (m, 1 H), 1.47–1.12 (m, 20 
H), 1.05–0.79 (m, 16 H), 0.16– -0.14 (m, 6 H); 13C NMR (100 MHz, CDCl3) δ 154.9, 
137.6, 133.5, 132.0, 128.6, 128.0, 127.4, 127.3, 125.6, 124.9, 78.8, 71.4, 62.4, 61.6, 55.7, 
38.7, 38.0, 37.2, 36.2, 31.9, 29.6, 29.5, 29.3, 28.3, 27.8, 26.5, 25.8, 22.7, 18.1, 14.1, -4.7, 
-5.0 (two aromatic carbons are incidentally equivalent); IR (film) 1693 cm-1. Anal calcd 
for C35H57NO3Si: C, 74.02; H, 10.12; N, 2.47. Found: C, 73.89; H, 10.28; N, 2.55. 
 
(±)–(2S,3S,5R)–2-(2-Methylbenzyl)-3-(tert-butyldimethylsilyloxy)-5-
nonylpyrrolidine-1-carboxylic acid tert-butyl ester (V-67). This compound was 
prepared on a 0.5 mmol scale using a procedure analogous to that employed for the 
synthesis of V-23 except 2-bromotoluene (66 µL, 0.6 mmol) was used in place of 
bromobenzene. This procedure afforded 148.3 mg (56%) of the title compound as a pale 
yellow oil. This compound was found to exist as a 9:1 mixture of rotamers as judged by 
1H NMR analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.15–7.03 (m, 




H), 3.29–3.12 (m, 1 H), 2.56–2.46 (m, 0.1 H), 2.40–2.19 (m, 5.8 H), 2.10–2.00 (m, 0.1 
H), 1.72–1.61 (m, 1 H), 1.46–1.19 (m, 20 H), 1.09–0.82 (m, 16 H), 0.16– -0.04 (m, 6 H); 
13C NMR (100 MHz, CDCl3) δ 154.9, 138.1, 136.4, 130.7, 129.9, 125.8, 125.7, 78.7, 
71.2, 60.0, 55.7, 38.0, 37.7, 33.3, 31.9, 29.8, 29.7, 29.5, 29.3, 27.7, 26.7, 25.8, 25.7, 22.7, 
19.6, 18.0, 14.1, -4.8, -5.1; IR (film) 1693 cm-1. Anal calcd for C32H57NO3Si: C, 72.26; 
H, 10.80; N, 2.63. Found: C, 72.07; H, 10.65; N, 2.62. 
 
(±)–(2S,3S,5R)–2-(4-Cyanobenzyl)-3-(tert-butyldimethylsilyloxy)-5-
nonylpyrrolidine-1-carboxylic acid tert-butyl ester (V-68). This compound was 
prepared on a 0.5 mmol scale using a procedure analogous to that employed for the 
synthesis of V-23 except 4-bromobenzonitrile (110 mg, 0.6 mmol) was used in place of 
bromobenzene. This procedure afforded 175 mg (65%) of the title compound as a 
colorless oil. This compound was found to exist as a 1.5:1 mixture of rotamers as judged 
by 1H NMR analysis; data are for the mixture. 1H NMR (500 MHz, CDCl3) δ 7.63–7.48 
(m, 2 H), 7.43–7.23 (m, 2 H), 4.34–4.21 (m, 1 H), 4.20–4.11 (m, 0.4 H), 4.05–3.92 (m, 
0.6 H), 3.74–3.45 (m, 1 H), 3.05 (dd, J = 5.1, 13.7, 1 H), 2.81–2.67 (m, 0.4 H), 2.66–2.51 
(m, 0.6 H), 2.36–2.10 (m, 1.6 H), 2.06–1.86 (m, 0.4 H), 1.75–1.50 (m, 1 H), 1.49–1.04 
(m, 24 H), 0.96–0.76 (m, 12 H), 0.14– -0.11 (m, 6 H); 13C NMR (125 MHz, CDCl3) 
δ 154.7, 146.1, 131.8, 130.6, 119.2, 109.4, 79.3, 71.3, 70.9, 62.0, 61.3, 55.6, 38.7, 37.9, 
37.2, 36.5, 31.9, 29.7, 29.5, 29.3, 28.1, 26.5, 25.8, 22.6, 18.0, 14.1, -4.7, -5.0; IR (film) 
1694 cm-1. Anal calcd for C32H54N2O3Si: C, 70.80; H, 10.03; N, 5.16. Found: C, 70.99; 






nonylpyrrolidine-1-carboxylic acid tert-butyl ester (V-69). This compound was 
prepared on a 0.5 mmol scale using a procedure analogous to that employed for the 
synthesis of V-23 except 3-bromopyridine (60 μL, 0.6 mmol) was used in place of 
bromobenzene. This procedure afforded 150.8 mg (58%) of the title compound as a 
colorless oil. This compound was found to exist as a ~ 1.5:1 mixture of rotamers as 
judged by 1H NMR analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) 
δ 8.47–8.34 (m, 2 H), 7.64–7.41 (m, 1 H), 7.20–7.10 (m, 1 H), 4.30–4.20 (m, 1 H), 4.19–
4.11 (m, 0.35 H), 4.02–3.90 (m, 0.65 H), 3.69–3.44 (m, 1 H), 3.02–2.92 (m, 1 H), 2.77–
2.64 (m, 0.35 H), 2.57–2.44 (m, 0.65 H), 2.34–2.08 (m, 1.65 H), 2.02–1.90 (m, 0.35 H), 
1.60–1.47 (m, 1 H), 1.44–1.04 (m, 24 H), 0.94–0.77 (m, 12 H), 0.13– -0.13 (m, 6 H); 13C 
NMR (100 MHz, CDCl3) δ 154.7, 151.1, 147.0, 137.1, 135.4, 122.9, 79.2, 71.2, 62.0, 
61.1, 55.6, 38.8, 37.9, 37.2, 33.3, 31.8, 29.6, 29.5, 29.2, 28.0, 26.4, 25.8, 22.6, 18.0, 14.0, 
-4.8, -5.1; IR (film) 1694 cm-1. Anal calcd for C30H54N2O3Si: C, 69.45; H, 10.49; N, 5.40. 
Found: C, 69.50; H, 10.45; N, 5.34. 
 
(±)–(2S,3S,5R)–2-(N-benzyl-5-indolyl-2-ylmethyl)-3-(tert-
butyldimethylsilyloxy)-5-nonylpyrrolidine-1-carboxylic acid tert-butyl ester (V-70). 
This compound was prepared on a 0.5 mmol scale using a procedure analogous to that 
employed for the synthesis of V-23 except N-benzyl-5-bromoindole (172 mg, 0.6 mmol) 
was used in place of bromobenzene. This procedure afforded 135.9 mg (42%) of the title 




rotamers as judged by 1H NMR analysis; data are for the mixture. 1H NMR (400 MHz, 
CDCl3) δ 7.53–7.40 (m, 1 H), 7.30–7.20 (m, 3 H), 7.18–6.96 (m, 5 H), 6.48–6.43 (m, 1 
H), 5.30 (s, 2 H), 4.31–4.21 (m, 1 H), 4.10–3.99 (m, 1 H), 3.79–3.50 (m, 1 H), 3.16–3.06 
(m, 1 H), 2.95–2.77 (m, 0.4 H), 2.69–2.53 (m, 0.6 H), 2.34–2.12 (m, 1.6 H), 2.08–1.86 
(m, 0.4 H), 1.70–1.58 (m, 1 H), 1.46–1.13 (m, 18 H), 1.03–0.81 (m, 18 H), 0.13– -0.14 
(m, 6 H); 13C NMR (100 MHz, CDCl3) δ 155.0, 137.9, 135.0, 130.8, 128.9, 128.6, 128.1, 
127.4, 126.6, 124.0, 121.7, 109.1, 101.2, 78.6, 71.4, 62.8, 55.6, 50.0, 38.0, 37.3, 35.8, 
35.2, 31.9, 29.73, 29.67, 29.5, 29.3, 28.5, 27.9, 26.6, 25.9, 25.7, 22.7, 18.1, 14.1, -4.7, -
5.0; IR (film) 1689 cm-1. Anal calcd for C40H62N2O3Si: C, 74.25; H, 9.66; N, 4.33. 
Found: C, 73.87; H, 9.90; N, 4.31. 
 
(±)–(2S,3S,5R)–2-(4-Chlorobenzyl)-3-(tert-butyldimethylsilyloxy)-5-
nonylpyrrolidine-1-carboxylic acid tert-butyl ester (V-71). This compound was 
prepared on a 0.5 mmol scale using a procedure analogous to that employed for the 
synthesis of V-23 except 4-bromochlorobenzene (115 mg, 0.6 mmol) was used in place 
of bromobenzene. This procedure afforded 195.4 mg (71%) of the title compound as a 
pale orange oil. This compound was found to exist as a ~ 1.5:1 mixture of rotamers as 
judged by 1H NMR analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) 
δ 7.32–7.09 (m, 4 H), 4.33–4.22 (m, 1 H), 4.21–4.11 (m, 0.35 H), 4.05–3.93 (m, 0.65 H), 
3.73–3.51 (m, 1 H), 3.04–2.94 (m, 1 H), 2.79–2.65 (m, 0.35 H), 2.60–2.46 (m, 0.65 H), 
2.36–2.13 (m, 1.65 H), 2.04–1.94 (m, 0.35 H), 1.66–1.49 (m, 1 H), 1.48–1.08 (m, 24 H), 




131.4, 131.2, 128.0, 79.1, 71.3, 62.2, 61.5, 55.6, 38.7, 38.0, 37.2, 35.4, 31.9, 29.6, 29.5, 
29.3, 28.0, 26.5, 25.8, 25.7, 25.5, 22.6, 18.0, 14.1, -4.7, -5.0; IR (film) 1694 cm-1. Anal 
calcd for C31H54ClNO3Si: C, 67.41; H, 9.85; N, 6.42. Found: C, 67.25; H, 9.82; N, 2.54. 
 
General Procedure for Pd-Catalyzed Carboamination Reactions of Aryl Bromides 
Using Cs2CO3. A flame-dried Schlenk tube equipped with a magnetic stirbar was cooled 
under a stream of nitrogen and charged with the aryl bromide (1.2 equiv), Pd(OAc)2 (2 
mol %), Dpe-phos (4 mol %) and Cs2CO3 (2.3 equiv). The tube was purged with nitrogen 
and a solution of the N-protected amine substrate (1.0 equiv) in dioxane (5 mL/mmol 
substrate) was then added via syringe. The resulting mixture was heated to 100 °C with 
stirring until the starting material had been consumed as determined by GC analysis. The 
reaction mixture was cooled to room temperature and saturated aqueous NH4Cl (1 mL) 
and ethyl acetate (1 mL) were added. The layers were separated, the aqueous layer was 
extracted with ethyl acetate (3 x 5 mL), and the combined organic layers were dried over 
Na2SO4, filtered, and concentrated in vacuo. The crude product was then purified by flash 
chromatography on silica gel. 
 
(±)–(2S,3S,5R)-2-Benzyl-3-(tert-butyldimethylsiloxy)-5-nonylpyrrolidine-1-
carboxylic acid tert-butyl ester (V-71).38 The general procedure was employed for the 
reaction of bromobenzene (26 μL, 0.24 mmol) with V-47 (89 mg, 0.20 mmol). 1H NMR 
analysis of the crude material obtained upon workup showed the formation of the desired 
product as a >20:1 mixture of diastereomers. This procedure afforded 74 mg (71%) of the 




comparison of the 1H NMR spectrum to data previously reported in the literature. This 
compound was found to exist as a 3:1 mixture of rotamers as judged by 1H NMR 
analysis; data are for the mixture. 1H NMR (400 MHz, CDCl3) δ 7.35–7.06 (m, 5 H), 
4.32– 4.15 (m, 1.25 H), 4.08–3.95 (m, 0.75 H), 3.83–3.44 (m, 1 H), 3.06–2.96 (m, 1 H), 
2.82–2.68 (m, 0.25 H), 2.61–2.47 (m, 0.75 H), 2.32–2.12 (m, 1.75 H), 2.05–1.93 (m, 0.25 
H), 1.67–1.54 (m, 1 H), 1.51–1.03 (m, 24 H), 0.97–0.84 (m, 12 H), 0.13– -0.08 (m, 6 H). 
 
(±)–(2S,3S,5R)-3-(tert-Butyldimethylsiloxy)-2-(4-methoxycarbonylbenzyl)-5-
nonylpyrrolidine-1-carboxylic acid tert-butyl ester (V-72). The general procedure was 
employed for the reaction of methyl 4-bromobenzoate (52 mg, 0.24 mmol) with V-47 (89 
mg, 0.20 mmol). The diastereoselectivity of the transformation was assessed by LAH 
reduction of the crude product obtained in a duplicate reaction, and was found to be 
>20:1 dr as judged by 1H NMR analysis. Chromatographic purification afforded 83 mg 
(72%) of the title compound as a colorless oil with >20:1 dr. This compound was found 
to exist as a 3:1 mixture of rotamers as judged by 1H NMR analysis; data are for the 
mixture. 1H NMR (400 MHz, CDCl3) δ 7.99–7.88 (m, 2 H), 7.39–7.22 (m, 2 H), 4.32–
4.19 (m, 1.3 H), 4.07–3.98 (m, 0.7 H), 3.90 (s, 3 H), 3.72–3.51 (m, 1 H), 3.11–3.01 (m, 1 
H), 2.87–2.75 (m, 0.3 H), 2.67–2.53 (m, 0.7 H), 2.33–2.12 (m, 1.7 H), 2.07–1.93 (m, 0.3 
H), 1.65–1.55 (m, 1 H), 1.46–1.05 (m, 24 H), 0.96–0.81 (m, 12 H), 0.12– -0.12 (m, 6 H); 
13C NMR (100 MHz, CDCl3) δ 167.3, 154.8, 145.9, 129.9, 129.4, 127.6, 79.2, 71.4, 62.1, 
55.7, 51.9, 38.0, 37.2, 36.3, 31.9, 29.7, 29.6, 29.3, 28.1, 26.5, 25.8, 22.7, 18.1, 14.1, -4.7, 




Found: C, 68.43; H, 9.98; N, 2.42. 
The stereochemistry of the above compound was determined through LAH 
reduction of V-72 to afford V-72a as shown below. The stereochemistry of V-72a was 
assigned by comparison of the 1H NMR spectrum of V-72a to that previously obtained 












V-72 V-72a  
 
(±)–(2S,3S,5R)-2-(4-Hydroxymethylbenzyl)-1-methyl-5-nonylpyrrolidin-3-ol 
(V-72a). A flame-dried flask was cooled under a steam of nitrogen and charged with V-
72 (70 mg, 0.12 mmol) and tetrahydrofuran (3 mL). The resulting solution was cooled to 
0 °C and LiAlH4 (1.2 mL, 1.2 mmol, 1 M in tetrahydrofuran) was added dropwise via 
syringe. The resulting mixture was heated to reflux until the starting material was 
consumed as judged by TLC analysis (ca. 21 h). The reaction mixture was cooled to 0 °C, 
slowly quenched with water (0.3 mL) and diluted with diethyl ether (5 mL). Aqueous 
NaOH (0.3 mL, 10 M) and water (0.3 mL) were added sequentially and an insoluble 
white precipitate formed. The organic supernatant was decanted to a clean Erlenmeyer 
flask and the precipitate was washed with diethyl ether. The combined organic extracts 
were dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The crude oil 
obtained was purified by flash chromatography using 10%  20% 




colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.32–7.28 (m, 4 H), 4.66 (s, 2 H), 3.83–3.75 
(m, 1 H), 2.94–2.80 (m, 2 H), 2.33 (s, 3 H), 2.30–2.03 (m, 5 H), 1.77–1.66 (m, 1 H), 
1.46–1.38 (m, 1 H), 1.37–1.15 (m, 15 H), 0.88 (t, J = 6.6 Hz, 3 H); 13C NMR (100 MHz, 
CDCl3) δ 138.8, 129.5, 127.1, 73.7, 70.2, 65.9, 64.9, 39.5, 38.6, 34.7, 33.1, 31.9, 29.9, 
29.6, 29.5, 29.3, 26.4, 22.6, 14.1 (two aromatic carbons are incidentally equivalent); IR 
(film) 3384 cm-1; MS (ESI): 348.2900 (348.2903 calculated for C22H37NO2, M + H+). 
 
Synthesis of Deprotected Preussin and 3-epi-Preussin Analogs (Table 15) 
 
(±)–(2S,3S,5R)–2-(4-Benzoylbenzyl)-3-hydroxy-5-nonylpyrrolidine (V-73). A 
flame-dried flask cooled under a steam of nitrogen was charged with V-60 (62.2 mg, 0.1 
mmol) and tetrahydrofuran (1 mL). Formic acid (1 mL, 26.5 mmol) was added dropwise 
and the resulting mixture was stirred at 60 °C until the starting material was consumed as 
judged by TLC analysis (ca. 5h). The reaction mixture was then cooled to 0 °C, an 
aqueous solution of formaldehyde (100 µL, 1.2 mmol, 37 wt. %) was added dropwise, 
and the mixture was stirred at 0 °C for 1h. The reaction mixture was then heated to 60 °C 
with stirring for 12h. The crude mixture was cooled to rt and was concentrated in vacuo. 
The resulting residue was then dissolved in tetrahydrofuran (1 mL). Solid K2CO3 (150 
mg, 1.1 mmol) was added and the resulting suspension was cooled to 0 °C. A solution of 
TBAF (1 mL, 1 mmol, 1 M in tetrahydrofuran) was then added dropwise and the reaction 
was stirred at rt until the silyl protecting group was completely removed as judged by 
crude 1H NMR analysis of an aliquot from the reaction mixture (ca. 5h). The crude 
mixture was concentrated in vacuo. The crude material was purified by flash 




compound as a light brown solid, m.p. 50–52 °C.  1H NMR (500 MHz, CDCl3) δ 7.79 (d, 
J = 8.1 Hz, 2 H), 7.74 (t, J = 8.1 Hz, 2 H), 7.60–7.56 (m, 1 H), 7.48 (t, J = 7.6 Hz, 2 H), 
7.42 (d, J = 8.1 Hz, 2 H), 3.84–3.78 (m, 1 H), 3.02–2.95 (m, 1 H), 2.94–2.89 (m, 1 H), 
2.39–2.30 (m, 4 H), 2.29–2.20 (m, 1 H), 2.19–2.13 (m, 1 H), 2.08–1.95 (s, br, 1 H), 1.77–
1.68 (m, 1 H), 1.48–1.42 (m, 1 H), 1.38–1.17 (m, 15 H), 0.88 (t, J = 6.8 Hz, 3 H); 13C 
NMR (125 MHz, CDCl3) δ 196.5, 144.6, 137.8, 135.5, 132.2, 130.3, 130.0, 129.3, 128.2, 
73.2, 70.4, 65.7, 39.4, 38.6, 34.9, 33.8, 31.9, 29.9, 29.6, 29.5, 29.3, 26.2, 22.7, 14.1; IR 




This compound was prepared on a 0.1 mmol scale using a procedure analogous to that 
employed for the synthesis of V-73. Substrate V-61 (62.2 mg, 0.1 mmol) was 
transformed to the title compound to afford 36.2 mg (86%) of a light brown solid, m.p. 
62–64 °C.  1H NMR (500 MHz, CDCl3) δ 7.79–7.72 (m, 4 H), 7.57 (t, J = 7.6 Hz, 1 H), 
7.47 (t, J = 7.8 Hz, 2 H), 7.37 (d, J = 8.1 Hz, 2 H), 4.02–3.97 (m, 1 H), 3.05 (dd, J = 4.9, 
13.7 Hz, 1 H), 2.74–2.67 (m, 1 H), 2.57–2.46 (m, 2 H), 2.34 (s, 3 H), 1.81–1.75 (m, 1 H), 
1.72–1.57 (m, 2 H), 1.35–1.11 (m, 16 H), 0.87 (t, J = 6.8 Hz, 3 H); 13C NMR (125 MHz, 
CDCl3) δ 196.4, 144.3, 137.7, 135.5, 132.3, 130.3, 129.9, 129.3, 128.2, 76.8, 74.5, 64.8, 
39.5, 39.4, 39.3, 33.8, 31.8, 29.9, 29.58, 29.53, 29.3, 26.3, 22.6, 14.1; IR (film) 3422, 
1658 cm-1; MS (ESI): 422.3057 (422.3059 calculated for C28H39NO2, M + H+). 
 




flame-dried flask was cooled under a stream of nitrogen and charged with V-62 (100 mg, 
0.2 mmol) and tetrahydrofuran (1 mL). The resulting solution was cooled to 0 °C and 
LiAlH4 (2 mL, 2 mmol, 1 M in tetrahydrofuran) was added dropwise via syringe. The 
resulting mixture was stirred at 60 °C until the starting material was consumed as judged 
by TLC analysis (ca. 16h). The reaction mixture was diluted with dry ether (2 mL), 
cooled to 0 °C and slowly quenched with an aqueous saturated solution of Na2SO4 (0.3 
mL). The heterogeneous mixture was diluted with additional ether (2 mL) and was 
filtered through a small pad of celite. The filter was washed with additional ether and the 
combined organic filtrates were dried over Na2SO4, filtered and concentrated in vacuo. 
The crude oil obtained was purified by flash chromatography using 5% MeOH/CH2Cl2 as 
the eluent to afford 62.8 mg (87%) of the title compound as a white solid, m.p. 47-49 °C.  
1H NMR (400 MHz, CDCl3) δ 7.21 (d, J = 8.6 Hz, 2 H), 6.83 (d, J = 8.6 Hz, 2H), 3.83–
3.76 (m, 4 H), 2.83–2.76 (m, 2 H), 2.33 (s, 3 H), 2.26–2.06 (m, 3 H), 1.94–1.74 (m, 1 H), 
1.76–1.55 (m, 2 H), 1.45–1.38 (m, 1 H), 1.37–1.16 (m, 14 H), 0.88 (t, J = 6.6 Hz, 3 H); 
13C NMR (100 MHz, CDCl3) δ 158.0, 131.1, 130.2, 113.8, 73.9, 70.3, 66.0, 55.2, 39.2, 
38.5, 34.6, 32.5, 31.9, 29.8, 29.6, 29.5, 29.3, 26.3, 22.7, 14.1; IR (film) 3412 cm-1; MS 
(ESI): 348.2902 (348.2903 calculated for C22H37NO2, M + H+). 
 
(±)–(2S,3R,5R)–2-(4-Methoxybenzyl)-3-hydroxy-5-nonylpyrrolidine (V-76). 
This compound was prepared on a 0.2 mmol scale using a procedure analogous to that 
employed for the synthesis of V-75 except that removal of the silyl group required the 
use of TBAF after LAH reduction (see V-73 for protocol, K2CO3 was not used). 




mg (88%) of a white solid, m.p. 49-50 °C.  1H NMR (400 MHz, CDCl3) δ 7.18 (d, J = 8.5 
Hz, 2 H), 6.85 (d, J = 8.5 Hz, 2 H), 4.03–3.96 (m, 1 H), 3.79 (s, 3 H), 3.05–2.97 (m, 1 H), 
2.55–2.41 (m, 2 H), 2.40–2.32 (m, 4 H), 1.80–1.73 (m, 1 H), 1.72–1.59 (m, 2 H), 1.35–
1.11 (m, 15 H), 0.96 (s, 1H), 0.88 (t, J = 6.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 
δ 158.1, 130.7, 130.2, 114.0, 74.8, 64.9, 55.2, 39.1, 39.0, 38.3, 33.9, 31.9, 30.0, 29.59, 
29.55, 29.3, 26.4, 22.7, 14.1 (two aliphatic carbons are incidentally equivalent); IR (film) 
3392 cm-1; MS (ESI): 348.2906 (348.2903 calculated for C22H37NO2, M + H+). 
 
(±)–(2S,3S,5R)–2-(4-Trifluoromethylbenzyl)-3-hydroxy-5-nonylpyrrolidine 
(V-77). This compound was prepared on a 0.1 mmol scale using a procedure analogous to 
that employed for the synthesis of V-73. Substrate V-64 (59 mg, 0.1 mmol) was 
transformed to the title compound to afford 31.5 mg (82%) of a white solid, m.p. 45–47 
°C.  1H NMR (500 MHz, CDCl3) δ 7.53 (d, J = 8.2 Hz, 2 H), 7.41 (d, J = 8.2 Hz, 2 H), 
3.80–3.72 (m, 1 H), 3.00–2.92 (m, 1 H), 2.88 (dd, J = 4.4, 13.2 Hz, 1 H), 2.34 (s, 3 H), 
2.30–2.11 (m, 3 H), 2.03–1.90 (m, 1 H), 1.78–1.67 (m, 1 H), 1.44 (dd, J = 5.6, 13.4 Hz, 1 
H), 1.37–1.17 (m, 15 H), 0.88 (t, J = 6.8 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 143.6, 
129.8, 128.4 (q, J = 32.2 Hz), 125.2, 124.3 (q, J = 272.0 Hz), 73.3, 70.3, 65.7, 39.3, 38.5, 
34.9, 33.6, 31.9, 29.9, 29.61, 29.55, 29.3, 26.2, 22.7, 14.1; IR (film) 3401 cm-1; MS 
(ESI): 386.2671 (386.2671 calculated for C22H34F3NO, M + H+). 
 
(±)–(2S,3R,5R)–2-(4-Trifluoromethylbenzyl)-3-hydroxy-5-nonylpyrrolidine 
(V-78). This compound was prepared on a 0.1 mmol scale using a procedure analogous to 




transformed to the title compound to afford 30.8 mg (80%) of a white solid, m.p. 48–49 
°C.  1H NMR (400 MHz, CDCl3) δ 7.54 (d, J = 8.0 Hz, 2 H), 7.37 (d, J = 8.0 Hz, 2 H), 
4.00–3.90 (m, 1 H), 3.00 (dd, J = 4.5, 13.5 Hz, 1 H), 2.75–2.62 (m, 1 H), 2.57–2.42 (m, 2 
H), 2.32 (s, 3 H), 1.83–1.52 (m, 3 H), 1.48–1.06 (m, 16 H), 0.88 (t, J = 6.2 Hz, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 143.3, 129.7, 128.5 (q, J = 32.4 Hz), 125.2, 124.3 (q, J = 
272.0 Hz), 76.7, 74.5, 64.7, 39.6, 39.3, 39.1, 33.9, 31.9, 30.0, 29.6, 29.5, 29.3, 26.3, 22.7, 
14.1; IR (film) 3369, 2927, 1326, 1126, 843 cm-1; MS (ESI): 386.2673 (386.2671 
calculated for C22H34F3NO, M + H+). 
 
Asymmetric aldol reaction of 2-undecanone with acrolein. A flame-dried flask 
was cooled under a steam of nitrogen and charged with (-)-DIPCl (514 mg, 1.6 mmol), 
and CH2Cl2 (6 mL). A thermocouple was inserted to the solution through a rubber septum 
and the mixture was cooled to an internal temperature of –78 °C. Triethylamine (280 µL, 
2 mmol) was added followed by a solution of 2-undecanone (207 µL, 1 mmol) in CH2Cl2 
(1 mL). The resulting was mixture was stirred at -78 °C for 1.5h, then a solution of 
acrolein (100 µL, 1.5 mmol) in CH2Cl2 (3 mL) was added slowly dropwise and the 
reaction mixture was stirred at –78 °C for an additional 2.5h then warmed to 0 °C with 
stirring for 1h. The disappearance of starting material was verified by TLC analysis. The 
reaction mixture was diluted with Et2O and quenched with a buffer solution (10 mL, pH 
= 7). The layers were separated and the aqueous phase was extracted with Et2O (3 x 15 
mL). The organic extracts were combined and concentrated in vacuo in a flask equipped 
with a magnetic stir bar. The crude oil obtained was diluted with MeOH (7 mL), a buffer 




H2O2 (2 mL, 30 wt. %) was slowly added and the mixture was stirred at rt for 3h. The 
reaction was then diluted with water (10 mL) and extracted with CH2Cl2 (3 x 15 mL). The 
extracts were washed with saturated aqueous NaHCO3 solution and FeSO4 saturated 
aqueous solution (3x, until the green color persisted). The organic phase was dried over 
anhydrous Na2SO4, filtered and concentrated in vacuo before being purified using 20 % 
Et2O/Hexanes as the eluent to afford 169.5 mg (78 %) of nonracemic V-48 as a colorless 
oil. This material was characterized by 1H NMR analysis prior to derivatization to assay 
enantiopurity; NMR data were identical to those given above. 
 
Benzoylation of nonracemic V-48. A flame-dried flask was cooled under a 
steam of nitrogen and charged with nonracemic V-48 (165 mg, 0.73 mmol), and pyridine 
(7 mL). The mixture was cooled to 0 °C and benzoyl chloride (340 µL, 2.92 mmol) was 
added dropwise via syringe.  The resulting mixture was stirred at 0 °C until the starting 
material was consumed as judged by TLC analysis (ca. 1h). The reaction mixture was 
then diluted with water (10 mL) and ethyl acetate (15 mL). The layers were separated and 
the aqueous phase was extracted with ethyl acetate (3 x 10 mL). The combined organic 
extracts were dried over anhydrous Na2SO4, filtered and concentrated in vacuo before 
being purified by flash chromatography using 5% ethyl acetate/hexanes as the eluent to 
afford 174.8 mg (73 %) of O-benzoyl-V-48 as a colorless oil. This optical purity of this 
material was judged to be 48% ee by HPLC analysis using the method described below. 
1H NMR (400 MHz, CDCl3) δ 8.02 (d, J = 7.0 Hz, 2 H), 7.56 (t, J = 7.2 Hz, 1 H), 7.43 (t, 
J = 7.8 Hz, 2 H), 6.00–5.90 (m, 2 H), 5.41–5.34 (m, 1 H), 5.26–5.20 (m, 1 H), 3.02–2.94 




12 H), 0.87 (t, J = 6.8 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 207.2, 165.4, 135.4, 
133.0, 130.1, 129.6, 128.4, 117.1, 71.1, 47.0, 43.5, 31.8, 29.38, 29.36, 29.2, 29.1, 23.6, 
22.6, 14.1.  
 
Assay for determination of enantiomeric excess of nonracemic V-48 prepared 
through asymmetric aldol reaction of undecanone with acrolein: The O-benzoyl 
derivative of V-48 (20 mg) was dissolved in hexanes (2 mL) and injected in an HPLC 
apparatus equipped with chiral column (R,R) WHELK-O 1 (Regis Tech.). The system 
permitting separation of enantiomers (RT = 8.200 min and 8.850 min) was found to be 5 
% isopropanol/hexanes, flow rate = 1 mL/min at wavelengths 220 nm and 254 nm. The 






1 Reproduced in part with permission from Beaudoin Bertrand, M.; Wolfe, J. P. “A 
Concise Stereoselective Synthesis of Preussin, 3-epi-Preussin, and Analogues” Org. Lett. 
2006, 8, 2353–2356. © 2006 American Chemical Society. 
2  Schwartz, R. E.; Liesch, J.; Hensens, O.; Zitano, L.; Honeycutt, S.; Garrity, G.; 
Fromtling, R. A.; Onishi, J.; Monaghan, R. J. Antibiot. 1988, 41, 1774–1779. 
3 (a) Johnson, J. H.; Phillipson, D. W.; Kahle, A. D.  J. Antibiot. 1989, 42, 1184–1185. 
(b) Kasahara, K.; Yoshida, M.; Eishima, J.; Takesako, K.; Beppu, T.; Horinouchi, S. J. 
Antibiot. 1997, 50, 267–269. 
4 Achenbach, T.V.; Slater, P. E.; Brummerhop, H.; Bach, T.; Müller, R. Antimicrob. 
Agents Chemother. 2000, 44, 2794–2801. 
5 Kinzy, T. G.; Harger, J. W.; Carr-Schmid, A.; Kwon, J.; Shastry, M.; Justice, M.; 
Dinman, J. D. Virology 2002, 300, 60–70. 
6  Okue, M.; Watanabe, H.; Kasahara, K.; Yoshida, M.; Horinouchi, S.; Kitahara, T. 
Biosci. Biotechnol. Biochem. 2002, 66, 1093–1096. 
7 Kitahara has described a non-stereoselective route that affords all eight stereoisomers of 
preussin in a two-step sequence. The isomers were separated by preparative chiral HPLC. 
See reference 6. 
8 For a recent review, see: Basler, B.; Brandes, S.; Spiegel, A.; Bach, T. Top. Curr. Chem. 
2005, 243, 1–42. 
9 For early synthetic studies see: (a) Shimazaki, M.; Okazaki, F.; Nakajima, F.; Ishikawa, 
T.; Ohta, A. Heterocycles 1993, 36, 1823–1826. (b) McGrane, P. L.; Livinghouse, T. J. 
Am. Chem. Soc. 1993, 115, 11485–11489. (c) Overhand, M.; Hecht, S. M. J. Org. Chem. 
1994, 59, 4721–4722. (d) Deng, W.; Overman, L. E. J. Am. Chem. Soc. 1994, 116, 
11241–11250. 
10 For recent syntheses, see: a) Davis, F. A.; Zhang, J.; Qui, H.; Wu, Y. Org. Lett. 2008, 
10, ASAP. b) Canova, S.; Bellosta, V.; Cossy, J. Synlett 2004, 1811–1813. c) Davis, F. 
A.; Deng, J. Tetrahedron 2004, 60, 5111–5115. d) Raghavan, S.; Rasheed, M. A. 
Tetrahedron 2003, 59, 10307–10312. e) Huang, P. -Q.; Wu, T. -J.; Ruan, Y. -P. Org. 
Lett. 2003, 5, 4341–4344. f) Dikshit, D. K.; Goswami, L. N. Singh, V. S; Synlett 2003, 
1737–1739. 
11 One strategy allows installation of the alkyl chain within three steps of the final target. 
Pak employed a Wittig reaction for the reaction of octyl phosphonium ylide with 2-
pyrrolidine aldehyde derivative (9:1 E:Z, 81% after separation of olefin isomers) 






final target preussin (40% yield, single diastereomer; 11 steps total, 42% overall yield). 
See: Pak C. S.; Lee, G. H. J. Org. Chem. 1991, 56, 1128–1133. 
12 Bach, T.; Brummerhop, H. Angew. Chem., Int. Ed. 1998, 37, 3400–3402. 
13 Four analogs that differ in the nature of the C3 substituent have been described in the 
patent literature. See: Suzuki, K.; Miike, N.; Kawamoto, E. Jpn. Kokai. Tokkyo Koho, 
2003277357, 2003. 
14 Beier, C.; Schaumann, E. Synthesis 1997, 1296–1300. 
15 Bach, T.; Brummerhop, H.; Harms, K. Chem. Eur. J. 2000, 6, 3838–3848. 
16 Hall, S. S.; Loebenberg, D.; Schumacher, D. P. J. Med. Chem. 1983, 26, 469–475. 
17 Schwardt, O.; Veith, U.; Gaspard, C.; Jäger, V. Synthesis 1999, 1473–1490. 
18 The stereoselective synthesis of trisubstituted pyrrolidines via the palladium-catalyzed 
carboamination chemistry was not precedented in our group at the time of this study. 
19  Smith, M. B.; March, J. In March’s Advanced Organic Chemistry: Reactions, 
Mechanisms, and Structure, 5th ed.; Wiley-Interscience: New York, 2001; p. 173. 
20 The shortest enantioselective route to Preussin was described by Hecht and coworkers. 
It consists of a five-step sequence starting with N-Boc phenylalanine. See ref 9c. 
21  The authors observed a 6:1 ratio of syn:anti isomers V-19:V-18 under the same 
reaction conditions. See: Veeresa, G.; Datta, A. Tetrahedron 1998, 54, 15673–15678. 
22 An extensive ligand screen revealed that Dpe-phos was superior, although the yield of 
pyrrolidine V-22 obtained was low (6%). 
23 This reaction was not optimized further since our main goal was the stereoselective 
synthesis of preussin. 
24 This compound was identified in the crude 1H NMR by analogy with V-21. 
25 Concomitant TBS deprotection occurs during the last step of the synthetic sequence to 
Preussin, which is a reduction with lithium aluminum hydride. See Scheme 22. 
26 Wuts, P. G. M.; Greene, T. W. In Protective Groups in Organic Synthesis, 4th ed.; 
Wiley-Interscience, Hoboken, 2007; p 32. 
27 Jensen, D. R.; Schultz, M. J.; Mueller, J. A.; Sigman, M. S. Angew. Chem., Int. Ed. 






28 Beaudoin Bertrand, M.; Wolfe, J. P. Tetrahedron 2005, 61, 6447–6459. 
29 For a discussion of allylic strain related to the partial double bond character between 
the nitrogen atom and the carbonyl carbon in α-substituted amides and carbamates see: a) 
Hoffmann, R. W. Chem. Rev. 1989, 89, 1841–1860. b) Hart, D. J. J. Am. Chem. Soc. 
1980, 102, 397–398. c) Williams, R. M.; Sinclair, P. J.; Zhai, D.; Chen, D. J. Am. Chem. 
Soc. 1988, 110, 1547–1557. d) Kano, S.; Yokomatsu, T.; Iwasawa, H.; Shibuya, S. 
Heterocycles 1987, 26, 2805–2809. 
30 Narasaka, K.; Ukaji, Y.; Yamazaki, S. Bull. Chem. Soc. Jpn. 1986, 59, 525–533. 
31  The (–)-B-chlorodiisopinocampheylborane-mediated asymmetric aldol reaction 
between 2-undecanone and acrolein provided V-48 in 78% yield and 48% ee using 
Paterson’s conditions. See: Paterson, I.; Goodman, J. M.; Lister, M. A.; Schumann, R. C.; 
McClure, C. K.; Norcross, R. D. Tetrahedron 1990, 46, 4663–4684. See Experimental 
Section for more details. 
32 Products V-54 and V-55 were observed by crude H NMR and identified by comparison 
with pyrrolidine compound V-23. 
33 Cogan, D. A.; Liu, G.; Ellman, J. Tetrahedron 1999, 55, 8883–8904. 
34 The crude reaction mixture was judged to be a 10:1 mixture of diastereomers by 1H 
NMR analysis. 
35 Toujas, J. -L.; Toupet, L.; Vaultier, M. Tetrahedron 2000, 56, 2665–2672. 
36 Use of high purity starting material (>97% by NMR and GC) was essential to obtain 
high yields in reactions of electron-rich aryl bromides. Use of starting material with trace 
(ca 5%) impurities led to catalyst deactivation and formation of complex mixtures of 
products with these substrate combinations. 
37 Hanessian, S.; Tehim, A.; Chen, P. J. Org. Chem. 1993, 58, 7768–7781. 
38 Huang, P. -Q.; Wu, T. -J.; Ruan, Y. -P. Org. Lett. 2003, 5, 4341–4344. 
39  Yamamoto, K.; Ogura, H.; Jukuta, J. -i.; Inoue, H.; Hamada, K.; Sugiyama, Y.; 





Studies Towards the Synthesis of (–)-Anisomycin 
Background 
 
The pyrrolidine natural product (–)-anisomycin (VI-1) was first isolated in 1954 
by Sobin and Tanner from the fermentation broths of Streptomyces griseolous and 
Streptomyces roseochromogens.1 In 1968 its structure was elucidated2 and its absolute 
configuration was determined as 2R,3S,4S. 3  Early studies revealed that anisomycin 
inhibits peptide synthesis in eukaryotic systems due to its ability to selectively bind to the 
60S ribosomal unit, which has led to its widespread use as a control reference for protein 
synthesis inhibition in molecular biology.4 The essential structural features anisomycin 
possesses that enable protein synthesis inhibition include a secondary amine group 
adjacent to an asymmetric carbon with the R configuration, linked through a methylene to 
a sterically unhindered six-membered aromatic ring.4 Anisomycin also exhibits 
antiprotozoal and antifungal properties,5 and is used in the clinical treatment of amoebic 
dysentery,6 Trichomona vaginitis,7 and for the eradication of bean mildew.8 Anisomycin 
was also shown to have antitumor activity against human tumor cell lines,9 and was 
found to be a potent activator of kinase cascades leading to apoptosis. 10  Finally, 




synthesis is required for memories to be saved in the brain,12 anisomycin’s ability to 
function as a protein synthesis inhibitor lends to its potential in the inhibition of “fear 












Owing to its interesting biological properties, (–)-anisomycin (VI-1) has been a 
popular target for total synthesis, and has been prepared via 21 different asymmetric 
routes 13  ranging from 8 to over 20 steps. However, these routes are not without 
limitations. The majority of these synthetic routes are lengthy, low yielding and/or suffer 
from inefficient protecting group chemistry in later stages of the syntheses due to 
problematic selective acylation of the hindered C3 hydroxyl group.14,15 Most of these 
syntheses intercept one of two common intermediates, 2-arylmethyldihydropyrrole (VI-
2)16 or biologically active (–)-deacylanisomycin (VI-3),9,17 which are further transformed 





















In all previously described (–)-anisomycin (VI-1) syntheses, the C2 p-
methoxybenzyl group is introduced at the beginning of the sequence, starting with the 
chiral amino acid tyrosine, or via the reaction of an organometallic species (aryllithium or 
Grignard reagent) on a sugar-derived electrophile. Thus, the previously described 
syntheses of (–)-anisomycin (VI-1) are generally not well suited for the rapid generation 
of analogues that differ in the nature of the aryl substituent. A concise approach to this 
molecule that involves the installation of the aryl group near the end of the synthetic 
route would be of great value, particularly if the arene could be incorporated in a manner 
that would permit synthesis of functionalized and/or heteroaryl analogs from readily 
available precursors. 
Due to the limitations of existing synthetic routes, few studies on the effect of 
arene substitution on the biological activity of anisomycin (VI-1) analogs have been 
performed. The aryl analogs prepared and tested for their antiprotozoal, antifungal and 
antibacterial activities are limited to racemic p-Me, p-H, o-OMe, m-OMe and C1’-Me 
substituted anisomycin derivatives.18 These investigations demonstrated that the nature of 
the C1’ aryl group has a profound effect on biological activity; only the p-Me and p-H 
analogs showed activity. The activity dropped dramatically as the methoxy substituent 
was moved to the meta and ortho position, or when an additional substituent was attached 
to the C1’ benzylic carbon. Later, a study on an enantiopure anisomycin analog bearing a 
phenyl group in place of the p-methoxyphenyl moiety showed 40-fold less cytotoxic 
potency than VI-1 against a human KB cell line.17b A number of other anisomycin 
analogs that differ on the oxygen substituent at C39,10,19 and C410 have been prepared and 




VI-1. From this information, in combination with the anisomycin aryl analog results, a 
general structure that includes requirements for the molecule’s bioactivity can be 
suggested (Figure 7).17b,18 It would be highly desirable to evaluate the biological effect of 
the presence of other substituents on the arene portion of the natural product, such as 
electron-withdrawing groups. For this reason, we felt that a short synthetic route to 
anisomycin that would allow facile modification of the arene moiety would be of 
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We envisioned that anisomycin (VI-1) could be potentially attainable using our 
developed carboamination chemistry (Scheme 31), through coupling of substrate VI-5 
with 4-bromoanisole in a stereoselective fashion. This reaction could provide pyrrolidine 
intermediate VI-4, which could be further transformed in one step to the natural product 
via tandem deprotection of the N-Cbz and O-Bn protecting groups. Substrate VI-5 could 
be accessed in three steps from protected diol VI-6, which could be prepared in two steps 
from a diastereoselective aldol reaction between VI-7 and acrolein. This synthetic 




advantages. First, it would circumvent the protecting group chemistry issues experienced 
previously, since both N-Cbz and O-Bn could potentially be removed in the final step in 
one operation (possibly via hydrogenation). 20  Additionally, this strategy would 
incorporate the aryl portion of the molecule towards the end of the sequence, which 
would allow for preparation of analogs by simply changing the aryl halide coupling 
partner in the key Pd-catalyzed carboamination step. The mild reaction conditions 
required for the N-Cbz and O-Bn deprotection of intermediate VI-4 would tolerate 
sensitive arene functional groups, and thus would allow for preparation of various 
functionalized anisomycin analogs otherwise not accessible via previous routes. If 
successful, this route would become the shortest synthesis of (–)-anisomycin (VI-1) to 
date with a total of seven steps.15 
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The key cyclization step proposed for the synthesis of trisubstituted pyrrolidine 
VI-4 would challenge our previously developed methodology, as well as our proposed 




moiety to be present in the allylic position of the substrate (VI-5). We anticipated that 
competing oxidative addition of the allylic acetate to generate a π-allyl palladium 
complex21  may occur under the cyclization reaction conditions. A potential solution 
would then involve the use of a different oxygen protecting group and/or use of an aryl 
iodide to increase the relative rate of Ar–X vs allyl–X oxidative addition. An additional 
challenge with our proposed strategy lies in the requirement for the formation of a 
pyrrolidine product with a cis relationship between the C2 and C3 substituents. Indeed, 
the carboamination chemistry developed so far has only permitted access to 2,3-trans 
pyrrolidines (Chapters II-III). In order to obtain the desired 2,3-cis pyrrolidine isomer VI-
9, transition state VI-8, in which both protected oxygen substituents lie in pseudo-axial 
positions, would have to be accessed (Scheme 32). In contrast, cyclization via transition 
state VI-10, in which both OR groups are pseudoequatorial, would produce the incorrect 
diastereoisomer (VI-11). 
 










































We imagined that electronic factors could play a critical role in the 
stereoselectivity of the carboamination, as it is possible that the C3-OAc and C4-OBn 
substituents would lie in the pseudoaxial positions (VI-8) to minimize dipole-dipole 
interactions. 22  Recent work from Woerpel and coworkers demonstrated that 
stereoelectronic effects have a large impact on diastereoselectivity in the reactions of 
alkoxy-substituted cyclohexanone oxocarbenium ions with enolsilanes. 23  When C4-
alkylsubstituted cyclohexane substrate VI-12 was treated with nucleophile VI-13 and 
Lewis acid SnBr4, a majority (96:4) of the expected 1,4-trans product VI-14 was formed 
(eq 52). Conversely, when C4 O-Bn substituted cyclohexane substrate VI-17 was 
subjected to the same reaction conditions, complete reversal of selectivity (4:96) was 
observed favoring the 1,4-cis product VI-19 (eq 53). It was proposed that products VI-14 
and VI-19 were formed via transition states VI-16 and VI-20, respectively. The authors 
postulated that the alkoxy OBn group (VI-17) prefers an axial conformation in order to 
bring the opposing charges in closer proximity, thus leading to the observed 1,4-cis 
selectivity. Although this work was not directly related to our current proposal, it 
provided some indications that the axial C3-OAc and C4-OBn substituents in transition 



















































We also believed that transition state VI-8 may be preferred on the basis of 
sterics. Marzabadi and co-workers demonstrated that at low temperature, the preferred 
conformation for 1,2-trans-cyclohexane diols protected with very bulky silyl groups was 
the 1,2-di-axial arrangement VI-22 (eq 54).24 Very recently, crystal structures of the 1,2-
di-axial TIPS and TBDPS derivatives VI-22 were obtained, showing that these di-axial 
conformations are preferred and stable at room temperature in the solid state as well as in 
solution.25 This phenomenon is more commonly observed in pyranose systems where 
introduction of bulky protecting groups at vicinal hydroxyl groups causes the substituents 










R3 = i-Pr3 (TIPS), 5:95
R3 = Ph2, t-Bu (TBDPS), 13:87
R3 = Me2, t-Bu (TBS), 89:11





This substrate-control strategy has previously been applied to the stereoselective 
synthesis of sugar derivatives. As part of the synthesis of ravidomycin, the substrate’s 
conformation was used to promote exclusive β-attack of the nucleophile VI-24 on the 
activated sugar VI-23 (eq 55).27 The bulky O-TBDPS group was believed to force the O-
Bn/O-TBDPS in the trans-diaxial conformation (VI-23) and consequently blocked the α-
face for nucleophilic attack. Another elegant example of this strategy was demonstrated 
in the total synthesis of herbicidin B.28 As shown in eq 56, the trans-diaxial conformation 
of VI-26 blocked the bottom face of the molecule and promoted alkene reduction from 
the top face. This method permitted the authors to generate the final target in three steps 
from VI-26 in 31% yield and as a single diastereoisomer. Other groups have used this 
strategy in the stereoselective formation of other sugar derivatives, 29  and crystal 






























































Herbicidin B31%single diastereomer  
 
These studies provided guidance in the choice of the oxygen protecting groups 
that could be used for the stereoselective cyclization of VI-5 to afford 2,3-cis pyrrolidine 
VI-4 via di-axial transition state VI-8 (Scheme 32). We hypothesized that it would be 
likely that at least one bulky silyl protecting group would be necessary to favor transition 
state VI-8, however changing the C3 oxygen protecting group in VI-5, for example, 
would add two additional steps to our synthesis (O-silyl deprotection and O-Ac 
protection). For this reason, we initially studied O-Bn/O-Ac substrate VI-5, which would 
permit access to anisomycin in the most efficient manner. 
 
Since our primary goal was to investigate the stereoselectivity of the key Pd-
catalyzed carboamination, we opted for a racemic synthesis of substrate VI-5 via 
intermediate VI-6. We believed this intermediate could be readily prepared via a syn 
selective boron-mediated aldol reaction between benzyl glycolate and acrolein. 31 




78 oC) were unsuccessful: unreacted starting material was recovered (eq 57). The reaction 
mixture was then warmed to rt and a new product VI-28 was obtained in high selectivity 
(dr >20:1) (eq 58). NMR analysis suggested that the benzyl group had migrated from the 
oxygen to the carbon atom of the benzyl glycolate, and that the acrolein moiety had been 
incorporated. This indicated that the combination of both a Wittig rearrangement and an 
aldol reaction had occurred under the reaction conditions. This new tandem reaction was 
further investigated, and the results of these studies are presented in Chapters VII and 
VIII. Upon obtaining these results, we decided to rely on a different synthetic plan in 





























Our new synthetic plan for the synthesis of VI-1 involved the use of the Evans 
chiral auxiliary VI-29, which would permit access to substrate VI-5 in an enantiopure 
fashion (Scheme 33). Boron-mediated aldol reaction between VI-30 and acrolein lead to 
29% yield of VI-31 as a 10:1 mixture of syn:anti diastereoisomers.32 Transamination33 of 
VI-31 with AlMe3/NH4Cl afforded amide VI-32 in 72% yield. Amide VI-32 was then 




of elimination product VI-34. 34  Finally, substrate VI-5 was accessed via acetate 
protection of VI-33. 
 
Scheme 33. Synthetic Studies Towards Anisomycin I 
1) 3 equiv Bu2BOTf, 




















1) LiAlH4, THF, 50 oC, 3 h
(85% conversion)
2) Cbz-Cl, Et3N, Et2O
Ac2O
85%




























Before attempting the key cyclization with chiral substrate VI-5, we tested the 
reactivity of model compound VI-35 containing an allylic O-Ac group with 
bromobenzene under the optimized reactions (eq 59). As anticipated, competing 
oxidative addition of the allylic acetate to generate π-allyl palladium complex led to the 
formation of primarily VI-37 and VI-38, and only a small amount of desired pyrrolidine 
VI-36 was observed by crude 1H NMR. We found that the use of iodobenzene improved 




observed in this case resulted from competing Heck arylation of the substrate (eq 60). 
 
4 mol % Dpe-phos 














unidentified mixture (17% GC yield)
VI-35 (6% GC yield)







4 mol % Dpe-phos 





















(~15% GC yield)  
 
The previous experiment provided the key information that an aryl iodide 
coupling partner would be preferable in the cyclization of anisomycin substrate VI-5. 
Thus, substrate VI-5 was treated with iodoanisole or iodobenzene under the optimized 
carboamination reactions. Unfortunately, very small amounts of products VI-40 or VI-41 
were generated, which was insufficient to elucidate the product stereochemistry. Most of 
the starting material (VI-5) was instead converted to Heck-type side-product VI-42. 
Since our initial efforts were towards evaluating the cyclization stereoselectivity, we 




modification would allow testing of the key cyclization reaction selectivity with an aryl 
bromide and, according to the above discussion, would possibly favor trans di-axial 
transition state VI-8 leading to the desired 2,3-cis pyrrolidine VI-9 (Scheme 32). 
 







R = OMe, VI-40 (5%)
R = H, VI-41 (10%)











2 mol % Pd(OAc)2






Substrates VI-43 and VI-44 were then prepared in one step from VI-33 and tested 
in the key cyclization (Scheme 35). Low yields of the pyrrolidines VI-45 and VI-46 were 
obtained, although in good diastereoselectivity (>15:1). The relative stereochemistry 
between C2-C3 was determined by comparison of NMR spectra of VI-47 to literature 
data.35 The stereochemistry of pyrrolidine isomers VI-45 and VI-46 was then assigned as 
the undesired 2,3-trans pyrrolidine isomer. We reasoned that a single bulky silyl group 
was not sufficient to favor the protected diol trans-diaxial arrangement at transition state 
VI-8, and that both oxygen silyl protecting groups needed to be bulkier. We were aware 
that the use of such a substrate would require many additional steps to prepare 
anisomycin and would most likely intercept (-)-deacylanisomycin (VI-3) (eq 51), leading 
to a formal synthesis of the natural product. At this point, however, our main goal was to 




stereochemistry at C2 and C3. 
 
Scheme 35. Synthetic Studies Towards Anisomycin II 
N
OSiR3BnO
2 mol % Pd(OAc)2 




R = TBS, VI-45, 23% iso.






R = TBS, VI-43











Di-TBDPS protected substrate VI-50 was then prepared in three steps from VI-32 
and was subjected to the reaction conditions shown in Scheme 36. Pyrrolidine product 
VI-52 was isolated in 77% yield and with good diastereoselectivity (>15:1), along with 
oxidative cyclization side-product VI-51. Derivative VI-47 was then prepared in two 
steps from VI-52 to compare to literature data as in the previous study. Unfortunately, the 

























-78 oC, 10 min
4 equiv TBDPS-Cl
Imidazole


























2 mol % Pd(OAc)2 







These results indicate that the carboamination reaction is highly selective for the 
formation of 2,3-trans disubstituted products in this series, which are possibly obtained 
via transition state VI-54 (Figure 8). It is surprising that the use of two bulky silyl 
protecting groups (TBDPS) did not affect the selectivity of the key cyclization and that 
the yield was dramatically increased (39% yield for VI-46 vs 77% yield for VI-52). 
Indeed, it would be expected that the vicinal di-equatorial O-TBDPS substituents would 
suffer from severe gauche interactions in VI-54. A possible explanation is that VI-54 
compares to an open five-membered ring structure where the protected diols are in 




the related equatorial trans 1,2-cyclohexane diol VI-55.25 In this transition state (VI-54), 
the O-TBDPS at C3 and olefin at C2 are in a trans relationship, leading to the observed 
2,3-trans pyrrolidine product VI-52 in high selectivity. The reasons for the higher yield 
























In conclusion, application of the carboamination methodology to the synthesis of 
(–)-anisomycin was investigated. The proposed synthetic route was designed to avoid 
protecting group issues, permit analog synthesis and limit the overall number of steps 
necessary to reach the natural product. A major challenge was the stereoselective 
formation of a product with 2,3-cis pyrrolidine stereochemistry, since our previous 
methodology only provided access to 2,3-trans pyrrolidines. Based on electronic and 
steric arguments, it was proposed that the desired pyrrolidine product should be obtained 
in high 2,3-cis selectivity. Unfortunately, performing the key reaction proposed initially 
did not afford synthetically useful amounts of the anisomycin precursor VI-40, and other 
substrate modifications led to the exclusive formation of a pyrrolidine with 2,3-trans 




anisomycin, it allowed the formation of VI-47, a biologically active stereoisomer of the 
natural product.35 Further studies on the synthesis of aryl analogs of VI-47 could be 
performed in order to evaluate their bioactivities. 
 
Experimental section 
General Considerations. All reactions were carried out under an argon or 
nitrogen atmosphere in oven- or flame-dried glassware. All catalysts and reagents were 
obtained from commercial sources and were used without further purification except (S)-
4-benzyloxazolidin-2-one (VI-29) 36  and tert-butyl (3S,5R)-3-hydroxytetradec-1-en-5-
ylcarbamate (V-51) 37  were prepared according to published procedures. Ratios of 
regioisomers and/or diastereomers were determined by 1H NMR and/or capillary GC 
analysis of crude reaction mixtures. Yields refer to isolated yields of compounds 
estimated to be ≥95% pure as determined by 1H NMR, GC, and/or combustion analysis, 
unless otherwise noted. The yields reported in the experimental section describe the result 
of a single experiment. 
 
  (S)-4-Benzyl-3-(2-benzyloxyethanoyl)oxazolidin-2-one (VI-30). 38  A flame-
dried flask equipped with a magnetic stirbar was cooled under a stream of nitrogen and 
charged with (S)-4-benzyloxazolidin-2-one VI-29 (2.5 g, 14.1 mmol), and THF (43 mL) 
and cooled to -78 oC.  A 1.59 M solution of BuLi in hexanes (9 mL, 14.2 mmol) was then 




mmol).  The resulting mixture was stirred at -78 oC for 30 min then warmed to rt for 30 
min.  The reaction was quenched with a saturated solution of NH4Cl (9 mL) and the 
solvent was removed under reduced pressure.  The crude mixture was extracted with 
CH2Cl2 (100 mL), and the organic layer was washed with 1 M NaOH (50 mL) and brine 
(50 mL). The organic layer was then dried over Na2SO4, filtered and concentrated in 
vacuo.  The crude product was purified by flash chromatography using 20% ethyl 
acetate/hexanes as the eluent to afford 4.32 g (94%) of the title compound as a white 
solid, m.p. 68-70 oC. 1H NMR (400 MHz, CDCl3) δ 7.45–7.23 (m, 8 H), 7.22–7.15 (m, 2 
H), 4.75–4.63 (m, 5 H), 4.28–4.15 (m, 2 H), 3.30 (dd, J = 3.1, 13.5 Hz, 1 H), 2.86–2.75 
(m, 1 H). 
 
(2S,3R)-4-Benzyl-3-2-(benzyloxy)-3-hydroxypent-4-enoyl)oxazolidin-2-one 
(VI-31).39 A flame-dried flask equipped with a magnetic stirbar was cooled under a 
stream of nitrogen and was charged with VI-30 (6 g, 18.4 mmol), and CH2Cl2 (43 mL) 
and was cooled to 0 oC.  A 1.0 M solution of Bu2BOTf in CH2Cl2 (55 mL, 55 mmol) was 
then added followed by Et3N (9.8 mL, 73.8 mmol).  The resulting mixture was stirred at 0 
oC for 1h. Neat acrolein (2.5 mL, 36.9 mmol) was then added and the mixture was stirred 
at 0 oC for 1h and at rt for 15 min. The reaction mixture was cooled to 0 oC and quenched 
by addition of pH 7 buffer (2 mL/mmol substrate).  The heterogeneous mixture was 
diluted with MeOH (ca. 5-8 mL/mmol substrate) to afford a clear and homogeneous 
solution, then 30% aqueous H2O2 (3 mL/mmol substrate) was added slowly. The 




CH2Cl2 (~15 mL/mmol substrate), water (~8 mL/mmol substrate) and transferred to a 
separatory funnel. The layers were separated and the organic layer was washed with a 
saturated aqueous solution of FeSO4 until the green color persisted in order to quench any 
peroxide remaining. Caution! This procedure is highly exothermic. The FeSO4 solution 
should be first added SLOWLY DROPWISE with a glass pipette. The organic layer was 
then washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated 
in vacuo. 1H NMR analysis of the crude reaction mixture indicated that the reaction went 
to 40% conversion.  The crude product was purified by flash chromatography using 20% 
ethyl acetate/hexanes as the eluent to afford 2.84 g (47%) of recovered starting material 
and 2.1 g (29%) of the title compound as a colorless oil and as a 10:1 mixture of syn:anti 
diol diastereomers. The data is for the major isomer. 1H NMR (400 MHz, CDCl3) δ 7.44–
7.22 (m, 8 H), 7.21–7.11 (m, 2 H), 6.03–5.88 (m, 1 H), 5.41–5.30 (m, 1 H), 5.27–5.18 
(m, 2 H), 4.75–4.54 (m, 3 H), 4.46–4.37 (m, 1 H), 4.22–4.11 (m, 2 H), 3.25–3.16 (m, 1 
H), 2.75–2.63 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 170.1, 153.4, 136.9, 136.5, 135.0, 
129.3, 128.9, 128.43, 128.35, 128.2, 127.4, 117.0, 79.6, 73.5, 73.3, 66.9, 55.5, 37.6.  
 
(2S,3R)-2-(Benzyloxy)-3-hydroxypent-4-enamide (VI-32). A flame-dried flask 
was cooled under a stream of nitrogen and charged with ammonium chloride (864 mg, 
16.2 mmol), and toluene (20 mL) and was cooled to 0 oC. A solution of 
trimethylaluminum in toluene (8 mL, 16 mmol, 2.0 M) was then added slowly.  The 
mixture was allowed to warm to rt and was stirred for 30 min (bubbling was observed). 




5.3 mmol), and toluene (40 mL), and the solution was cooled to 0 oC. The NH4Cl/AlMe3 
solution was then added slowly dropwise to this mixture.  The resulting mixture was 
heated at 50 oC until the starting material was consumed as judged by TLC analysis (ca. 
14 h). The mixture was cooled to 0 oC and a 1 M solution of HCl was added slowly 
dropwise (60 mL). Ethyl acetate was added and the layers were separated. The organic 
layer was washed with saturated aqueous NaHCO3 (100 mL) and brine (100 mL). The 
organic layer was then dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. 
The crude product was purified by flash chromatography using 5% ethyl MeOH/CH2Cl2 
as the eluent to afford 606 mg (52%) of the title compound as a colorless oil and as a 20:1 
mixture of syn:anti diastereomers. The data is for the major isomer. 1H NMR (400 MHz, 
CDCl3) δ 7.41–7.30 (m, 5 H), 6.65 (s, 1 H), 6.16 (s, 1 H), 5.98–5.88 (m, 1 H), 5.43–5.41 
(m, 1 H), 5.39–5.36 (m, 1 H), 4.65 (s, 2 H), 4.48–4.42 (m, 1 H), 3.97 (d, J = 3.9 Hz, 1 H), 
3.45 (s, 1 H); 13C NMR (100 MHz, CDCl3) δ 174.1, 136.5, 136.1, 128.7, 128.4, 128.2, 
116.8, 80.8, 73.5, 72.0; IR (film) 1668 cm–1. 
 
(2R,3R)-Benzyl-2-(benzyloxy)-3-hydroxypent-4-enylcarbamate (VI-33). A 
flame-dried round-bottom flask was cooled under a stream of nitrogen and charged with 
VI-32 (140 mg, 0.63 mmol). The flask was purged with nitrogen, THF (5 mL) was added, 
and the resulting solution was cooled to 0 oC. A solution of LiAlH4 in THF (3.2 mL, 3.2 
mmol, 1.0 M) was added dropwise. The reaction mixture was warmed to 50 oC, and 
stirred for 3 h, then was cooled to 0 oC, quenched with H2O (0.5 mL), and diluted with 




(0.5 mL), and an insoluble white material precipitated. The organic supernatant was 
decanted to a clean Erlenmeyer flask and the precipitate was washed with ether (15 mL).  
The combined extracts were dried over anhydrous sodium sulfate and filtered to afford a 
solution of (3R,4R)-5-amino-4-(benzyloxy)pent-1-en-3-ol in diethyl ether, which was 
used without purification. 
 
A flame-dried round-bottom flask was cooled under a stream of nitrogen and 
charged with a solution of (3R,4R)-5-amino-4-(benzyloxy)pent-1-en-3-ol (6.3 mL, 0.63 
mmol, 0.1 M) in diethyl ether and was cooled to 0 °C. Triethylamine (0.3 mL, 1.89 
mmol) and benzyl chloroformate (0.2 mL, 1.26 mmol) were added, and the resulting 
mixture was stirred at rt until the starting material was consumed as judged by TLC 
analysis (ca. 24 h). A solution of 1.0 M HCl (10 mL) was added, the mixture was 
transferred to a separatory funnel, and was extracted with diethyl ether (3 X 5 mL). The 
combined organic extracts were washed with saturated aqueous NaHCO3 (10 mL) and 
brine (10 mL). The organic layer was then dried over anhydrous Na2SO4, filtered, and 
concentrated in vacuo. The crude material was purified by flash chromatography using 
2.5% MeOH/CH2Cl2 as the eluent to afford 146 mg (68%) of the title compound as a 
colorless oil. Elimination side-product VI-34 was also isolated during purification and 
data for this product are provided below. 1H NMR (500 MHz, CDCl3) δ 7.37–7.22 (m, 10 
H), 5.96–5.86 (m, 1 H), 5.39–5.31 (m, 1 H), 5.24–5.19 (m, 1 H), 5.18–5.12 (m, 1 H), 5.08 
(s, 2 H), 4.68–4.49 (m, 2 H), 4.17–4.09 (m, 1 H), 3.54–3.38 (m, 2 H), 3.36–3.26 (m, 1 H), 




128.48, 128.46, 128.10, 128.05, 128.0, 126.9, 116.8, 80.0, 73.0, 72.9, 66.7, 40.9. 
(E)-(2S)-Benzyl 2-(benzyloxy)pent-3-enylcarbamate (VI-34). 1H NMR (500 
MHz, CDCl3) δ 7.41–7.23 (m, 10 H), 5.82–5.70 (m, 1 H), 5.40–5.30 (m, 1 H), 5.10 (s, 2 
H), 4.58 (d, J =11.7 Hz, 1 H), 4.31 (d, J = 11.7 Hz, 1 H), 3.88–3.80 (m, 1 H), 3.47–3.39 
(m, 1 H), 3.26–3.15 (m, 2 H), 1.74 (dd, J = 1.5, 6.6 Hz, 3 H). 
The stereochemistry of VI-33 was determined by 1H NMR nOe analysis of the 

















(5R,6R)-5-(Benzyloxy)-6-vinyl-1,3-oxazinan-2-one (VI-33a). A flame-dried 
flask was cooled under a stream of nitrogen and charged with VI-33 (52.2 mg, 0.153 
mmol), KH (6.0 mg, 0.153 mmol) and THF (3 mL). The mixture was stirred at rt until the 
starting material was consumed as judged by TLC analysis (ca. 0.5h). The reaction 
mixture was then diluted with diethyl ether (10 mL), and water (1 mL) was added slowly 
followed by a solution of 1.0 M HCl (1 mL). The layers were separated and the aqueous 
layer was washed with diethyl ether (3 x 5 mL). The combined organic layers were then 
dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The crude product was 
purified by flash chromatography using 5% MeOH/CH2Cl2 as the eluent to afford 22 mg 




diastereomers. The data is for the major isomer. 1H NMR (400 MHz, CDCl3) δ 7.39–7.27 
(m, 5 H), 6.43 (s, br, 1 H), 6.08–6.00 (m, 1 H), 5.48–5.42 (m, 1 H), 5.39–5.34 (m, 1 H), 
4.81–4.77 (m, 1 H), 4.68–4.64 (m, 1 H), 4.59–4.55 (m, 1 H), 3.84–3.79 (m, 1 H), 3.45–
3.34 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 153.7, 137.2, 132.2, 128.5, 128.0, 127.7, 
118.8, 78.5, 71.6, 69.2, 42.2. 
 
 (3R,4R)-4-Benzyloxy-5-(benzyloxycarbonylamino)pent-1-en-3-yl acetate (VI-
5). A flame-dried flask was cooled under a stream of nitrogen and charged with VI-33 
(100 mg, 0.29 mmol), pyridine (5 mL) and acetic anhydride (6 mL). The mixture was 
stirred at rt until the starting material was consumed as judged by TLC analysis (ca. 14h). 
The reaction mixture was diluted with water (5 mL) and extracted with CH2Cl2 (3 x 10 
mL).  The combined organic layers were dried over anhydrous Na2SO4, filtered and 
concentrated in vacuo. The crude product was purified by flash chromatography using 
20% EtOAc/hexanes as the eluent to afford 90 mg (81%) of the title compound as a 
colorless oil and as a 10:1 mixture of syn:anti diastereomers. The data is for the major 
isomer. 1H NMR (400 MHz, CDCl3) δ 7.41–7.21 (m, 10 H), 5.91–5.80 (m, 1 H), 5.50–
5.43 (m, 1 H), 5.37–5.22 (m, 2 H), 5.13–4.99 (m, 3 H), 4.73–4.65 (m, 1 H), 4.64–4.55 
(m, 1 H), 3.68–3.59 (m, 1 H), 3.44–3.34 (m, 1 H), 3.28–3.14 (m, 1 H), 2.08 (s, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 170.1, 156.2, 137.6, 136.4, 132.2, 128.4, 128.1, 128.0, 127.9, 
















(3S,5R)-5-(tert-Butoxycarbonylamino)tetradec-1-en-3-yl acetate (VI-35). A 
flame-dried flask was cooled under a stream of nitrogen and charged with V-5137 (400 
mg, 1.2 mmol), pyridine (4 mL) and acetic anhydride (8 mL). The mixture was stirred at 
rt until the starting material was consumed as judged by TLC analysis (ca. 6h). The 
reaction mixture was diluted with water (5 mL) and extracted with CH2Cl2 (3 x 10 mL).  
The combined organic layers were dried over anhydrous Na2SO4, filtered and 
concentrated in vacuo. The crude product was purified by flash chromatography using 
10% EtOAc/hexanes as the eluent to afford 413 mg (92%) of the title compound as a 
colorless oil. 1H NMR (400 MHz, CDCl3) δ 5.85–5.74 (m, 1 H), 5.33–5.27 (m, 1 H), 
5.26–5.21 (m, 1 H), 5.18–5.13 (m, 1 H), 4.29–4.21 (m, 1 H), 3.75–3.66 (m, 1 H), 2.08 (s, 
3 H), 1.86–1.76 (m, 1 H), 1.62–1.54 (m, 2 H), 1.50–1.20 (m, 25 H), 0.88 (t, J = 6.8 Hz, 3 
H); 13C NMR (100 MHz, CDCl3) δ 170.2, 155.3, 136.5, 116.3, 78.9, 71.4, 47.1, 39.7, 
35.8, 31.8, 29.9, 29.52, 29.46, 29.2, 28.3, 25.8, 22.6, 21.1, 14.0; IR (film) 1745, 1691 cm–
1. Anal calcd for C21H39NO4: C, 68.25; H, 10.64; N, 3.79. Found: C, 68.12; H, 10.70; N, 
3.89. 
 (E)-(5R)-(tert-Butoxycarbonylamino)tetradec-2-enyl acetate (VI-37). 1H NMR 
(400 MHz, CDCl3) δ 5.79–5.69 (m, 1 H), 5.66–5.55 (m, 1 H), 4.52 (d, J = 6.3 Hz, 2 H), 




3 H), 1.52–1.19 (m, 25 H), 0.88 (t, J = 6.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) 
δ 170.8, 156.0, 131.9, 126.8, 65.0, 50.0, 38.1, 34.8, 31.9, 29.6, 29.52, 29.47, 29.3, 28.4, 
25.9, 22.7, 21.0, 14.1 (two aliphatic carbons are incidentally equivalent). 
 
(2S,3S,5R)-tert-Butyl-3-acetoxy-2-benzyl-5-nonylpyrrolidine-1-carboxylate 
(VI-36). A flame-dried Schlenk tube equipped with a magnetic stirbar was cooled under a 
stream of nitrogen and charged with VI-35 (74 mg, 0.2 mmol), Pd(OAc)2 (0.9 mg, 0.004 
mmol, 2 mol %), Dpe-phos (4.3 mg, 0.008 mmol, 4 mol %), Cs2CO3 (150 mg, 0.46 
mmol) and iodobenzene (27 µL, 0.24 mmol). The tube was purged with nitrogen and 
dioxane (1 mL) was added. The resulting mixture was heated to 100 °C with stirring for 
17 hours until the starting material had been consumed as determined by GC analysis. 
The reaction mixture was cooled to room temperature and saturated aqueous NH4Cl (1 
mL) and ethyl acetate (1 mL) were added. The layers were separated, the aqueous layer 
was extracted with ethyl acetate (3 x 5 mL), and the combined organic layers were dried 
over Na2SO4, filtered, and concentrated in vacuo. The crude product was then purified by 
flash chromatography using 2.5% ethyl acetate/hexanes as the eluent to afford 45 mg 
(50%) of the title compound as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.29–7.14 
(m, 5 H), 5.12–5.04 (m, 1 H), 4.37 (q, J = 7.0 Hz, 1 H), 3.78–3.69 (m, 1 H), 2.85–2.76 
(m, 2 H), 2.43–2.30 (m, 1 H), 2.19–2.02 (m, 1 H), 1.91 (s, 3 H), 1.83–1.73 (m, 1 H), 
1.52–1.21 (m, 24 H), 0.89 (t, J = 6.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 170.2, 
154.7, 138.7, 129.4, 128.2, 126.0, 79.5, 72.5, 59.9, 55.8, 36.7, 34.5, 31.9, 29.63, 29.56, 




IR (film) 1745, 1694 cm–1. 
 
(E)-(3S,5R)-5-(tert-Butoxycarbonylamino)-1-phenyltetradec-1-en-3-yl acetate 
(VI-39). 1H NMR (400 MHz, CDCl3) δ 7.44–7.20 (m, 5 H), 6.60 (d, J = 16 Hz, 2 H), 
6.19–6.09 (m, 1 H), 5.53–5.43 (m, 1 H), 4.32–4.23 (m, 1 H), 3.83–3.69 (m, 1 H), 2.10 (s, 




enylcarbamate (VI-43). A flame-dried flask was cooled under a stream of nitrogen and 
charged with VI-33 (345 mg, 1.0 mmol), imidazole (136 mg, 2.0 mmol), TBS-Cl (242 
mg, 1.6 mmol) and DMF (2 mL). The resulting mixture was stirred at rt until the starting 
material was consumed as judged by TLC analysis (ca. 20 h). The reaction mixture was 
diluted with water (10 mL) and ethyl acetate (10 mL). The layers were separated and the 
aqueous layer was extracted with ethyl acetate (3 x 10 mL). The combined organic layers 
were dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The crude 
product was purified by flash chromatography using 10% ethyl acetate/hexanes as the 
eluent to afford 330 mg (72%) of the title compound as a colorless oil and as a 10:1 
mixture of syn:anti diastereomers. The data is for the major isomer. 1H NMR (400 MHz, 
CDCl3) δ 7.35–7.20 (m, 10 H), 5.97–5.88 (m, 1 H), 5.32–5.24 (m, 1 H), 5.21–5.14 (m, 1 
H), 5.13–5.00 (m, 3 H), 4.67–4.48 (m, 2 H), 4.30–4.25 (m, 1 H), 3.49–3.38 (m, 2 H), 




δ 156.1, 138.1, 136.5, 128.35, 128.31, 128.26, 127.9, 127.73, 127.70, 127.67, 116.0, 80.0, 
73.6, 72.6, 66.4, 40.6, 25.7, 18.0, -4.9, -5.1.   
 
(2R,3R)-Benzyl-2-(benzyloxy)-3-(tert-butyldiphenylsilyloxy)pent-4-
enylcarbamate (VI-44). A flame-dried flask was cooled under a stream of nitrogen and 
charged with VI-33 (396 mg, 1.2 mmol), imidazole (157 mg, 2.3 mmol), TBDPS-Cl (523 
mg, 1.9 mmol) and DMF (4 mL). The resulting mixture was stirred at rt until the starting 
material was consumed as judged by TLC analysis (ca. 20 h). The reaction mixture was 
diluted with water (10 mL) and ethyl acetate (10 mL). The layers were separated and the 
aqueous layer was extracted with ethyl acetate (3 x 10 mL). The combined organic layers 
were dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The crude 
product was purified by flash chromatography using 10% ethyl acetate/hexanes as the 
eluent to afford 289 mg (67%) of the title compound as a colorless oil and as a ~15:1 
mixture of syn:anti diastereomers. The data is for the major isomer. 1H NMR (400 MHz, 
CDCl3) δ 7.74–7.59 (m, 5 H), 7.44–7.37 (m, 2 H), 7.38–7.26 (m, 8 H), 7.27–7.16 (m, 3 
H), 7.08–7.01 (m, 2 H), 5.99–5.87 (m, 1 H), 5.35–5.27 (m, 1 H), 5.19–5.13 (m, 1 H), 
5.12–5.02 (m, 2 H), 4.94 (s, 1 H), 4.46–4.39 (m, 1 H), 4.25–4.19 (m, 1 H), 4.10–4.05 (m, 
1 H), 3.61–3.53 (m, 1 H), 3.30–3.23 (m, 1 H), 3.20–3.11 (m, 1 H), 1.14–1.00 (m, 9 H); 
13C NMR (100 MHz, CDCl3) δ 156.1, 137.9, 136.7, 135.9, 135.8, 135.6, 134.8, 133.5, 
133.1, 129.9, 129.7, 129.4, 128.4, 128.3, 127.91, 127.89, 127.7, 127.58, 127.55, 127.52, 





General Procedure for Pd-Catalyzed Carboamination Reactions of Aryl 
Bromides. A flame-dried Schlenk tube equipped with a magnetic stirbar was cooled 
under a stream of nitrogen and charged with the aryl bromide (1.2 equiv), Pd(OAc)2 (2 
mol %), dpe-phos (4 mol %) and Cs2CO3 (2.3 equiv). The tube was purged with nitrogen 
and a solution of the N-protected amine substrate (1.0 equiv) in dioxane (5 mL/mmol 
substrate) was then added via syringe. The resulting mixture was heated to 100 °C with 
stirring until the starting material had been consumed as determined by GC analysis. The 
reaction mixture was cooled to room temperature and saturated aqueous NH4Cl (1 mL) 
and ethyl acetate (1 mL) were added. The layers were separated, the aqueous layer was 
extracted with ethyl acetate (3 x 5 mL), and the combined organic layers were dried over 
Na2SO4, filtered, and concentrated in vacuo. The crude product was then purified by flash 
chromatography on silica gel. 
 
(2R,3R,4R)-Benzyl-2-benzyl-4-(benzyloxy)-3-(tert-
butyldimethylsilyloxy)pyrrolidine-1-carboxylate (VI-45). The general procedure was 
employed for the reaction of bromobenzene (41 mg, 0.26 mmol) with VI-43 (100 mg, 
0.22 mmol). This procedure afforded 27 mg (23%) of the title compound as a colorless 
oil. This compound was found to exist as a 1:1 mixture of rotamers as judged by 1H NMR 
analysis and as a single diastereoisomer; data are for the mixture of rotamers. 1H NMR 
(500 MHz, CDCl3) δ 7.44–7.29 (m, 13 H), 7.23–7.07 (m, 2 H), 5.27–5.15 (m, 2 H), 4.65–
4.56 (m, 2 H), 4.10 (d, J = 3.7 Hz, 1 H), 3.90 (dd, J = 3.9, 11.7 Hz, 0.5 H), 3.84–3.76 (m, 
2 H), 3.75–3.65 (m, 1.5 H), 3.38 (d, J = 4.1, 12.9 Hz, 0.5 H), 3.16 (d, J = 4.2, 12.9 Hz, 1 







butyldiphenylsilyloxy)pyrrolidine-1-carboxylate (VI-46). The general procedure was 
employed for the reaction of bromobenzene (49 mg, 0.31 mmol) with VI-44 (151 mg, 
0.26 mmol). This procedure afforded 66 mg (39%) of the title compound as a colorless 
oil. This compound was found to exist as a 1:1 mixture of rotamers as judged by 1H NMR 
analysis and as a single diastereoisomer; data are for the mixture of rotamers. 1H NMR 
(500 MHz, CDCl3) δ 7.49–7.03 (m, 24 H), 6.90–6.84 (m, 1 H), 5.25–5.14 (m, 2 H), 4.27–
4.22 (m, 0.5 H), 4.19–4.15 (m, 1 H), 4.13–4.07 (m, 0.5 H), 3.99–3.93 (m, 1.5 H), 3.90–
3.83 (m, 1 H), 3.81–3.76 (m, 0.5 H), 3.71–3.68 (m, 0.5 H), 3.67–3.58 (m, 1.5 H), 3.37–
3.31 (m, 0.5 H), 3.10–3.04 (m, 0.5 H), 2.76–2.67 (m, 1 H), 0.89 (s, 9 H); 13C NMR (100 
MHz, CDCl3) δ 155.3, 155.1, 138.6, 138.5, 137.7, 136.9, 136.8, 136.0, 135.7, 135.6, 
133.6, 133.4, 132.7, 132.5, 129.9, 129.69, 129.67, 129.6, 129.3, 128.5, 128.43, 128.41, 
128.3, 128.0, 127.9, 127.8, 127.7, 127.5, 127.09, 127.07, 126.1, 83.5, 82.9, 76.5, 75.2, 
70.9, 70.8, 68.3, 67.8, 67.0, 66.7, 51.6, 51.4, 37.7, 36.9, 26.73, 26.70, 18.9. 
 
(2R,3R,4R)-2-Benzylpyrrolidine-3,4-diol (VI-47).35 A flame-dried flask was 
charged with VI-45 (27 mg, 0.05 mmol) and 6 M HCl solution (~5 mL). The mixture was 
heated to reflux with stirring 3 h. The reaction mixture was diluted with water (5 mL) and 
extracted with Et2O (5 mL).  The aqueous phase was basified with a 10 M NaOH solution 
to pH ~12. The aqueous layer was then extracted with CH2Cl2 (5 x 5 mL), and the 




vacuo to afford 5 mg (35%) of the title compound. This compound was found to be 
water-soluble. 1H NMR (500 MHz, CDCl3) δ 7.34–7.19 (m, 5 H), 4.13–4.07 (m, 1 H), 
3.84–3.78 (m, 1 H), 3.19–3.13 (m, 1 H), 3.12–3.07 (m, 1 H), 3.00–2.93 (m, 1 H), 2.92–
2.87 (m, 1 H), 2.86–2.78 (m, 1 H). 
 
(2R,3R)-tert-Butyl-2-(benzyloxy)-3-hydroxypent-4-enylcarbamate (VI-48). A 
flame-dried round-bottom flask was cooled under a stream of nitrogen and charged with 
VI-32 (157 mg, 0.71 mmol). The flask was purged with nitrogen, THF (6 mL) was added, 
and the resulting solution was cooled to 0 oC. A solution of LiAlH4 in THF (3.5 mL, 3.5 
mmol, 1.0 M) was added dropwise. The reaction mixture was warmed to 50 oC with 
stirring for 3 h, and then was cooled to 0 oC, quenched with H2O (0.5 mL), and diluted 
with ether (5 mL).  An aqueous solution of NaOH (2 mL, 10 M) was added followed by 
H2O (0.5 mL) and an insoluble white material precipitated. The organic supernatant was 
decanted to a clean Erlenmeyer flask and the precipitate was washed with ether (15 mL).  
The combined extracts were dried over anhydrous sodium sulfate and filtered to afford a 
solution of (3R,4R)-5-amino-4-(benzyloxy)pent-1-en-3-ol in diethyl ether, which was 
used without purification. 
 
A flame-dried round-bottom flask was cooled under a stream of nitrogen and 
charged with a solution of (3R,4R)-5-amino-4-(benzyloxy)pent-1-en-3-ol (0.71 mmol) in 




mixture was stirred for 4 h and then aqueous NaOH (20 mL, 1.0 M) was added.  The 
biphasic mixture was vigorously stirred for 12 h and the layers were separated. The 
aqueous layer was extracted with diethyl ether (3 x 20 mL).  The combined organic 
extracts were dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo.  
The crude product was then purified using 5% MeOH/CH2Cl2 as the eluent to afford 185 
mg (85%) of the title compound as a colorless oil and as a ~15:1 mixture of syn:anti 
diastereomers. The data is for the major isomer. 1H NMR (500 MHz, CDCl3) δ 7.39–7.25 
(m, 5 H), 5.97–5.88 (m, 1 H), 5.40–5.34 (m, 1 H), 5.26–5.20 (m, 1 H), 4.94–4.87 (m, 1 
H), 4.68–4.57 (m, 2 H), 4.18–4.11 (m, 1 H), 3.52–3.46 (m, 1 H), 3.44–3.35 (m, 1 H), 
3.30–3.21 (m, 1 H), 2.82–2.77 (m, 1 H), 1.43 (s, 9 H); 13C NMR (125 MHz, CDCl3) 
δ 156.1, 137.8, 137.0, 128.4, 127.94, 127.92, 116.7, 80.4, 72.9, 72.3, 40.3, 28.3. 
 
(2R,3R)-tert-Butyl-2,3-dihydroxypent-4-enylcarbamate (VI-49). Following a 
published procedure,40 treatment of VI-48  (65 mg, 0.21 mmol) with Li/NH3 at –78 oC 
followed by column chromatography (5%  10% MeOH/CH2Cl2) provided 43 mg 
(66%) of the title compound as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 5.94–5.85 
(m, 1 H), 5.41–5.34 (m, 1 H), 5.29–5.23 (m, 1 H), 5.17–5.10 (m, 1 H), 4.09–4.00 (m, 1 
H), 3.64–3.55 (m, 1 H), 3.50–3.43 (m, 1 H), 3.41–3.33 (m, 1 H), 3.32–3.24 (m, 1 H), 
3.20–3.09 (m, 1 H), 1.45 (s, 9 H); 13C NMR (125 MHz, CDCl3) δ 157.1, 136.9, 117.4, 
80.0, 73.5, 73.4, 43.0, 28.3. 





(VI-50). A flame-dried flask was cooled under a stream of nitrogen and charged with VI-
49 (97 mg, 0.45 mmol), imidazole (137 mg, 2.0 mmol), TBDPS-Cl (492 mg, 1.8 mmol) 
and DMF (1 mL). The resulting mixture was stirred at rt until the starting material was 
consumed as judged by TLC analysis (ca. 2 days). The reaction mixture was diluted with 
water (5 mL) and ethyl acetate (5 mL). The layers were separated and the aqueous layer 
was extracted with ethyl acetate (3 x 5 mL). The combined organic layers were dried over 
anhydrous Na2SO4, filtered, and concentrated in vacuo. The crude product was purified 
by flash chromatography using 2.5%  5% ethyl acetate/hexanes as the eluent to afford 
214 mg (69%) of the title compound as a colorless oil. 1H NMR (400 MHz, CDCl3) 
δ 7.53–7.47 (m, 4 H), 7.46–7.41 (m, 4 H), 7.40–7.31 (m, 4 H), 7.30–7.25 (m, 4 H), 7.24–
7.16 (m, 4 H), 6.08–5.98 (m, 1 H), 5.32–5.23 (m, 1 H), 5.19–5.12 (m, 1 H), 4.64–4.57 
(m, 1 H), 4.30–4.23 (m, 1 H), 3.75–3.69 (m, 1 H), 3.38–3.31 (m, 1 H), 3.30–3.22 (m, 1 
H), 1.37 (s, 9 H), 1.06–0.89 (m, 18 H); 13C NMR (100 MHz, CDCl3) δ 155.4, 135.8, 
135.71, 135. 68, 135.5, 133.4, 133.2, 133.0, 129.65, 129.57, 127.6, 127.53, 127.50, 127.4, 
116.3, 78.5, 75.2, 73.4, 42.1, 28.4, 27.0, 26.8, 19.22, 19.19. 
 
(2R,3R,4R)-tert-Butyl 2-benzyl-3,4-bis(tert-butyldiphenylsilyloxy)pyrrolidine-
1-carboxylate (VI-52). The general procedure was employed for the reaction of 
bromobenzene (49 mg, 0.31 mmol) with VI-50 (105 mg, 0.15 mmol). This procedure 
afforded 90 mg (77%) of the title compound as a colorless oil. This compound was found 




mixture of diastereoisomer; data is for the major isomer (mixture of rotamers). 1H NMR 
(500 MHz, CDCl3) δ 7.60–6.98 (m, 24 H), 6.90–6.84 (m, 1 H), 4.20–4.17 (m, 1.5 H), 
4.15–4.09 (m, 1.5 H), 3.97–3.90 (m, 1.5 H), 3.70–3.63 (m, 1 H), 3.45–3.37 (m, 2 H), 
3.17–3.10 (m, 1 H), 2.92–2.84 (m, 1.5 H), 1.53–1.38 (m, 9 H), 1.07–0.94 (m, 9 H), 0.86–
0.76 (m, 9 H); 13C NMR (100 MHz, CDCl3) δ 155.1, 155.0, 139.12, 139.07, 136.2, 136.1, 
136.0, 135.8, 135.70, 135.65, 135.6, 135.5, 135.4, 133.5, 133.2, 133.01, 133.00, 132.9, 
132.7, 130.1, 129.9, 129.71, 129.66, 129.62, 129.5, 129.40, 129.36, 128.4, 128.3, 127.9, 
127.80, 127.76, 127.7, 127.60, 127.58, 127.5, 126.0, 125.9, 125.7, 79.7, 79.3, 79.1, 78.9, 
78.4, 77.8, 77.4, 74.8, 68.4, 68.1, 59.1, 54.0, 53.7, 49.5, 37.8, 37.1, 33.9, 31.6, 28.6, 28.4, 
27.9, 27.4, 27.1, 27.0, 26.9, 26.8, 26.6, 22.6, 19.0, 18.9, 14.1. 
 
(2R,3R,4R)-tert-Butyl 2-benzyl-3,4-dihydroxypyrrolidine-1-carboxylate (VI-
53). A flame-dried flask was cooled under a stream of nitrogen and charged with VI-52 
(45 mg, 0.06 mmol), THF (1 mL) and TBAF (0.5 mL, 1.0 M in THF). The resulting 
mixture was stirred at rt until the starting material was consumed as judged by TLC 
analysis (ca. 12 h). The reaction mixture was concentrated in vacuo and the crude product 
was purified by flash chromatography using 5%  10% MeOH/CH2Cl2 as the eluent to 
afford 10 mg (61%) of the title compound as a colorless oil. 1H NMR (500 MHz, CDCl3) 
δ 7.36–7.18 (m, 5 H), 4.17–4.11 (m, 1 H), 4.03–3.93 (m, 1 H), 3.92–3.74 (m, 2 H), 3.40–
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During our studies towards the synthesis of Anisomycin (Chapter VI), we 
discovered a tandem Wittig rearrangement-aldol reaction (eqs 61 and 62). The studies of 
this transformation in terms of scope, limitations and mechanism are presented in Chapter 
VIII. This chapter describes the significance of this new reaction as well as relevant 


































Significance and Synthesis of α-Alkyl-α-β-Dihydroxy Carbonyl Derivatives 
 
Substituted α-alkyl-α-β-dihydroxy carbonyl-containing molecules (VII-3) 
bearing a tertiary alcohol moiety are important building blocks for organic synthesis and 
are found in various biologically active natural products (Figure 9). For example, 
alternaric acid (VII-4) inhibits germination of certain fungal strains at low concentrations 
(100 nM),1 and displays selective phytotoxic activities.2 Additionally, the natural product 
3’S-hydroxyneoharringtonine (VII-5) exhibits antileukemia properties.3 Substituted α-
alkyl-α-β-amino ester derivatives (VII-6) are also of importance since they are used in 
the construction of unnatural β-peptides, 4  and in the preparation of active taxol 
derivatives (VII-7). 5  Substituted α-alkyl-α-β-amino esters (VII-6) are also found in 
biologically active natural products such as leuhistin (VII-8), which was identified as a 
potent aminopeptidase inhibitor.6 
 
















































Many approaches have been developed for the construction of substituted α-
alkyl-α,β-dihydroxy ester derivatives VII-3. However, most of these methods involve 
multiple synthetic steps, proceed with low selectivity, or are limited in scope. For 
example, aldol reactions of O-protected glycolate esters that form α-quaternary centers 
typically proceed with low diastereoselectivity (~3:1) unless BHT esters or chiral 
auxiliaries are employed.7 A shown in eq 63, Kobayashi has demonstrated that the use of 



















THF, 78 oC to 40 oC




More recently, Shibasaki demonstrated that unprotected alcohols such as VII-11 
can react with various aldehydes in catalytic asymmetric aldol reactions that afford highly 
substituted products VII-12, albeit with modest ee and low diastereoselectivity (eq 64).9 
A drawback of this study is that additional chemical steps are required to effect oxidative 




























Finally, a recent report from Johnson and coworkers described a three component 
coupling reaction between silyl glyoxylates, alkynes and aldehydes to afford products 
such as VII-13 in good yields and good diastereoselectivity (eq 65).10 The scope of this 
transformation has not been fully established, but it appears to be complementary to the 



















The tandem Wittig rearrangement-aldol reactions described in the following 
chapter have many potential advantages compared to the methodologies discussed above. 
The tandem reaction allows formation of two C–C bonds and creation of two 
stereocenters with high diastereoselectivity without the need for an auxiliary. 




readily available starting materials. 
 
Boron-Mediated Glycolate Aldol Reactions 
 
 
Despite the large amount of literature on boron-mediated aldol reactions,11 only a 
single study on boron-mediated aldol reactions of methyl-O-benzyl glycolate VII-14 has 
been reported (eq 66).12 These reactions afforded good yields of the syn diol products 
VII-15 with high diastereoselectivity using both benzaldehyde and aliphatic aldehydes. 
The authors did not observe the [1,2]-Wittig rearrangement of VII-14 at low temperature 












Ph 78 oC VII-15
(66)
VII-14







R1 = alkyl, >93:7 dr
R1 = phenyl, 86:14 dr  
 
Our discovery occurred when we attempted to conduct the aldol reaction of VII-
14 with acrolein at low temperature (–78 oC). We observed incomplete conversion (60%) 
to aldol product VII-15 by crude 1H NMR. We opted to change DIPEA to a less hindered 
base such as Et3N, but this modification lead to even lower conversion to product VII-15 
(<5 %) at –78 oC.13 The reaction mixture was then warmed up to 0 oC and a new product 




product VII-2 originated from an unprecedented combination of an aldol reaction and a 
[1,2]-Wittig rearrangement.14 
 
The Enolate [1,2]-Wittig Rearrangement 
 
 
The classic [1,2]-Wittig rearrangement refers to the carbanion rearrangement of 
α-lithioethers, and involves a 1,2-alkyl shift onto the α-alkoxy carbanion terminus.15 In a 
representative example, the benzyl ether carbanion VII-18 is generated via 
transmetallation of VII-17 with n-BuLi. This intermediate then undergoes a 1,2-benzyl 
migration to produce alkoxide VII-21, which yields VII-22 upon aqueous workup 
(Scheme 37).16 This reaction is believed to proceed via homolysis of the C−O bond to 
generate a radical (VII-19) and a radical anion (VII-20). As a result, the yields of the 
[1,2]-Wittig reactions depend highly on the migrating group radical stability. 
Additionally, since these transformations require strongly basic conditions, the yields are 
often low and the scope is frequently limited. 
 






















Although many reports of [1,2]-Wittig rearrangement reactions of organolithium 
species exist,15 only six individual examples of 1,2-Wittig rearrangement of enolates have 
been described so far.17 None of these examples involved the [1,2]-Wittig rearrangement 
from a boron enolate. 
Early work described by Curtin dealt with the rearrangement of substrate VII-23 
under basic conditions at high temperature to afford product VII-24 in low yield (eq 
67).17a,b Later, the [1,2]-Wittig rearrangement of α-alkoxy lactam VII-25 was observed 
using LiHMDS at rt to produce VII-26 in 63% yield as a single diastereomer (eq 68).17c 
More recently, scientists at Merck subjected a 1:1 mixture of six-membered lactam 
diastereomers VII-27 to basic conditions (KOt-Bu in THF at -78 oC) in order to improve 
the stereochemical purity of VII-27 via C-3 enolization (eq 69). However, during the 
equilibration process they observed α-methyl benzyl migration of VII-27 to afford VII-
28 as a mixture of diastereomers (~3.6:1 dr); no yield was reported for this 
transformation.17d,18 Finally, Paquette demonstrated that the [1,2]-Wittig rearrangement 
could also occur from a ketone substrate (VII-29) to afford product VII-30 in 65% yield 
































































VII-29 VII-30  
 
The use of the [1,2]-Wittig rearrangement in tandem processes is rare;19 to date 
only two reports involving enolate 1,2-rearrangement have been described.17e,f In a first 
example, Paquette demonstrated the tandem oxy-Cope/[1,2]-Wittig rearrangement of 
VII-31 to afford 94% yield of product VII-35. 

























The second example, also reported by Paquette and coworkers, involved the [1,2]-
Wittig rearrangement/α-ketol rearrangement of substrate VII-36 to afford product VII-39 
in 91% yield.17f 
 

















VII-36 VII-37 VII-38 VII-39  
 
The related [2,3]-Wittig rearrangement of alkyl allyl ethers (VII-40) is a useful 
transformation often used in organic synthesis (Scheme 40).15d,e,20 It is believed to occur 
via a symmetry-allowed concerted process (VII-41). Contrary to the [1,2]-Wittig 
rearrangement counterpart, the [2,3]-Wittig rearrangement of enolates is a well-known 
process.21 More specifically, the boron-mediated enolate [2,3]-Wittig rearrangement was 
reported in two detailed studies.22 In the first study, use of Bu2BOTf and DIPEA reagents 
promoted the [2,3]-Wittig rearrangement of substrate VII-43 to afford 55% yield of VII-
44 with modest diastereoselectivity (dr 5:1, eq 71).22a The second study involved the 
asymmetric [2,3]-Wittig rearrangement of substrate VII-45 mediated by chiral boron 
reagent VII-46 and Et3N (eq 72).22b Under these reaction conditions, product VII-47 was 




Scheme 40. [2,3]-Wittig Rearrangement 
 







































(2R, 3R), 96% ee














To date, only two reports of tandem reactions using enolate Wittig rearrangements 
have been described.23 Both of these studies involved a [2,3]-Wittig reaction followed by 
a [3,3]-sigmatropic rearrangement of a dienolate species. For example, deprotonation of 
substrate VII-48 with LDA afforded dienolate VII-49 which underwent a [2,3]-Wittig 
rearrangement. The intermediate (VII-50) formed then underwent a [3,3] rearrangement 



























These transformations illustrate the potential utility of the Wittig rearrangement in 
the context of tandem reactions, and provide the background relevant to our investigation 
of the tandem Wittig rearrangement-aldol reaction. The following chapter describes the 
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Investigation of the Tandem Wittig Rearrangement-Aldol Reaction of Glycolate 
Esters with Aldehydes1 
During our studies towards the synthesis of anisomycin (Chapter VI), we sought 
to effect a stereoselective boron-mediated aldol reaction between methyl O-
benzylglycolate (VIII-1) and acrolein (eqs 74 and 75). This reaction failed to proceed at 
–78 °C, but when the transformation was attempted at 0 °C an interesting result was 
obtained. The expected aldol product VIII-2 was not generated in significant amounts, 
but instead α-alkyl-α-β-dihydroxy ester VIII-3 resulting from benzyl migration was 
observed with >20:1 diastereoselectivity. The conversion of VIII-1 to VIII-3 appears to 
involve the unprecedented combination of a [1,2]-Wittig rearrangement and an aldol 
reaction. This chapter describes our studies on the scope, limitations and mechanism of 


































Optimization studies and mechanism 
 In our preliminary experiments we sought to determine which of the two reactions 
that led to the conversion of VIII-1 to VIII-3 occurred first, as this knowledge could aid 
in the development of optimal conditions for this transformation. The possibility that the 
sequence is initiated by an initial aldol reaction of VIII-1 was rapidly discounted. The 
expected product of the boron-mediated aldol reaction, β−hydroxy ester VIII-2, was 
prepared as a 2:1 mixture of diastereomers2 and treated with a mixture of Bu2BOTf and 
Et3N in CH2Cl2 at rt for 15 minutes. As shown in eq 76, these conditions resulted 
predominantly in decomposition of the starting material, and provided only trace amounts 
(< 5%) of VIII-3. The failure of VIII-2 to undergo clean conversion to VIII-3 suggested 
that the transformation of VIII-1 to VIII-3 likely proceeded via an initial [1,2]-Wittig 
rearrangement of boron ester enolate VIII-5 to generate VIII-6. This hypothesis was 
supported by the fact that treatment of methyl O-benzyl glycolate ester (VIII-1) with 




VIII-4 in 81% yield (eq 77). 
Bu2BOTf, Et3N  

















Bu2BOTf, Et3N  





A proposed mechanism for this new tandem [1,2]-Wittig rearrangement-aldol 
reaction is shown in Scheme 42. First, enolization of glycolate ester VIII-1 would afford 
enolate VIII-5. A 1,2-Wittig rearrangement would then occur to afford intermediate 
VIII-6. 3  Following the initial Wittig rearrangement, conversion of VIII-6 to boron 
enolate VIII-7 presumably would occur with high selectivity for E(O)-enolate generation 
due to chelation between the ester carbonyl and the adjacent boron alkoxide. Enolate 
VIII-7 would then undergo an aldol reaction via a closed, Zimmerman-Traxler4 type 
transition state VIII-8 to provide the observed syn-diol product VIII-3 with excellent 
stereoselectivity. Evidence for the intermediacy of doubly borylated ester enolate VIII-7 
was obtained through HRMS analysis of a reaction mixture resulting from treatment of 
VIII-1 with Bu2BOTf/Et3N for 15 min at rt. A signal was observed for m/z 428.3650 
(calculated mass = 428.3633) with an isotopic distribution in accordance with the 



























































With knowledge of the reaction mechanism in hand, improved conditions were 
developed in which VIII-1 was treated with excess Bu2BOTf/Et3N and allowed to 
undergo rearrangement before introduction of the aldehyde. In a representative 
experiment, VIII-1 was added to a solution of Et3N (4 equiv) and Bu2BOTf (3.2 equiv) in 
CH2Cl2 at 0 °C and then warmed to rt for 15 min. The mixture was then cooled to 0 °C, 
acrolein (1.5 equiv) was added, and the reaction mixture was allowed to warm to rt and 
stir for 1h. Upon workup, the diol product VIII-3 was obtained in 67% yield with >20:1 
diastereoselectivity (eq 75).  
Scope and Limitations 
Having the reaction conditions for the Wittig rearrangement optimized, we next 




shown in Table 16, the diol products were obtained in good yields and excellent 
diastereoselectivities. 5  The transformation was effective when coupling VIII-1 with 
α,β−unsaturated aldehydes (entry 1), aromatic aldehydes (entry 2), and both branched 
and linear aliphatic aldehydes (entries 3−4). A range of aliphatic and aromatic aldehydes 
were also coupled with methyl O-allyl glycolate ester (VIII-9) to afford the desired 
products with similarly high yields and diastereoselectivities. However, methyl O-(p-
methoxybenzyl) glycolate ester VIII-10 was found to rearrange and to undergo the aldol 
reaction in low yield (17%), possibly due to deprotection of the alcohol under the 




Table 16. Scope of the Tandem Wittig Rearrangement/Aldol Reactiona 














































































































aConditions: 1.0 equiv ester, 3.2 equiv Bu2BOTf, 4.0 equiv Et3N, CH2Cl2, 0.2 M, rt, 15 min, then add 1.5 
equiv aldehyde, 0 °C–rt. bDiastereomeric ratio obtained upon purification. In most cases the crude product 
was obtained in >20:1 dr prior to purification. cYields represent average isolated yields of two or more 
experiments. dThe crude product was obtained in 14:1 dr. eThe crude product was obtained in 17:1 dr. fThe 
crude product was obtained in 20:1 dr. fA product resulting from 1,2-Wittig rearrangement of VIII-10 was 





Preliminary studies towards the application of the methodology to natural product 
synthesis were performed. The chosen target was compound VIII-20, a key intermediate 
in Trost’s synthesis of alternaric acid VII-4 that was previously synthesized in eight steps 
(eq 78).7 The new tandem Wittig rearrangement-aldol reaction would allow the synthesis 
of VIII-20 in two steps (oxidation to aldehyde VIII-19 and tandem Wittig-aldol reaction 
of VIII-9). Encouraging results were obtained when VIII-9 was treated with VIII-19 
under the optimized reaction conditions: product VIII-20 was isolated in 63% yield with 
high syn selectivity. The diastereoselectivity observed with chiral aldehyde VIII-19 was 
low (~2:1 dr) but this result could potentially be improved upon the use of a chiral boron 

























Preliminary studies towards an asymmetric version of the tandem reaction were 
also performed (Scheme 43). Different strategies were investigated, including the use of 
chiral boron reagents such as DIP-Cl, DIP-OTf, IPC2-OTf, VIII-228 and the use of chiral 
auxiliaries9 such as Masamune auxiliary VIII-2310 Evans auxiliaries VIII-24 and VIII-
25. 11  Unfortunately, none of the chiral boron reagents promoted the [1,2]-Wittig 
rearrangement, and substrates VIII-23 and VIII-24 bearing chiral auxilaries did not 




rearrange, but did not undergo the subsequent aldol reaction. The rearranged product 
VIII-26 was then observed as a 1.5:1 mixture of diastereomers and 31% yield. It is likely 
that the steric bulk of the auxiliary impedes the aldol reaction with these substrates. 
 






































































At the present time, the scope of the tandem [1,2]-Wittig rearrangement-aldol 
reaction is limited to methyl O-benzyl (VIII-1), methyl O-allyl (VIII-9) glycolate esters 




glycolate ester VIII-27 was found to rearrange under the optimized reaction conditions, 
but did not undergo the subsequent aldol reaction, possibly due to increased steric bulk 
(Scheme 44). The other substrates tested did not react (VIII-29–VIII-32 and VIII-34) or 
decomposed under the Lewis acidic conditions (VIII-28 and VIII-34).  
 







































VIII-31, R = Me
VIII-32, R = Bn






[1,2]- vs [2,3]-Wittig rearrangement 
The rearrangement of methyl O-allyl glycolate VIII-9 to product VIII-35 could 
occur via either a [1,2]- or a [2,3]-Wittig rearrangement. However, these pathways cannot 



























 We reasoned that by using a substrate containing a substituted olefin such as 
VIII-36, it would be possible to determine which pathway is operative (eq 81). When 
VIII-36 was treated with Bu2BOTf, Et3N for 15 min at rt, the [2,3]-Wittig rearrangement 
product VIII-37 was observed exclusively as a 2:1 mixture of diastereomers.14 Thus, it is 
likely that methyl O-allyl glycolate ester VIII-9 also rearranges via a [2,3]-Wittig 





















The use of basic conditions to promote the enolate [1,2]-Wittig rearrangement 
was briefly examined. When amide substrate VIII-34 was treated with excess KHMDS 
in THF for 15 minutes at rt, a 2:1 mixture of [1,2]- and [2,3]-Wittig rearrangement 




LiHMDS afforded a 1:1 mixture of VIII-38:VIII-39 and NaHMDS afforded a 2:1:1 
mixture of VIII-38:VIII-39:VIII-40. Unfortunately, efforts to effect the tandem Wittig-
aldol reaction were not successful with this substrate. Methyl O-benzyl glycolate ester 
































In conclusion, we have developed a new tandem Wittig rearrangement-aldol 
reaction for the synthesis of glycolate aldol products bearing tertiary alcohols. A 
migrating group study revealed that benzyl and allyl glycolate esters VIII-1 and VIII-9 
underwent the Wittig rearrangement followed by an aldol reaction. Under optimized 
reaction conditions, a wide array of aldehyde electrophiles were used with these 




Preliminary studies towards an asymmetric version of this new transformation included 
the use of various chiral boron reagents and auxiliaries, but few promoted the initial 
[1,2]-Wittig rearrangement and none the subsequent aldol reaction. Additionally, 
application of the methodology to the preparation of synthetic intermediate VIII-20 
provided encouraging results. Future work regarding the tandem Wittig rearrangement-
aldol reaction could include expansion of the scope to other electrophiles such as Michael 
acceptors and imines.16 In particular, reaction with imines would permit access to α-
hydroxy-β-amino derivatives, which could be applied to the synthesis of natural products 
such as leuhistin (VII-8). Finally, studies towards the modifications of the reaction 
conditions to afford 1,2-trans diol products would be of interest, as well as mechanistic 
studies related to the 1,2-Wittig rearrangement.17 
 
Experimental Section 
General Considerations. All reactions were carried out under a nitrogen 
atmosphere in oven or flame dried glassware. Dibutylboron triflate (1.0 M solution in 
methylene chloride) was purchased from Aldrich Chemical Co. and used without further 
purification. All aldehydes were obtained from commercial sources (Aldrich Chemical 
Co. or Acros Chemical Co.) and were purified by distillation from Ca2SO4 except 
acrolein, which was obtained from Fluka Chemical Co. and used without further 
purification. Triethylamine was obtained from Aldrich Chemical Co. and was purified by 
distillation from CaH. Phosphate buffer solution (pH 7) was obtained from Aldrich 




system. Allyloxyacetic acid methyl ester (VIII-9) 18  was prepared from methyl 2-
hydroxyacetate using a procedure analogous to that employed for the conversion of ethyl 
2-hydroxyacetate to allyloxyacetic acid ethyl ester.19 Yields refer to isolated yields of 
compounds estimated to be ≥95% pure as determined by 1H NMR, GC, and/or 
combustion analysis. The yields reported in the supporting information describe the result 
of a single experiment, whereas the yields reported in Table 16 are average yields of two 
or more experiments. Thus, the yields reported in the supporting information may differ 
from those shown in Table 16.   
 
 Methyl O-benzylglycolate (VIII-1).20 A flame-dried flask was cooled under a 
stream of nitrogen and charged with benzyloxyacetyl chloride (3.67 g, 19.9 mmol), 
methylene chloride (60 mL) and methanol (1.6 mL, 39.8 mmol). The resulting solution 
was cooled to 0 °C, pyridine (3.4 mL, 41.7 mmol) was added slowly, and the mixture was 
warmed to rt and stirred for 15 h. The reaction mixture was then concentrated in vacuo 
and the crude material was partitioned between water (50 mL) and diethyl ether (100 mL). 
The layers were separated and the aqueous layer was extracted with diethyl ether (3 x 50 
mL). The combined organic extracts were dried over anhydrous Na2SO4, filtered, and 
concentrated in vacuo. The crude product was purified by flash chromatography using 
15% ethyl acetate/hexanes as the eluent to afford 3.23 g (90%) of the title compound as a 
colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.40–7.25 (m, 5 H), 4.64 (s, 2 H), 4.11 (s, 2 





General procedure for tandem Wittig rearrangement/aldol reactions (Table 
16). An oven or flame-dried flask was cooled under a stream of nitrogen and charged 
with a 1 M solution of dibutylboron triflate in methylene chloride (4.0 equiv). The pale 
yellow solution was cooled to 0 °C and triethylamine (3.2 equiv) was added dropwise to 
afford a colorless solution. The ester substrate (1.0 equiv) was added dropwise and the 
mixture was warmed to rt and stirred for 15 min then cooled to 0 °C. The aldehyde was 
added dropwise (1.5 equiv) and the reaction mixture was warmed to rt and allowed to stir 
for 1-6 h. The reaction was then quenched by addition of pH 7 buffer (2 mL/mmol 
substrate).  The heterogeneous mixture was transferred to a larger flask and diluted with 
MeOH (ca. 5–8 mL/mmol substrate) to afford a clear and homogeneous solution. The 
solution was cooled to 0 °C, 30% aqueous H2O2 (6 mL/mmol substrate) was added 
slowly, and the resulting mixture was warmed to rt and stirred for 1 h. The reaction 
mixture was then diluted with Et2O (~15 mL/mmol substrate), water (~8 mL/mmol 
substrate) and transferred to a separatory funnel. The layers were separated and the 
organic layer was washed with a saturated aqueous solution of FeSO4 until the green 
color persisted in order to quench any peroxide remaining. Caution! This procedure is 
highly exothermic. The FeSO4 solution should be first added SLOWLY DROPWISE with a 
glass pipette. The organic layer was then washed with brine, dried over anhydrous 
sodium sulfate, filtered, and concentrated in vacuo. The crude product was purified by 
flash chromatography on silica gel using 15–30% ethyl acetate/hexanes as the eluent.  
 




reaction of VIII-1 (181 mg, 1.0 mmol) and acrolein (100 μL, 1.5 mmol) was conducted 
following the general procedure. 1H NMR analysis of the crude product showed the 
formation of the desired product with >20:1 dr. Chromatographic purification afforded 
163 mg (69%) of the title compound as a white solid, m.p. 65–67 °C. This material was 
judged to be of >20:1 dr by 1H NMR analysis. 1H NMR (500 MHz, CDCl3) δ 7.30–7.22 
(m, 3 H), 7.19–7.15 (m, 2 H), 6.10–6.02 (m, 1 H), 5.47–5.37 (m, 2 H), 4.38–4.33 (m, 1 
H), 3.74 (s, 3 H), 3.32 (s, 1 H), 3.00–2.95 (m, 1 H), 2.91–2.86 (m, 1 H), 2.40 (d, J = 9.5 
Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 174.4, 135.2, 135.1, 129.9, 128.2, 127.0, 119.1, 
80.8, 77.1, 52.8, 41.6; IR (film) 3497, 1740 cm-1. Anal calcd for C13H16O4:  C, 66.09; H, 
6.83.  Found:  C, 66.07; H, 6.97. 
 
(±)-(2R*,3S*)-Methyl-2-benzyl-2,3-dihydroxy-3-phenylpropanoate (VIII-11).  
The reaction of VIII-1 (181 mg, 1.0 mmol) and benzaldehyde (153 μL, 1.5 mmol) was 
conducted following the general procedure. 1H NMR analysis of the crude product 
showed the formation of the desired product with >20:1 dr. Chromatographic purification 
afforded 216 mg (75%) of the title compound as a white solid, m.p. 134–135 °C. This 
material was judged to be of >20:1 dr by 1H NMR analysis. 1H NMR (500 MHz, CDCl3) 
δ 7.48–7.42 (m, 2 H), 7.40–7.31 (m, 3 H), 7.24–7.15 (m, 3 H), 7.11–7.04 (m, 2 H), 4.93 
(d, J = 7.6 Hz, 1 H), 3.70 (s, 3 H), 3.43 (s, 1 H), 3.03–2.92 (m, 2 H), 2.46 (d, J = 13.4 Hz, 
1 H); 13C NMR (125 MHz, CDCl3) δ 174.6, 138.9, 135.2, 129.8, 128.3, 128.2, 128.1, 




C, 71.31; H, 6.34.  Found:  C, 71.10; H, 6.38. 
 
(±)-(2R*,3S*)-Methyl-2-benzyl-3-cyclohexyl-2,3-dihydroxypropanoate (VIII-
12).  The reaction of VIII-1 (181 mg, 1.0 mmol) and cyclohexane carboxaldehyde (182 
μL, 1.5 mmol) was conducted following the general procedure. 1H NMR analysis of the 
crude product showed the formation of the desired product with 14:1 dr. 
Chromatographic purification afforded 227 mg (78%) of the title compound as a white 
solid, m.p. 115–116 °C. This material was judged to be of >20:1 dr by 1H NMR analysis.  
1H NMR (500 MHz, CDCl3) δ 7.29–7.20 (m, 3 H), 7.19–7.15 (m, 2 H), 3.76–3.71 (m, 1 
H), 3.69 (s, 3 H), 3.34 (s, 1 H), 3.05–2.94 (m, 2 H), 2.27 (d, J = 11.2 Hz, 1 H), 1.95–1.89 
(m, 1 H), 1.84–1.73 (m, 3 H), 1.71–1.58 (m, 2 H), 1.54–1.44 (m, 1 H), 1.38–1.22 (m, 2 
H), 1.20–1.09 (m, 2 H); 13C NMR (125 MHz, CDCl3) δ 175.4, 135.4, 129.9, 128.2, 127.0, 
81.5, 78.6, 52.8, 42.0, 38.9, 31.6, 26.7, 26.2, 25.8 (two aliphatic carbon signals are 
incidentally equivalent); IR (film) 3512, 1728 cm-1.  Anal calcd for C17H24O4:  C, 69.84; 
H, 8.27.  Found:  C, 69.75; H, 8.39. 
 
(±)-(2R*,3S*)-Methyl-2-benzyl-2,3-dihydroxydodecanoate (VIII-13).  The 
reaction of VIII-1 (181 mg, 1.0 mmol) and decanal (282 μL, 1.5 mmol) was conducted 
following the general procedure. 1H NMR analysis of the crude product showed the 
formation of the desired product with >20:1 dr. Chromatographic purification afforded 




judged to be of >20:1 dr by 1H NMR analysis. 1H NMR (500 MHz, CDCl3) δ 7.31–7.22 
(m, 3 H), 7.20–7.16 (m, 2 H), 3.88–3.79 (m, 1 H), 3.73 (s, 3 H), 3.27 (s, 1 H), 3.02–2.92 
(m, 2 H), 1.97–1.86 (m, 1 H), 1.78–1.70 (m, 1 H), 1.68–1.54 (m, 1 H), 1.52–1.22 (m, 14 
H), 0.90 (t, J = 6.8 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 175.0, 135.5, 129.9, 128.3, 
127.0, 81.4, 75.4, 52.7, 41.3, 31.9, 31.0, 29.60, 29.57, 29.3, 25.9, 22.7, 14.1 (two pairs of 
aliphatic carbon signals are incidentally equivalent); IR (film) 3501, 1731 cm-1.  Anal 
calcd for C20H32O4:  C, 71.39; H, 9.59.  Found:  C, 71.13; H, 9.60. 
 
(±)-(E)-(2R*,3S*)-Methyl-2-allyl-2,3-dihydroxy-5-phenylpent-4-enoate (VIII-
14).  The reaction of VIII-9 (130 mg, 1.0 mmol) and cinnamaldehyde (189 μL, 1.5 mmol) 
was conducted following the general procedure. 1H NMR analysis of the crude product 
showed the formation of the desired product with 17:1 dr. Chromatographic purification 
afforded 173 mg (66%) of the title compound as a white solid, m.p. 97–99 °C. This 
material was judged to be of >20:1 dr by 1H NMR analysis. 1H NMR (500 MHz, CDCl3) 
δ 7.42–7.38 (m, 2 H), 7.34–7.29 (m, 2 H), 7.28–7.23 (m, 1 H), 6.68–6.62 (m, 1 H), 6.34–
6.27 (m, 1 H), 5.77–5.67 (m, 1 H), 5.13–5.06 (m, 2 H), 4.41 (t, J = 8.1 Hz, 1 H), 3.82 (s, 
3 H), 3.60 (s, 1 H), 2.60–2.55 (m, 1 H), 2.45–2.34 (m, 2 H); 13C NMR (125 MHz, CDCl3) 
δ 174.9, 136.1, 134.5, 131.5, 128.5, 128.1, 126.7, 125.8, 119.2, 80.4, 76.7, 53.0, 40.0; IR 







enoate (VIII-15).  The reaction of VIII-9 (130 mg, 1.0 mmol) and isobutyraldehyde (137 
μL, 1.5 mmol) was conducted following the general procedure. 1H NMR analysis of the 
crude product showed the formation of the desired product with 20:1 dr. 
Chromatographic purification afforded 131 mg (64%) of the title compound as a colorless 
oil. This material was judged to be of >20:1 dr by 1H NMR analysis. 1H NMR (500 MHz, 
CDCl3) δ 5.77–5.67 (m, 1 H), 5.15–5.08 (m, 2 H), 3.79 (s, 3 H), 3.69 (dd, J = 2.4, 10.7 
Hz, 1 H), 3.49 (s, 1 H), 2.45 (d, J = 7.3 Hz, 2 H), 2.22 (d, J = 10.7 Hz, 1 H), 2.07–1.97 (m, 
1 H), 1.04 (d, J = 6.8 Hz, 3 H), 0.93 (d, J = 6.8 Hz, 3 H); 13C NMR (125 MHz, CDCl3) δ 
175.9, 131.8, 119.2, 80.7, 78.0, 53.0, 40.4, 28.5, 21.7, 15.4; IR (film) 3502, 2960 cm-1.  
Anal calcd for C10H18O4:  C, 59.39; H, 8.97.  Found:  C, 59.60; H, 9.22. 
 
(±)-(1’S*,2R*)-Methyl-2-hydroxy-2-(1’-hydroxybenzyl)pent-4-enoate (VIII-
16).  The reaction of VIII-9 (130 mg, 1.0 mmol) and benzaldehyde (153 μL, 1.5 mmol) 
was conducted following the general procedure. 1H NMR analysis of the crude product 
showed the formation of the desired product with >20:1 dr. Chromatographic purification 
afforded 174 mg (74%) of the title compound as a white solid, m.p. 104–105 °C. This 
material was judged to be of >20:1 dr by 1H NMR analysis.  1H NMR (500 MHz, CDCl3) 
δ 7.44–7.28 (m, 5 H), 5.71–5.59 (m, 1 H), 5.09–4.97 (m, 2 H), 4.84 (d, J = 7.6 Hz, 1 H), 
3.83 (s, 3 H), 3.54 (s, 1 H), 2.83 (d, J = 7.6 Hz, 1 H), 2.44–2.36 (m, 1 H), 2.01–1.93 (m, 1 




77.5, 52.9, 40.1; IR (film) 3490, 1734 cm-1.  Anal calcd for C13H16O4:  C, 66.09; H, 6.83.  
Found:  C, 66.11; H, 6.93. 
 
(±)-(2R*,3S*)-Methyl-2-hydroxy-2-(1-hydroxy-3-phenylpropyl)pent-4-enoate 
(VIII-17).  The reaction of VIII-9 (130 mg, 1.0 mmol) and 3-phenylpropionaldehyde 
(201 μL, 1.5 mmol) was conducted following the general procedure. 1H NMR analysis of 
the crude product showed the formation of the desired product with >20:1 dr. 
Chromatographic purification afforded 195 mg (74%) of the title compound as a white 
solid, m.p. 60–62 °C. This material was judged to be of >20:1 dr by 1H NMR analysis. 1H 
NMR (500 MHz, CDCl3) δ 7.30–7.25 (m, 2 H), 7.23–7.15 (m, 3 H), 5.74–5.64 (m, 1 H), 
5.12–5.05 (m, 2 H), 3.79–3.71 (m, 4 H), 3.57 (s, 1 H), 2.97–2.88 (m, 1 H), 2.71–2.62 (m, 
1 H), 2.42–2.34 (m, 3 H), 1.96–1.87 (m, 1 H), 1.81–1.71 (m, 1 H); 13C NMR (125 MHz, 
CDCl3) δ 175.3, 141.7, 131.7, 128.4, 128.3, 125.8, 119.2, 80.6, 74.4, 52.8, 39.5, 32.3, 
31.9; IR (film) 3493, 1732 cm-1.  Anal calcd for C15H20O4:  C, 68.16; H, 7.63.  Found:  C, 




























18). The reaction of VIII-10 (211 mg, 1.0 mmol) and acrolein (101 μL, 1.5 mmol) was 
conducted following the general procedure for the Wittig-aldol reaction. 1H NMR 
analysis indicated that a ~25:75 mixture of aldol product VIII-18 and rearranged product 
VIII-10a were present. This procedure afforded 44 mg (17%) of the title compound as a 
colorless oil and as a single diastereoisomer and 73 mg (26%) of rearranged product 
VIII-10a (described below). 1H NMR (500 MHz, CDCl3) δ 7.08 (d, J = 8.3 Hz, 2 H), 
6.80 (d, J = 8.3 Hz, 2 H), 6.09–6.00 (m, 1 H), 5.45–5.34 (m, 2 H), 4.33 (t, J = 8.8 Hz, 1 
H), 3.78 (s, 3 H), 3.74 (s, 3 H), 3.28 (s, 1 H), 2.92 (d, J = 13.9 Hz, 1 H), 2.82 (d, J = 13.7 
Hz, 1 H), 2.32 (d, J = 9.5 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 174.6, 158.6, 135.1, 
130.9, 127.1, 119.0, 113.7, 80.9, 55.2, 52.8, 40.7. 
 
Methyl 2-hydroxy-3-(4-methoxyphenyl)propanoate (VIII-10a). 21  1H NMR 
(500 MHz, CDCl3) δ 7.12 (d, J = 8.5 Hz, 2 H), 6.83 (d, J = 8.8 Hz, 2 H), 4.43–4.39 (m, 1 
H), 3.77 (s, 3 H), 3.78 (s, 3 H), 3.06 (dd, J = 6.3, 13.9 Hz, 1 H), 2.91 (dd, J = 6.6, 13.9 Hz, 
1 H), 2.76 (d, J = 6.3 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 174.6, 158.5, 130.4, 128.2, 
113.8, 71.3, 55.2, 52.4, 39.6. 
 
(±)-Methyl-2-hydroxy-3-phenylpropanoate (VIII-4)22 The reaction of VIII-1 
(180 mg, 1.0 mmol) was conducted following the general procedure except that no 




(82%) of the title compound as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.31–7.26 
(m, 2 H), 7.25–7.17 (m, 3 H), 4.46–4.40 (m, 1 H), 3.74 (s, 3 H), 3.14–3.07 (m, 1 H), 
2.98–2.87 (m, 2 H). 
 
 (E)-7-benzyl-5,10-dibutyl-8-methoxy-6,9-dioxa-5,10-diboratetradec-7-ene 
(VIII-7). The reaction of VIII-1 (90 mg, 0.5 mmol) was conducted following the general 
procedure except that no aldehyde was added. After stirring for 15 min the crude reaction 
mixture was analyzed by mass spectrometry. A signal was observed with an isotopic 
distribution and exact mass in accord with the calculated value for VIII-7. MS (EI): 
428.3650 (428.3633 calculated for C26H46B2O3, M +). 
 
 
Assignment of stereochemistry 
 
The stereochemistry of (2R*,3S*)-methyl-2-benzyl-2,3-dihydroxypent-4-enoate 
(VIII-3) was assigned by 1H NMR nOe analysis of the corresponding acetonide 
derivative VIII-3a as shown below. The stereochemistry of the other 1,2-diol products 




















carboxylate (VIII-3a). A flame-dried flask was cooled under a stream of nitrogen and 
charged with VIII-3 (118 mg, 0.5 mmol), dry acetone (5 mL), 2,2-dimethoxypropane 
(0.7 mL, 5.7 mmol) and camphorsulfonic acid (14 mg, 0.06 mmol).  The reaction mixture 
was stirred at rt for 25 h and then was concentrated in vacuo. The residue obtained was 
purified by flash chromatography using 10% ethyl acetate/hexanes as the eluant to afford 
111 mg (80%) of the title compound as a colorless oil.  1H NMR (400 MHz, CDCl3) δ 
7.28–7.13 (m, 5 H), 6.10–5.99 (m, 1 H), 5.59–5.52 (m, 1 H), 5.46–5.40 (m, 1 H), 4.69 (d, 
J = 5.9 Hz, 1 H), 3.64 (s, 3 H), 3.06–3.00 (m, 1 H), 2.82–2.76 (m, 1 H), 1.67 (s, 3 H), 
1.44 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 172.5, 135.7, 131.4, 130.0, 128.1, 126.7, 
119.1, 110.2, 86.3, 81.4, 52.1, 40.6, 28.0, 25.3; IR (film) 1732 cm–1.  MS (ESI): 299.1262 
(299.1259 calculated for C16H20O4, M + Na+). 
 
(±)-(2R,3S,4S)-Methyl-2-allyl-2,3-dihydroxy-4-methylhexanoate (VIII-20).7 
The reaction of methyl O-allylglycolate VIII-9 (131 mg, 1.0 mmol) and S-(+)-2-
methylbutanal VIII-19 23  (220 mg, 2 mmol) was conducted following the general 
procedure. 1H NMR analysis of the crude reaction mixture indicated that a 2:1 ratio of 
diastereoisomers was obtained. Chromatographic purification (10% ethyl acetate/hexanes) 
afforded 163 mg (64%) of the title compound as a colorless oil. This material was judged 
to be a 2:1 mixture of diastereoisomers by 1H and 13C NMR analysis. The data is for the 
mixture. 1H NMR (500 MHz, CDCl3) δ 5.79–5.64 (m, 1 H), 5.16–5.07 (m, 2 H), 3.84–




(dd, J = 3.9, 10.9 Hz, 1 H), 1.82–1.66 (m, 2 H), 1.52–1.30 (m, 2 H), 1.16–1.07 (m, 0.66 
H), 1.03 (d, J = 9.5 Hz, 1.33 H), 0.96–0.87 (m, 3 H); 13C NMR (100 MHz, CDCl3) δ 
176.0, 176.0, 131.84, 131.78, 119.3, 80.9, 78.6, 76.0, 53.1, 40.4, 40.3, 35.8, 35.1, 28.3, 
22.2, 17.5, 12.8, 12.0, 11.9. 
 
(4S)-4-Benzyl-3-(2-hydroxy-3-(4-methoxyphenyl)propanoyl)oxazolidin-2-one 
(VIII-26). The reaction of VIII-25 (101 mg, 0.3 mmol) and benzaldehyde (46 μL, 0.45 
mmol) was conducted following the general procedure except that VIII-25 was stirred at 
rt for 45 min before the aldehyde was added. 1H NMR analysis of the crude reaction 
mixture indicated that VIII-25 rearranged but did not undergo the aldol reaction. The 
diastereomeric ratio was observed to be 1.5:1. Chromatographic purification allowed the 
separation of the diastereoisomers. The first compound to elute was the minor isomer (8 
mg, 8%) followed by the major isomer (23 mg, 23%, description below). 1H NMR (500 
MHz, CDCl3) δ 7.39–7.32 (m, 2 H), 7.31–7.28 (m, 1 H), 7.24–7.18 (m, 4 H), 6.85 (d, J = 
8.6 Hz, 2 H), 5.30–5.22 (m, 1 H), 4.65–4.57 (m, 1 H), 4.28–4.21 (m, 2 H), 3.79 (s, 3 H), 
3.44 (d, J = 8.0 Hz, 1 H), 3.31 (dd, J = 3.3, 13.5 Hz, 1 H), 3.12 (dd, J = 4.3, 13.9 Hz, 1 H), 
2.90–2.79 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 174.1, 158.5, 153.2, 134.8, 130.6, 
129.5, 129.1, 128.6, 127.5, 113.8, 71.8, 67.0, 55.6, 55.2, 39.6, 37.5.  
The major diastereoisomer of VIII-26 was obtained as a solid, m.p. 86–88 oC. 1H 
NMR (500 MHz, CDCl3) δ 7.37–7.32 (m, 2 H), 7.31–7.28 (m, 1 H), 7.26–7.18 (m, 4 H), 




H), 4.26 (dd, J = 3.4, 9.0 Hz, 1 H), 3.78 (s, 3 H), 3.25 (dd, J = 3.4, 13.4 Hz, 1 H), 3.22–
3.17 (m, 2 H), 2.86–2.73 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 174.6, 158.6, 153.0, 
134.7, 130.7, 129.4, 129.1, 128.6, 127.6, 113.8, 71.8, 67.1, 55.2, 55.0, 40.0, 38.0; IR 
(film) 3497, 1781 cm-1.  Anal calcd for C20H21NO5:  C, 67.59; H, 5.96; N, 3.94.  Found:  
C, 67.37; H, 6.04; N, 3.79. 
 
Methyl 2-(benzhydryloxy)acetate (VIII-27).24 A flame-dried flask was cooled 
under a stream of nitrogen and charged with benzhydrol (9.2 g, 50 mmol), chloroacetic 
acid (9.5 g, 100 mmol) and THF (200 mL). The resulting mixture was cooled to 0 oC and 
solid NaH (20 g, 500 mmol, 60% in oil) was added in portions. The reaction mixture was 
warmed to rt then heated to reflux until the starting material was consumed as judged by 
TLC analysis (ca. 8 h). The reaction mixture was then cooled to 0 oC and quenched by 
the addition of water (10 mL), and 1 M HCl was then added until pH ~7. The mixture 
was extracted with ethyl acetate (3 x 100 mL). The combined organic extracts were 
washed with brine and dried over Na2SO4, filtered and concentrated. The residue 
obtained was used without purification in the next reaction.  
A flame-dried flask was cooled under a stream of nitrogen and charged with crude 
2-(benzhydryloxy)acetic acid (50 mmol) and DMF (50 mL). The mixture was cooled to 0 
oC and K2CO3 (35 g, 250 mmol) was added followed by dropwise addition of 
iodomethane (9.3 mL, 150 mmol). The reaction mixture was stirred at rt until the starting 




acetate (100 mL) were then added and the organic layer was separated. The organic layer 
was washed with brine, dried over Na2SO4, filtered and concentrated. The residue 
obtained was purified by flash chromatography using 10% ethyl acetate/hexanes as the 
eluent to afford 7.43 g (58%) of the title compound as a colorless oil. 1H NMR (500 MHz, 
CDCl3) δ 7.48 (d, J = 7.1 Hz, 4 H), 7.40 (t, J = 7.1 Hz, 4 H), 7.33 (tt, J = 7.3, 1.2 Hz, 2 


























Methyl 2-hydroxy-3,3-diphenylpropanoate (VIII-27a).25 The reaction of VIII-
27 (130 mg, 1.0 mmol) and benzaldehyde (201 μL, 1.5 mmol) was conducted following 
the general procedure for the Wittig-aldol reaction. 1H NMR analysis of the crude 
reaction mixture indicated that VIII-27 rearranged but did not undergo the aldol reaction. 
This procedure afforded 60 mg (23%) of the title compound as a colorless oil. 1H NMR 
(500 MHz, CDCl3) δ 7.43–7.34 (m, 2 H), 7.33–7.17 (m, 8 H), 4.96 (dd, J = 3.9, 6.8 Hz, 1 
H), 4.49 (d, J = 3.7 Hz, 1 H), 3.69 (s, 3 H), 2.78 (d, J = 6.3 Hz, 1 H); 13C NMR (100 MHz, 
CDCl3) δ 174.1, 141.2, 138.9, 129.3, 128.5, 128.42, 128.37, 127.1, 126.7, 73.4, 54.2, 52.5; 






Methyl 2-(4-methoxybenzyloxy)acetate (VIII-10). 26  This compound was 
prepared on a 52 mmol scale using a procedure analogous to that employed for the 
synthesis of VIII-27 except that p-methoxybenzyl alcohol (7.25 g, 52 mmol) was used in 
place of benzhydrol. This procedure afforded 1.8 g (17%) of the title compound as a 
colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.29 (d, J = 8.6 Hz, 2 H), 6.88 (d, J = 8.6 Hz, 
2 H), 4.56 (s, 2 H), 4.07 (s, 2 H), 3.80 (s, 3 H), 3.75 (s, 3 H). 
 
Methyl 2-(methoxymethoxy)acetate (VIII-28).27 A flame-dried flask was cooled 
under a stream of nitrogen and charged with methyl glycolate (4.5 g, 50 mmol) and 
methylene chloride (150 mL). The mixture was cooled to 0 oC and DIPEA (61 mL, 350 
mmol) was added via syringe. MOM-Cl (11.4 mL, 150 mmol) was then added slowly and 
the reaction mixture was stirred at rt until the starting material was consumed as judged 
by TLC analysis (ca. 2 h). The reaction mixture was then washed with 1 M HCl (100 mL), 
and brine (100 mL), and the organic layer was separated. The organic layer was then 
dried over Na2SO4, filtered and concentrated. The residue obtained was distilled at 70 oC 
(water aspirator) to afford 1.61 g (24%) of the title compound. 1H NMR (300 MHz, 
CDCl3) δ 4.71 (s, 2 H), 4.18 (s, 2 H), 3.77 (s, 3 H), 3.40 (s, 3 H). 
 




on a 50 mmol scale using a procedure analogous to that employed for the synthesis of 
VIII-27 except that cyclopropylmethanol (3.6 g, 50 mmol) was used in place of 
benzhydrol. This procedure afforded 2.1 g (29%) of the title compound as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ 4.13 (s, 2 H), 3.76 (s, 3 H), 3.39 (d, J = 7.1 Hz, 2 H), 
1.15–1.06 (m, 1 H), 0.59–0.54 (m, 2 H), 0.27–0.22 (m, 2 H); 13C NMR (100 MHz, CDCl3) 
δ 170.7, 76.1, 67.4, 51.5, 10.0; IR (film) 1756 cm-1. Anal calcd for C7H12O3:  C, 58.32; H, 
8.39.  Found:  C, 58.03; H, 8.27. 
 
 
Methyl 2-(cyclohexyloxy)acetate (VIII-30). This compound was prepared on a 
50 mmol scale using a procedure analogous to that employed for the synthesis of VIII-27 
except that cyclohexanol (5.1 g, 50 mmol) was used in place of benzhydrol. This 
procedure afforded 2.8 g (32%) of the title compound as a colorless oil. 1H NMR (500 
MHz, CDCl3) δ 4.09 (s, 2 H), 3.72 (s, 3 H), 3.33–3.27 (m, 1 H), 1.95–1.87 (m, 2 H), 
1.76–1.68 (m, 2 H), 1.55–1.47 (m, 1 H), 1.35–1.13 (m, 6 H). 
 
Methyl 2-ethoxyacetate (VIII-31). 28  A flask was cooled under a stream of 
nitrogen and charged with ethoxy acetic acid (5.3 g, 50 mmol) and methanol (50 mL). 
The mixture was cooled to 0 oC and H2SO4 (0.3 mL, 5 mmol) was added dropwise. The 
reaction mixture was stirred at rt for 20 h. The mixture was cooled to 0 oC and quenched 
with a saturated solution of NaHCO3 (50 mL). Diethyl ether (100 mL) was added and the 




Na2SO4, filtered, and concentrated. The residue obtained was distilled at 40 oC (water 
aspirator) to afford 2.7 g (46%) of the title compound. 1H NMR (400 MHz, CDCl3) δ 
3.87 (s, 2 H), 3.54 (s, 3 H), 3.38 (q, J = 7.0 Hz, 2 H), 1.04 (t, J = 7.0 Hz, 3 H). 
 
Benzyl 2-ethoxyacetate (VIII-32). A flame-dried flask was cooled under a 
stream of nitrogen and charged with CDI (10 g, 50 mmol) and THF (100 mL). Ethoxy 
acetic acid (4.8 mL, 50 mmol) was then added slowly and the reaction mixture was 
stirred at rt for 2 h. The mixture was then cooled to 0 oC and benzyl alcohol (5.7 mL, 55 
mmol) was added. The mixture was stirred at rt for 3h. The reaction mixture was then 
diluted with ethyl acetate (100 mL) and water (100 mL). The organic layer was separated 
and washed with 1 M HCl (2 x 50 mL), saturated Na2CO3 (2 x 50 mL) and brine. The 
organic layer was then dried over Na2SO4, filtered, and concentrated. The residue 
obtained was purified by column chromatography (20% ethyl acetate/hexanes) to afford 
8.9 g (92%) of the title compound as a colorless oil. 1H NMR (400 MHz, CDCl3) δ 7.39–
7.30 (m, 5 H), 5.19 (s, 2 H), 4.11 (s, 3 H), 3.59 (q, J = 6.8 Hz, 2 H), 1.24 (t, J = 7.1 Hz, 3 
H). 
 
2-(Benzyloxy)-N,N-dimethylacetamide (VIII-34). A flame-dried flask was 
cooled under a stream of nitrogen and charged with dimethylamine hydrochloride (4.1 g, 
50 mmol) and methylene chloride (100 mL). The resulting solution was cooled to 0 °C 




chloride (4.62 g, 25 mmol) in methylene chloride (25 mL) was added slowly to the 
reaction mixture. The resulting mixture was then warmed to rt and stirred until the 
starting material was consumed as judged by TLC analysis (ca. 22 h). The reaction 
mixture was then diluted with 1 M HCl (100 mL) and the organic layer was separated. 
The layer was washed with a saturated solution of NaHCO3 (100 mL) and brine (50 mL). 
The organic layer was then dried over anhydrous Na2SO4, filtered, and concentrated in 
vacuo. The crude product was purified by flash chromatography using 50% ethyl 
acetate/hexanes as the eluent to afford 3.13 g (65%) of the title compound as a colorless 
oil. 1H NMR (500 MHz, CDCl3) δ 7.40–7.28 (m, 5 H), 4.62 (s, 2 H), 4.18 (s, 2 H), 2.99 
(s, 3 H), 2.96 (s, 3 H). 
 
Methyl 2-(cinnamyloxy)acetate (VIII-36).29 This compound was prepared on a 
50 mmol scale using a procedure analogous to that employed for the synthesis of VIII-27 
except that cinnamyl alcohol (6.7 g, 50 mmol) was used in place of benzhydrol. This 
procedure afforded 2.2 g (41%) of the title compound as a colorless oil. 1H NMR (500 
MHz, CDCl3) δ 7.38 (d, J = 7.3 Hz, 2 H), 7.30 (t, J = 7.1 Hz, 2 H), 7.24 (t, J = 7.1 Hz, 1 
H), 6.62 (d, J = 15.9 Hz, 1 H), 6.32–6.24 (m, 1 H), 4.25 (dd, J = 1.2, 6.3 Hz, 2 H), 4.13 
(s, 2 H), 3.75 (s, 3 H). 
 
Methyl 2-hydroxy-3-phenylpent-4-enoate (VIII-37). The reaction of VIII-36 
(207 mg, 1.0 mmol) and benzaldehyde (153 μL, 1.5 mmol) was conducted following the 




reaction contained 80% of rearranged product VIII-37 in a 2:1 ratio and 20% of aldol 
products. Chromatographic purification (10 % ethyl acetate/hexanes) allowed the 
isolation of the major diastereomer of the title compound. 1H NMR (500 MHz, CDCl3) δ 
7.33–7.28 (m, 2 H), 7.27–7.20 (m, 3 H), 6.27–6.19 (m, 1 H), 5.27–5.19 (m, 2 H), 4.54 (q, 
J = 4.2 Hz, 1 H), 3.80–3.75 (m, 1 H), 3.70 (s, 3 H), 2.68 (d, J = 7.1 Hz, 1 H). 
 
Equation 82. A flame-dried flask was cooled under a stream of nitrogen and 
charged with KHMDS (300 mg, 1.5 mmol) and THF (2.5 mL). The resulting solution 
was cooled to 0 °C and VIII-34 (97 mg, 0.5 mmol) was added neat to the solution. The 
mixture was allowed to warm to rt and was stirred for 30 min. The reaction mixture was 
then diluted with water (5 mL) and methylene chloride (5 mL). The organic layer was 
separated, dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The crude 
product was purified by flash chromatography using 5% methanol/methylene chloride as 
the eluent to afford 30 mg (31%) of the title compound as a colorless oil and as a 2:1 
mixture of amides VIII-38 and VIII-39 determined by 1H NMR analysis. Data are from 
the mixture. 1H NMR (500 MHz, CDCl3) δ 7.32–7.15 (m, 4.66 H), 5.16 (d, J = 5.9 Hz, 
0.33 H), 4.70 (d, J = 6.1 Hz, 0.33 H), 4.59 (q, J = 5.6 Hz, 0.66 H), 3.70 (d, J = 7.8 Hz, 
0.66 H), 3.02 (s, 1 H), 2.97 (s, 2 H), 2.95–2.85 (m, 1.25 H), 2.80 (s, 2 H), 2.77 (s, 1 H), 
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